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Summary {#efs25797-sec-0001}
=======

For the preparation of the 51st session of the Codex Committee on Pesticide Residues (CCPR meeting), the European Commission asked the European Food Safety Authority (EFSA) to provide comments on the individual active substances assessed in the 2018 Joint FAO/WHO Meeting on Pesticide Residues (JMPR), in particular on the recommended toxicological reference values and the proposed MRLs at steps 3 and 6 of the Codex procedure.

In 2018, JMPR evaluated 15 active substances regarding the setting of toxicological reference values to be used in consumer risk assessment (chlorfenapyr, ethiprole, fenpicoxamid, fluazinam, fluxapyroxad, imazalil, kresoxim‐methyl, lambda‐cyhalothrin, mandestrobin, mandipropamid, norflurazon, pydiflumetofen, pyraclostrobin, pyriofenone, tioxazafen). EFSA compared the acceptable daily intake (ADI) and acute reference dose (ARfD) values derived by JMPR with the values derived at EU level and, in case differences were identified, EFSA provided further explanations for the reasons of the differences.

As regards the setting of maximum residue limits (MRLs), JMPR assessed 27 active substances (abamectin, bentazone, chlorfenapyr, cyantraniliprole, cyazofamid, diquat, ethiprole, fenpicoxamid, fenpyroximate, fluazinam, fludioxonil, fluxapyroxad, imazalil, isofetamid, kresoxim‐methyl, lufenuron, mandipropamid, norflurazon, oxathiapiproline, profenofos, propamocarb, pydiflumetofen, pyraclostrobin, pyriofenone, pyriproxyfen, sulfoxaflor and tioxazafen).

EFSA provided comments on the proposed Codex MRLs as well as on active substances that were re‐assessed by JMPR following specific concerns raised in the previous years or other requests to perform a follow‐up evaluation (benzovindiflupyr, bromopropylate, fenpyroximate, fluopyram, oxamyl, spinetoram, cyprodinil, propiconazole, 2,4‐D, phosphonic acid, picoxystrobin, quinclorac) and on general issues discussed in the 2018 JMPR meeting.

It is highlighted that the JMPR report summarising the recommendations of the 2018 JMPR meeting was published on 11 January 2019. The full evaluations were published on 11 March 2019, thus after the deadline for the preparation of the draft EFSA report. Due to the limited details available and the short timelines for providing the comments, an in‐depth analysis taking into account the detailed information provided in the JMPR evaluation could not always be performed. The conclusions reached in this report should be considered as indicative and might have to be reconsidered in a more detailed assessment when needed. The comments presented in this report have to be seen in the context of the currently applicable guidance documents and the MRL legislation applicable at the time of commenting. The comments may not be valid any more or may have to be modified, if the legal or scientific framework changes.

1. Introduction {#efs25797-sec-0003}
===============

1.1. Background {#efs25797-sec-0004}
---------------

Manufacturers of pesticides who are interested in the setting of Codex Maximum Residue Limits (CXLs) submit data to the Joint FAO/WHO meeting on pesticide residues (JMPR) for assessment. The most recent JMPR evaluations of the toxicological data and the residue studies are summarised in the JMPR 2018 Report (FAO, [2018](#efs25797-bib-0152){ref-type="ref"}).

On 12 November 2018, the European Commission requested the European Food Safety Authority (EFSA) to provide support for the preparation of the EU‐coordinated position for the 51st session of the Codex Committee on Pesticide Residues (CCPR) in April 2019 in China. In particular, EFSA was asked to give advice and to provide comments on the recommendations of the 2018 Joint FAO/WHO meeting on pesticide residues (JMPR). Additionally, the European Commission requested EFSA to give its comments on other proposed Codex MRLs that were retained at step 4 or 7, respectively, in previous years and are likely to be discussed in the 51st CCPR meeting, in case that such new advice from EFSA is needed and appropriate.

Furthermore, the European Commission asked for comments on the general chapters of the JMPR 2018 report, where relevant for risk assessment as well as other comments on the proposed crop groupings, the JMPR priority list and documents related to the revision of the international estimated of short‐term intake (IESTI) equation.

For reasons of transparency and traceability, EFSA has created separate questions for each of the active substances covered by the mandate in the EFSA Register of Questions with the following reference numbers and subjects:

Question numberSubjectEFSA‐Q‐2018‐00956Abamectin (177) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00957Bentazone (172) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00983Benzovindiflupyr (261) -- EFSA comments on the follow‐up assessment by JMPR in 2018EFSA‐Q‐2018‐00958Chlorfenapyr (254) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00959Cyantraniliprole (263) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2019‐00193Cyazofamid -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00984Cyprodinil (207) -- EFSA comments on the follow‐up assessment by JMPR in 2018EFSA‐Q‐2018‐00960Diquat (031) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00971Ethiprole (304) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00972Fenpicoxamid (XDE‐777) (307) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00985Fenpyroximate (193) -- EFSA comments on the follow‐up assessment and the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00973Fluazinam (306) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00961Fludioxonil (211) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00986Fluopyram (243) -- EFSA comments on the follow‐up assessment of JMPR in 2018EFSA‐Q‐2018‐00962Fluxapyroxad (256) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00974Imazalil (1108) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00963Isofetamid (290) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00975Kresoxim‐methyl (199) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00964Lambda‐cyhalothrin (146) -- EFSA comments on the toxicological reference values evaluated by JMPR in 2018EFSA‐Q‐2018‐00965Lufenuron (286) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00976Mandestrobin (307) -- EFSA comments on the toxicological reference values evaluated by JMPR in 2018EFSA‐Q‐2018‐00966Mandipropamid (231) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00977Norflurazon (308) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00967Oxathiapiproline (291) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00968Profenofos (171) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00969Propamocarb (148) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00987Propiconazole (160) -- EFSA comments on the follow‐up assessment by JMPR in 2018EFSA‐Q‐2018‐00978Pydiflumetofen (309) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00979Pyraclostrobin (210) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00980Pyriofenone (310) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00970Pyriproxyfen (200) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00981Sulfoxaflor (252) -- EFSA comments on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00982Tioxazafen (311) -- EFSA comments on the toxicological reference values and on the proposed Codex MRLs evaluated by JMPR in 2018EFSA‐Q‐2018‐00988EFSA comments on the general considerations provided by JMPR in 2018 and other follow‐up assessments[^1]

The draft scientific report was submitted for commenting to the EU Member State experts and European Commission on 19 February 2019. The comments provided by Member States were uploaded on EFSA Document Management System (DMS). All the comments received were addressed either directly in the final EFSA scientific report or though discussion during the Council Working Party meetings for the preparation of the 51st Session of the Codex Committee on Pesticide Residues.

1.2. Terms of Reference {#efs25797-sec-0005}
-----------------------

The requested advice and comments on the recommendations of the 2018 Joint FAO/WHO meeting on pesticides residues (JMPR) and, where appropriate, on other proposed Codex MRLs, retained in the step procedure and reviewed by JMPR in previous years, should contain the following information: Background information on all active substances under discussion regarding the status of the active substance at EU level (approval status of the active substance, availability of EFSA conclusions and availability of EFSA reasoned opinions on MRL applications or MRL review);In case new toxicological reference values were proposed by JMPR, a comparison of the proposed reference values with agreed EU reference values and an evaluation of the reasons for possible differences;As regard the proposed draft Codex MRLs for discussion in CCPR 2019, EFSA should provide any relevant comments on the proposed MRLs and specifically address the following questions:‐Whether the residue definitions derived by JMPR are comparable with the existing EU residue definitions,‐Whether the proposed draft Codex MRLs are comparable with the existing EU MRLs,‐Whether the proposed draft Codex MRLs are sufficiently supported by data,‐Whether the proposed Codex draft MRLs are appropriate in terms of the data that have been used to establish them and in terms of the method used for their calculation,‐Whether the proposed draft Codex MRLs are safe for European consumers with regard to chronic, and where relevant, acute exposure.

The requested comments to the general chapters of the JMPR 2018 report relevant for risk assessment as well as comments on the JMPR priority list can be provided as contribution to the EU coordinated positions when these are discussed with the Member States and do not need to be covered by the scientific report.

*(Terms of reference as provided by the European Commission in the Mandate of 12 November 2018)*

EFSA agreed with the European Commission to respond to this request with a scientific report. The first draft report should be shared with the European Commission and Member States on 15 February 2019, inviting Member States to provide comments.

After discussion between EFSA and the requestor, the deadline for the first draft report was extended to 19 February 2019 to allow the presentation of a complete document.

The final draft addressing the Member State comments should be completed in time to be discussed in the second Council meeting scheduled for 25 March 2019. It was agreed with the requestor that the report is published by 31 July 2019.

2. Assessment {#efs25797-sec-0006}
=============

EFSA provided the requested background information regarding the toxicological reference values (second bullet point of the Terms of Reference) by comparing the assessments performed by JMPR with the assessments performed at EU level in the framework of the peer review under Regulation (EC) No 1107/2009[1](#efs25797-note-5001){ref-type="fn"}. The sources of information used are the EFSA conclusions available for the active substances under consideration, the review reports, draft assessment reports (DARs) prepared by the rapporteur Member States and other sources of information if available.

For deriving the comments on the third bullet point in the Terms of Reference (comments on the Codex MRL proposals), EFSA compared the levels of the Codex MRL proposals and the enforcement residue definition derived by JMPR with the MRLs and the residue definition established in the EU legislation (Regulation (EC) No 396/2005) or the legislation under preparation. The EU residue definitions for risk assessment were retrieved from the EFSA conclusions, EFSA reasoned opinions on MRL review under Article 12 of Regulation 396/2005[2](#efs25797-note-1004){ref-type="fn"} or, where these documents are not available, the reports prepared by the European Commission in the framework of the peer review of active substances or Member State evaluations in DARs. The comparison of the existing EU MRLs and the proposed Codex MRLs are presented in tabular form. Codex MRL proposals that are higher than the existing EU MRLs are printed in bold. In line with the presentation of MRLs in the EU legislation, limit of quantification (LOQ) MRLs are indicated by adding an asterisk ('\*') after the value.

For assessing whether the draft Codex MRL proposals are sufficiently supported by data, EFSA took into account the currently valid EU guidance documents for consumer risk assessment and the agreed EU policies (European Commission, [1996](#efs25797-bib-0116){ref-type="ref"}, [1997a](#efs25797-bib-0117){ref-type="ref"},[b](#efs25797-bib-0118){ref-type="ref"},[c](#efs25797-bib-0119){ref-type="ref"},[d](#efs25797-bib-0120){ref-type="ref"},[e](#efs25797-bib-0121){ref-type="ref"},[f](#efs25797-bib-0122){ref-type="ref"},[g](#efs25797-bib-0123){ref-type="ref"}, [2000](#efs25797-bib-0124){ref-type="ref"}, [2010a](#efs25797-bib-0131){ref-type="ref"}, [2011a](#efs25797-bib-0133){ref-type="ref"}; OECD, [2011](#efs25797-bib-0153){ref-type="ref"}, [2013](#efs25797-bib-0154){ref-type="ref"}) as well as the JMPR risk assessment methodologies and policies agreed in previous CCPR meetings. It is noted that due to the different data requirements and policies in JMPR (FAO, [2016](#efs25797-bib-0150){ref-type="ref"}), the assessment of identical residue data sets submitted in support of a EU MRL and Codex MRL request may result in different recommendations at EU level and by JMPR. In this report EFSA provides background information on the reasons for these differences. For calculating the numerical MRL value, EFSA used the same methodology as JMPR (OECD calculator) (OECD, [2011](#efs25797-bib-0153){ref-type="ref"}).

To assess the Codex MRL proposals for food of animal origin, EFSA focussed mainly on the consumer risk assessment and the validity of feeding studies and animal metabolism studies. For Codex MRL proposals for animal commodities, a full assessment of the expected dietary burden at EU level is not possible in the framework of this report because relevant information is not available to EFSA (e.g. use of the active substance on all feed items in the EU and in Third Countries).

It should be highlighted that due to the limited information available in the JMPR reports, EFSA cannot assess the following aspects of studies that are normally assessed in detail when MRL applications are submitted in the framework of Art. 10 of Regulation (EC) No 396/2005: the appropriateness of analytical methods provided by the manufacturer to be used for MRL enforcement, including method validation data, confirmatory data and independent laboratory validation (ILV);storage stability of residues;the duration and the conditions of storage for samples derived from supervised field trials prior to their analysis;independence of residue trials;details of processing studies.

For the assessment of the safety of the draft Codex MRL proposals, EFSA used the EFSA PRIMo rev. 3 (EFSA, [2018e](#efs25797-bib-0094){ref-type="ref"}). For assessing the acute consumer risk, EFSA applied the standard EU methodology, including the agreed EU variability factors and the ARfD agreed at EU level. For the assessment of the long‐term consumer risk, EFSA calculated the exposure resulting from the existing EU MRLs, taking into account the most recent information on supervised trials median residues (STMRs) and including the STMR values derived by JMPR for commodities where the proposed Codex MRLs are higher than the existing EU MRLs. This approach is likely to overestimate the actual exposure, because normally the food items consumed do not all contain residues at the maximum level allowed in the European legislation; thus, this approach is a sufficiently conservative risk assessment screening. For active substances where the MRL review has not yet been completed, a less refined calculation was performed for the commodities where the EU MRL is higher than the proposed Codex MRL, using the EU MRL as input values for the risk assessment. The contribution of the individual crops under consideration in the CCPR meeting was calculated separately. The exposure assessments are usually based on the EU toxicological reference values, unless it is specifically mentioned that the JMPR values were used. In Appendix [A](#efs25797-sec-1001){ref-type="sec"} of the report, the summary of the risk assessment calculations are provided.

For pesticides where the EU and JMPR residue definitions for risk assessment are not comparable, EFSA calculated indicative risk assessment scenarios. The assumptions and uncertainties of these scenarios are described individually.

The information related to draft Codex MRL proposals currently at step 4 or 7 is summarised in Appendix [B](#efs25797-sec-1002){ref-type="sec"}.

It is highlighted that the JMPR report summarising the recommendations of the 2018 JMPR meeting was published on 11 January 2019. The full evaluations were published on 11 March 2019. Thus, due to the limited time available for providing the comments, an in‐depth analysis could not always be performed. Thus, the conclusions reached in this report should be considered as indicative and might have to be reconsidered in a more detailed assessment, when needed. The comments presented in this report have to be seen in the context of the currently applicable guidance documents and the MRL legislation valid at the time of commenting. Thus, the comments may not be valid any more or may have to be modified, if the legal or scientific framework changes.

3. General consideration {#efs25797-sec-0007}
========================

3.1. Toxicological profiling of compounds and less‐than lifetime dietary exposure assessment {#efs25797-sec-0008}
--------------------------------------------------------------------------------------------

In general, the initiative to critically review the currently used concepts for dietary exposure assessment and to develop a new methodology for less‐than‐lifetime exposure is fully supported by the EU, considering that the approaches for chronic and acute exposure assessments have been developed more than 20 years ago and are substantially unchanged, while in the meantime substantial progress has been made in the field of toxicology and with regard to availability and quality of food consumption data.

However, before the new methodology is developed, a dialogue with risk managers is necessary to define the regulatory question that should be addressed with this new exposure methodology. In particular, the following aspects should be clearly defined: Which period is considered as 'less‐than‐lifetime'?Which are the age groups (and the period) that are considered relevant?Definition of protection goal.

[Toxicological considerations:]{.ul}

For the derivation of a short‐term health‐based guidance value (corresponding to a 'dietary' acceptable operator exposure level -- AOEL -- in the EU peer review of pesticidal active substances), similar qualitative considerations are given to those described in the text. Considering the decision‐tree (page 7 of the JMPR report), the proposed factor of 3 is currently not taken into account when comparing developmental toxicity and systemic toxicity; however, it is noted that, according to the recent EFSA opinion on pesticides in foods for infants and young children (EFSA PPR Panel, [2018](#efs25797-bib-0080){ref-type="ref"}), pending on the completeness of the dossier (whether the active substance was sufficiently investigated, for instance through an extended one‐generation reproductive toxicity study), an additional uncertainty factor of 3 may be considered in deriving the toxicological reference values to protect infant and young children \> 16 weeks of age and additional considerations have to be made for infant \< 16 weeks of age. This approach is not specific for less‐than‐lifetime exposures but would be relevant to derive any health‐based guidance value.

[Dietary exposure considerations:]{.ul}

The methodologies to estimate the chronic and acute exposure have been developed in the late nineties of the last century, making best use of food consumption data available at that time. It is acknowledged that the international estimated daily intake (IEDI) and the IESTI methodology are not sufficiently addressing the fact that within a certain developmental phase (e.g. infancy/childhood/pregnancy) exposure to pesticide residues may exceed repeatedly the exposure calculated according to the IEDI. The frequency of these events, the extent of the exposure above the IEDI and the possible consumer risk related to these exposure peaks is not captured by the currently used risk assessment methodologies.

Before a new methodology is developed, it would be appropriate to perform an analysis of the exposure with regard to seasonal variations, variations for different subgroups of the population and to identify the relevant parameters and to develop a model that will address these aspects in the best way. The outcome of the project on the probabilistic modelling for the IESTI equations (see point 2.10) will be a useful source of information to identify the variabilities of exposure across individuals and should be used to underpin the model development for less‐than‐lifetime exposure.

3.2. Need for sponsors to submit all requested data {#efs25797-sec-0009}
---------------------------------------------------

The EU supports the reminder of JMPR that all data and studies have to be submitted to JMPR within the agreed deadlines. In the interest to efficiency, JMPR should not waste time in assessing incomplete dossiers submitted by sponsors.

3.3. Hazard characterisation in the 21st century: assessing data generated using new mechanism‐based approaches for JMPR evaluations {#efs25797-sec-0010}
------------------------------------------------------------------------------------------------------------------------------------

In the EU Regulation No 283/2013[3](#efs25797-note-5003){ref-type="fn"}, describing the data requirements, it is recommended to undertake tests on vertebrate animals only when no other validated methods are available, and it is also noted that alternative methods to be considered shall include *in vitro* methods and *in silico* methods. The list of test methods and guidance documents relevant to the implementation of this Regulation has been published and should be regularly updated.

3.4. Update on the revision of principles and methods for risk assessment of chemicals in food (EHC 240) {#efs25797-sec-0011}
--------------------------------------------------------------------------------------------------------

An EFSA update on the use of the benchmark dose (BMD) approach in risk assessment has been published in January 2017 (EFSA Scientific Committee, [2017](#efs25797-bib-0081){ref-type="ref"}), and concludes that the BMD approach is applicable to all chemicals in food for the establishment of health‐based guidance values or to calculate margins of exposure. Its practical implementation in the EU peer review of pesticides still needs further development and harmonisation.

EFSA has also overarching working groups on BMD and genotoxicity, both working groups (WG) dealing with specific questions from the EFSA panels, including from the pesticides Unit on request.

3.5. Microbiological effects {#efs25797-sec-0012}
----------------------------

No comments.

3.6. Transparency of JMPR procedures {#efs25797-sec-0013}
------------------------------------

At EU level, transparency is a key requirement for risk assessment for pesticides. It is essential to describe the source of the data used, the validity of the studies, the results of studies and the assessment of the data leading to conclusions as well as the potential conflict of interest of assessors. Any initiative to increase transparency is supported.

3.7. Review of the large portion data used for IESTI equation {#efs25797-sec-0014}
-------------------------------------------------------------

The EU fully supports the update of food consumption data to be used in acute exposure assessment. The EU would like to offer support to collaborate with FAO/WHO in the preparation of the guidance how to calculate the large portions; in the EU a lot of experience has been gained on the compilation and aggregation of food consumption data provided by different data providers. This experience might be of value for FAO/WHO.

3.8. Update of the IEDI and IESTI models used for the calculation of dietary exposure: commodity grouping according to the revised codex classification and new large portion data {#efs25797-sec-0015}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The work done by National Institute for Public Health and the Environment (RIVM) to develop and maintain the calculation spreadsheets for IEDI and IESTI calculations is highly appreciated, in particular the efforts made to integrate the large portion (LP) data used in the EU dietary risk assessment tool (EFSA PRIMo revision 3). It should be noted that also at EU level new diets will be incorporated in future revisions of the EFSA PRIMo. Thus, to maintain a high level of consistency of the EU tool and the IEDI/IESTI models used by JMPR, the EU will keep FAO/WHO informed on progress made in the update of the EU diets.

3.9. Recommendations for (sub) group maximum residue levels for fruiting vegetables, other than cucurbits revisited {#efs25797-sec-0016}
-------------------------------------------------------------------------------------------------------------------

The EU appreciates the re‐evaluation of the extrapolation approach for the fruiting vegetables group by JMPR. The use of normalised initial residue concentrations can give valuable indications whether the residue behaviour in different crops is comparable.

[Subgroup of tomatoes]{.ul}: The extrapolation of residue data from tomatoes (any variety) to other crops belonging to the subgroup of tomatoes bears the risk that the MRL may not cover small varieties, such as cherry tomatoes or goji berries, which usually contain higher residues than varieties with bigger fruit size.

It is noted that for cape gooseberries the CXLs are applicable to the commodity after removal of the husk. Thus, for this crop, the CXL proposal derived from tomatoes may be too high. However, risk managers may agree on a pragmatic approach, considering that the OECD calculator implements a statistical approach that accommodates for a certain level of variability. Regarding consumer exposure, it is important that for the commodities with the highest consumption within the subgroup the risk assessment values (highest residue (HR) and STMR values) are reliable.

[Subgroup of peppers]{.ul}: Based on the data presented in the JMPR report, it seems plausible not to accept extrapolations from peppers to okra, because pepper data are expected to underestimate the residues occurring in okra. This type of extrapolation is currently also accepted in the EU but may have to be reconsidered. The restriction proposed by JMPR to extrapolate from bell peppers and non‐bell peppers to the subgroup of peppers except okra, seems plausible; as regards martynia and roselle, considering the low relevance of these commodities in diet, a more pragmatic approach may be decided by risk managers, allowing extrapolation from peppers. Also, in chili peppers, higher residues are expected compared to bell and non‐bell peppers. A case‐by‐case decision may be necessary to decide whether the MRL for peppers can be applied to chili peppers.

[Subgroup of eggplants]{.ul}: At EU level, the extrapolation from tomatoes to eggplants is acceptable. Considering that the normalised initial residue concentrations in eggplants are higher than in tomatoes, trials in bell peppers may be more appropriate to derive the MRL for eggplants than residue trials in tomatoes. However, it needs to be born in mind that the growth stage of the crop at the time of treatment and the PHI are parameters that may influence the residues in the harvested product. The growth rate of eggplants is expected to be higher, leading to a higher dilution of residues compared to tomatoes or peppers. Thus, if the last application is close to harvest, the use of pepper data might be more appropriate, while in the case of earlier applications, depending on the residue decline of the pesticide, the tomato data might be also valid.

3.10. Preliminary results for probabilistic modelling of acute dietary exposure to evaluate the IESTI equation {#efs25797-sec-0017}
--------------------------------------------------------------------------------------------------------------

The outcome of the probabilistic modelling of acute dietary exposure is expected with great interest and the EU is prepared to provide comments once the results are made available. This exercise is an important milestone in the project on reviewing the currently used IESTI equation and to provide answers to the question whether the currently used IESTI equations are sufficiently conservative to ensure that MRLs are set at levels that are protective for the consumers.

4. EFSA Comments on JMPR report chapter 3 (Responses to specific concerns raised by the Codex Committee on Pesticide Residues) {#efs25797-sec-0018}
==============================================================================================================================

4.1. Benzovindiflupyr (261) {#efs25797-sec-0019}
---------------------------

See comments in Section [5.20](#efs25797-sec-0143){ref-type="sec"}.

4.2. Bromopropylate (070) {#efs25797-sec-0020}
-------------------------

The EU has submitted a concern form because the toxicological assessments are outdated (last toxicological assessment was performed in 1993; the setting of an ARfD was not yet standard practice at that time). The following arguments were provided in support of the concern form:

*The active substance was first included in 1973 and re‐evaluated in 1993, but not since. In the evaluation of 1993 an ADI was set at 0.03 mg/kg bw/d but no ARfD. Since no ARfD was ever set and data for evaluation are missing (supervised field trials, processing studies), the MRLs should be re‐evaluated after 41 years. Since in 1993 it was not yet common practice to set an ARfD, EFSA used the ADI to assess the acute effects in the short term intake. A risk assessment was performed using the EFSA PRIMo including the existing CXLs for citrus fruits, pome fruits and grapes. The highest chronic exposure was calculated for the German child, representing 124% of the ADI. Since there were no supervised field trials complying with the critical GAP or reliable processing studies, the intake could not be further refined. The acute intake assessment (using the ADI‐value) shows exceedance of the toxicological reference value for citrus fruits (884% for oranges, 594% for grapefruit, 371% for mandarins, 230% for lemons, and 134% for limes), pome fruits (653% for apples, 607% for pears), table grapes (437%) and wine grapes (158%)*.

JMPR recognised that the assessment is outdated, but since no new data were made available, and considering that no evidence was provided that triggered the setting of an ARfD, JMPR was of the opinion that bromopropylate was unlikely to present a major, acute health concern and therefore no further action was taken.

Considering that in 2018 CCPR bromopropylate was added to the list of unsupported compounds, since no data package was presented for the 2018 periodic review, CCPR should discuss appropriate risk management actions, e.g. deletion of the existing CXLs.

4.3. Crop groups -- reconsideration of maximum residue estimations made by the 2017 JMPR for fenpyroximate (193), fluopyram (243), oxamyl (126) and spinetoram (233) {#efs25797-sec-0021}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

In 2017, JMPR assessed the uses on tomatoes and peppers. Reconsidering the policy for extrapolation in the subgroups of tomatoes and peppers, JMPR reviewed the previously derived MRL proposals.

The revised proposals for fenpyroximate and fluopyram are reported in Sections [5.9](#efs25797-sec-0077){ref-type="sec"} and [5.16](#efs25797-sec-0119){ref-type="sec"}.

For oxamyl (126) and spinetoram (233), the previous MRL proposals were confirmed since the Good Agricultural Practice (GAP) referred only to tomatoes and peppers and not to other crops listed in the subgroup.

4.4. Cyprodinil (207) and propiconazole (160) post‐harvest uses {#efs25797-sec-0022}
---------------------------------------------------------------

See Sections [5.12](#efs25797-sec-0095){ref-type="sec"}(cyprodinil) and 5.5 (propiconazole).

4.5. 2,4‐D (020) {#efs25797-sec-0023}
----------------

USA submitted a concern form requesting clarification on the conclusion of 2017 JMPR regarding the lack of stability of residues in cotton seed in frozen storage, noting that a storage stability study on soya beans indicated stability of 2,4‐D in soya beans under frozen conditions.

JMPR confirmed the previous view that due to limited storage stability observed in cotton seed the residue data were considered inadequate for estimating an MRL for 2,4‐D in genetically modified maize.

It is noted that in an EU import tolerance application for genetically modified maize the available data were found sufficient to demonstrate stability of parent 2,4‐D.

For cotton, no import tolerance request was submitted so far to the EU. Application for authorisation of genetically modified cotton DAS‐81910‐7 for food and feed uses, import and processing under Regulation (EC) No 1829/2003[4](#efs25797-note-1005){ref-type="fn"} by Dow AgroSciences (EFSA‐GMO‐NL‐2016‐136) has been submitted to EFSA. The DAS‐81910‐7 cotton has been genetically modified to express the AAD‐12 and PAT proteins. The expression of AAD‐12 and PAT proteins confers tolerance to application of 2,4‐D and glufosinate‐ammonium herbicides, respectively.

4.6. Fluopyram (243) {#efs25797-sec-0024}
--------------------

See Section [5.16](#efs25797-sec-0119){ref-type="sec"}.

4.7. Phosphonic acid (301)/Fosetyl‐Aluminium (302) {#efs25797-sec-0025}
--------------------------------------------------

JMPR concluded that phosphonic acid is toxicologically similar to fosetyl‐aluminium and is covered by the ADI for fosetyl‐aluminium (1 mg/kg body weight (bw) per day).

In the EU peer review (renewal of the approval for fosetyl‐aluminium), an ADI of 1 mg/kg bw per day was derived. An ARfD was not considered necessary. Since phosphonic acid is a major metabolite in rat (73% in the urine), its toxicity (including developmental and reproductive toxicity (DART)) is considered covered by the studies performed with fosetyl‐Al (EFSA, [2018k](#efs25797-bib-0100){ref-type="ref"}).

4.8. Picoxystrobin (258) {#efs25797-sec-0026}
------------------------

A concern form was submitted by USA, requesting a clear explanation why the JMPR concluded that there were an inadequate number of MOR (magnitude of residue) trials for rapeseed available for review to recommend a maximum residue level for picoxystrobin on oilseed rape.

JMPR clarified that the submitted trials did not match the critical US GAP.

No further comments required.

4.9. Quinclorac (287) {#efs25797-sec-0027}
---------------------

The EU submitted a concern form asking to reconsider the residue definition because quinclorac methyl ester, which is ten times more toxic than quinclorac was not included in the residue definition for enforcement.

In 2017 and 2018, JMPR confirmed the residue definition for enforcement, concluding that quinclorac plus quinclorac conjugates are appropriate marker residues and taking into account the overall low exposure.

Since no new arguments were put forward by JMPR, the previous EU position should be maintained.

5. Comments on JMPR report chapter 5 (individual substances assessed) {#efs25797-sec-0028}
=====================================================================

In the following sections, the active substances assessed by JMPR in the most recent assessment are presented (FAO, [2018](#efs25797-bib-0152){ref-type="ref"}). The terms in brackets after the name of the active substance in the header of the sections refer to the code number used by JMPR; the second parenthesis provides information whether the substance was assessed for toxicological properties (T) and/or for residues (R). The substances are sorted according to the codex number.

5.1. Diquat (31) R {#efs25797-sec-0029}
------------------

### 5.1.1. Background information {#efs25797-sec-0030}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           | Last periodic review was performed by 2013 JMPR                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | UK                | SE accepted to take over from UK                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved      | Commission Implementing Regulation (EU) 2018/1532[a](#efs25797-note-0006){ref-type="fn"}                                                                                                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2015r](#efs25797-bib-0061){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2015a](#efs25797-bib-0044){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                | No RO issued after art 12 review;                                                                                                                                                                                 |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | MRL application for hops under preparation (DE EMS)                                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Others                                                                                                                                 |                   | EFSA ([2018c](#efs25797-bib-0092){ref-type="ref"}) (statement on non‐dietary exposure)                                                                                                                            |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCaringogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonised classification for CMR --Annex VI: no entry for CMR                                                                                                                                                    |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU Peer Review proposal for CMR: toxic for reproduction cat. 2.;                                                                                                                                                  |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0007){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; CMR: Carcinogenic, Mutagenic or Toxic for Reproduction.

Commission Implementing Regulation (EU) 2018/1532 of 12 October 2018 concerning the non‐renewal of approval of the active substance diquat, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011. OJ L 257, 15.10.2018, p. 10--12.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.1.2. Toxicological reference values {#efs25797-sec-0031}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                        | EU evaluation | TRV comparable                      |                                                                                                                                                                                        |    |
+========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=====================================+========================================================================================================================================================================================+====+
| **ADI**                | 0.006 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR (2013)   | 0.002 mg/kg bw per day (diquat ion) | European Commission ([2001](#efs25797-bib-0125){ref-type="ref"}) confirmed in EFSA ([2015r](#efs25797-bib-0061){ref-type="ref"}) (2‐year study in rats with uncertainty factor of 100) | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.8 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR (2013)   | 0.01 mg/kg bw                       | EFSA ([2015r](#efs25797-bib-0061){ref-type="ref"}) (developmental toxicity study in rabbits with uncertainty factor of 100); ARfD formally not approved                                | No |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The EU toxicological reference values are in general lower than the JMPR values. In the EU assessment, a lower NOAEL of 0.2 mg diquat ion/kg bw per day for eye effects (cataracts) was set in the 2‐year study in rats compared to 0.6 mg/kg bw per day in the JMPR assessment                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        | The basis for setting the ARfD was different in the EU and JMPR assessment, whereas in the JMPR the basis was the acute neurotoxicity study, the peer review considered appropriate to set the ARfD based on the NOAEL of 1 mg/kg bw per day for reduced body weight gain observed at 3 mg/kg bw per day in the developmental toxicity study in rabbits. An uncertainty factor of 100 was applied. The reference values as agreed during the peer review are supported |               |                                     |                                                                                                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        | Under the MRL review, toxicological data for the major plant metabolite TOPPS were requested as confirmatory data (deadline for submission 24 June 2018)                                                                                                                                                                                                                                                                                                               |               |                                     |                                                                                                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        | Confirmatory data for Diquat (data gaps Article 12 assessment) were submitted to the RMS, co‐RMS, EFSA and the EU COM on 20 June 2018g. No new data on TOPPS was available. Syngenta considered that this was not necessary since in their opinion TOPPS is of no toxicological concern. The applicant proposed use a conversion factor of 1.5 for TOPPS to diquat residues, as a conservative approach. These confirmatory data have not yet been evaluated by UK     |               |                                     |                                                                                                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        | In the EFSA conclusion (EFSA, [2015r](#efs25797-bib-0061){ref-type="ref"}), toxicological information was also requested for diquat monopyridone and dipyridone. Considering that in October 2018 a decision on non‐approval was taken, it is unlikely that the requested toxicological data will be provided for diquat monopyridone and dipyridone. However, before new Codex MRLs are taken over in the EU legislation, this open point should be addressed         |               |                                     |                                                                                                                                                                                        |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                                     |                                                                                                                                                                                        |    |
|                        | JMPR did not assess the toxicological profile of the metabolites, because they were considered as not relevant due to the low amount expected in plant and animal products (FAO, [2013](#efs25797-bib-0149){ref-type="ref"})                                                                                                                                                                                                                                           |               |                                     |                                                                                                                                                                                        |    |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; RMS: rapporteur Member State; MRL: maximum residue level.
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### 5.1.3. Residue definitions {#efs25797-sec-0032}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                                                                                  | EU evaluation                                                                                                                                                           | RDs comparable                |
+=========================+====================================================================================================================================================================================================================================================================================================================================================================================+==================================================================================================================+=========================================================================================================================================================================+===============================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                     | Diquat cation                                                                                                    | EU Reg. 2016/1002: Diquat                                                                                                                                               | Yes                           |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | MRL Review (EFSA, [2015a](#efs25797-bib-0044){ref-type="ref"}):                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | Sum of diquat and its salts, expressed as diquat                                                                                                                        |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | Peer‐review (EFSA, [2015r](#efs25797-bib-0061){ref-type="ref"}): Diquat                                                                                                 |                               |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| Animal products         | Diquat cation                                                                                                                                                                                                                                                                                                                                                                      | EU Reg. 2016/1002: Diquat                                                                                        | Yes (for existing RD)                                                                                                                                                   |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                     | MRL Review (EFSA, [2015a](#efs25797-bib-0044){ref-type="ref"}): Sum of diquat and its salts, expressed as diquat |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    | Peer‐review (EFSA, [2015r](#efs25797-bib-0061){ref-type="ref"}): Ruminant tissues and milk: Diquat dipyridone    |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    | Poultry tissues and eggs: Diquat                                                                                 |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    | The residue is not fat soluble                                                                                   |                                                                                                                                                                         |                               |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                     | Diquat cation                                                                                                    | MRL Review (EFSA, [2015a](#efs25797-bib-0044){ref-type="ref"}):                                                                                                         | Yes, except for desiccant use |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | Peer‐review (EFSA, [2015r](#efs25797-bib-0061){ref-type="ref"}): Herbicide uses: Diquat; Desiccant uses:                                                                |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | 1\) Diquat &                                                                                                                                                            |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | 2\) TOPPS, to be considered separately (insufficient data to conclude on the toxicological profile of TOPPS)                                                            |                               |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
|                         | Animal products                                                                                                                                                                                                                                                                                                                                                                    | Diquat cation                                                                                                    | MRL Review (EFSA, [2015a](#efs25797-bib-0044){ref-type="ref"}): Sum of diquat, its salts and TOPPS expressed as diquat (tentative)                                      | No                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    | Sum of diquat, its salts and TOPPS expressed as diquat (tentative)                                               | Peer‐review (EFSA, [2015r](#efs25797-bib-0061){ref-type="ref"}): Diquat, diquat monopyridone and diquat dipyridone                                                      |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  | Whether residues of the two metabolites can be expressed as diquat is pending a conclusion on the toxicological properties of diquat monopyridone and diquat dipyridone |                               |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+
| **Conclusion/comments** | The current EU enforcement residue definitions implemented in the MRL legislation are comparable with the residue definitions of Codex                                                                                                                                                                                                                                             |                                                                                                                  |                                                                                                                                                                         |                               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                  |                                                                                                                                                                         |                               |
|                         | For risk assessment, the EU residue definitions are broader; however, in the EU, toxicological data are still missing for the metabolites TOPPS, diquat monopyridone, diquat dipyridone to conclude that they have toxicity comparable with the parent compound. Thus, at EU level, the data gaps related to the metabolites need to be addressed, before new MRLs are established |                                                                                                                  |                                                                                                                                                                         |                               |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; RMS: rapporteur Member State; MRL: maximum residue level.
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### 5.1.4. Codex MRL proposals {#efs25797-sec-0033}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                          | Codex MRL proposal                                                                                                                                                                                                                                                                          | EU MRL                                              | Comment                                                                                                                                                                                                                                                                                                                |
+====================================================================+=============================================================================================================================================================================================================================================================================================+=====================================================+========================================================================================================================================================================================================================================================================================================================+
| Barley                                                             | **5**                                                                                                                                                                                                                                                                                       | 0.02[\*](#efs25797-note-0011){ref-type="fn"}        | Critical GAP: AU, 600 g a.i./ha, no PHI defined, but worst case would be harvest after 4 days                                                                                                                                                                                                                          |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Number of trials: 1 trial matching the GAP, 5 trials where residue concentration was interpolated from different PHIs                                                                                                                                                                                                  |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: For barley at least 8 trials would be required                                                                                                                                                                                                                                         |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is not acceptable because of insufficient number of trials. The risk assessment value derived by JMPR does not reflect the EU residue definition                                                                                                                                    |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder, dry                                       | **40 (dw)**                                                                                                                                                                                                                                                                                 | --                                                  | In the EU, MRLs are not established for feed items                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | The proposed Codex MRL was derived from the combined data set of trials in barley, oat and wheat (17 trials), reflecting the use of 600 g/ha shortly before harvest                                                                                                                                                    |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Beans, dry                                                         | 0.2 W                                                                                                                                                                                                                                                                                       | 0.2                                                 | The existing CXL is proposed to be withdrawn and to be replaced by the proposed Codex MRL for dry beans, subgroup                                                                                                                                                                                                      |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Chick‐pea (dry)                                                    | **0.9**                                                                                                                                                                                                                                                                                     | 0.3 (peas dry)                                      | Critical GAP: CA, 408 g a.i./ha for preharvest desiccation, no PHI defined, but worst case would be harvest after 4--5 days Number of trials: 9                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: The samples were analysed only for diquat; no information on the amount of TOPPS                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is acceptable. However, the risk assessment values derived by JMPR do not reflect the EU residue definition                                                                                                                                                                         |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry beans, Subgroup of (includes all commodities in this subgroup) | **0.4**                                                                                                                                                                                                                                                                                     | Beans dry: 0.2;                                     | Critical GAP: CA, 552 g a.i./ha for preharvest desiccation; no PHI defined, but worst case would be harvest after 4--5 days                                                                                                                                                                                            |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             | Soya bean: 0.3                                      | Number of trials: 24 trials for beans and 3 trials in soya beans                                                                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: Additional trials in soybeans (major crop) would be required. The samples were analysed only for diquat; no information on the amount of TOPPS                                                                                                                                         |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is not acceptable. However, the risk assessment values derived by JMPR do not reflect the EU residue definition                                                                                                                                                                     |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry peas, Subgroup of (except chick‐pea (dry))                     | **0.9**                                                                                                                                                                                                                                                                                     | 0.3                                                 | Critical GAP: CA, 552 g a.i./ha for preharvest desiccation, no PHI defined, but worst case would be harvest after 4--5 days. Number of trials: 8 trials in lentils, 21 trials in peas (dry). Since residue trials in lentils and peas differed significantly, the MRL proposal was derived from the lentil trials only |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: The samples were analysed only for diquat; no information on the amount of TOPPS                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is acceptable. However, the risk assessment values derived by JMPR do not reflect the EU residue definition                                                                                                                                                                         |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                  | 0.01[\*](#efs25797-note-0011){ref-type="fn"}                                                                                                                                                                                                                                                | 0.05[\*](#efs25797-note-0011){ref-type="fn"} (ft)   | From feeding studies performed with exaggerated dose rates JMPR concluded that no residues are expected in fat                                                                                                                                                                                                         |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                       |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peas (dry)                                                         | W                                                                                                                                                                                                                                                                                           | 0.3                                                 | The existing CXL for pea of 0.3 mg/kg will be replaced by the proposed MRL for peas dry, subgroup (0.9 mg/kg)                                                                                                                                                                                                          |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                       | 0.01[\*](#efs25797-note-0011){ref-type="fn"}                                                                                                                                                                                                                                                | 0.05[\*](#efs25797-note-0011){ref-type="fn"} (ft)   | From feeding studies performed with exaggerated dose rates, JMPR concluded that no residues are expected in fat                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                       |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye                                                                | **1.5**                                                                                                                                                                                                                                                                                     | 0.02[\*](#efs25797-note-0011){ref-type="fn"}        | Critical GAP: 600 g a.i./ha, PHI not defined                                                                                                                                                                                                                                                                           |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Number of trials: 6 trials in wheat; residues measured 2‐4 days after application                                                                                                                                                                                                                                      |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: For rye, 5 trials are sufficient according to JMPR rules; extrapolation from wheat to rye is acceptable. At EU level, 8 trials would be required                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is sufficiently supported by residue trials. The risk assessment value derived by JMPR does not reflect the EU residue definition. A chronic consumer intake concern was identified for rye                                                                                         |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rye straw and fodder, dry                                          | **40 (dw)**                                                                                                                                                                                                                                                                                 | --                                                  | See comments on barley straw                                                                                                                                                                                                                                                                                           |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                    | W                                                                                                                                                                                                                                                                                           |                                                     | The existing CXL for soya beans of 0.3 mg/kg will be replaced by the proposed MRL for beans dry, subgroup (0.4 mg/kg)                                                                                                                                                                                                  |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean hulls                                                    | 1.5                                                                                                                                                                                                                                                                                         | --                                                  | PF of 3.1 derived from two processing studies                                                                                                                                                                                                                                                                          |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                                          | **1.5**                                                                                                                                                                                                                                                                                     | Wheat: 0.02[\*](#efs25797-note-0011){ref-type="fn"} | Critical GAP: 600 g a.i./ha, PHI not defined                                                                                                                                                                                                                                                                           |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Number of trials: 6 trials in wheat; residues measured 2--4 days after application                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Specific comments/observations: For triticale, 5 trials are sufficient according to JMPR rules; extrapolation from wheat to triticale is acceptable                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     | Conclusion: The proposed Codex MRL is sufficiently supported by residue trials. The risk assessment value derived by JMPR does not reflect the EU residue definition                                                                                                                                                   |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder, dry                                    | 40 (dw)                                                                                                                                                                                                                                                                                     |                                                     | See comments on barley straw                                                                                                                                                                                                                                                                                           |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                               | It is noted that 2013 JMPR recommended withdrawal of the CXL for barley, wheat, wheat bran, wheat flour and wheat wholemeal. Since no sufficiently supported alternative GAPs were provided, the CXL should be withdrawn in 2019 CCPR                                                       |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                             |                                                     |                                                                                                                                                                                                                                                                                                                        |
|                                                                    | 2018 JMPR confirmed the draft MRLs for edible offal (mammalian) eggs, meat (from mammals other than marine mammals), milks, poultry meat, poultry edible offal which were maintained at step 4. If these MRL proposals are advanced, the old CXLs for these commodities should be withdrawn |                                                     |                                                                                                                                                                                                                                                                                                                        |
+--------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

a.i.: active ingredient; PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.1.5. Consumer risk assessment {#efs25797-sec-0034}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                   | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                        | Comments on JMPR exposure assessment |
+=============================================================================================================================================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                         | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                | **Specific comments:**               |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
| The short‐term dietary risk assessment was performed for the unprocessed food commodities for which Codex MRLs were proposed                | The most recent long‐term risk assessment (EFSA, [2015a](#efs25797-bib-0044){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the commodities for which the Codex MRLs are higher than the existing EU MRLs. Animal products were not included in the calculation, considering that according to the feeding studies no diquat residues are expected to occur in animal products | --                                   |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
| The risk assessment is indicative because information on the occurrence of TOPPS and toxicological data for TOPPs is not available          | The risk assessment is indicative because information on the occurrence of TOPPS and toxicological data for TOPPs is not available                                                                                                                                                                                                                                                                                                                                 |                                      |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
| The EU ARfD was used                                                                                                                        | The EU ADI was used                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                       | **Results:**                         |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
| No short‐term exposure concern was identified for the food products for which Codex MRLs were proposed (maximum 87% of the ARfD for barley) | A long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                                                                                                                                                    | Long‐term exposure:                  |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                             | The overall chronic exposure accounted for 193% of the ADI                                                                                                                                                                                                                                                                                                                                                                                                         | 30% of the ADI                       |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                             | The contribution of rye to the exposure was 139% of the ADI (Danish children)                                                                                                                                                                                                                                                                                                                                                                                      | Short‐term exposure:                 |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                      |
|                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Maximum of 10% of the ARfD           |
+---------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; ARfD: acute reference dose; ADI: acceptable daily intake; RA: risk assessment.

John Wiley & Sons, Ltd

5.2. Imazalil (110) R,T {#efs25797-sec-0035}
-----------------------

### 5.2.1. Background information {#efs25797-sec-0036}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Periodic review   |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | NL                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) No 705/2011[a](#efs25797-note-0014){ref-type="fn"}                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA PPR Panel ([2007](#efs25797-bib-0078){ref-type="ref"})                                                                                                                                                       |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2010a](#efs25797-bib-0011){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2017h](#efs25797-bib-0085){ref-type="ref"}) EFSA ([2018o](#efs25797-bib-0104){ref-type="ref"})                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}) (Art.43)                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonised classification and labelling for CMR -- Annex VI: Carc. 2                                                                                                                                              |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0800){ref-type="fn"}): not finalised |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State.

Commission Implementing Regulation (EU) No 705/2011 of 20 July 2011 approving the active substance imazalil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 190, 21.7.2011, p. 43--49.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.2.2. Toxicological reference values {#efs25797-sec-0037}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable         |                                                                   |     |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+========================+===================================================================+=====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR (2018)   | 0.025 mg/kg bw per day | EFSA ([2010a](#efs25797-bib-0011){ref-type="ref"})                | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        | European Commission ([2011b](#efs25797-bib-0134){ref-type="ref"}) |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------------------+-----+
| **ARfD**               | 0.05 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR (2018)   | 0.05 mg/kg bw          | EFSA PPR Panel ([2007](#efs25797-bib-0078){ref-type="ref"})       | Yes |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------------------+-----+
| **Conclusion/comment** | Studies with **parent imazalil** assessed **by JMPR:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | It seems that not all of the studies reported in the JMPR report have been evaluated in the RAR or addendum to the RAR of imazalil (to be verified in the JMPR evaluation). However, according to the RMS, most of the new studies are not expected to influence the outcome of the evaluation in the RAR: e.g. acute tox results are in line with studies RAR and lead to same classification category; genotoxicity studies are negative, confirming the studies and conclusions reached in the RAR; mechanistic studies demonstrating liver enzyme induction and a CAR‐dependent mechanism for liver effects                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | Assessment of **metabolites:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | The **JMPR Meeting** concluded that, based on the structure of R014821, its acute toxicity profile as well as its detection in rats at significant levels, this metabolite would be covered by the health‐based guidance values for the parent compound. As regards R061000 (FK‐772) JMPR was of the opinion that the toxicity would be covered by the parent compound, given its toxicity profile as well as its detection in rats at significant levels. For R043449 (FK‐284) JMPR considered that the expected exposure was below the threshold Cramer Class III                                                                                                                                                                                                                                                                                                                                                                                                                                                           |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | In the JMPR evaluation, all *in vitro* genotoxicity assays were concluded to be negative                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | In 2018, **EFSA concluded** that insufficient data are available to conclude on the toxicological profile of metabolites formed in plants after post‐harvest treatment (R014821) and observed in animal metabolism (FK‐772 and FK‐284) (EFSA, [2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}). In the EU evaluation, one study for metabolite R14821 and one study for metabolite FK772 was considered to give equivocal results, as the findings did not comply to either negative or positive outcome as defined in the respective OECD guidelines. Furthermore, the genotoxic endpoint of aneugenicity was not sufficiently addressed for any of the metabolites as the *in vitro* studies provided are not specifically designed to address this endpoint. Therefore, it was concluded that additional data are required regarding genotoxicity. Furthermore, EFSA set a data gap for a repeated dose study to be able to set specific reference values for these three metabolites |               |                        |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |                                                                   |     |
|                        | Although the same studies were available for the metabolites, **different conclusions were derived by JMPR and at EU level**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |               |                        |                                                                   |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; RAR: renewal assessment report; OECD: Organisation for Economic Co‐operation and Development.

John Wiley & Sons, Ltd

### 5.2.3. Residue definitions {#efs25797-sec-0038}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR evaluation                                                                                                                                                                                                                                                     | EU evaluation                                                                                                                            | RDs comparable    |
+=========================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================================================+==========================================================================================================================================+===================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Imazalil                                                                                                                                                                                                                                                            | Reg. (EU) No 750/2010: Imazalil                                                                                                          | Yes               |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}): Imazalil (any ratio of constituent isomers) |                   |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+
| Animal products         | Imazalil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Reg. (EU) No 750/2010: Imazalil                                                                                                                                                                                                                                     | JMPR RD is comparable with the currently implemented RD, but comparison not appropriate with recent proposals                            |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | EFSA ([2017h](#efs25797-bib-0085){ref-type="ref"}): Sum of imazalil and metabolite FK‐772 (any ratio of constituent isomers), expressed as imazalil (tentative, pending full assessment of toxicological properties of FK‐772) (not implemented in MRL legislation) |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}): Open                                                                                                                                                                   |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | The residue is not fat soluble                                                                                                                                                                                                                                      |                                                                                                                                          |                   |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Free and conjugated imazalil                                                                                                                                                                                                                                        | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}): Open for post‐harvest use                   | See comment below |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     | Imazalil (any ratio of constituent isomers) for foliar treatment and seed treatment                                                      |                   |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+
| Animal products         | Sum of imazalil and the metabolite R061000 (FK‐772) ((*RS*)‐3‐\[2‐(2,4‐dichlorophenyl)‐2‐(2,3‐ dihydroxypropoxy) ethyl\]imidazolidine‐ 2,4‐dione (+)‐1‐\[2‐(2,4‐dichlorophenyl)‐2‐\[(2,3‐dihydroxypropyl)oxy\]ethyl\]‐ dihydroxypropyl)oxy\]ethyl\]‐2,5‐imidazolidinedione), expressed as imazalil equivalents                                                                                                                                                                                                        | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}): Open                                                                                                                                                                   | See comment below                                                                                                                        |                   |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+
| **Conclusion/comments** | It should be noted that the last EFSA recommendations derived under Article 43 (i.e. no residue definition for risk assessment can be derived for post‐harvest uses and for livestock commodities) will be discussed at PAFF meeting of February 2019                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         | For all plant commodities for which the critical GAP is a post‐harvest use as well as for animal commodities, a comparison of the residue definition for risk assessment derived by JMPR with the EU residue definition is not appropriate, as long as the toxicological information requested for R014821, and FK‐772 and FK‐284 is not available                                                                                                                                                                    |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
|                         | The RMS proposed to discuss with MS in the PAFF committee (February 2019) to set the residue definition for risk assessment (plant commodities) tentatively as the sum of imazalil and R014821, expressed as imazalil. For animal products, the RMS proposed to set the residue definition for risk assessment as the sum of imazalil and all identified/characterised metabolites observed in the goat metabolism study. CF from enforcement to risk assessment can be derived tentatively from the metabolism study |                                                                                                                                                                                                                                                                     |                                                                                                                                          |                   |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------+-------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MS: Member State; RMS: rapporteur Member State; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.2.4. Codex MRL proposals {#efs25797-sec-0039}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                     | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | EU MRL/ proposed MRL (Art. 43, EFSA, [2018o](#efs25797-bib-0104){ref-type="ref"},[j](#efs25797-bib-0099){ref-type="ref"}) | Comment                                                                                                                                                                                                                                                                                                                                                                                                                         |
+===============================================================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===========================================================================================================================+=================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Citrus fruit                                                                  | W 5Po                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 5/--                                                                                                                      | JMPR proposed to withdraw the existing CXL and to replace it with MRLs for the subgroup of lemons and limes and oranges                                                                                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lemons and limes, Subgroup of (includes all commodities in this subgroup)     | **15Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 5/--                                                                                                                      | Critical GAP: USA, post‐harvest application (dip or drench) at 0.075 kg a.i./hl + post‐harvest wax application at 0.2 kg a.i./hl (total: 0.275 kg a.i./hl); withholding period: 0 day                                                                                                                                                                                                                                           |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 9 on lemons                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: See general comment for post‐harvest applications and RMS proposal to re‐discuss the residue definitions                                                                                                                                                                                                                                                                                        |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is not acceptable because the toxicity of metabolite R014821 (released after post‐harvest treatment) is not sufficiently addressed                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, sweet, sour, Subgroup of (includes all commodities in this subgroup) | **8Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 5/--                                                                                                                      | USA, post‐harvest application (dip or drench) at 0.075 kg a.i./hl + post‐harvest wax application at 0.2 kg a.i./hl (total: 0.275 kg a.i./hl); withholding period: 0 day                                                                                                                                                                                                                                                         |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 12 on oranges                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: See general comment for post‐harvest applications                                                                                                                                                                                                                                                                                                                                               |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is not acceptable because the toxicity of metabolite R014821 (released after post‐harvest treatment) is not addressed                                                                                                                                                                                                                                                                        |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | See also proposal of RMS below (General comments)                                                                                                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits                                                                   | **5W**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 2/--                                                                                                                      | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Banana                                                                        | **3Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 2/--                                                                                                                      | [Critical GAP]{.ul}: FR, post‐harvest dip application at 0.0375 kg a.i./hl; withholding period: 0 day                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 13 trials available                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: See general comment for post‐harvest applications. It is expected that following the recent EFSA assessment under Art. 43, the French GAP will be withdrawn                                                                                                                                                                                                                                     |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is not acceptable because the toxicity of metabolite R014821 (released after post‐harvest treatment) is not addressed                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Raspberries, red and black                                                    | **W2**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberry                                                                    | **W2**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                        | **9Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 3/0.01[\*](#efs25797-note-0018){ref-type="fn"}                                                                            | Critical GAP: EU post‐harvest application at 0.015 kg a.i./tonne; with‐holding period of 0 day                                                                                                                                                                                                                                                                                                                                  |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: In the framework of the MRL review, EFSA assessed the post‐harvest use reported to JMPR, resulting in a similar MRL proposal (9 mg/kg). However, since intake concerns were identified, the EU MRL was derived for an alternative GAP; thus the GAP assessed by JMPR is no longer valid in the EU. See general comment for post‐harvest applications. See also results of acute risk assessment |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is not acceptable because it is based on a GAP that is no longer valid for the EU and because of acute intake concerns. In addition, the comments regarding the toxicity of metabolite R014821 (released after post‐harvest treatment) are not addressed                                                                                                                                     |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Persimmon, Japanese                                                           | **W 2Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 0.05[\*](#efs25797-note-0018){ref-type="fn"}/--                                                                           | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                        | 0.3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.5/0.3                                                                                                                   | Critical GAP: Belgium, foliar (indoor) 3 × 0.02 kg a.i./hL; PHI 1 day (corresponding to 3 × 300 g a.i./ha assuming 1,500 L water/ha is applied)                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: 2 additional trials would be required. However, in the EU assessment (art. 43), the critical EU use (indoor, 3 × 300 g /ha, PHI 1 day) was fully supported by data and lead to similar MRL. It is noted that for the EU assessment in total 8 trials were provided                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                                      | W 0.5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.2/0.5                                                                                                                   | JMPR proposed to withdraw the existing CXL because of insufficient data to support critical GAP or alternative GAP                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Gherkins                                                                      | W 0.5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.2/0.5                                                                                                                   | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except Watermelon                                                     | W 2Po                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 2/--                                                                                                                      | JMPR proposed to withdraw the existing CXL because not supported any longer by the manufacturer                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley                                                                        | 0.01[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}/0.01[\*](#efs25797-note-0018){ref-type="fn"}                                 | Critical GAP: seed treatment at 0.1 kg a.i./tonnes                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 5 trials on barley (all \< LOQ) + 5‐fold overdosed metabolism study on spring wheat (all \< LOQ)                                                                                                                                                                                                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: acceptable as no‐residue situation is expected                                                                                                                                                                                                                                                                                                                                                  |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale                                                                     | 0.01[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}/0.01[\*](#efs25797-note-0018){ref-type="fn"}                                 | See barley                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley straw and fodder (dry)                                                 | 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | Critical GAP: seed treatment at 0.1 kg a.i./tonnes                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Number of trials: 5 on barley (all \< LOQ)                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: acceptable as no‐residue situation is expected and similar residue behaviour expected in barley and wheat straw                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat straw and fodder (dry)                                                  | 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See barley straw                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Triticale straw and fodder (dry)                                              | 0.01                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See barley straw                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                 | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | Max estimated burden for beef cattle: 28.9 ppm (EU)                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Feeding study available that covers the estimated burden for imazalil; samples were analysed for parent, R043449 and R061000                                                                                                                                                                                                                                                                                                    |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: The feeding studies seem acceptable. See also general comment                                                                                                                                                                                                                                                                                                                                   |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                             | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | Conclusion: The proposed Codex MRL is not acceptable because of the lack of toxicological studies for metabolite FK‐772 and FK‐284                                                                                                                                                                                                                                                                                              |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | The RMS proposed to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                      | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See Mammalian fats (except milk fats)                                                                                                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                         | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See Mammalian fats (except milk fats)                                                                                                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                  | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | Max estimated burden for poultry: 2.3 ppm (EU)                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Feeding study available that covers the estimated burden for imazalil; samples were analysed for parent, R042639 (FK‐284), R043449 (FK‐772) and R044085                                                                                                                                                                                                                                                                         |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Specific comments/observations: The feeding studies seem acceptable                                                                                                                                                                                                                                                                                                                                                             |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                                  | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal                                                         | 0.02[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                          | 0.01[\*](#efs25797-note-0018){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 0.05[\*](#efs25797-note-0018){ref-type="fn"}                                                                              | See poultry meat                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                          | The proposed Codex MRLs for post‐harvest uses are not acceptable because the toxicity of metabolite R014821 (formed after post‐harvest treatment) is not sufficiently addressed. This recommendation is in line with the recommendations derived in the recently published reasoned opinions of EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}, [o](#efs25797-bib-0102){ref-type="ref"}) which were supported by MS in a MS consultation                                                                         |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               | The RMS proposed to discuss with MS whether the proposed Codex MRLs are compatible with the EU policy on setting MRLs although the toxicity of metabolite R014821 is not sufficiently addressed. The recommendations to be updated for lemons, oranges, bananas, after the PAFF meeting                                                                                                                                                                                                                             |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                               | Although toxicological data for metabolites expected in animal commodities are also missing, the Codex MRL proposals for livestock commodities except edible offal might be acceptable, considering that at the relevant feed levels the total imazalil residues (sum of imazalil, R061000 (FK‐772) and R043449 (FK‐284) in animal matrices (except liver and kidney) were below the LOQ. The MRL proposal for edible offal mammalian is not supported since the occurrence of FK‐772 and FK‐284 cannot be excluded |                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; CXL: Codex Maximum Residue Limit; LOQ: limit of quantification; RMS: rapporteur Member State; MS: Member State.

Indicates that the input value is proposed at the limit of quantification.
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### 5.2.5. Consumer risk assessment {#efs25797-sec-0040}

###### 

Summary of the consumer risk assessment

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                       | Comments on JMPR exposure assessment                                                                                                                                              |
+================================================================================================================================================================================================================================================================================================================================================+===================================================================================================================================================================================================================================================================================================================================================================================================================================+===================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                               | **Specific comments:**                                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
| An indicative short‐term dietary risk assessment was performed for all commodities for which JMPR has derived MRL proposals higher than the existing EU MRLs. The risk assessment is indicative, because the residue definitions for risk assessment could not be finalised for all MRLs derived from a post‐harvest uses The EU ARfD was used | The most recent long‐term risk assessment (EFSA, [2018n](#efs25797-bib-0103){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for all commodities for which an MRL was derived by JMPR. The risk assessment is indicative, because the residue definitions for risk assessment could not be finalised for all MRLs derived from a post‐harvest uses | JMPR calculated acute risk assessment for potatoes, using the HR and a PF for baked potatoes (with peel), resulting in a HR‐p of 2.8. The exposure accounted for 60% of the ARfD. |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR should be asked to explain why the risk assessment was not performed with the processing factor derived for microwaved potatoes with peel (HR‐p = 6.5)                       |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                   | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                      | **Results:**                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
| Short‐term exposure concern was identified for potatoes (1,415% of the ARfD), noting that for this commodity EFSA does not support any proposal due to the open issues regarding the residue definition for risk assessment                                                                                                                    | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                                                                                                                  | Long‐term exposure:                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                | The overall chronic exposure accounted for 61% of the ADI                                                                                                                                                                                                                                                                                                                                                                         | 2--40% of the ADI                                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   | Short‐term exposure:                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0--40% of the ARfD (children)                                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0‐90% ARfD (adults)                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; ARfD: acute reference dose; ADI: acceptable daily intake; RA: risk assessment.

John Wiley & Sons, Ltd

5.3. Lambda‐cyhalothrin (146) T {#efs25797-sec-0041}
-------------------------------

### 5.3.1. Background information {#efs25797-sec-0042}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                               | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===============================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Other evaluation, see comment | New toxicological data was submitted to JMPR                                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | SE                            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Renewal of the approval       | Commission Implementing Regulation (EU) 2016/146[a](#efs25797-note-0021){ref-type="fn"}                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments             | EFSA ([2014c](#efs25797-bib-0037){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments             | EFSA ([2014a](#efs25797-bib-0035){ref-type="ref"})                                                                                                                                                                |
|                                                                                                                                        |                               |                                                                                                                                                                                                                   |
|                                                                                                                                        |                               | EFSA ([2015t](#efs25797-bib-0063){ref-type="ref"}) (Art.43)                                                                                                                                                       |
|                                                                                                                                        |                               |                                                                                                                                                                                                                   |
|                                                                                                                                        |                               | EFSA ([2017e](#efs25797-bib-0082){ref-type="ref"}) (Art.43)                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments             | EFSA ([2019a](#efs25797-bib-0110){ref-type="ref"}) (celeries, fennel and rice)                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded                 | Harmonized classification and labelling for CMR -- Annex VI: no classification                                                                                                                                    |
|                                                                                                                                        |                               |                                                                                                                                                                                                                   |
|                                                                                                                                        |                               | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0801){ref-type="fn"}): not finalised |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State.

Commission Implementing Regulation (EU) 2016/146 of 4 February 2016 renewing the approval of the active substance lambda‐cyhalothrin, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No 540/2011. OJ L 30, 5.2.2016, p. 7--11.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.3.2. Toxicological reference values {#efs25797-sec-0043}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | EU evaluation | TRV comparable          |                                                                                                                                               |    |
+========================+==============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=========================+===============================================================================================================================================+====+
| **ADI**                | 0.02 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR (2007)   | 0.0025 mg/kg bw per day | Multigeneration rat study (cyhalothrin),                                                                                                      | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         | EFSA ([2014a](#efs25797-bib-0035){ref-type="ref"}) confirmed in European Commission ([2015c](#efs25797-bib-0143){ref-type="ref"})             |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.02 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR (2007)   | 0.005 mg/kg bw          | 1‐year dog, EFSA ([2014a](#efs25797-bib-0035){ref-type="ref"}) confirmed in European Commission ([2015c](#efs25797-bib-0143){ref-type="ref"}) | No |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | At EU level, the toxicological reference values were lowered in the framework of the renewal of the approval of the active substance. Compared to the JMPR toxicological reference values, the EU ADI/ARfD are significantly lower. The available data on cyhalothrin and lambda‐cyhalothrin were interpreted differently by the JMPR and at EU level. The EU assessment considered that lambda‐cyhalothrin is about twice as toxic as cyhalothrin while the JMPR concluded on a similar level of toxicity of the two a.s. The EU peer review applied an additional uncertainty factor of 2 (overall 200) on studies performed with cyhalothrin to derive the toxicological reference values for lambda‐cyhalothrin (i.e. the ADI) while the JMPR used a reduced uncertainty factor of 25 based on toxicokinetic considerations. The point of departure to derive the ADI was the same for the two assessments although based on different studies                                                                                                                                                           |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        | Regarding the ARfD setting, the point of departure was the same value based on the same study, however a different uncertainty factor was applied (100 in the EU vs. 25 in the JMPR assessment) resulting in different ARfDs. In the EU dossier toxicological data (acute oral toxicity and genotoxicity studies) were provided on metabolites 1a, II, III, VI and XIII showing that these metabolites are less acutely toxic than lambda‐cyhalothrin and are unlikely to be genotoxic. Metabolite V (PBA) was shown to be less acutely toxic than the parent, but no genotoxicity or repeated dose toxicity data are available for this metabolite. Confirmatory data have been required by the EC for the applicant to address the toxicological profile (including the genotoxicity potential) of the metabolites V (3‐phenoxybenzoic acid or PBA) and XXIII (3‐(4‐hydroxyphenoxy)benzoic acid or PBA(OH)) that are relevant to consumer exposure, and to clarify sperm effects reported upon lambda‐cyhalothrin administration in the published literature; these data are currently being peer reviewed |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        | In 2018, JMPR assessed new toxicological studies with lambda‐cyhalothrin (biliary elimination and biotransformation study in rats, 21‐day dermal toxicity study, 21‐day toxicity study by inhalation, two bacterial gene mutation assays and a preliminary developmental neurotoxicity study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        | Furthermore, toxicological studies R119890, R41207 and R110649 (all three are plant metabolites) were assessed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        | According to JMPR, these studies did not have an impact on the ADI and ARfD established in 2007                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
|                        | The new toxicological studies assessed by JMPR were probably not all made available at EU level                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                         |                                                                                                                                               |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; RMS: rapporteur Member State; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.3.3. Residue definitions {#efs25797-sec-0044}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                              | EU evaluation                                                                   | RDs comparable |
+=========================+====================================================================================================================================================================================================================================================================================================================+==============================================================+=================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                     | Cyhalothrin (sum of all isomers).                            | EU Reg. 2019/50:                                                                | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              |                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                    | The residue is fat soluble                                   | lambda‐cyhalothrin                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              |                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              | Art. 43 (EFSA, [2017e](#efs25797-bib-0082){ref-type="ref"}): lambda‐cyhalothrin |                |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              |                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              | The residue is fat soluble                                                      |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+
| Animal products         | Yes                                                                                                                                                                                                                                                                                                                |                                                              |                                                                                 |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                     | Art. 43 (EFSA, [2017e](#efs25797-bib-0082){ref-type="ref"}): | Yes                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                    |                                                              |                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                    | Lambda‐cyhalothrin                                           |                                                                                 |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+
| Animal products         | Yes                                                                                                                                                                                                                                                                                                                |                                                              |                                                                                 |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions derived by JMPR cover all isomers of cyhalothrin, while in the EU only lambda‐cyhalothrin was included. However, the Codex MRLs refer to the use of lambda‐cyhalothrin. Therefore, the JMPR residue definition has been considered in the past as equivalent to the EU residue definitions |                                                              |                                                                                 |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------+---------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.3.4. Codex MRL proposals {#efs25797-sec-0045}

No new codex MRL proposals were derived by 2018 JMPR.

### 5.3.5. Consumer risk assessment {#efs25797-sec-0046}

Not relevant since no new Codex MRL proposals were derived.

5.4. Propamocarb (148) R {#efs25797-sec-0047}
------------------------

### 5.4.1. Background information {#efs25797-sec-0048}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                                                                                                   | Comments, references                                                                                                                                                         |
+========================================================================================================================================+===================================================================================================+==============================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Other evaluation, see comment                                                                     | A new livestock feeding study was provided to JMPR                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | PT                                                                                                |                                                                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Renewal of the approval                                                                           | Commission Directive 2007/25/EC[a](#efs25797-note-0025){ref-type="fn"} as amended by Commission Implementing Regulation (EU) 2018/917[b](#efs25797-note-0026){ref-type="fn"} |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments                                                                                 | EFSA ([2006b](#efs25797-bib-0004){ref-type="ref"})                                                                                                                           |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | Renewal peer‐review ongoing                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments                                                                                 | EFSA ([2013d](#efs25797-bib-0028){ref-type="ref"})                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments                                                                                 | EFSA ([2013e](#efs25797-bib-0029){ref-type="ref"}) (rocket and leek)                                                                                                         |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | EFSA ([2014f](#efs25797-bib-0040){ref-type="ref"}) (spring onions and cabbage)                                                                                               |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | EFSA ([2015j](#efs25797-bib-0053){ref-type="ref"}) (bulb vegetables and leeks)                                                                                               |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | EFSA ([2015s](#efs25797-bib-0062){ref-type="ref"}) (various corps)                                                                                                           |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | EFSA ([2017l](#efs25797-bib-0089){ref-type="ref"}) (chards/beet leaves)                                                                                                      |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | Art.10 on poppy seeds (ongoing, currently on clock‐stop)                                                                                                                     |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Cut‐off criteria not met according to the Draft RAR ‐\> To be discussed in April experts' meeting | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                            |
|                                                                                                                                        |                                                                                                   |                                                                                                                                                                              |
|                                                                                                                                        |                                                                                                   | Peer review ongoing -- Experts' meeting in April 2019                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2007/25/EC of 23 April 2007 amending Council Directive 91/414/EEC to include dimethoate, dimethomorph, glufosinate, metribuzin, phosmet and propamocarb as active substances. OJ L 106, 24.4.2007, p. 34--42.

Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha‐cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, *Gliocladium catenulatum* strain: J1446, isoxaflutole, metalaxyl‐m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, *Paecilomyces lilacinus* strain 251, phenmedipham, phosmet, pirimiphos‐methyl, propamocarb, prothioconazole, pymetrozine and s‐metolachlor. OJ L 163, 28.6.2018, p. 13--16.

John Wiley & Sons, Ltd

### 5.4.2. Toxicological reference values {#efs25797-sec-0049}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-----------------------+-------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                        | EU evaluation                                   | TRV comparable        |                                                                   |    |
+========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================+=======================+===================================================================+====+
| **ADI**                | 0.4 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR (2005) (1‐year study in dogs, SF 100)      | 0.24 mg/kg bw per day | EFSA ([2006b](#efs25797-bib-0004){ref-type="ref"});               | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        | per day                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                 |                       | European Commission ([2007a](#efs25797-bib-0128){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       | (52‐week rat study, UF 100)                                       |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-----------------------+-------------------------------------------------------------------+----+
| **ARfD**               | 2 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR (2005) (acute neurotoxicity study, SF 100) | 0.84 mg/kg bw         | EFSA ([2006b](#efs25797-bib-0004){ref-type="ref"});               | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       | European Commission ([2007a](#efs25797-bib-0128){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       | (28‐day gavage study in rats, UF 100)                             |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-----------------------+-------------------------------------------------------------------+----+
| **Conclusion/comment** | The currently agreed ADI and ARfD values reported in the table above were recalculated to propamocarb free base                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        | Peer review ongoing -- The toxicological reference values proposed by the RMS will be discussed in April experts' meeting                                                                                                                                                                                                                                                                                                              |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        | The proposed ADI from the draft RAR is 0.29 mg propamocarb hydrochloride/kg bw per day based on the NOAEL of 29 mg/kg bw per day from a 52‐week rat study and a safety factor of 100 The proposed ARfD is 1.0 mg propamocarb hydrochloride/kg bw per day, based on the NOAEL of 100 mg/kg bw from a 28‐day rat gavage study and a safety factor of 100                                                                                 |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        | Also, the ADI and ARfD of JMPR are expressed for propamocarb free base                                                                                                                                                                                                                                                                                                                                                                 |                                                 |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                 |                       |                                                                   |    |
|                        | In 2005, JMPR derived an ADI of 0.4 mg/kg bw per day is set based on a NOAEL of 39 mg/kg bw per day, on the basis of vacuolisation observed in a range of organs in a 52‐week study in dogs, and using a safety factor of 100. An ARfD of 2 mg/kg bw is set based on a NOAEL of 200 mg/kg bw, on the basis of a decreased in activity in rats 1 h after dosing from the rat acute neurotoxicity study and using a safety factor of 100 |                                                 |                       |                                                                   |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------+-----------------------+-------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; RMS: rapporteur Member State; MRL: maximum residue level; UF: uncertainty factor.

John Wiley & Sons, Ltd

### 5.4.3. Residue definitions {#efs25797-sec-0050}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | JMPR evaluation                                                                                                                               | EU evaluation                                                            | RDs comparable |
+=========================+======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================+==========================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Propamocarb                                                                                                                                   | EU Reg. 2018/832:                                                        | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               | Propamocarb (Sum of propamocarb and its salts, expressed as propamocarb) |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+
| Animal products         | Propamocarb                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | EU Reg. 2018/832:                                                                                                                             | No                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | *N*‐oxide propamocarb (products of animal origin, except poultry/birds eggs)                                                                  |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | *N*‐desmethyl propamocarb (poultry, birds eggs)                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | The residue is not fat soluble                                                                                                                |                                                                          |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Propamocarb                                                                                                                                   | MRL review (EFSA, [2013e](#efs25797-bib-0029){ref-type="ref"}):          | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               | Sum of propamocarb and its salts, expressed as propamocarb               |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+
| Animal products         | Propamocarb                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | MRL review (EFSA, [2013e](#efs25797-bib-0029){ref-type="ref"}):                                                                               | No                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Sum of propamocarb, *N*‐oxide propamocarb, oxazolidin‐2‐one propamocarb and 2‐hydroxypropamocarb, expressed as propamocarb (ruminants, pigs); |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Sum of propamocarb and *N*‐desmethyl propamocarb, expressed as propamocarb (poultry)                                                          |                                                                          |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant commodities**: The residue definition set for enforcement and risk assessment by JMPR and at EU level are substantially the same                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | **Animal commodities**: The residue definition set for enforcement and risk assessment by JMPR and at EU level EU are quite different                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | EFSA proposed to limit the residue definition for enforcement to the best marker compound, identified as *N*‐oxide propamocarb in tissues of ruminants (and pigs) and in milks and as *N*‐desmethyl propamocarb in poultry tissues and eggs (details are reported below as background information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | For risk assessment, the EU residue definition is more comprehensive and includes the major plant and animal metabolites. Based on metabolism studies, tentative conversion factors for risk assessment were proposed during the MRL review (4.25 for milk; 2.2 for ruminant kidney, 1.7 for ruminant liver and muscle; 1 for ruminant fat; 1.3 for all poultry tissues and eggs)                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | Overall, the residue definitions for animal products derived at EU level and by JMPR are not compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | Both assessments concluded residues in products of animal origin are not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | According to the MRL review, in ruminants, metabolite *N*‐oxide propamocarb was the predominant metabolite of the total residues found in kidney (41% TRR -- 0.044 mg/kg), liver (49% TRR -- 0.203 mg/kg), muscle (40.5% TRR -- 0.008 mg/kg) and also in milk (21% TRR -- 0.012 mg/kg). Oxazolidine‐2‐one propamocarb occurred in significant amounts in kidney, liver and milk (14--23% TRR; 0.014--0.09 mg/kg). 2‐hydroxy propamocarb was the major metabolite of the total residues in milk (37.5% TRR -- 0.022 mg/kg) but was also identified at a lower level in liver (5% TRR) and kidney (13% TRR). Parent propamocarb accounted for 24.6% TRR in muscle (0.005 mg/kg), 23.5% TRR in kidney (0.025 mg/kg), 6.2% TRR in liver (0.026 mg/kg) and 6.0% TRR in milk (0.003 mg/kg) |                                                                                                                                               |                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
|                         | In poultry, the predominant compound of the total residues was the *N*‐desmethyl propamocarb in eggs (45% TRR), liver (22% TRR), muscle (29% TRR) and to a minor extend in fat (6% TRR) while the parent compound occurred at a lower level in all matrices (2--12% TRR). Bis desmethyl propamocarb and *N*‐oxide propamocarb accounted for less than 10% TRR. It is noted that a significant fraction of the radioactive residues remained uncharacterised in liver and muscle (32% and 41% TRR, respectively)                                                                                                                                                                                                                                                                      |                                                                                                                                               |                                                                          |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; TRR: total radioactive residues.
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### 5.4.4. Codex MRL proposals {#efs25797-sec-0051}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                         | Codex MRL proposal                                                                                                                                                      | EU MRL                                         | Comment                                                                                                                                                                                                                                                                            |
+===================================+=========================================================================================================================================================================+================================================+====================================================================================================================================================================================================================================================================================+
| Edible offal (Mammalian)          | **1.5**                                                                                                                                                                 | Edible offal, liver from                       | In 2014, JMPR calculated the maximum dietary burden using the OECD diets listed in the 2009 Edition of the FAO manual. The maximum and mean dietary burden was identified for Australian Dairy cattle (31.55 ppm DM and 10.7 ppm DM; the dietary burden is expressed as free base) |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         | -- ruminants, equine, others: 0.2 --swine: 0.1 | In 2018, JMPR assessed a new feeding study with dairy cows administered propamocarb‐HCl with feed levels equivalent to 13.6, 26.3 and 138 ppm propamocarb equivalents in feed                                                                                                      |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         | Kidney from                                    | The Codex MRL proposal refers to propamocarb residues only                                                                                                                                                                                                                         |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         | -- ruminants, equine, others: 0.05             | Conclusion: The proposed Codex MRL is not acceptable because it is not compatible with the EU residue definition for enforcement                                                                                                                                                   |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         | -- swine: 0.2                                  |                                                                                                                                                                                                                                                                                    |
+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats) | **0.03**                                                                                                                                                                | 0.01 (ft)                                      | See comment on mammalian edible offal                                                                                                                                                                                                                                              |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         |                                                | Conclusion: The proposed Codex MRL is not acceptable because derived according to a different residue definition                                                                                                                                                                   |
+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat from mammals                 | **0.03**                                                                                                                                                                | 0.01 (ft)                                      | See comment on mammalian edible offal                                                                                                                                                                                                                                              |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
| (other than marine mammals)       |                                                                                                                                                                         |                                                | Although Codex MRL proposal refers to meat, samples of muscle tissue were analysed                                                                                                                                                                                                 |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         |                                                | Conclusion: The proposed Codex MRL is not acceptable because derived according to a different residue definition                                                                                                                                                                   |
+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                             | 0.01[\*](#efs25797-note-0030){ref-type="fn"}                                                                                                                            | 0.01 (ft)                                      | See comment on mammalian edible offal                                                                                                                                                                                                                                              |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         |                                                | Conclusion: The proposed Codex MRL is not acceptable because derived according to a different residue definition                                                                                                                                                                   |
+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**              | The proposed Codex MRLs for tissues and milks cannot be taken over in EU legislation because of incompatible residue definitions                                        |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   | In 2014, the proposed Codex MRLs for cabbages, head and kale were retained on step 4, awaiting the livestock feeding study                                              |                                                |                                                                                                                                                                                                                                                                                    |
|                                   |                                                                                                                                                                         |                                                |                                                                                                                                                                                                                                                                                    |
|                                   | In 2014, JMPR also recommended withdrawal of the CXLs for animal products that were derived by Codex in 2007, (once the CXLs are replaced with new Codex MRL proposals) |                                                |                                                                                                                                                                                                                                                                                    |
+-----------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; DM: dry matter; CXL: Codex Maximum Residue Limit.

Indicates that the input value is proposed at the limit of quantification. Ft: EFSA identified some information on analytical methods and a feeding study as unavailable. When re‐viewing the MRL, the Commission will take into account the information referred to in the first sentence, if it is submitted by 22 March 2016 or, if that information is not submitted by that date, lack of it.
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### 5.4.5. Consumer risk assessment {#efs25797-sec-0052}

Considering that the residue definitions are not compatible, and currently reliable conversion factors could not be derived, EFSA did not perform a dietary risk assessment for the proposed Codex MRLs.

5.5. Propiconazole (160) R {#efs25797-sec-0053}
--------------------------

### 5.5.1. Background information {#efs25797-sec-0054}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                                          | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+==========================================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Follow‐up evaluation due to concern form | In 2018 CCPR, the EU raised a reservation:                                                                                                                                                                        |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                                          | over the decision of the 2017 JMPR to use the CF\*3 Mean to recommend the CXL for post‐harvest uses (oranges, mandarins, lemons/limes, pumelo/grapefruit, peach, cherries, plums, pineapple);                     |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                                          | due to toxicological concerns with certain metabolites.                                                                                                                                                           |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                                          | (2018 JMPR followed up on 1)                                                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FI                                       |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved                             | Commission Implementing Regulation (EU) No 2018/1865[a](#efs25797-note-0032){ref-type="fn"}                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments                        | EFSA ([2017e](#efs25797-bib-0082){ref-type="ref"}); EFSA ([2018m](#efs25797-bib-0102){ref-type="ref"}) conclusion confirmatory data on TDMs                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments                        | EFSA ([2015b](#efs25797-bib-0045){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                                       | UK is evaluating an import tolerance application from USA on behalf Finland (agreed at PAFF June 2018 meeting). The application concerns the following crops: barley, wheat, pineapple and peanuts                |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Yes                                      | Harmonised classification and labelling for CMR -- Annex VI: Toxic for reproduction cat. 1B                                                                                                                       |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                                          | EU Peer Review proposal for CMR: Toxic for reproduction cat. 1B                                                                                                                                                   |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                                          | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0802){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level; TDMs: triazole‐derivative metabolites.

Commission Implementing Regulation (EU) 2018/1865 of 28 November 2018 concerning the non‐renewal of approval of the active substance propiconazole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.5.2. Toxicological reference values {#efs25797-sec-0055}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable        |                                                                                                       |    |
+========================+===============================================================================================================================================================================================================================================================================================================================+===============+=======================+=======================================================================================================+====+
| **ADI**                | 0.07 mg/kg bw per day                                                                                                                                                                                                                                                                                                         | JMPR (2015)   | 0.04 mg/kg bw per day | EFSA ([2017e](#efs25797-bib-0082){ref-type="ref"}) (chronic rat study with uncertainty factor of 100) | No |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                  | JMPR (2015)   | 0.1 mg/kg bw          | EFSA ([2017e](#efs25797-bib-0082){ref-type="ref"})                                                    | No |
|                        |                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                               |               |                       | (developmental study in rat with uncertainty factor of 300)                                           |    |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | In the framework of the renewal of the approval (EFSA, [2017e](#efs25797-bib-0082){ref-type="ref"}), EFSA proposed to lower the ARfD; the new value is not yet formally adopted. The ADI has been confirmed                                                                                                                   |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                       |    |
|                        | Propiconazole is proposed to be classified as toxic for reproduction category 1B by the Risk Assessment Committee of ECHA ([2016](#efs25797-bib-0001){ref-type="ref"}), in accordance with the provisions of Regulation (EC) No 1272/2008, and toxic effects on the endocrine organs have been observed in the available data |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                       |    |
|                        | Due to classification (ECHA, [2016](#efs25797-bib-0001){ref-type="ref"}), a non‐approval decision was taken in 2018                                                                                                                                                                                                           |               |                       |                                                                                                       |    |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose.
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### 5.5.3. Residue definitions {#efs25797-sec-0056}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                   | JMPR evaluation                                                                                                                                                      | EU evaluation                                                                                                                                                                                 | RDs comparable |
+=========================+===================================================================================================================================================================================================================================================================================+======================================================================================================================================================================+===============================================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                    | Propiconazole                                                                                                                                                        | EU Reg. 2017/626 and EFSA ([2017e](#efs25797-bib-0082){ref-type="ref"}): Propiconazole (sum of isomers)                                                                                       | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Propiconazole                                                                                                                                                                                                                                                                     | EU Reg. 2017/626: Propiconazole (sum of isomers)                                                                                                                     | Yes                                                                                                                                                                                           |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                        | Peer review (EFSA, [2017e](#efs25797-bib-0082){ref-type="ref"}): CGA91305 (free and conjugated) ((1*RS*)‐1‐(2,4‐dichlorophenyl)‐2‐(1*H*‐1,2,4‐triazol‐1‐yl) ethanol) |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | The residue is fat soluble                                                                                                                                           |                                                                                                                                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                    | Propiconazole plus all metabolites convertible to 2,4‐dichloro‐benzoic acid, expressed as propiconazole                                                              | MRL review(EFSA, [2015b](#efs25797-bib-0045){ref-type="ref"}): Propiconazole and all the metabolites convertible to the 2,4‐dichlorobenzoic acid, expressed as propiconazole (sum of isomers) | Yes            |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      | Peer review (EFSA, [2017e](#efs25797-bib-0082){ref-type="ref"}):                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      | 1\) Propiconazole (sum of isomers);                                                                                                                                                           |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      | 2\) CGA 118244 (3,5‐dideoxy‐1,2‐O‐\[(1*RS*)‐1‐(2,4‐dichlorophenyl)‐2‐(1*H*‐1,2,4‐triazol‐1‐yl)ethylidene\]‐D,L‐pentitol) free and glucoside conjugated                                        |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      | Whether the parent compound and CGA 118244 have to be considered together or separately is pending upon the submission of toxicological data to address the toxicity profile on CGA118244)    |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      | 3\) TDMs (EFSA, [2018m](#efs25797-bib-0102){ref-type="ref"})                                                                                                                                  |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Propiconazole plus all metabolites convertible to 2,4‐dichloro‐benzoic acid, expressed as propiconazole                                                                                                                                                                           | [MRL review (EFSA,]{.ul} [[2015b]{.ul}](#efs25797-bib-0045){ref-type="ref"} [):]{.ul}                                                                                | Yes                                                                                                                                                                                           |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | Parent propiconazole and all the metabolites convertible to the 2,4‐dichlorobenzoic acid, expressed as propiconazole (sum of isomers)                                |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | [Peer review (EFSA,]{.ul} [[2017e]{.ul}](#efs25797-bib-0082){ref-type="ref"} [):]{.ul}                                                                               |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | 1\) Propiconazole, CGA91305 (free and conjugated) and CGA118244                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | (The way the residue definition will be expressed is pending upon the requested toxicological profile on CGA91305 and CGA118244)                                     |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   | 2\) TDMs (EFSA, [2018m](#efs25797-bib-0102){ref-type="ref"})                                                                                                         |                                                                                                                                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The enforcement RD for plants established in Reg. 2017/626 is comparable with the RD of JMPR. For the risk assessment residue definitions, JMPR covers the common moiety (2,4‐dichlorobenzoic acid); in the MRL review, the same risk assessment residue definitions were derived |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         | In the framework of the peer review, data gaps on the genotoxicity potential and toxicological profile of metabolite CGA118244 and CGA91305 were identified                                                                                                                       |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         | JMPR did not set specific residue definitions for the TDMs (TAA and TA).                                                                                                                                                                                                          |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                   |                                                                                                                                                                      |                                                                                                                                                                                               |                |
|                         | Due to the different risk assessment residue definitions for plant commodities and the open questions as regards the toxicological properties of some of the metabolites, only a tentative risk assessment can be performed                                                       |                                                                                                                                                                      |                                                                                                                                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; TDMs: triazole‐derivative metabolites.
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### 5.5.4. Codex MRL proposals {#efs25797-sec-0057}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                                        | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                            |
+==================================================================================================================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==============================================+====================================================================================================================================================================================================================================================================================================================================================+
| Cherries, Subgroup of (including all commodities in this subgroup)                                               | **3Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 0.01[\*](#efs25797-note-0036){ref-type="fn"} | Critical GAP: US post‐harvest GAP: 1 × 12.9 g a.s./100 L (in‐line dip/drench)                                                                                                                                                                                                                                                                      |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 5                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Cherries are a major crop according the JMPR and at EU level. Thus, additional residue trials would be required. Last year, the EU did not make a formal reservation on the lack of residue trials                                                                                                                 |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | The recalculation of the MRL using mean residue + 4 SD resulted in the same MRL proposal as suggested last year                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lemons and limes (including citron) Subgroup of (including all commodities in this subgroup)                     | **10Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 5 (ft)                                       | Critical GAP: US post‐harvest GAP: 2 × 52.7 g a.s./100 L (dip/drench)                                                                                                                                                                                                                                                                              |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 16                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Specific comments/observations: See assessment for the subgroup of oranges                                                                                                                                                                                                                                                                         |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mandarins (including mandarin‐like hybrids) subgroup of (including all commodities in this subgroup)             | **10Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 5 (ft)                                       | Critical GAP: US post‐harvest GAP: 2 × 52.7 g a.s./100 L (dip/drench)                                                                                                                                                                                                                                                                              |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 16                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil                                                                                                       | 1850                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                              | A single‐processing study is available (PF 185). In the EU, no MRLs are set for processed products                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, Sweet, Sour (including orange‐like hybrids) Subgroup of (including all commodities in this subgroup)    | **10Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 9                                            | Critical GAP: USA, post‐harvest GAP: 2 × 52.7 g a.s./100 L (dip/drench),                                                                                                                                                                                                                                                                           |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 16 (8 trials on oranges, 4 trials on mandarins and 4 trials on lemons)                                                                                                                                                                                                                                                           |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Specific comments/observations: The CF for risk assessment was derived from residue trials in cherries. The validity of this extrapolation is not questionable, but formally the EU did not make a reservation on that point                                                                                                                       |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                                                            | 0.7Po                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 5                                            | Critical GAP: US post‐harvest GAP: 1 × 0.54 g a.s./1,000 kg (in‐line aqueous/fruit‐coating spray)                                                                                                                                                                                                                                                  |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 3                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Specific comments/observations: Peaches are a category 3 crop for JMPR; therefore, at least 5 trials would be required. Last year, the EU did not make a formal reservation on the lack of residue trials                                                                                                                                          |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480. Furthermore, a acute intake concern was identified for peaches |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                                                        | **2Po**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 0.02[\*](#efs25797-note-0036){ref-type="fn"} | Critical GAP: US post‐harvest GAP: 1 × 25.8 g a.s./100 L (drench) + 1 × 25.8 g a.s./100 L (directed peduncle spray)                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Specific comments/observations: According the JMPR, pineapples are a category 3 crop, thus, at least 5 residue trials would be required. Last year, the EU did not make a formal reservation on the lack of residue trials                                                                                                                         |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | UK is evaluating an import tolerance application from USA on behalf Finland (agreed at PAFF June 2018 meeting). The application concerns also pineapples. The GAP and residue data for pineapple seems to be the same as the ones considered by JMPR                                                                                               |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Plums, Subgroup of (includes all commodities in this subgroup)                                                   | 0.4Po                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.01[\*](#efs25797-note-0036){ref-type="fn"} | Critical GAP: US post‐harvest GAP: 1 9 0.54 g a.s./1,000 kg (in‐line aqueous/fruit‐coating spray)                                                                                                                                                                                                                                                  |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 5                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Specific comments/observations: Sufficient number of trials according to JMPR rules, but at EU level 8 trials would be required                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pumelo and grapefruit (including Shaddock‐like hybrids) Subgroup of (including all commodities in this subgroup) | 4Po                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 5 (ft)                                       | Critical GAP: US post‐harvest GAP: 2 9 52.7 g a.s./100 L (dip/drench)                                                                                                                                                                                                                                                                              |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              | Conclusion: It is recommended to discuss with MSs whether the proposed Codex MRL is acceptable considering the fact that propiconazole is proposed to be classified as toxic for reproduction category 1B in accordance with that Regulation. Commission Regulation (EU) 2018/1480                                                                 |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                                             | 2018 CCPR Meeting agreed that more refined maximum residue levels are possible for the post‐harvest uses considered by the 2017 JMPR using the mean + 4 SD. The residue data assessed by the 2017 JMPR for post‐harvest uses are suitable for estimating maximum residue levels, and for estimating STMR and HR for long‐term and acute dietary exposure assessments. The Meeting recommended the following maximum residue levels based on the mean + 4 SD for the post‐harvest uses of propiconazole on the crops considered in the 2017 Meeting                                                                                                                                                                                                                                                                                                                                                                                |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  | In the light of the recent decision on non‐approval of the a.s. and the lowering of the ARfD in 2017, the existing EU MRLs should be reviewed. Finland has screened the existing EU MRLs in the light of the new toxicological reference values. The assessment was based on the existing RD for RA. STMR, HR and CFs were taken from the previous EFSA assessment on the complete MRL review (EFSA, [2015b](#efs25797-bib-0045){ref-type="ref"}) and JMPR reports. Calculations by PRIMO rev. 3 resulted in the ARfD exceedance for the following crops: oranges, peaches, grapefruits, mandarins, lemons and tomatoes. In all cases, the GAPs are based on post‐harvest uses (consequently, a CF of 1 was used in the assessment). MRLs for orange, peach and tomatoes are based on CXLs, implemented in the EU legislation. The results of the screening exercise will be presented to the PAFF‐Residues meeting February 2019 |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                              |                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                  | (ft) In the framework of the MRL review, certain information was considered for lemons, lime, mandarins and grapefruit; deadline for submission of the missing data: 30 March 2018. Finland received an MRL application concerning Art. 12 confirmatory data. The submission included studies on the toxicological properties of the metabolites convertible to 2,4‐dichlorobenzoic acid and new residue trials on barley, wheat, maize and sugar beet; and a processing study on cereals. Studies on magnitude of residues were also requested to confirm MRLs for grapefruits, lemon, limes, mandarins, apples, apricots, grapes, bananas and rice, but not submitted. Evaluation of residue data has not been started yet, but the tox. part is going to be finalised during spring and can be submitted earlier, if needed                                                                                                    |                                              |                                                                                                                                                                                                                                                                                                                                                    |
+------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; MS: Member State; a.s.: active substance; CF: conversion factor; STMR: supervised trials median residue; HR: highest residue; ARfD: acute reference dose; RD: residue definition; RA: risk assessment; PRIMo: (EFSA) Pesticide Residues Intake Model; CXL: Codex Maximum Residue Limit.

Indicates that the input value is proposed at the limit of quantification.
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### 5.5.5. Consumer risk assessment {#efs25797-sec-0058}

###### 

Summary of the consumer risk assessment

+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                             | Chronic exposure assessment                                                                                                                                                                                                                                                                                                             | Comments on JMPR exposure assessment |
+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                   | **RA assumptions:**                                                                                                                                                                                                                                                                                                                     | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| The short‐term dietary risk assessment was performed for crops under consideration in 2018 JMPR                                                                                                                                                                                                                                                                                                                                                                       | The most recent long‐term risk assessment (EFSA, [2015b](#efs25797-bib-0045){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for rape seed                                                                                                               | --                                   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| The EU ARfD was used                                                                                                                                                                                                                                                                                                                                                                                                                                                  | The most recent long‐term risk assessment for parent propiconazole (EFSA, [2015b](#efs25797-bib-0045){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR pulp values derived by JMPR for citrus fruits, the STMR whole fruit cherries, peaches, plums and the STMR‐P for pineapple |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| A tentative short‐term dietary risk assessment was performed for parent propiconazole for citrus fruits with exception of grapefruits, cherries, peaches, plums and pineapples using the HR pulp value for citrus fruit, the HR whole fruit for peaches, cherries and plums and the HR‐P for pineapple. For grapefruits, the STMR and HR derived by JMPR for the post‐harvest use were included, because they were higher than the previously derived EU input values | The EU ADI was used                                                                                                                                                                                                                                                                                                                     |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| The risk assessment is considered tentative, because of the difference of residue definitions established at EU level and by JMPR. Additional uncertainties in the risk assessment are resulting from the lack of data                                                                                                                                                                                                                                                | The risk assessment is considered                                                                                                                                                                                                                                                                                                       |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| on the residue concentration compliant with the residue definition for risk assessment for citrus and the lack of information on the possible impact of plant and livestock metabolism on the isomer ratio of propiconazole                                                                                                                                                                                                                                           | tentative, because of the difference of                                                                                                                                                                                                                                                                                                 |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| Risk management decision required how to proceed with active substances that are not approved in the EU due non‐compliance with cut‐off criteria                                                                                                                                                                                                                                                                                                                      | residue definitions established at EU level                                                                                                                                                                                                                                                                                             |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | and by JMPR                                                                                                                                                                                                                                                                                                                             |                                      |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                          | **Results:**                                                                                                                                                                                                                                                                                                                            | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| A short‐term exposure concern was identified (209% of the ARfD for peaches                                                                                                                                                                                                                                                                                                                                                                                            | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                        | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
| Furthermore, an acute intake concern was identified for the EU MRL for tomatoes due to the use of PRIMo 3                                                                                                                                                                                                                                                                                                                                                             | The overall chronic exposure accounted for 21% of the ADI (NL toddler).                                                                                                                                                                                                                                                                 | 21% of the ADI (NL toddler)          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | The contribution of apples and maize corn to the exposure was 3% each of the ADI                                                                                                                                                                                                                                                        | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         | 209% of the ARfD for peaches         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                         | 57% of the ARfD for oranges          |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue; HR: highest residue; ADI: acceptable daily intake; MRL: maximum residue level; RA: risk assessment; PRIMo: (EFSA) Pesticide Residues Intake Model.
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5.6. Profenofos (171) R {#efs25797-sec-0059}
-----------------------

### 5.6.1. Background information {#efs25797-sec-0060}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
|                                                                                                                                        |                                                    | Comments, references                                                           |
+========================================================================================================================================+====================================================+================================================================================+
| Type of JMPR evaluation                                                                                                                | New use                                            | Last periodic review 2008                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| RMS                                                                                                                                    | --                                                 | RMS Germany: toxicological evaluation in the framework of setting MRLs         |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved                                       | Commission Regulation (EC) No 2076/2002[a](#efs25797-note-0039){ref-type="fn"} |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | No                                                 |                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                                                 |                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                                                 |                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met                                            | Harmonised classification and labelling for CMR -- Annex VI: none              |
|                                                                                                                                        |                                                    |                                                                                |
|                                                                                                                                        | ED: No information available as not approved in EU |                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+--------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Regulation (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in Article 8(2) of Council Directive 91/414/EEC and concerning the non‐inclusion of certain active substances in Annex I to that Directive and the withdrawal of authorisations for plant protection products containing these substances. OJ L 319, 23.11.2002, p. 3--11.
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### 5.6.2. Toxicological reference values {#efs25797-sec-0061}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                           | EU evaluation                               | TRV comparable          |                                                                                                                                                                               |    |
+========================+===========================================================================================================================================================================================================+=============================================+=========================+===============================================================================================================================================================================+====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                     | JMPR (2007)                                 | 0.0002 mg/kg bw per day | German evaluation of 2001                                                                                                                                                     | No |
|                        |                                                                                                                                                                                                           |                                             |                         |                                                                                                                                                                               |    |
|                        |                                                                                                                                                                                                           | (dog: 90 days, 6 months and 1 year studies) |                         | (dog 1‐year study. Toxicological evaluation at EU level performed in the framework of setting MRLs under Council Directive 90/642/EEC[a](#efs25797-note-0041){ref-type="fn"}) |    |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 1 mg/kg bw                                                                                                                                                                                                | JMPR (2007)                                 | 0.005 mg/kg bw          | No                                                                                                                                                                            |    |
|                        |                                                                                                                                                                                                           |                                             |                         |                                                                                                                                                                               |    |
|                        |                                                                                                                                                                                                           | (rat acute neurotoxicity)                   |                         |                                                                                                                                                                               |    |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The German ADI is based on the LOAEL 1 mg/kg bw per day with an UF of 200                                                                                                                                 |                                             |                         |                                                                                                                                                                               |    |
|                        |                                                                                                                                                                                                           |                                             |                         |                                                                                                                                                                               |    |
|                        | The ARfD is based on the NOAEL for the inhibition of brain cholinesterase activity                                                                                                                        |                                             |                         |                                                                                                                                                                               |    |
|                        |                                                                                                                                                                                                           |                                             |                         |                                                                                                                                                                               |    |
|                        | Due to the limited details available in the JMPR Report and the German evaluation, a final conclusion on the acceptability of the toxicological reference values derived by the two bodies cannot be made |                                             |                         |                                                                                                                                                                               |    |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; LOAEL: lowest observed adverse effect level; NOAEL: no observed adverse effect level; RMS: rapporteur Member State; MRL: maximum residue level; UF: uncertainty factor.

Council Directive 90/642/EEC of 27 November 1990 on the fixing of maximum levels for pesticide residues in and on certain products of plant origin, including fruit and vegetables. OJ L 350, 14.12.1990, p. 71--79.
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### 5.6.3. Residue definitions {#efs25797-sec-0062}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+
|                         | Commodity group                                                                                                         | JMPR evaluation              | EU evaluation                | RDs comparable |
+=========================+=========================================================================================================================+==============================+==============================+================+
| **RD enf**              | Plant products                                                                                                          | Profenofos                   | EU Reg. 2017/978: Profenofos | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+
| Animal products         | Profenofos                                                                                                              | EU Reg. 2017/978: Profenofos | Yes                          |                |
|                         |                                                                                                                         |                              |                              |                |
|                         | The residue is not fat soluble                                                                                          | The residue is fat soluble   |                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                          | Profenofos                   | EU Reg. 2017/978: Profenofos | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+
| Animal products         | Yes                                                                                                                     |                              |                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+
| **Conclusion/comments** | The JMPR defines the residues as not fat soluble, whereas the EU residue definition defines the residues as fat soluble |                              |                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------+------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.
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### 5.6.4. Codex MRL proposals {#efs25797-sec-0063}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal                                                                                                                                                                                             | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+======================+================================================================================================================================================================================================================+==============================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Coffee bean          | 0.04                                                                                                                                                                                                           | 0.05[\*](#efs25797-note-0044){ref-type="fn"} | Critical GAP: Brazil, 2 × 400 g/ha, 30‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                      |                                                                                                                                                                                                                |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                      |                                                                                                                                                                                                                |                                              | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                      |                                                                                                                                                                                                                |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                      |                                                                                                                                                                                                                |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                      |                                                                                                                                                                                                                |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                      |                                                                                                                                                                                                                |                                              | Specific comments/observations: According to the JMPR criteria, the number of trials is not sufficient because coffee beans are classified as a major crop and a minimum of 8 trials are normally required. The number of trials is not sufficient according to the EU data requirements. The limited number of trials is of low relevance since the Codex MRL proposal is lower than the current EU MRL at the LOQ of 0.05 mg/kg. Further consideration may be required in case the LOQ is in future lowered |
|                      |                                                                                                                                                                                                                |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                      |                                                                                                                                                                                                                |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. The long‐term risk assessment indicated a potential consumer health risk in the scenario where the toxicological reference value (ADI) derived by the EU evaluation was used                                                                                                                                                                                     |
+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments** | Monitoring data carried out between 2012 and 2015 show that residues of profenofos occur in herbs and rose petals and Commission Regulation (EU) 2017/978 extend the validity of EU MRLs for these commodities |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+----------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; LOQ: limit of quantification; ADI: acceptable daily intake.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.6.5. Consumer risk assessment {#efs25797-sec-0064}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                               | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Comments on JMPR exposure assessment |
+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================+==================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                     | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
| The short‐term dietary risk assessment was performed for coffee beans using STMR derived by JMPR for coffee beans. EFSA calculated two scenarios because a conclusion on the acceptability of the toxicological reference values (ARfD) derived by the JMPR and the EU evaluation cannot be made on the basis of the available information. Scenario 1: The EU evaluation ARfD was used (German evaluation of 2001). Scenario 2: The JMPR ARfD was used | An indicative long‐term risk assessment was performed using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for coffee beans, as well as the STMR values previously derived by JMPR for mango, mangosteen (EU classification 0163040 papayas), tomato, anise seeds, star anise seeds (EU classification 0820040 cardamom), caraway seeds, coriander seeds, cumin seeds, fennel seeds, juniper berries, nutmeg, mace, cardamom (higher STMR value for star anise seeds used) and grains of paradise (EU classification 0820060 peppercorn). For chili peppers, the existing EU MRL was used for the EU classification of sweet peppers/bell peppers considering the low contribution expected from the specific use on chili peppers. | None                                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         | For other commodities, EFSA applied the MRLs established in the EU legislation according to the Corrigendum to Commission Regulation (EU) 2017/978 except for where the EU MRL is set at the LOQ (no use expected) and for animal commodities (contamination of imported feed items is not expected). EFSA calculated two scenarios because a conclusion on the acceptability of the toxicological reference values (ADI) derived by the JMPR and the EU evaluation cannot be made on the basis of the available information                                                                                                                                                                                                                                                     |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Scenario 1: The EU evaluation ADI was used (German evaluation of 2001)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         | Scenario 2: The JMPR ADI was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                            | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
| No short‐term exposure concern was identified                                                                                                                                                                                                                                                                                                                                                                                                           | The long‐term risk assessment indicated a potential consumer health risk in the scenario where the toxicological reference value (ADI) derived by the EU evaluation was used. No long‐term consumer health risk was identified in the scenario where the toxicological reference value (ADI) derived by the JMPR was used                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
| [Scenario 1, EU evaluation ARfD:]{.ul} The estimated short‐term exposure from coffee beans accounted for \< 0.3% of the ARfD                                                                                                                                                                                                                                                                                                                            | [Scenario 1, EU evaluation ADI:]{.ul} The overall chronic exposure accounted for 2,800% of the ADI (GEMS/Food G06). The diet with the highest contribution of coffee beans to the chronic exposure was 56% of the ADI for the FI adult diet. The main contributor to the exposure is tomatoes (2,327%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 0--20% of the ADI                    |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
| [Scenario 2, JMPR ARfD:]{.ul} The estimated short‐term exposure from coffee beans accounted for \< 0.01% of the ARfD                                                                                                                                                                                                                                                                                                                                    | [Scenario 2, JMPR ADI:]{.ul} The overall chronic exposure accounted for 19% of the ADI (GEMS/Food G06). The diet with the highest contribution of coffee beans to the chronic exposure was 0.37% of the ADI for the FI adult diet                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 0% of the ARfD                       |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; STMR: supervised trials median residue; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; LOQ: limit of quantification; ADI: acceptable daily intake.
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5.7. Bentazone (172) R {#efs25797-sec-0065}
----------------------

### 5.7.1. Background information {#efs25797-sec-0066}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use                 |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | NL                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Renewal of the approval | Commission Decision 2000/68/EC[a](#efs25797-note-0047){ref-type="fn"} amended by Commission Implementing Regulation (EU) 2018/660[b](#efs25797-note-0048){ref-type="fn"}                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2015i](#efs25797-bib-0052){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments       | EFSA ([2012c](#efs25797-bib-0022){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | EFSA ([2011b](#efs25797-bib-0016){ref-type="ref"}) (legume vegetables and fresh herbs)                                                                                                                            |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | In sweet corn (EFSA, [2010b](#efs25797-bib-0012){ref-type="ref"})                                                                                                                                                 |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | Confirmatory data following Art.12 under‐finalisation                                                                                                                                                             |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | Art. 10 MRLs in various commodities under‐consideration                                                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonized classification and labelling for CMR -- Annex VI: Toxic for reproduction cat. 2                                                                                                                        |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[c](#efs25797-note-0803){ref-type="fn"}): not finalised |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

2000/68/EC: Commission Directive 2000/68/EC of 23 October 2000 including an active substance (bentazone) in Annex I to

Council Directive 91/414/EEC concerning the placing of plant protection products on the market. OJ L 276, 28.10.2000, p. 41--43.

Commission Implementing Regulation (EU) 2018/660 of 26 April 2018 renewing the approval of the active substance bentazone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 110, 30.4.2018, p. 122--126.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.7.2. Toxicological reference values {#efs25797-sec-0067}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | EU evaluation | TRV comparable        |                                                                                                                           |     |
+========================+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+===========================================================================================================================+=====+
| **ADI**                | 0.09 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | JMPR (2016)   | 0.09 mg/kg bw per day | EFSA ([2015i](#efs25797-bib-0052){ref-type="ref"})                                                                        | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       | (rat, 2‐year study with an UF of 100) conformed in European Commission ([2018c](#efs25797-bib-0148){ref-type="ref"})      |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.5 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR (2016)   | 1 mg/kg bw            | EFSA ([2015i](#efs25797-bib-0052){ref-type="ref"})                                                                        | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       | (rat developmental toxicity study, 100 UF) conformed in European Commission ([2018c](#efs25797-bib-0148){ref-type="ref"}) |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | Regarding the setting of the ADI, both the JMPR and EU assessments are based on the same NOAEL of 9 mg/kg bw per day from the same two‐year toxicity study in rats and applying an uncertainty factor of 100                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | The ARfD established by the JMPR is based on an acute neurotoxicity study in rats that was not available to the EU peer review; this study should be reviewed in the EU peer review to re‐visit the established ARfD                                                                                                                                                                                                                                                                                                                                                                                       |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | In the opinion of the EU peer review, the toxicological reference values of the parent, bentazone, are applicable to the metabolite 8‐hydroxy‐bentazone, however according to the EFSA conclusion, insufficient toxicological information is available to establish reference values for metabolite 6‐hydroxy‐bentazone                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | In the Review report for the active substance bentazone finalised in the Standing Committee, the following statement for the bentazone metabolites (6‐OH and 8‐OH bentazone) was made:                                                                                                                                                                                                                                                                                                                                                                                                                     |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | *According to the JMPR review of bentazone (Bentazone 31‐98, JMPR 2012) the 8‐hydroxy and 6‐hydroxy metabolites of bentazone are of comparable toxicity by the oral route of administration and are both less toxic than the parent compound. In addition the RMS informed that even if 6‐OH bentazone would not be regarded as toxicologically equivalent to 8‐OH‐bentazone, the consumer exposure falls below 1.5 μg/kg bw/day (TTC Cramer Class III for non‐genotoxic substances). The TTC approach was recommended in the Scientific Opinion (EFSA,* [*2012c*](#efs25797-bib-0022){ref-type="ref"} *)* |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | According to the RMS NL, the EU Commission Review Report (2018c) closed the EFSA data gap. The reference values of the parent should also be applicable to 6‐hydroxy‐bentazone                                                                                                                                                                                                                                                                                                                                                                                                                             |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | For the 8‐hydroxy‐bentazone, the peer review concluded that it is less toxic than parent compound and the reference values of parent can be applied to this metabolite. The peer review did not consider this metabolite relevant for the inclusion in the residue definitions. Actual levels of this metabolite in plants are low                                                                                                                                                                                                                                                                         |               |                       |                                                                                                                           |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                       |                                                                                                                           |     |
|                        | Following the setting of an ARfD by JMPR in 2016, JMPR re‐assessed the previously derived CXLs as regards possible acute intake concerns                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                       |                                                                                                                           |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; TTC: threshold of toxicological concern; RMS: rapporteur Member State; CXL: Codex Maximum Residue Limit.
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### 5.7.3. Residue definitions {#efs25797-sec-0068}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | JMPR evaluation                                                                                                     | EU evaluation                                                                                                                                                                      | RDs comparable |
+=========================+======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================+====================================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | Bentazone                                                                                                           | MRL review 2012c and Reg. (EC) No 1146/2014: Sum of bentazone, its salts and 6‐hydroxy (free and conjugated) and 8‐hydroxy bentazone (free and conjugated), expressed as bentazone | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | The residue is not fat soluble                                                                                      | Peer review (2015i) proposal: Bentazone                                                                                                                                            |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | MRL review 2012c and Reg. (EC) No 1146/2014: Sum of bentazone, its salts and 6‐hydroxy (free and conjugated), expressed as bentazone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | No                                                                                                                  |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         | Not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         | Peer review (2015i) (provisional):                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         | 6‐hydroxy‐bentazone, expressed as bentazone (all animal commodities, except milk)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         | 6‐hydroxy‐bentazone (sulphate) conjugates, expressed as bentazone (milk only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                     |                                                                                                                                                                                    |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | MRL review (2012c): same as RD for enforcement                                                                      | No                                                                                                                                                                                 |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Peer review (2015i): Sum of bentazone, 6‐hydroxy‐bentazone and its conjugates, expressed as bentazone (provisional) |                                                                                                                                                                                    |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                     |                                                                                                                                                                                    |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The EU and JMPR residue definitions for bentazone are not comparable. The metabolite 6‐hydroxy‐bentazone is included in the currently applicable enforcement and risk assessment residue definitions in the EU. For plant commodities, additionally, the 8‐hydroxy‐metabolite is included in the enforcement and risk assessment residue definitions. Thus, as long as the EU residue definitions are not modified, the Codex MRL proposals are not compatible with the EU enforcement residue definitions. Furthermore, a common understanding regarding the data gap on toxicological information for metabolite 6‐hydroxy‐bentazone should be derived (see Conclusion/comments on toxicological reference values) |                                                                                                                     |                                                                                                                                                                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                     |                                                                                                                                                                                    |                |
|                         | The enforcement residue definition for plant commodities as proposed by the peer review (not yet enforced) complies with the residue definition derived by the JMPR, but this residue definition is not yet implemented                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                     |                                                                                                                                                                                    |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.
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### 5.7.4. Codex MRL proposals {#efs25797-sec-0069}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                          | Codex MRL proposal                                                                                                                                                                                 | EU MRL                             | Comment                                                                                                                                                                                                                                                                                                                                      |
+====================================================================+====================================================================================================================================================================================================+====================================+==============================================================================================================================================================================================================================================================================================================================================+
| Beans (dry)                                                        | W 0.04                                                                                                                                                                                             | 0.1                                | Withdrawal on the basis of new CXL as extrapolated from dry peas (see comment below)                                                                                                                                                                                                                                                         |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry beans, subgroup of (includes all commodities in this subgroup) | **0.5**                                                                                                                                                                                            | 0.1                                | Critical GAP: USA, foliar, 2 × 1.12 kg/ha, PHI 30 days                                                                                                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    | Soya beans: 0.03\*                 | Number of trials: 8                                                                                                                                                                                                                                                                                                                          |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                           |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Specific comments/observations: Extrapolation from peas. The Codex MRL proposal would also cover soya beans; residue trials on soybeans would be also required                                                                                                                                                                               |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Conclusion: The proposed Codex MRL is not acceptable because the Codex residue definition is not compatible with the EU residue definition (occurrence of 6‐hydroxy and 8‐hydroxy‐bentazone has not been investigated)                                                                                                                       |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry peas, subgroup of (includes all commodities in this subgroup)  | 0.5                                                                                                                                                                                                | 1                                  | Critical GAP: USA, foliar, 2 × 1.12 kg/ha, PHI 30 days                                                                                                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Number of trials: 8                                                                                                                                                                                                                                                                                                                          |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                          |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Specific observations: The CXL derived in 1997 has been taken over in the EU. 2013 JMPR recommended withdrawal of this old CXL; since JMPR derived a new MRL proposal, the CXL for Field peas (dry) VD0561) should be withdrawn                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Conclusion: The proposed Codex MRL is not acceptable because the Codex residue definition is not compatible with the EU residue definition (occurrence of 6‐hydroxy and 8‐hydroxy‐bentazone has not been investigated). Risk managers to discuss the replacement of the existing EU MRL, considering that the previous CXL will be withdrawn |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                           | 0.04                                                                                                                                                                                               | 1 (ft) except swine with 0.15 (ft) | The Codex MRL proposal is based on the maximum dietary burden calculated by 2013 JMPR based on the OECD feeding tables of 2009, and the new cow feeding study submitted for the current meeting. The CXL for edible offal derived on the basis of estimated residues in kidney at the calculated DB                                          |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | The new use on beans/peas does not have an impact on the DB                                                                                                                                                                                                                                                                                  |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | The existing EU MRL is currently assessed for the Article 12 confirmatory data. The same cow feeding study was provided in the EU assessment for the Article 12 confirmatory data gap/EU peer review data gap                                                                                                                                |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | Considering the different residue definitions, the proposed Codex MRL would not be compatible with the EU legislation                                                                                                                                                                                                                        |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                  | 0.01\*                                                                                                                                                                                             | 1 (ft) except swine 0.15 (ft)      | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                      | 0.01\*                                                                                                                                                                                             | 0.02\* (ft)                        | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                              | 0.01\*                                                                                                                                                                                             | 0.02\* (ft)                        | The CXL proposal is based on the maximum dietary burden calculated for Australian dairy cattle by the 2013 JMPR, and the new cow feeding study submitted for the current meeting. The new use on beans/peas does not have an impact on the DB                                                                                                |
|                                                                    |                                                                                                                                                                                                    |                                    |                                                                                                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                    |                                    | The existing EU MRL is currently assessed for the Article 12 confirmatory data. The same cow feeding study was submitted for EU assessment. Considering the different residue definitions, the proposed Codex MRL would not be compatible with the EU legislation                                                                            |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean                                                          | W 0.01\*                                                                                                                                                                                           | 0.03\*                             | See comments on dry beans, subgroup of (includes all commodities in this subgroup)                                                                                                                                                                                                                                                           |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                               | The Codex MRL proposals are not compatible with the EU residue definitions; in the residue trials assessed by JMPR the metabolites included in the EU residue definition are not reported/analysed |                                    |                                                                                                                                                                                                                                                                                                                                              |
+--------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; PHI: preharvest interval; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; OECD: Organisation for Economic Co‐operation and Development; DB: Dietary Burden.
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### 5.7.5. Consumer risk assessment {#efs25797-sec-0070}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                     | Chronic exposure assessment                                                                                                                                                                                                                                  | Comments on JMPR exposure assessment                                                                                                                      |
+===============================================================================================================================================================================================================================================================+==============================================================================================================================================================================================================================================================+===========================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                           | **RA assumptions:**                                                                                                                                                                                                                                          | **Specific comments:**                                                                                                                                    |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
| The short‐term dietary risk assessment was performed using PRIMo rev.3, considering all commodities for which the authorised uses were reported for the Article 12 MRL review and for which the MRL proposal was enforced in the Regulation (EU) No 1146/2014 | The long‐term dietary risk assessment was performed using PRIMo rev.3, considering all commodities for which the authorised uses were reported for the Article 12 MRL review and for which the MRL proposal was enforced in the Regulation (EU) No 1146/2014 | The occurrence of 6‐hydroxy and 8‐hydroxy bentazone was not investigated by the JMPR. The exposure assessment was performed for the parent bentazone only |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
| The crops for which no uses were reported under Article 12 MRL review were excluded from the calculation.                                                                                                                                                     | The crops for which no uses were reported under Article 12 MRL review were excluded from the calculation                                                                                                                                                     | The ARfD set by the JMPR for bentazone is lower (0.05 mg/kg bw) than the value established in the EU (1 mg/kg bw)                                         |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
| The Codex MRL proposal for dry beans and soya beans was included for an indicative calculation, noting that the RD of JMPR does not cover the metabolites included in the EU RD                                                                               | The Codex MRL proposal for dry beans and soya beans was included for an indicative calculation, noting that the RD of JMPR does not cover the metabolites included in the EU RD                                                                              |                                                                                                                                                           |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
| The EU ARfD was used for the calculation                                                                                                                                                                                                                      | The EU ADI was used                                                                                                                                                                                                                                          |                                                                                                                                                           |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                  | **Results:**                                                                                                                                                                                                                                                 | **Results:**                                                                                                                                              |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
| No short‐term exposure concern was identified                                                                                                                                                                                                                 | No long‐term consumer health risk was identified                                                                                                                                                                                                             | Long‐term exposure:                                                                                                                                       |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
|                                                                                                                                                                                                                                                               | The overall chronic exposure accounted for a maximum of 3% of the ADI                                                                                                                                                                                        | 1% of the ADI                                                                                                                                             |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              | Short‐term exposure:                                                                                                                                      |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              |                                                                                                                                                           |
|                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                              | 0% of the ARfD                                                                                                                                            |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; PRIMo: (EFSA) Pesticide Residues Intake Model; MRL: maximum residue level; RD: residue definition; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake; ARfD: acute reference dose; bw: body weight.
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5.8. Abamectin (177) R {#efs25797-sec-0071}
----------------------

### 5.8.1. Background information {#efs25797-sec-0072}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                             |
+========================================================================================================================================+===================+==================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | AT                |                                                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) No 2017/438[a](#efs25797-note-0054){ref-type="fn"}                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"}) (acaricide use)                                                                                                                                               |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | EFSA ([2016d](#efs25797-bib-0067){ref-type="ref"}) (nematicide use)                                                                                                                                              |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | EFSA conclusions ongoing (AIR IV)                                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2014h](#efs25797-bib-0042){ref-type="ref"})                                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2015l](#efs25797-bib-0055){ref-type="ref"}) (various crop)                                                                                                                                                |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | EFSA ([2017k](#efs25797-bib-0088){ref-type="ref"}) (banana)                                                                                                                                                      |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | EFSA ([2018g](#efs25797-bib-0096){ref-type="ref"}) (citrus fruits)                                                                                                                                               |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | Celery and fennel (ongoing, currently on clock‐stop)                                                                                                                                                             |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | Confirmatory data Art. 12 and Art 10 application on a number of crops (certain nuts, pomefruit, berries, papaya, radish, leafy vegetables, legume vegetables) (ongoing)                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonized classification and labelling for CMR -- Annex VI: Toxic for reproduction cat. 2                                                                                                                       |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | EU Peer Review proposal for CMR: Toxic for reproduction cat. 2                                                                                                                                                   |
|                                                                                                                                        |                   |                                                                                                                                                                                                                  |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0804){ref-type="fn"}): no conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

2017/438/EU: Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin. OJ L 67, 14.3.2017, p. 67--69.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.8.2. Toxicological reference values {#efs25797-sec-0073}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable          |                                                                  |    |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=========================+==================================================================+====+
| **ADI**                | 0.001 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR (2015)   | 0.0025 mg/kg bw per day | EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"});              | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        | bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                         | European Commission ([2008](#efs25797-bib-0130){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         | (18‐ and 53‐week dog study, UF 100)                              |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+------------------------------------------------------------------+----+
| **ARfD**               | 0.003 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR (2015)   | 0.005 mg/kg bw          | EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"});              | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         | European Commission ([2008](#efs25797-bib-0130){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         | (acute neurotoxicity rat, UF 100)                                |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+------------------------------------------------------------------+----+
| **Conclusion/comment** | The toxicological reference values derived by JMPR are lower than the ones derived at EU level. It is noted that the ADI/ARfD of JMPR applies also to the 8,9‐Z‐isomer and the 24‐hydroxymethyl metabolite of abamectin                                                                                                                                                                                                                                                                                       |               |                         |                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        | The developmental neurotoxicity study in rats was not peer reviewed by EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"}). EFSA would consider appropriate to use this study as a point of departure for setting the ADI. The use of the dog studies for setting the ARfD would be also consider appropriate since the effects described by JMPR were observed during the first week of treatment                                                                                                             |               |                         |                                                                  |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                         |                                                                  |    |
|                        | Regarding metabolites, EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"}) also concluded that 8,9‐*Z*‐isomer showed a similar profile to abamectin. EFSA ([2008b](#efs25797-bib-0007){ref-type="ref"}) did not discuss the toxicological profile of 24‐hydroxymethyl metabolite of abamectin; however, being a major rat metabolite as described by JMPR, EFSA would support the view that it could be considered covered by parent and then the reference values of abamectin would apply to this metabolite |               |                         |                                                                  |    |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------+------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose.
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### 5.8.3. Residue definitions {#efs25797-sec-0074}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR evaluation                                                                   | EU evaluation                                                                                                         | RDs comparable |
+=========================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===================================================================================+=======================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Avermectin B1a                                                                    | EU Reg. 2018/1514:                                                                                                    | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   | Abamectin (sum of avermectin B1a, avermectin B1b and delta‐8,9‐isomer of avermectin B1a, expressed as avermectin B1a) |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Avermectin B1a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | EU Reg. 2018/1514:                                                                | Yes                                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Avermectin B1a                                                                    |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | (except honey; for honey, see plant RD)                                           |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | The residue is fat soluble                                                        |                                                                                                                       |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Avermectin B1a                                                                    | Abamectin (sum of avermectin B1a, avermectin B1b and delta‐8,9 isomer of avermectin B1a, expressed as avermectin B1a) | No             |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Avermectin B1a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Abamectin (sum of avermectin B1a and avermectin B1b, expressed as avermectin B1a) | No                                                                                                                    |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant commodities:** The residue definitions set for enforcement and risk assessment by JMPR and at EU level in plant commodities are not comparable                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         | In the EU, the residue definitions are more comprehensive. Beside the minor abamectin component avermectin B1b (≤ 20% of abamectin mixture), the photodegradate (8,9‐*Z*‐isomer, identified also as delta‐8,9‐isomer or NOA427011) of avermectin B1a was included, since it is found in plant metabolism studies in concentrations three times higher than avermectin B1a. The three compounds can be determined with the enforcement analytical method simultaneously. In addition, the formation of the photodegradate during the sample analysis cannot be excluded as well |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         | Overall, the enforcement residue definitions established by JMPR and at EU level are not compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         | **Animal commodities:** The residue definition set for enforcement by JMPR and at EU level are comparable. NB: The residue definition for enforcement reported in EU Reg. 2018/1514 was taken over from the legislation on veterinary medicinal products (marker substance avermectin B1a). The current uses of abamectin as pesticide does not lead to residues in animal products.                                                                                                                                                                                           |                                                                                   |                                                                                                                       |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                   |                                                                                                                       |                |
|                         | Both assessments concluded that residues in products of animal origin are fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                   |                                                                                                                       |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 5.8.4. Codex MRL proposals {#efs25797-sec-0075}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                             | Codex MRL proposal                                                                                                                                                                                                                                                                 | EU MRL                                           | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+=======================================================================================+====================================================================================================================================================================================================================================================================================+==================================================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Blackberries                                                                          | 0.05 (W)                                                                                                                                                                                                                                                                           |                                                  | The previous CXL was withdrawn. It will be covered by the proposed CXL for the subgroup of cane barriers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cane berries, subgroup of includes all commodities in this subgroup)                  | **0.2**                                                                                                                                                                                                                                                                            | 0.08                                             | Critical GAP: USA, 2 × 0.0213 kg/ha, interval 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (blackberries, raspberries)                      | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (dewberries, other cane berries)                 | Specific comments/observations: Trials conducted on blackberry and raspberry, all with 3 instead of 2 applications. Based on decline trials results, JMPR concluded that number of applications do not had an impact on the final residue concentrations of avermectin B1a. Information on the magnitude and the decline behaviour of avermectin B1b and of the delta‐8,9‐isomer of avermectin B1a in cane berries not reported. The Codex MRL proposal refers to avermectin B1a residues only and would cover blackberries, raspberries and dewberries                                                                                                                                                         |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL for cane fruits is not acceptable because residue definitions for enforcement are not compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Chives, dried                                                                         | 0.08                                                                                                                                                                                                                                                                               | --                                               | Critical GAP: not reported in the summary report                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: PF of 5 refers to avermectin B1a residues only. It is noted that in the EU the MRL is set for the fresh product, but not for dried chives                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grape (= currants, raisins and sultanas)                                        | 0.1                                                                                                                                                                                                                                                                                |                                                  | Critical GAP: information assessed by JECFA in 2015                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: median PF of 2.8 refers to avermectin B1a residues only. It is noted that in the EU the MRL is set for the fresh product, but not for dried grapes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape juice                                                                           | 0.05                                                                                                                                                                                                                                                                               | --                                               | Critical GAP: information assessed by JECFA in 2015                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: best estimate of 1.4 refers to avermectin B1a residues only. It is noted that in the EU the MRL is set for the fresh product, but not for grape juice                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                                                | **0.03**                                                                                                                                                                                                                                                                           | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: Brazil, 2 × 0.0108 kg/ha, interval 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (table grapes, wine grapes)                      | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: all trials overdosed (0.0144 or 0.018 kg/ha) and with higher number of applications (3‐5), proportionally scaled to the GAP rate (scaling factor: 0.75 or 0.60). Based on decline trials results, JMPR concluded that number of applications does not have an impact on the final residue concentrations of avermectin B1a. Information on the magnitude and the decline behaviour of avermectin B1b and of the delta‐8,9‐isomer of avermectin B1a in crops not reported in the JMPR report. Considering the decline (half‐lives of abamectin in grape were 2.1--3.7 days), the higher number of applications is unlikely to affect significantly the final residues at harvest |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Grapes are major crop both for JMPR and EU and a minimum of 8 trials is required. The Codex MRL proposal refers to avermectin B1a residues only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL for grapes is not acceptable because (1) number of trials not sufficient to derive an MRL proposal; (2) residue definitions for enforcement are not compatible; and (3) the proportionality approach should not be applied when more than one parameter is deviating from critical GAP (3)                                                                                                                                                                                                                                                                                                                                                                                   |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Green onions, subgroup of (includes all commodities in this subgroup)                 | **0.01**                                                                                                                                                                                                                                                                           | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: USA, 2 × 0.0213 kg/ha, interval 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (spring/green/welsh onion)                       | Number of trials: 6 trials in spring onions; additional 3 trials in chives (not used to calculate the MR proposal)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (leeks)                                          | Specific comments/observations: all trials on spring onions conducted with 4 instead of 2 applications. Based on two decline trials on onions, JMPR concluded that number of applications do not had an impact on the final residue concentrations of avermectin B1a. Information on the magnitude and the decline behaviour of avermectin B1b and of the delta‐8,9‐isomer of avermectin B1a in spring onions not reported. The Codex MRL proposal refers to avermectin B1a residues only                                                                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | 2                                                | Conclusion: The proposed Codex MRL may be acceptable, despite the incompatibility of the residue definitions, considering the level of the MRL. The proposed Codex MRL would also cover leeks. See also general comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (Chives, leaves and bulbs)                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Herbs, subgroup of, except mint                                                       | 0.015                                                                                                                                                                                                                                                                              | 2                                                | Critical GAP: USA, 2 × 0.0213 kg/ha, interval 7 days, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (herbs and edible flowers, except celery leaves) | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | 0.09 (ft)                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (celery leaves)                                  | Specific comments/observations: Trial on basil (3) and mint (2) with 3 instead of 2 applications. For the extrapolation to the whole group (which includes mint in the basil subgroup), a minimum of 6 trials would be required in the EU. However, for JMPR, 5 trials are sufficient. None of the trials designed as decline. Based on decline trials results from other crops, JMPR concluded that number of applications do not had an impact on the final residue concentrations of avermectin B1a. Information on the magnitude and the decline behaviour of avermectin B1b and of the delta‐8,9‐isomer of avermectin B1a in herbs not reported                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | The Codex MRL proposal refers to avermectin B1a residues only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL for herbs and edible flowers is not acceptable because the residue definitions are not compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leek                                                                                  | 0.005 (W)                                                                                                                                                                                                                                                                          |                                                  | The previous CXL was withdrawn. It will be covered by the proposed CXL for the Subgroup of green onions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil                                                                            | 0.1                                                                                                                                                                                                                                                                                | --                                               | Critical GAP: not reported in the summary report                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: median PF 5.5 refers to avermectin B1a residues only. It is noted that in the EU the MRL is set for the fresh product, but not for orange oil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                             | 0.002[\*](#efs25797-note-0058){ref-type="fn"}                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: USA, 2 × 0.0261 kg/ha, interval 7 days, PHI 112 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: Residues of avermectin B1a \< LOQ of 0.002 mg/kg in all 6 trials. Number of trials is in line with JMPR rules                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | The Codex MRL proposal refers to avermectin B1a residues only, but avermectin B1b and of the delta‐8,9‐isomer of avermectin B1a are not expected to be found in the edible part of the fruit at the long PHI of the cGAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL is acceptable, despite the incompatibility of the residue definitions, considering the level of the MRL. See also general comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Raspberries, Red, Black                                                               | 0.05 (W)                                                                                                                                                                                                                                                                           |                                                  | The previous CXL was withdrawn. It will be covered by the proposed CXL for the Subgroup of cane barriers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                                       | 0.002[\*](#efs25797-note-0058){ref-type="fn"}                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: USA, 2 × 0.0213 kg/ha (foliar application), interval 6 days, PHI 28 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: Trails conducted with a seed treatment followed by 2 foliar applications with residues of avermectin B1a \< LOQ of 0.002 mg/kg. The Codex MRL proposal refers to avermectin B1a residues only, but avermectin B1b and of the delta‐8,9 isomer of avermectin B1a are not expected to be found in the seed at the long PHI of the cGAP                                                                                                                                                                                                                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL is acceptable, despite the incompatibility of the residue definitions, considering the level of the MRL. See also general comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Succulent beans without pods, subgroup of (includes all commodities in this subgroup) | 0.002[\*](#efs25797-note-0058){ref-type="fn"}                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: USA, 2 × 0.0213 kg/ha, interval 6 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    | (beans w/out pod)                                | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: All trials on beans w/out pods with 3 or 4 instead of 2 applications with residues of avermectin B1a \< 0.002 mg/kg. Based on decline trials results from other crops, JMPR concluded that number of applications do not had an impact on the final residue concentrations of avermectin B1a. Information on the magnitude and the decline behaviour of avermectin B1b and of the delta‐8,9 isomer of avermectin B1a in beans not reported. The Codex MRL proposal refers to avermectin B1a residues only                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL is acceptable, despite the incompatibility of the residue definitions, considering the level of the MRL. See also general comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corns                                                                           | 0.002[\*](#efs25797-note-0058){ref-type="fn"}                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0058){ref-type="fn"}     | Critical GAP: USA, 2 × 0.0213 kg/ha, interval 7 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Specific comments/observations: GAP‐compliant trials with residues of avermectin B1a \< LOQ of 0.002 mg/kg. Information on the magnitude of avermectin B1b and of the delta‐8,9 isomer of avermectin B1a in sweet corns not reported. The Codex MRL proposal refers to avermectin B1a residues only                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  | Conclusion: The proposed Codex MRL is acceptable, despite the incompatibility of the residue definitions, considering the level of the MRL. See also general comments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                  | Overall, the residue definitions for plant products derived at EU level and by JMPR are not compatible                                                                                                                                                                             |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                    |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       | Risk managers to discuss whether this is a sufficient reason: to make a reservation for all crops or whether a reservation is only justified for crops with MRL proposals higher than the existing EU MRL or a reservation is appropriate only for crops with MRL proposals \> LOQ |                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; PHI: preharvest interval; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue limit; PF: processing factor; JECFA: Joint FAO/WHO Expert Committee on Food Additives; LOQ: limit of quantification

Indicates that the input value is proposed at the limit of quantification. Ft: Under the MRL review, some information on residue trials were missing and were requested as confirmatory data. The assessment of the data submitted by the manufacturer in response to the identified data gaps is currently ongoing.
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### 5.8.5. Consumer risk assessment {#efs25797-sec-0076}

###### 

Summary of the consumer risk assessment

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                     | Comments on JMPR exposure assessment                          |
+==========================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                      | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                             | **Specific comments:**                                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
| An indicative short‐term dietary risk assessment was performed with the products of plant origin for which Codex proposed higher MRLs compared to the existing EU MRLs. The HRs derived for raw agricultural commodities by JMPR refer to the avermectin B1a component only and were used if higher in absolute value (cane fruits, grapes) compared to the HRs derived based on the EU use according with the EU residue definition for risk assessment | An indicative long‐term risk assessment was performed with the products of plant origin for which Codex proposed higher MRLs compared to the existing EU MRLs, and the existing MRL values in Reg 396/2005                                                                                                                                                                                                      | Consumer exposure considering residues of avermectin B1a only |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
| The risk assessment is indicative because information on the residue concentration in accordance with the EU risk assessment residue definition is not available for the crops assessed by JMPR                                                                                                                                                                                                                                                          | The STMRs derived for raw agricultural commodities by JMPR refer to the avermectin B1a component only and were used if higher in absolute value (grapes) compared to the STMRs derived based on the EU use according with the EU residue definition for risk assessment. A conversion factor for risk assessment of 1.25 was used for the MRLs on products of animal origin set in the regulation above the LOQ |                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
| The EU ARfD was used                                                                                                                                                                                                                                                                                                                                                                                                                                     | The risk assessment is indicative because information on the residue concentration in accordance with the EU risk assessment residue definition is not available for the crops assessed by JMPR                                                                                                                                                                                                                 |                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          | The EU ADI was used                                                                                                                                                                                                                                                                                                                                                                                             |                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                             | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                    | **Results:**                                                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
| The consumer risk assessment is indicative                                                                                                                                                                                                                                                                                                                                                                                                               | The consumer risk assessment is indicative                                                                                                                                                                                                                                                                                                                                                                      | Long‐term exposure:                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
| No short‐term exposure concern was identified (maximum 24% of the ARfD for blackberries)                                                                                                                                                                                                                                                                                                                                                                 | No long‐term exposure concern was identified (maximum 74% of the ADI)                                                                                                                                                                                                                                                                                                                                           | 1‐6% of the JMPR ADI                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 | Short‐term exposure:                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                 | Max. 40% of the JMPR ARfD                                     |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------+

RA: risk assessment; HR: highest residue; MRL: maximum residue level; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; LOQ: limit of quantification; ADI: acceptable daily intake; ARfD: acute reference dose.
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5.9. Fenpyroximate (193) R {#efs25797-sec-0077}
--------------------------

### 5.9.1. Background information {#efs25797-sec-0078}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                      | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+======================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Follow‐up evaluation | First evaluation of the crops under assessment in 2017 JMPR; due to intake concerns in dried tomatoes, Codex MRL proposal was not advanced                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | AT                   |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved             | Commission Directive 2008/107/EC[a](#efs25797-note-0061){ref-type="fn"} (approval)                                                                                                                                |
|                                                                                                                                        |                      |                                                                                                                                                                                                                   |
|                                                                                                                                        |                      | Commission Regulation (EU) 2016/183[b](#efs25797-note-0062){ref-type="fn"} (renewal)                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments    | EFSA ([2008c](#efs25797-bib-0008){ref-type="ref"})                                                                                                                                                                |
|                                                                                                                                        |                      |                                                                                                                                                                                                                   |
|                                                                                                                                        |                      | EFSA ([2013j](#efs25797-bib-0034){ref-type="ref"}) (amendment approval and confirmatory data)                                                                                                                     |
|                                                                                                                                        |                      |                                                                                                                                                                                                                   |
|                                                                                                                                        |                      | EFSA conclusion ongoing (AIR IV)                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments    | EFSA ([2015c](#efs25797-bib-0046){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments    | Art. 10 celery (currently on clock‐stop additional data request)                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | No concluded         | Harmonised classification and labelling for CMR -- Annex VI: no classification                                                                                                                                    |
|                                                                                                                                        |                      |                                                                                                                                                                                                                   |
|                                                                                                                                        |                      | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[c](#efs25797-note-0805){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

2008/107/EC: Commission Directive 2008/107/EC of 25 November 2008 amending Council Directive 91/414/EEC to include abamectin, epoxiconazole, fenpropimorph, fenpyroximate and tralkoxydim as active substances. OJ L 316, 26.11.2008, p. 4--11.

2016/187/EC: Commission Implementing Regulation (EU) 2016/183 of 11 February 2016 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (Text with EEA relevance). OJ L 37, 12.2.2016, p. 44--55.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.9.2. Toxicological reference values {#efs25797-sec-0079}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+----------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation                  | TRV comparable        |                                                    |     |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+================================+=======================+====================================================+=====+
| **ADI**                | 0.01 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR (2017)                    | 0.01 mg/kg bw per day | EFSA ([2013j](#efs25797-bib-0034){ref-type="ref"}) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Rat, 2‐year study              |                       | Rat, 2‐year study                                  |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+----------------------------------------------------+-----+
| **ARfD**               | 0.01 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR (2017)                    | 0.02 mg/kg bw         | EFSA ([2013j](#efs25797-bib-0034){ref-type="ref"}) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Dog, 1‐day and 13‐week studies |                       | Dog, 1‐ and 5‐day study                            |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+----------------------------------------------------+-----+
| **Conclusion/comment** | For the derivation of the ADI, the JMPR considered the NOAEL of 1 mg/kg bw per day in the 2‐year rat study, applying an uncertainty factor (UF) of 100. The same derivation was adopted at EU level                                                                                                                                                                                                                                                                                                                                                           |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | In 2017, the JMPR withdrew the ARfD of 0.02 mg/kg bw from 2008 and established an ARfD of 0.01 mg/kg bw on the basis of the LOAEL of 2 mg/kg bw for the induction of diarrhoea seen in a newly submitted single bolus gavage study and 13‐week study of toxicity in dogs. A safety factor of 200 was used since no NOAEL was identified                                                                                                                                                                                                                       |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | In the EU assessment, an ARfD of 0.02 mg/kg bw was established in 2008 on the same basis as conclusion reached by the JMPR in 2007 (1‐ and 5‐day toxicity study in dogs presenting a NOAEL of 2 mg/kg bw per day for the occurrence of diarrhoea, applying an UF of 100)                                                                                                                                                                                                                                                                                      |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | It appears that the JMPR had access to a new acute toxicity study in dogs in 2017 resulting in a LOAEL at 2 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | The RMS informed EFSA that for the renewal of fenpyroximate an additional single dose study in dogs has been submitted, which was not available for the first approval. In this study, dogs showed diarrhoea already after acute exposure to 2 mg/kg bw. No NOAEL could be determined and the LOAEL of the study is set at 2 mg/kg bw. The RMS will propose to lower the ARfD from 0.02 mg/kg bw to 0.01 mg/kg bw, on the basis of the LOAEL of 2 mg/kg bw from the single oral dose study in dogs and application of a uncertainty factor of 200 (for LOAEL) |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | For the metabolites, the JMPR concluded that M‐1, M‐3, M‐5, M‐21, M‐22 and Fen‐OH would be covered by the reference values of the parent compound since these metabolites were also detected in rats at significant levels                                                                                                                                                                                                                                                                                                                                    |                                |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
|                        | During the EU evaluation, the metabolites M‐1 and M‐12 were concluded of equal or lower acute toxicity than the parent compound                                                                                                                                                                                                                                                                                                                                                                                                                               |                                |                       |                                                    |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+-----------------------+----------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; LOAEL: lowest observed adverse effect level; RMS: rapporteur Member State.
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### 5.9.3. Residue definitions {#efs25797-sec-0080}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR evaluation                                                                                                                                                           | EU evaluation                                                                                                                                                    | RDs comparable |
+=========================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================+===========================================================================================================================================================================+==================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                  | Fenpyroximate                                                                                                                                                             | EU Reg. 2019/552: Fenpyroximate                                                                                                                                  | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           | Peer review (2013l): Fenpyroximate (fruit crops, pulses and oilseeds, only)                                                                                      |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpyroximate, 2‐hydroxymethyl‐2‐propyl (*E*)‐4‐\[(1,3‐dimethyl‐5‐ phenoxypyrazol‐4‐yl)‐methylenaminooxymethyl\]benzoate (Fen‐OH), and (*E*)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)methyleneaminooxymethyl\]benzoic acid (M‐3), expressed as fenpyroximate                                                                                                                                                                             | EU Reg. 2019/552: Fenpyroximate for all animal products, except liver and kidney of ruminants:                                                                            | No                                                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                      | Liver and kidney of ruminants: metabolite M‐3                                                                                                                             |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Peer review (2013l):                                                                                                                                                      |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Metabolite M‐3 expressed as fenpyroximate                                                                                                                                 |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 | The residue is fat soluble                                                                                                                                                |                                                                                                                                                                  |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                  | Sum of parent fenpyroximate and *tert*‐butyl (*Z*)‐α‐(1,3‐ dimethyl‐5‐phenoxypyrazol‐4‐ylmethyleneamino‐oxy)‐*p*‐toluate (its *Z*‐isomer M‐1), expressed as fenpyroximate | (EFSA, [2015c](#efs25797-bib-0046){ref-type="ref"}) Sum of fenpyroximate and its *Z*‐isomer, expressed as fenpyroximate (fruit crops, pulses and oilseeds, only) | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fenpyroximate, 2‐hydroxymethyl‐2‐propyl (*E*)‐4‐\[(1,3‐dimethyl‐5‐ phenoxypyrazol‐4‐yl)‐methylenaminooxymethyl\]benzoate (Fen‐OH), and (*E*)‐4‐\[(1,3‐dimethyl‐5‐phenoxypyrazol‐4‐yl)methyleneaminooxymethyl\]benzoic acid (M‐3), expressed as fenpyroximate                                                                                                                                                                             | (EFSA, [2015c](#efs25797-bib-0046){ref-type="ref"}) Sum of fenpyroximate, Fen‐OH, M‐3 and their *Z*‐isomers (M‐1), expressed as fenpyroximate                             | No                                                                                                                                                               |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant:**                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | Residue definitions for enforcement and risk assessment in plant commodities are comparable. Additional metabolism studies with fenpyroximate following foliar application to citrus, apples, grapes, snaps beans, cotton and Swiss chard were evaluated by the JMPR. These studies allowed deriving a general residue definition                                                                                                               |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | **Animal:**                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | RD enf: Fen‐OH is not included in the residue definition for enforcement established at EU level. However, according to the results of the metabolism and livestock‐feeding studies, at the calculated dietary burden, residues in livestock consist mainly of metabolite M‐3 (liver and kidney) and fenpyroximate (fat). Therefore, the difference in the residue definitions for enforcement in animal commodities can be considered as minor |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | RD‐RA: In 2018, JMPR revised the definition for risk assessment considering that M‐5 and its conjugates were only detected in liver and kidney and only below or equal to 10% TRR. Thus, these metabolites were excluded                                                                                                                                                                                                                        |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | In the EU residue definition, the *Z*‐isomers of parent fenpyroximate, Fen‐OH and M‐3 are also included in the residue definition. JMPR considered not necessary to include them in the residue definition since there was no evidence in the goat metabolism study of significant levels of *Z*‐isomers                                                                                                                                        |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
|                         | The process on the renewal of the approval is currently ongoing; the RMS informed EFSA that the RD enf animal might be revised (M‐3 expressed as fenpyroximate)                                                                                                                                                                                                                                                                                 |                                                                                                                                                                           |                                                                                                                                                                  |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; RMS: rapporteur Member State; TRR: total radioactive residues.
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### 5.9.4. Codex MRL proposals {#efs25797-sec-0081}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                                                                                                                                                                                                                                        | EU MRL                                                              | Comment                                                                                                                                                                                                                                 |
+===============================================+===========================================================================================================================================================================================================================================================================================================================================+=====================================================================+=========================================================================================================================================================================================================================================+
| Cherry tomato                                 | **W 0.3**                                                                                                                                                                                                                                                                                                                                 | 0.2 (ft) (tomato)                                                   | The previous MRL is replaced by the MRL proposal for tomatoes, subgroup                                                                                                                                                                 |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | **0.5**                                                                                                                                                                                                                                                                                                                                   | 0.09 except swine with 0.01[\*](#efs25797-note-0066){ref-type="fn"} | Max dietary burden: 3.503 mg/kg DM (Australian diet after refinement excluding bean forage)                                                                                                                                             |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | The feeding study covered the max DB                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                     |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Specific comments/observations: MRL proposal reflects the                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | residue definition of JMPR which is different than the EU RD                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Conclusion: The proposed Codex MRL is not fully compatible                                                                                                                                                                              |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | with the EU residue definition                                                                                                                                                                                                          |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | **0.1**                                                                                                                                                                                                                                                                                                                                   | 0.01[\*](#efs25797-note-0066){ref-type="fn"}                        | Max dietary burden: 3.503 mg/kg DM (Australia diet after                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | refinement excluding bean forage)                                                                                                                                                                                                       |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Number of trials: 1 feeding study with highest dose level                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | (10 ppm) covering the max DB                                                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                     |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Specific comments/observations: MRL proposal reflects the                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | residue definition of JMPR which is different than the EU RD.                                                                                                                                                                           |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | HR in fat is 0.089 mg/kg; thus, a MRL proposal of                                                                                                                                                                                       |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | 0.09 mg/kg should be enough                                                                                                                                                                                                             |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Conclusion: The proposed Codex MRL is not fully compatible                                                                                                                                                                              |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | with the EU residue definition                                                                                                                                                                                                          |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | **0.1(fat)**                                                                                                                                                                                                                                                                                                                              | 0.01[\*](#efs25797-note-0066){ref-type="fn"}                        | Since the residue definition is fat soluble, according to the Codex rules, an MRL proposal was derived for fat only                                                                                                                     |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Considering the result of the feeding study assessed by JMPR, the existing EU MRL for muscle may not be sufficient, since at the expected dietary burden, the maximum residues measured in muscle are 0.02 mg/kg                        |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.01                                                                                                                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0066){ref-type="fn"}                        | Max dietary burden: 3.503 mg/kg DM (Australia diet after                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | refinement excluding bean forage)                                                                                                                                                                                                       |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | 1 feeding study with highest dose level (10 ppm) covering the max DB                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                     |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Specific comments/observations: See comments on residue                                                                                                                                                                                 |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | definitions                                                                                                                                                                                                                             |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Conclusion: The proposed Codex MRL is acceptable, despite the difference in the RD, considering the level                                                                                                                               |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                        | **W 0.3**                                                                                                                                                                                                                                                                                                                                 |                                                                     | The previous MRL is replaced by the MRL proposal for tomatoes, subgroup                                                                                                                                                                 |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomatoes, subgroup of (includes               | **0.3**                                                                                                                                                                                                                                                                                                                                   | 0.2 (ft) (tomato)                                                   | Critical GAP: 2 × 117 g a.i./ha; PHI 1 day                                                                                                                                                                                              |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
| all commodities in this subgroup)             |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Number of trials: 19 trials on tomatoes conducted in the USA                                                                                                                                                                            |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                     |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Specific comments/observations: As residues in cherry tomato is normally higher than that in tomato, the Meeting estimated a maximum residue level, STMR and HR of 0.3, 0.10 and 0.17 mg/kg, respectively, for cherry tomato and tomato |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                        |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                          | Considering that the JMPR residue definition for animal products (enforcement) is more comprehensive than the EU residue definition, the proposed MRLs for animal commodities may be slightly higher than required according to the EU residue definition. However, it is not expected that this difference has a major impact on the MRL |                                                                     |                                                                                                                                                                                                                                         |
|                                               |                                                                                                                                                                                                                                                                                                                                           |                                                                     |                                                                                                                                                                                                                                         |
|                                               | The RMS informed EFSA that in the framework of the renewal of the approval for fenpyroximate some EU MRLs will be modified, but since the EU MRL assessment is not related to crops/commodities assessed by JMPR, the future modification of existing EU MRLs does not affect the EU position for CCPR                                    |                                                                     |                                                                                                                                                                                                                                         |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue limit; DM: dry matter; RD: residue definition; HR: highest residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice; STMR: supervised trials median residue; RMS: rapporteur Member State; DB: Dietary Burden.

Indicates that the input value is proposed at the limit of quantification.
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### 5.9.5. Consumer risk assessment {#efs25797-sec-0082}

###### 

Summary of the consumer risk assessment

+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                 | Chronic exposure assessment                                                                                                                                                                                                                     | Comments on JMPR exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+===========================================================================================================================================================================================================+=================================================================================================================================================================================================================================================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                       | **RA assumptions:**                                                                                                                                                                                                                             | **Specific comments and Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                           |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| The short‐term dietary risk assessment was performed for all commodities for which uses were assessed in the Art. 12 review, including HR/STMR values derived by JMPR for tomatoes and animal commodities | The most recent long‐term risk assessment (EFSA, [2015c](#efs25797-bib-0046){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for tomatoes and animal commodities | The Meeting concluded that the exceedance of the ARfD identified by JMPR in 2017 based on residues in dried tomatoes is now unlikely since a consumption figure was recently amended. For tomatoes (including dried tomatoes), the IESTI represents 2--20% of the ARfD for the general population and 5--60% for children. The Meeting concluded that the acute dietary exposure to residues of fenpyroximate in food commodities in the subgroup of tomatoes when used in ways that have been considered by the JMPR, is unlikely to present a public health concern |
|                                                                                                                                                                                                           |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| The risk assessment for animal commodities is indicative since the EU RD covers the *Z*‐isomers which are not included in the JMPR risk assessment values                                                 | The risk assessment for animal commodities is indicative since the EU RD covers the *Z*‐isomers which are not included in the JMPR risk assessment values                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                           |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| The EU ARfD was used                                                                                                                                                                                      |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                              | **Results:**                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                           |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| For the Codex MRL proposals no short‐term exposure concern was identified (maximum for tomatoes 49% of EU ARfD)                                                                                           | No long‐term consumer health risk was identified                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                           |                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                           | The overall chronic exposure accounted for 25% of the ADI                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; HR: highest residue; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; ARfD: acute reference dose RD: residue definition; ADI: acceptable daily intake; IESTI: international estimated of short‐term intake.
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5.10. Kresoxim‐methyl (199) R,T {#efs25797-sec-0083}
-------------------------------

### 5.10.1. Background information {#efs25797-sec-0084}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Periodic review         |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | SE                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Renewal of the approval | Commission Implementing Regulation (EU) No 810/2011[a](#efs25797-note-0069){ref-type="fn"}                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2010c](#efs25797-bib-0013){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments       | EFSA ([2014b](#efs25797-bib-0036){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | EFSA ([2015m](#efs25797-bib-0056){ref-type="ref"}) (leeks)                                                                                                                                                        |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EFSA ([2018s](#efs25797-bib-0107){ref-type="ref"}) Confirmatory data assessment following Art. 12                                                                                                                 |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonised classification for CMR -- Annex VI: Carcinogen Cat. 2                                                                                                                                                  |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EU Peer Review proposal for CMR: Carcinogen. Cat. 2                                                                                                                                                               |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0806){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) No 810/2011 of 11 August 2011 approving the active substance kresoxim‐methyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 207, 12.8.2011, p. 7--11.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.10.2. Toxicological reference values {#efs25797-sec-0085}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+----------------------+-----------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU evaluation                                                           | TRV comparable       |                                                                                                     |     |
+========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================+======================+=====================================================================================================+=====+
| **ADI**                | 0.3 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR (2018) (2‐year chronic toxicity and carcinogenicity study in rats) | 0.4 mg/kg bw per day | EFSA ([2010c](#efs25797-bib-0013){ref-type="ref"}) (2‐yr oral rat with a uncertainty factor of 100) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                         |                      |                                                                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                         |                      | European Commission ([2014](#efs25797-bib-0140){ref-type="ref"})                                    |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+----------------------+-----------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR (2018)                                                             | Not allocated        | Not necessary                                                                                       | Yes |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+----------------------+-----------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The ADI in the EU and JMPR are based on a 2‐year rat studies. Whereas in the EU assessment the point of departure was the NOAEL for systemic toxicity of 36 mg/kg bw per day, JMPR derived a benchmark dose for a 10% response (BMDL~10~) for liver tumours in female rats of 29.1 mg/kg bw per day. The use of a BMD is an alternative approach to the NOAEL that it is also considered acceptable and give a very similar value that the NOAEL. During the peer review, it was considered unlikely that metabolites BF 490‐1, BF 490‐2 and BF 490‐9 are more toxic than kresoxim‐methyl, and therefore the reference values of the parent are applicable in case a consumer risk assessment is needed |                                                                         |                      |                                                                                                     |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------+----------------------+-----------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.10.3. Residue definitions {#efs25797-sec-0086}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR evaluation                                                                                                                                                                                                                                                          | EU evaluation                                                                                                              | RDs comparable |
+=========================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==========================================================================================================================================================================================================================================================================+============================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Kresoxim‐methyl                                                                                                                                                                                                                                                          | EU Reg. 2016/486:                                                                                                          | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | Kresoxim‐methyl                                                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of metabolites (2*E*)‐(methoxyimino){2‐\[(2‐methylphenoxy)methyl\]phenyl}acetic acid (490M1), and (2*E*)‐{2‐\[(4‐hydroxy‐2‐methylphenoxy)methyl\]phenyl}(methoxyimino)acetic acid (490M9) expressed as kresoxim‐methyl                                                                                                                                                                                                                                                                                                        | EU Reg. 2016/486:                                                                                                                                                                                                                                                        | No                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Milk: 490M9, expressed as kresoxim‐methyl                                                                                                                                                                                                                                |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Other animal products: 490M1, expressed as kresoxim‐methyl                                                                                                                                                                                                               |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | The residue is not fat soluble                                                                                                                                                                                                                                           |                                                                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Sum of kresoxim‐methyl and metabolites (2*E*)‐(methoxyimino){2‐\[(2‐methylphenoxy)methyl\]phenyl}acetic acid (490M1) and (2*E*)‐{2‐\[(4‐hydroxy‐2‐methylphenoxy)methyl\]phenyl}(methoxyimino)acetic acid (490M9) including their conjugates expressed as kresoxim‐methyl | Art.12 (EFSA, [2014b](#efs25797-bib-0036){ref-type="ref"}):                                                                | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | Sum of kresoxim‐methyl and the metabolites BF 490‐2 (490M2) and BF 490‐9 (490M9), free and conjugated, expressed as parent |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+
| ** **                   | Animal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Sum of metabolites (2*E*)‐(methoxyimino){2‐\[(2‐methylphenoxy)methyl\]phenyl}acetic acid (490M1), and (2*E*)‐{2‐\[(4‐hydroxy‐2‐methylphenoxy)methyl\]phenyl}(methoxyimino)acetic acid (490M9) expressed as kresoxim‐methyl                                               | Art.12 (EFSA, [2014b](#efs25797-bib-0036){ref-type="ref"}):                                                                | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | Sum of metabolites BF 490‐1, BF 490‐2 (490M2) and BF 490‐9 (490M9), expressed as parent                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | Peer‐review (EFSA, [2010c](#efs25797-bib-0013){ref-type="ref"}):                                                           |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | Ruminant matrices, milk: Sum of BF 490‐1 (490M1), BF 490‐2 (490M2) and BF 490‐9 (490M9);                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          | No residue definition is proposed for poultry matrices                                                                     |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The metabolite codes BF 490‐1, BF 490‐2 and BF 490‐9, which were at some occasions used in the EU residue definitions, correspond to metabolites with codes 490M1, 490M2 and 490M9 (used by JMPR), respectively                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         | The EU risk assessment RD for plant products is different from the one of JMPR. JMPR did not include metabolite BF 490‐2. BF 490‐2 (490M2) was found as a major residue in the metabolism studies in grapes (unconjugated and conjugated, up to 14% TRR), but was not present in significant amounts in apple, wheat and sugar beet metabolism studies. BF 490‐2 was found at significant levels in field residue trials (fruit crops). Thus, the risk assessment values derived by JMPR are likely to underestimate the exposure |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         | RD for processed products: Considering that kresoxim‐methyl is significantly hydrolysed to kresoxim acid (BF 490‐1), the RD for processed products (enforcement) was defined as the sum of kresoxim‐methyl and BF 490‐1, expressed as kresoxim; RD for risk assessment of processed products: sum of kresoxim‐methyl, BF 490‐1 (490M1), BF 490‐2 (490M2) and BF 490‐9 (490M9), free and conjugated, expressed as parent (EFSA, [2014b](#efs25797-bib-0036){ref-type="ref"})                                                       |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         | For animal products, the residue definitions are not fully compatible. The EU residue definition for enforcement is restricted to the most relevant metabolite for the respective matrix, while JMPR established a comprehensive residue definition that covers all metabolites observed in animal products                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
|                         | Thus, the residue definitions for animal products proposed by JMPR differ from the current EU residue definitions, both for enforcement and for risk assessment                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                          |                                                                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRR: total radioactive residues.
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### 5.10.4. Codex MRL proposals {#efs25797-sec-0087}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                         | Codex MRL proposal                             | EU MRL                                                                                                      | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+===================================================================================+================================================+=============================================================================================================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Barley                                                                            | W 0.1                                          | 0.1                                                                                                         | JMPR proposes to withdraw the MRL for barley and replace it with an MRL of 0.15 for the whole barley grain subgroup (see below)                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Barley, subgroup of (includes all commodities in this subgroup)                   | **0.15**                                       | 0.1 (barley and oats)                                                                                       | Critical GAP: UK, 2 foliar applications at 125 g a.i./ha (RTI not given) PHI not needed (last application up to BBCH 59)                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                | 0.01[\*](#efs25797-note-0073){ref-type="fn"} (buckwheat)                                                    | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The proposed Codex MRL would be also applicable to oats and buckwheat. At EU level, the extrapolation of residue trials in barley to buckwheat would not be acceptable                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Beet root                                                                         | 0.05[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | Critical GAP: German GAP for beet root in Germany allows two foliar applications of kresoxim‐methyl at 125 g a.i./ha with a RTI of 10 days and a PHI of 28 days                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 10 trials in sugar beet                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cucumber                                                                          | W 0.05[\*](#efs25797-note-0073){ref-type="fn"} | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | JMPR proposes to replace existing CXL by a MRL for the whole group of fruiting vegetables (including edible and non‐edible peel) (see below)                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Currants, Black, Red, White                                                       | 0.9                                            | 0.9                                                                                                         | Critical GAP: UK, 3 × 100 g a.i./ha, RTI of 10 days, PHI of 14 days, foliar use                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grapes (= currants, raisins and sultanas)                                   | **3**                                          | 1                                                                                                           | PF of 1.6, based on 3 trials. It is noted that in the EU MRLs are set only for the fresh product, but not for dried grapes                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                          | 0.05                                           | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | JMPR calculated the dietary burden, including the feed items sufficiently supported by data. Maximum dietary burden in Australia 3.2 ppm                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Feeding studies (7, 21 and 77 ppm) on lactating cow, corrected for maximum dietary burden of 3.2 ppm                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The maximum residue expected in kidney is 0.02 mg/kg. The proposed Codex MRL was derived by rounding up; according to EFSA a lower MRL of 0.02 mg/kg would be sufficient. Further discussion with MS recommended, whether the proposed MRL is acceptable, taking into account that the residue definitions are not fully compatible                                                                                                                                                         |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                              | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | JMPR calculated the dietary burden, including the feed items sufficiently supported by data. Maximum dietary burden in EU (0.33 ppm)                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | No feeding study available; MRL proposal were derived from metabolism study which is about 500 times overdosed compared to the expected maximum dietary burden                                                                                                                                                                                                                                                                                                                                          |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable; a MRL of 0.01 mg/kg would be sufficient. Considering the proposed level of the MRL, the difference of the residue definition may not be relevant                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, Cucurbits, Group of (includes all commodities in this group) | **0.5**                                        | cucurbits with edible peel: 0.05[\*](#efs25797-note-0073){ref-type="fn"}; cucurbits with inedible peel: 0.3 | Critical GAP: Cucumber, summer squash, melon: USA: 4 × 168 g a.i./ha, RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 8 cucumber, 5 summer squash and 5 melon                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: No; according to EFSA\'s interpretation of the JMPR rules, additional 3 trials on melons (major crop in Codex classification) would be required to derive a group MRL for cucurbits                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: JMPR proposes an MRL for the whole group of fruiting vegetables (including edible and non‐edible peel). According to the agreement on extrapolation, trials on cucumbers and summer squash and/or gourd and melon would be required. Since this condition is not fulfilled, and the number of trials for melons is not sufficient, it would be possible to derive a group MRL for the subgroup fruiting vegetables, cucurbits‐ cucumber and summer squashes (0.3 mg/kg) |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | For melons, the number of trials is insufficient (melons are classified as major crop)                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Garlic                                                                            | 0.01                                           | 0.3                                                                                                         | Critical GAP: BR GAP: 4 × 70 g a.i./ha, RTI 10 days, 7 days PHI                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: The existing EU MRL is based on a more critical GAP (DE, NL, 3 × 200 g/ha, 7 days PHI)                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape                                                                             | **1.5**                                        | 1                                                                                                           | Critical GAP: USA, 4 × 224 g a.i./ha, RTI 7 days, PHI of 14 days, foliar                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapefruit                                                                        | W 0.5                                          | 0.5                                                                                                         | The existing CXL was proposed to be withdrawn since insufficient data were provided to support the GAPs reported to JMPR                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The existing EU MRL was derived from the CXL; in the framework of the MRL review, no EU GAPs were reported for citrus                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS to revise the existing EU MRL                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leek                                                                              | 10                                             | 10                                                                                                          | Critical GAP: NL GAP: 3 × 375 g a.i./ha, RTI 10 days, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: The existing EU MRL was derived from the same data and on the basis of the same cGAP                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                 | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | At the expected maximum dietary burden, the residues in fat were \< 0.01 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable. Considering the proposed level of the MRL, the difference of the residue definition may not be relevant                                                                                                                                                                                                                                                                                                                                               |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                             | **0.1**                                        | 0.01[\*](#efs25797-note-0073){ref-type="fn"}                                                                | Critical GAP: BR, 2 × 120 g a.i./ha, RTI 15 days, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                     | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | At the expected maximum dietary burden, the residues in muscle were \< 0.01 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable; a MRL of 0.01 mg/kg would be sufficient. Considering the proposed level of the MRL, the difference of the residue definition may not be relevant                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                             | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.01[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | At the expected maximum dietary burden, the residues in milk were \< 0.002 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable; a MRL of 0.01 mg/kg would be sufficient. Considering the proposed level of the MRL, the difference of the residue definition may not be relevant                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Olive oil, Virgin                                                                 | 1                                              |                                                                                                             | The MRL proposal for olive oil was derived from the MRL proposal for olives, applying a processing factor of 4.5 (derived from one processing study) and rounding up to the next MRL class. It is noted that in the EU MRLs are set only for the fresh product, but not for olive oil                                                                                                                                                                                                                   |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Olives for oil production                                                         | 0.2                                            | 0.2                                                                                                         | Critical GAP: France, 3 × 100 g a.i./ha, PHI of 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: Since olives for oil production are a major crop (in the EU and in Codex), at least 8 trials are required. In the MR review, the same cGAP was assessed which was sufficiently supported by data. Thus, additional trials were available in the EU which were not made available to JMPR                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: To discuss with RMS, whether the proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, Sweet, Sour (including Orange‐like hybrids):several cultivars            | W0.5                                           | 0.5                                                                                                         | The existing CXL was proposed to be withdrawn since insufficient data were provided to support the GAPs reported to JMPR                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The existing EU MRL was derived from the CXL; in the framework of the MRL review, no EU GAPs were reported for citrus                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS to revise the existing EU MRL                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                             | **1.5**                                        | 0.01[\*](#efs25797-note-0073){ref-type="fn"}                                                                | Critical GAP: Japan, 3 × 25 g a.i./hL, PHI of 1 day, RTI not specified, foliar use.                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: According to Codex classification, peaches are a crop for which at least 5 trials are required to derive a MRL proposal. At EU level, 8 trials would be required                                                                                                                                                                                                                                                                                                        |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pecan nuts                                                                        | 0.05[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | Critical GAP: USA, 3 × 168 g a.i./ha, RTI 14 days, PHI 45 days.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: The same USA cGAP and trial data had been considered in the framework of the EU MRL review; the same MRL was derived as proposed by JMPR                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, sweet                                                                    | 0.3                                            | 0.8                                                                                                         | Critical GAP: BR, 4 × 100 g a.i./ha, RTI 10 days, PHI 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 4 according GAP + 2 overdosed proportionality corrected (0.4 scaling factor)                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: For peppers, at least 8 trials would be required, since it is classified as a major crop in Codex                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The EU MRL was derived from a more critical GAP (ES, CY, 4 × 250 g/ha, 3 d PHI). The EU GAP was not reported the JMPR                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. Furthermore it should be highlighted that data for a more critical EU GAP are available that have not been notified to JMPR                                                                                                                                                                                                                                |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits                                                                       | W0.2 (apple)                                   | 0.2                                                                                                         | The existing CXL was proposed to be withdrawn since insufficient data were provided to support the GAPs reported to JMPR                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The existing EU MRL was derived from the CXL; in the framework of the MRL review, EU GAPs were reported for pome fruits (apples, pears, quinces, medlar, loquat) and an MRL of 0.15 mg/kg was proposed for the EU uses                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS to ask for maintaining the current CXL under the 4‐years rule and to encourage the applicant to provide the EU GAPs and EU residue data to JMPR for evaluation                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                                      | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                      | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, Edible offal of                                                          | 0.02[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Straw and fodder (dry) of cereal grains                                           | 3(DM)                                          | --                                                                                                          | United Kingdom GAP for wheat and barley:                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | It is noted that in the EU no MRLs are set for feed products                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar beet                                                                        | 0.05[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | Critical GAP: Germany, 1 × 125 g a.i./ha, PHI of 28 days.                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Table olives                                                                      | 0.2                                            | 0.2                                                                                                         | Critical GAP: France 3 × 100 g a.i./ha, PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Specific comments/observations: According to JMPR criteria, table olives are considered a major crop and therefore at least 8 trials would be required. In the EU, table olives are a minor crop and therefore 5 trials would be sufficient                                                                                                                                                                                                                                                             |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, considering that at EU level the number of trials would be sufficient and that the MRL proposal relates to a EU GAP                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Turnip                                                                            | 0.05[\*](#efs25797-note-0073){ref-type="fn"}   | 0.05[\*](#efs25797-note-0073){ref-type="fn"}                                                                | MRL proposal was derived by extrapolation from sugar beets (see comments on sugar beets)                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat                                                                             | W 0.05[\*](#efs25797-note-0073){ref-type="fn"} | 0.08                                                                                                        | JMPR proposed to withdraw the MRL of 0.05 for wheat and replace it with an MRL of 0.05 applicable to the whole subgroup of wheat grain (see below)                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat, subgroup of (includes all commodities in this subgroup)                    | 0.05                                           | 0.08                                                                                                        | Critical GAP: UK: GAP for wheat, rye and triticale, 2 × 125 g a.i./ha, no PHI (last application up to BBCH 65)                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | The proposed Codex MRL would be also applicable to rye.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                |                                                                                                             | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                              | --                                             |                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+-----------------------------------------------------------------------------------+------------------------------------------------+-------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; PHI: preharvest interval; BBCH: growth stages of mono‐ and dicotyledonous plants; PF: processing factor; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.10.5. Consumer risk assessment {#efs25797-sec-0088}

###### 

Summary of the consumer risk assessment

+------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                | Chronic exposure assessment                                                                                                                                                                                                                                                  | Comments on JMPR exposure assessment |
+==========================================+==============================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                      | **RA assumptions:**                                                                                                                                                                                                                                                          | **Specific comments**                |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
| Not relevant since no ARfD was allocated | The most recent long‐term risk assessment (EFSA, [2018s](#efs25797-bib-0107){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for crops where the Codex MRL proposal is higher than the EU MRL |                                      |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
|                                          | The risk assessment is indicative, because for the proposed Codex MRLs the STMRs do not cover BF 490‐2; instead BF 490‐1 is covered which is not included in the EU RD                                                                                                       |                                      |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
|                                          | The risk assessment was performed with the EU ADI                                                                                                                                                                                                                            |                                      |
+------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                             | **Results:**                                                                                                                                                                                                                                                                 | **Results:**                         |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
| --                                       | No long‐term consumer health risk was identified                                                                                                                                                                                                                             | Long‐term exposure:                  |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
|                                          | The overall chronic exposure accounted for 1% of the ADI                                                                                                                                                                                                                     | 0--0.4% of the ADI                   |
|                                          |                                                                                                                                                                                                                                                                              |                                      |
|                                          | Among the crops under consideration. wine grapes were identified as the main contributor, accounting for up to 0.23% of the ADI                                                                                                                                              |                                      |
+------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; RD: residue definition; ADI: acceptable daily intake.

John Wiley & Sons, Ltd

5.11. Pyriproxyfen (200) R {#efs25797-sec-0089}
--------------------------

### 5.11.1. Background information {#efs25797-sec-0090}

###### 

Background information

+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                       |                   | Comments, references                                                                                                                                                                                         |
+=======================================================================================================================================+===================+==============================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                               | New use           |                                                                                                                                                                                                              |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                   | NL                |                                                                                                                                                                                                              |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                       | Approved          | Commission Directive 2008/69/EC[a](#efs25797-note-0076){ref-type="fn"}                                                                                                                                       |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                       | Yes, see comments | EFSA ([2009b](#efs25797-bib-0010){ref-type="ref"})                                                                                                                                                           |
|                                                                                                                                       |                   |                                                                                                                                                                                                              |
|                                                                                                                                       |                   | Renewal ongoing                                                                                                                                                                                              |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                            | Ongoing           | On hold pending renewal process                                                                                                                                                                              |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                      | Yes, see comments | EFSA ([2013i](#efs25797-bib-0033){ref-type="ref"}) (stone fruits and tea)                                                                                                                                    |
|                                                                                                                                       |                   |                                                                                                                                                                                                              |
|                                                                                                                                       |                   | EFSA ([2015e](#efs25797-bib-0048){ref-type="ref"}) (bananas)                                                                                                                                                 |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupter (ED) potential | Not met           | Harmonised classification and labelling for CMR -- Annex VI: no entry for CMR                                                                                                                                |
|                                                                                                                                       |                   |                                                                                                                                                                                                              |
|                                                                                                                                       |                   | EU Peer Review proposal: none for CMR                                                                                                                                                                        |
|                                                                                                                                       |                   |                                                                                                                                                                                                              |
|                                                                                                                                       |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0807){ref-type="fn"}): negative |
+---------------------------------------------------------------------------------------------------------------------------------------+-------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2008/69/EC of 1 July 2008 amending Council Directive 91/414/EEC to include clofentezine, dicamba, difenoconazole, diflubenzuron, imazaquin, lenacil, oxadiazon, picloram and pyriproxyfen as active substances. OJ L 172, 2.7.2008, p. 9--14.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.11.2. Toxicological reference values {#efs25797-sec-0091}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------+------------------------------+-------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | EU evaluation                   | TRV comparable               |                                                                   |     |
+========================+======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================+==============================+===================================================================+=====+
| **ADI**                | 0.1 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR (1999)                     | 0.1 mg/kg bw per day         | EFSA ([2009b](#efs25797-bib-0010){ref-type="ref"})                | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | (1‐year dog, safety factor 100) |                              | (1‐year, dog with a safety factor of 100)                         |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              | Confirmed in                                                      |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              | European Commission ([2010b](#efs25797-bib-0132){ref-type="ref"}) |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------+------------------------------+-------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | JMPR (1999)                     | Was not set, not appropriate | EFSA ([2009b](#efs25797-bib-0010){ref-type="ref"}) confirmed in   | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              | European Commission ([2010b](#efs25797-bib-0132){ref-type="ref"}) |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------+------------------------------+-------------------------------------------------------------------+-----+
| **Conclusion/comment** | In the framework of the EU peer review for renewal (expert meeting January, 2019), the TRV for pyriproxyfen were proposed to be changed: --the ADI was lowered to 0.05 mg/kg bw per day based on the LOAEL of 16.4 mg/kg bw per day from the 18‐month mouse study and applying an uncertainty factor of 300;--an ARfD was set at 1 mg/kg bw based on an increased incidence of malformations in the developmental rabbit study, applying an uncertainty factor of 100. In relationship with the ADI, the EU peer review reconsidered the assessment of the 18‐month mouse study in which the decreased survival in males at the low dose was considered to be an adverse effect. JMPR has not considered this dose‐related increase in mortality rate relevant at the low‐dose level |                                 |                              |                                                                   |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                 |                              |                                                                   |     |
|                        | In relationship with the ARfD, the EU peer review reconsidered the assessment of one developmental rabbit study in which multiple visceral malformations in one animal and single visceral malformation in 2 animals at 300 mg/kg bw per day were concluded to be treatment‐related and adverse, leading to a lower NOAEL of 100 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                 |                              |                                                                   |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------+------------------------------+-------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; LOAEL: lowest observed adverse effect level; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 5.11.3. Residue definitions {#efs25797-sec-0092}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                   | JMPR evaluation                                                                                                         | EU evaluation                                                                 | RDs comparable |
+=========================+===================================================================================================================================================================================================================================+=========================================================================================================================+===============================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                    | Pyriproxyfen                                                                                                            | EU Reg. 2016/1902: Pyriproxyfen                                               | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+
| Animal products         | Pyriproxyfen                                                                                                                                                                                                                      | EU Reg. 2016/1902: Pyriproxyfen                                                                                         | Yes                                                                           |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         | The residue is fat soluble                                                                                                                                                                                                        | Peer‐review (EFSA, [2009b](#efs25797-bib-0010){ref-type="ref"}):                                                        |                                                                               |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   | Not relevant for notified uses. (No significant intake; no accumulation of residues in edible animal products expected) |                                                                               |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   | The residue is fat soluble                                                                                              |                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                    | Pyriproxyfen                                                                                                            | Peer‐review (EFSA, [2009b](#efs25797-bib-0010){ref-type="ref"}): Pyriproxyfen | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+
| Animal products         | Pyriproxyfen                                                                                                                                                                                                                      | Peer‐review (EFSA, [2009b](#efs25797-bib-0010){ref-type="ref"}):                                                        | Yes                                                                           |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   | Not relevant for notified uses. (No significant intake; no accumulation of residues in edible animal products expected) |                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | In the framework of the peer‐review process, no investigation of the residues of pyriproxyfen in animal origin commodities has been performed (representative use on tomatoes and cotton seed -- residues in cotton seeds at LOQ) |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         | In succeeding MRL applications, no need for setting MRLs in animal commodities was identified (intended uses on fruits and tea)                                                                                                   |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         | JMPR 1999 assessed animal commodities and derived the residue definition for animal products which covers only parent compound                                                                                                    |                                                                                                                         |                                                                               |                |
|                         |                                                                                                                                                                                                                                   |                                                                                                                         |                                                                               |                |
|                         | Residue definitions for plant commodities identical                                                                                                                                                                               |                                                                                                                         |                                                                               |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; LOQ: limit of quantification; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 5.11.4. Codex MRL proposals {#efs25797-sec-0093}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                 | Codex MRL proposal                                                                                                                                                           | EU MRL                                       | Comment                                                                                                                                                                                             |
+===========================+==============================================================================================================================================================================+==============================================+=====================================================================================================================================================================================================+
| Cucumbers                 | 0.04                                                                                                                                                                         | 0.1                                          | Critical GAP: Europe (Italy, Greece, France, Spain) 2 × 0.12 kg a.s./ha, RTI 14 days, PHI 3 days                                                                                                    |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggplant                  | 0.6                                                                                                                                                                          | 1                                            | Critical GAP: Europe (Italy), 2 × 0.12, RTI 14 days, PHI 3 days                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8 trials in peppers were used to derive MRL proposal by extrapolation                                                                                                             |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | At EU level an extrapolation from peppers to eggplants would not be appropriate. However, this extrapolation was proposed by JMPR in the general considerations                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Gherkins                  | 0.04                                                                                                                                                                         | 0.1                                          | Critical GAP: Europe (Italy, Greece, France, Spain) 2 × 0.12 kg a.s./ha, RTI 14 days, PHI 3 days                                                                                                    |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8 residue trials in cucumbers, used to derive MRL proposal by extrapolation                                                                                                       |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except Watermelon | **0.07**                                                                                                                                                                     | 0.05[\*](#efs25797-note-0080){ref-type="fn"} | Critical GAP: USA, 2 × 0.075 kg a.i./ha, RTI 14 days, PHI 7 days                                                                                                                                    |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 7                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: No                                                                                                                                                                  |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Specific comments/observations: Since melons are classified as a major crop in Codex and at EU level, a minimum of 8 residue trials would be required                                               |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, considering the fact that 1 additional trial would be required                                       |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Papaya                    | **0.3**                                                                                                                                                                      | 0.05[\*](#efs25797-note-0080){ref-type="fn"} | Critical GAP: Philippines, 2 × 0.1 kg a.s./ha, RTI 14 days, PHI 1 day                                                                                                                               |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 6                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers                   | 0.6                                                                                                                                                                          | 1                                            | Critical GAP: Europe (Italy), 2 × 0.12, RTI 14 days, PHI 3 days                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers chili, dried      | **6**                                                                                                                                                                        |                                              | Proposed MRL was derived from residue trials in peppers, applying the default dehydration factor of 10                                                                                              |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | At EU level, MRLs are set only for fresh products, but not for processed chili peppers                                                                                                              |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                 | 0.01                                                                                                                                                                         | 0.05[\*](#efs25797-note-0080){ref-type="fn"} | Critical GAP: USA, 2 × 0.06 kg a.s./ha, RTI 21 days, PHI 1 day                                                                                                                                      |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 6                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Specific comments/observations: Although for pineapples a minimum of 8 residue trials would be required in the EU, according to Codex classification, 5 trials are sufficient to derive a Codex MRL |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Summer squash             | 0.04                                                                                                                                                                         | 0.05[\*](#efs25797-note-0080){ref-type="fn"} | Critical GAP: Europe (Italy, Greece, France, Spain) 2x 0.12 kg a.s./ ha, RTI 14 days, PHI 3 days                                                                                                    |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8 residue trials in cucumbers, used to derive MRL proposal by extrapolation                                                                                                       |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                    | 0.4                                                                                                                                                                          | 1                                            | Critical GAP: Italy, 2 × 0.12 kg a.s./ha, RTI 14 days, PHI 3 days                                                                                                                                   |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of trials: 8                                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Sufficiently supported by data: Yes                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                    |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Canned pepper             |                                                                                                                                                                              |                                              | PF (best estimate or mean): 0.08                                                                                                                                                                    |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Individual processing factors: 0.08, 0.08                                                                                                                                                           |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of studies to derive the PF: 2                                                                                                                                                               |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Canned tomato             |                                                                                                                                                                              |                                              | PF (best estimate or mean): \< 0.18                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Individual processing factors: \< 0.17, \< 0.2                                                                                                                                                      |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of studies to derive the PF: 2                                                                                                                                                               |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato Juice              |                                                                                                                                                                              |                                              | PF (best estimate or mean): \< 0.18                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Individual processing factors: \< 0.17, \< 0.2                                                                                                                                                      |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of studies to derive the PF: 2                                                                                                                                                               |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato Puree              |                                                                                                                                                                              |                                              | PF (best estimate or mean): 1.2                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Individual processing factors: 0.67, 1.8                                                                                                                                                            |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of studies to derive the PF: 2                                                                                                                                                               |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Ketchup                   |                                                                                                                                                                              |                                              | PF (best estimate or mean):0.67                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Individual processing factors: 0.67                                                                                                                                                                 |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              | Number of studies to derive the PF would not be sufficient in the EU                                                                                                                                |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**      | According to the information reported, pyriproxyfen is stable under standard hydrolysis studies. This was also concluded by EFSA in the framework of the peer‐review process |                                              |                                                                                                                                                                                                     |
|                           |                                                                                                                                                                              |                                              |                                                                                                                                                                                                     |
|                           | Additionally, the processing factors for tomato processed commodities in the JMPR report are the same that the ones assessed by EFSA during the peer‐review process          |                                              |                                                                                                                                                                                                     |
+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; a.s.: active substance; PF: processing factor; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.
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### 5.11.5. Consumer risk assessment {#efs25797-sec-0094}

###### 

Summary of the consumer risk assessment

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                              | Chronic exposure assessment                                                                                                                                                                                                                                                                                | Comments on JMPR exposure assessment                                                         |
+========================================================================================================================================================================================================================================================================================+============================================================================================================================================================================================================================================================================================================+==============================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                    | **RA assumptions:**                                                                                                                                                                                                                                                                                        | **Specific comments:**                                                                       |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
| An indicative short‐term exposure calculation was performed for papayas and melons, using the proposed ARfD derived in the ongoing renewal process. For the other commodities no acute risk assessment was performed, since the existing EU MRL is higher than the proposed Codex MRLs | The most recent long‐term risk assessment (EFSA, [2015e](#efs25797-bib-0048){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for papaya since it is the only commodity for which the CXL proposal is higher than the EU MRL | No further comments                                                                          |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | Tentatively the Codex MRL proposal for melons has been considered in the exposure calculation; although the MRL proposal is not fully compliant with EU policies                                                                                                                                           |                                                                                              |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | The MRL proposal for dried peppers was not included in the PRIMO since consumption data for dried peppers is not included in the PRIMO rev 3.1.                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | For the commodities where the MRL was lower than the existing MRL, the STMR values derived from the EU uses were used for exposure calculations                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | Since the review of the EU existing uses is pending of finalisation, EU MRLs established by Reg (EU). 2016/1902 were used for exposure calculations in chronic exposure scenario                                                                                                                           |                                                                                              |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | The calculations were performed with the currently approved ADI and in an indicative calculation with the ADI proposal derived recently in the framework of the renewal                                                                                                                                    |                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                           | **Results:**                                                                                                                                                                                                                                                                                               | **Results:**                                                                                 |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
| No exceedance of the recently proposed ARfD (1 mg/kg bw) was identified for papaya and melons (exposure calculation with the proposed MRL)                                                                                                                                             | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                           | Long‐term exposure:                                                                          |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
| For other crops, no calculations were considered necessary                                                                                                                                                                                                                             | The overall chronic exposure accounted for 15% of the ADI, being the diet for Dutch toddlers the most critical one                                                                                                                                                                                         | 15% of the ADI                                                                               |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | The contribution of the proposed Codex is considered low, accounting for less than 0.1%                                                                                                                                                                                                                    | Review of existing EU uses ongoing. Exposure estimates must be considered in tentative basis |
|                                                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                                                                            |                                                                                              |
|                                                                                                                                                                                                                                                                                        | With the proposed new ADI, no intake concern is expected either                                                                                                                                                                                                                                            | Short‐term exposure: not calculate since no ARfD is available                                |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; MRL: maximum residue level; CXL: Codex Maximum Residue Limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PRIMo: (EFSA) Pesticide Residues Intake Model; ADI: acceptable daily intake.
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5.12. Cyprodinil (207) R {#efs25797-sec-0095}
------------------------

### 5.12.1. Background information {#efs25797-sec-0096}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                                          | Comments, references                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+========================================================================================================================================+==========================================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Follow‐up evaluation due to concern form | In 2018 CCPR, the EU made a reservation: --regarding the MRL proposals for post‐harvest uses, calculated according to a wrong methodology leading to MRLs higher than necessary (CF\*3 Mean);--regarding the cyprodinil metabolism data that did not reflect post‐harvest applications (studies with foliar applications only) 2018 JMPR revised the MRL proposals for post‐harvest uses (mean + 4SD); regarding the metabolism studies JMPR concluded that the residue definitions are also appropriate for post‐harvest uses, considering that less extensive metabolism is expected |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FR                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                                 | Commission Implementing Regulation (EU) No 678/2014[a](#efs25797-note-0083){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments                        | EFSA ([2006a](#efs25797-bib-0003){ref-type="ref"}) EFSA conclusions ongoing (AIR III)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments                        | EFSA ([2013h](#efs25797-bib-0032){ref-type="ref"})                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments                        | EFSA ([2015g](#efs25797-bib-0050){ref-type="ref"}) (celery)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                        |                                          | EFSA ([2019e](#efs25797-bib-0114){ref-type="ref"}) (Florence fennel)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded                            | Harmonised classification for CMR -- Annex VI: none                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                        |                                          | EU peer review proposal for CMR: none                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                                        |                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                        |                                          | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0808){ref-type="fn"}): not finalised                                                                                                                                                                                                                                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

678/2014/EU: Commission Implementing Regulation (EU) No 678/2014 of 19 June 2014 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances clopyralid, cyprodinil, fosetyl, pyrimethanil and trinexapac. OJ L 180, 20.6.2014, p. 11--12.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.12.2. Toxicological reference values {#efs25797-sec-0097}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+-----------------------+----------------------------------------------------+---------------------------------+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | EU evaluation        | TRV comparable        |                                                    |                                 |
+========================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+======================+=======================+====================================================+=================================+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | JMPR (2003)          | 0.03 mg/kg bw per day | EFSA ([2006a](#efs25797-bib-0003){ref-type="ref"}) | Yes                             |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                      |                       |                                                    |                                 |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | (2‐year rat, SF 100) |                       | (2‐year rat, UF 100)                               |                                 |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+-----------------------+----------------------------------------------------+---------------------------------+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR (2003)          | Not necessary/^(b)^   | EFSA ([2006a](#efs25797-bib-0003){ref-type="ref"}) | see comments under footnote (b) |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+-----------------------+----------------------------------------------------+---------------------------------+
| **Conclusion/comment** | ^(a)^ Confirmed for the renewal of the approval (not yet finalised in an EFSA conclusion)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                      |                       |                                                    |                                 |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                      |                       |                                                    |                                 |
|                        | ^(b)^ In the French RAR, an ARfD was proposed (1.5 mg/kg bw); in the expert meeting, the ARfD was agreed to be set at a level of 2 mg/kg bw. The conclusion is not yet published                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                      |                       |                                                    |                                 |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                      |                       |                                                    |                                 |
|                        | During the EU peer review meeting (September 2018), several metabolites were discussed: --**NOA422054**: not concluded since genotoxicity potential could not be concluded due to lack of data and repeat‐dose toxicity had not been investigated--**CGA232449**: not concluded since genotoxicity potential could not be concluded due to lack of data and repeat‐dose toxicity had not been investigated--**CGA249287**: ADI is 0.08 mg/kg bw per day based on the 90‐day rat study, applying an uncertainty factor of 1000 to take into account the limited data package.--**CGA263208**: ADI is 0.02 mg/kg bw per day based on the 90‐day rat study, applying an uncertainty factor of 1000 to take into account the limited data package.--**CGA304075**: the ADI and ARfD of cyprodinil can be applied to this major rat metabolite.--**CGA304076**: not concluded since genotoxicity potential could not be concluded due to lack of data and repeat‐dose toxicity had not been investigated--**I13C** and **I13b**: not concluded since genotoxicity potential could not be concluded due to lack of data and repeat‐dose toxicity had not been investigated--**CGA275535**: no genotoxic potential, use of TTC value (Cramer class III) was proposed--**CGA321915**: no genotoxic potential, use of TTC value (Cramer class III) was proposed |                      |                       |                                                    |                                 |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                      |                       |                                                    |                                 |
|                        | For the TTC approach, the sum of the exposure for all non‐toxicological characterised metabolite should be compared to the TTC. It is noted that currently the TTC is not used at European Level for assessing residues metabolites since there is no agreement yet on how this tool should be used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                      |                       |                                                    |                                 |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------+-----------------------+----------------------------------------------------+---------------------------------+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; RAR: renewal assessment report; TTC: threshold of toxicological concern.
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### 5.12.3. Residue definitions {#efs25797-sec-0098}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | JMPR evaluation            | EU evaluation                | RDs comparable |
+=========================+==========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+============================+==============================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Cyprodinil                 | EU Reg. 2019/552: Cyprodinil | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | The residue is fat soluble |                              |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+
| Animal products         | EU Reg. 2019/552: [Milk]{.ul}: Cyprodinil (sum of cyprodinil and CGA 304075 (free and conjugated), expressed as cyprodinil)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | No                         |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | [Other animal products:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | Cyprodinil (sum of cyprodinil and CGA 304075 (free), expressed as cyprodinil)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                            |                              |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Cyprodinil                 | Cyprodinil                   | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+
| Animal products         | [Milk]{.ul}: Cyprodinil (sum of cyprodinil and CGA 304075 (free and conjugated), expressed as cyprodinil)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | No                         |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | [Other animal products:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | Cyprodinil (sum of cyprodinil and CGA 304075 (free), expressed as cyprodinil)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                            |                              |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+
| **Conclusion/comments** | [Plant products:]{.ul} The residue definition for enforcement and risk assessment derived by the JMPR and at EU level is identical                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | [Animal products]{.ul}: For animal products, the EU residue definition for enforcement and risk assessment is wider as comprises the metabolite CGA304075 (4‐\[(4‐cyclopropyl‐6‐methylpyrimidin‐2‐yl)amino)\]phenol) for tissues. In the framework of the MRL review also, the conjugates of CGA 304075 were also included in the residue definition for milk. However, this difference is of no relevance for the current MRL proposal                                                                                                                                                                                                                                                  |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | The RMS informed EFSA that in the framework of the renewal of the approval, residue definitions may be revised (e.g. residue definition for animal products (risk assessment and enforcement): sum of cyprodinil and CGA 304075 (free form and glucuronide), expressed as cyprodinil; residue definition for plant products (risk assessment) -- fruit crops: cyprodinil and CGA232449 (free and conjugated) (pending submission of toxicity data on CGA232449 to be decided whether a separate residue definition for the metabolite would be more appropriate); cereals: cyprodinil by default (cereal) (provisional); rotational crops: NOA422054 (free and conjugated) (provisional) |                            |                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                            |                              |                |
|                         | However, since the modification of new residue definitions has not yet been implemented, the ongoing discussions at EU level do not affect the conclusions on Codex MRL proposals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                            |                              |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.
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### 5.12.4. Codex MRL proposals {#efs25797-sec-0099}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal                                                                                                                                                                                  | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                      |
+======================+=====================================================================================================================================================================================================+==============================================+==============================================================================================================================================================================================================================================================================================================+
| Pomegranate          | **5Po**                                                                                                                                                                                             | 0.02[\*](#efs25797-note-0087){ref-type="fn"} | Critical GAP: US post‐harvest (dip/drench) GAP, 1 × 54 g/hL before storage + 1 × 54 g/hL before trading, PHI 0 days                                                                                                                                                                                          |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | Number of trials: 1 storage facility, 4 trials at different dates                                                                                                                                                                                                                                            |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | Sufficiently supported by data: to be discussed with MS. AT EU level the trials would not be considered independent                                                                                                                                                                                          |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | Specific comments/observations: Residue data were submitted for the 2017 JMPR, who proposed a CXL of 10 mg/kg                                                                                                                                                                                                |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | The EU made a reservation due to uncertainty over the relevance of the foliar metabolism study used to support the post‐harvest treatments and because for post‐harvest use the MRL should be calculated using mean + 4SD instead of CF × 3 Mean. The CXL proposal for pomegranates was maintained at step 4 |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | 2018 JMPR derived a revised MRL proposal calculated as proposed by the EU (5 mg/kg instead of 10 mg/kg)                                                                                                                                                                                                      |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | 2018 JMPR confirmed the metabolism studies are appropriate since post‐harvest treatment is unlikely to result in a more extensive metabolism than observed from foliar treatments                                                                                                                            |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | As regards question on the independence of residue trials and the lack of clarity of the GAP raised last year by the EU (see EFSA report on preparing EU position for the 50th CCPR), new information was not provided to 2018 JMPR                                                                          |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | A risk management decision to be taken on the acceptability of the CXL proposal                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              |                                                                                                                                                                                                                                                                                                              |
|                      |                                                                                                                                                                                                     |                                              | The proposed Codex MRL is supported by the RMS                                                                                                                                                                                                                                                               |
+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments** | Further comments on residue trials can be found in EFSA, [2018n](#efs25797-bib-0103){ref-type="ref"} (50th Session of CCPR), and JMPR 2018 Report (FAO, [2017](#efs25797-bib-0151){ref-type="ref"}) |                                              |                                                                                                                                                                                                                                                                                                              |
+----------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; MS: Member State; CXL: Codex Maximum Residue Limit; CF: conversion factor; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State.

Indicates that the input value is proposed at the limit of quantification.
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### 5.12.5. Consumer risk assessment {#efs25797-sec-0100}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                   | Chronic exposure assessment                                                                                                                                                                                  | Comments on JMPR exposure assessment        |
+=============================================================================================================================================================================================================================================================================================+==============================================================================================================================================================================================================+=============================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                         | **RA assumptions:**                                                                                                                                                                                          | **Specific comments:**                      |
|                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                              |                                             |
| Currently, no ARfD is established formally for cyprodinil. Thus, an acute risk assessment would not be required                                                                                                                                                                             | The most recent long‐term risk assessment (EFSA, [2019e](#efs25797-bib-0114){ref-type="ref"}), which was performed with EFSA PRIMo rev.3 was updated, including the CXL proposal of 5 mg/kg for pomegranates |                                             |
|                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                              |                                             |
| However, considering that in the framework of the renewal of the approval ARfD values were proposed/agreed in expert meetings, EFSA calculated an indicative acute risk assessment using the ARfD proposed in the RAR/agreed in the expert meeting (scenario 1/scenario 2) for pomegranates |                                                                                                                                                                                                              |                                             |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                | **Results:**                                                                                                                                                                                                 | **Results:**                                |
|                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                              |                                             |
| No short‐term exposure concern was identified; exposure to residues from pomegranate accounted for a maximum of 12.5% of the ARfD (scenario 1); 9% of the ARfD (scenario 2)                                                                                                                 | No long‐term consumer health risk was identified                                                                                                                                                             | Long‐term exposure:                         |
|                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                              |                                             |
|                                                                                                                                                                                                                                                                                             | The overall chronic exposure accounted for 55% of the ADI                                                                                                                                                    | 8--70% of the ADI                           |
|                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                              |                                             |
|                                                                                                                                                                                                                                                                                             | The contribution of pomegranate to the exposure was 1.7% of the ADI                                                                                                                                          | Acute exposure not necessary (ARfD not set) |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; RAR: renewal assessment report; CXL: Codex Maximum Residue Limit; PRIMo: (EFSA) Pesticide Residues Intake Model; ADI: acceptable daily intake.
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5.13. Pyraclostrobin (210) R,T {#efs25797-sec-0101}
------------------------------

### 5.13.1. Background information {#efs25797-sec-0102}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           | Additional toxicological studies on parent and a number of metabolites were provided and assessed by JMPR; a new ARfD has been derived and the previous ARfD has been withdrawn                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | DE                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Directive 2004/30/EC[a](#efs25797-note-0090){ref-type="fn"}                                                                                                                                            |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | amended by Commission Regulation (EU) No 823/2012[b](#efs25797-note-0091){ref-type="fn"} and Commission Implementing Regulation (EU) 2016/2016[c](#efs25797-note-0092){ref-type="fn"}                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Ongoing           | Peer‐review ongoing                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2011e](#efs25797-bib-0019){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2011a](#efs25797-bib-0015){ref-type="ref"}) (oranges)                                                                                                                                                      |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2012b](#efs25797-bib-0021){ref-type="ref"}) (crops)                                                                                                                                                        |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2013a](#efs25797-bib-0025){ref-type="ref"}) (Jerusalem artichokes)                                                                                                                                         |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2014d](#efs25797-bib-0038){ref-type="ref"}) (chicory roots)                                                                                                                                                |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2014i](#efs25797-bib-0043){ref-type="ref"}) (swedes and turnips)                                                                                                                                           |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2016g](#efs25797-bib-0070){ref-type="ref"}) (beet leaves)                                                                                                                                                  |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2017a](#efs25797-bib-0072){ref-type="ref"}) (various crops)                                                                                                                                                |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2018p](#efs25797-bib-0800){ref-type="ref"}) (confirmatory data)                                                                                                                                            |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2018q](#efs25797-bib-0105){ref-type="ref"}) (rice)                                                                                                                                                         |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2018r](#efs25797-bib-0106){ref-type="ref"}) (various crops & import tolerances)                                                                                                                            |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2018u](#efs25797-bib-0109){ref-type="ref"}) (soya bean)                                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonized classification and labelling for CMR -- Annex VI: none                                                                                                                                                 |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU Peer Review proposal for CMR: Toxic for reproduction cat. 2                                                                                                                                                    |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[d](#efs25797-note-0809){ref-type="fn"}): not finalised |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2004/30/EC of 10 March 2004 amending Council Directive 91/414/EEC to include benzoic acid, flazasulfuron and pyraclostrobin as active substances. OJ L 77, 13.3.2004, p. 50--53.

Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active substances 2,4‐DB, benzoic acid, beta‐cyfluthrin, carfentrazone ethyl, *Coniothyrium minitans* strain CON/M/91‐08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid‐P, ethofumesate, ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop‐P, mesosulfuron, mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb, propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide. OJ L 250, 15.9.2012, p. 13--14.

Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, benzoic acid, flazasulfuron, mecoprop‐P, mepanipyrim, mesosulfuron, propineb, propoxycarbazon, propyzamide, propiconazole, *Pseudomonas chlororaphis* Strain: MA 342, pyraclostrobin, quinoxyfen, thiacloprid, thiram, ziram, zoxamide. OJ L 312, 18.11.2016, p. 21--23.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.13.2. Toxicological reference values {#efs25797-sec-0103}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------+-----------------------+------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | EU evaluation                                                                                                                          | TRV comparable        |                                                                  |     |
+========================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+========================================================================================================================================+=======================+==================================================================+=====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR (2003)                                                                                                                            | 0.03 mg/kg bw per day | European Commission ([2004](#efs25797-bib-0127){ref-type="ref"}) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       | (2‐year rat study, uncertainty factor of 100)                    |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------+-----------------------+------------------------------------------------------------------+-----+
| **ARfD**               | 0.7 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR Report 2019 (FAO, [2018](#efs25797-bib-0152){ref-type="ref"}), 90‐day and 1‐year feeding studies in dogs, uncertainty factor of 8 | 0.03 mg/kg bw         | European Commission ([2004](#efs25797-bib-0127){ref-type="ref"}) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       | (Rabbit developmental study, with an uncertainty factor of 100   |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------+-----------------------+------------------------------------------------------------------+-----+
| **Conclusion/comment** | [JMPR assessment]{.ul}:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        | The previous ARfD of 0.05 mg/kg bw (JMPR, 2003), based on embryo and fetal toxicity in a developmental toxicity study in rabbits (SF 100), has been withdrawn. Based on additional studies, the meeting concluded that the effects secondary to local irritation following gavage dosing in rabbits were not relevant to human dietary risk assessment. Therefore, the meeting established a new ARfD of 0.7 mg/kg bw based on vomiting and diarrhoea seen during the first week of dosing of dogs (90‐day and 1‐yr studies), and applying a safety factor of 8 since the critical effects are considered to be secondary to a direct local effect on the gastrointestinal tract, which is independent of absorption and metabolism |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        | Additional toxicological information on certain metabolites/degradation products was assessed by JMPR, e.g. degradation product formed under high temperature conditions, (see olives for oil production). The conclusions were: --for **500M04**: No evidence of genotoxicity, oral LD~50~ \> 2,000 mg/kg bw (rats), 3‐month oral toxicity study NOAEL 100 mg/kg bw per day (rats),--for **500M49**: no evidence of genotoxicity *in vitro* [EU peer review assessment]{.ul}:                                                                                                                                                                                                                                                      |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        | Peer review for the renewal is ongoing -- The same toxicological reference values established during the first assessment (European Commission, [2004](#efs25797-bib-0127){ref-type="ref"}) are proposed by the RMS. To be discussed at the experts' meeting                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                        |                       |                                                                  |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                        |                       |                                                                  |     |
|                        | The agreed ARfD of the first peer review was based on maternal toxicity (body weight losses) during the initial phase of the treatment in the rabbit developmental toxicity studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                        |                       |                                                                  |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------+-----------------------+------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; LD~50~: lethal dose, median; RMS: rapporteur Member State.
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### 5.13.3. Residue definitions {#efs25797-sec-0104}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                     | JMPR evaluation                                                                                                                                                                                                                                    | EU evaluation                                                              | RDs comparable |
+=========================+=====================================================================================================================================================+====================================================================================================================================================================================================================================================+============================================================================+================+
| **RD enf**              | Plant products                                                                                                                                      | Pyraclostrobin                                                                                                                                                                                                                                     | EU Reg. 2017/1016: Pyraclostrobin                                          | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+
| Animal products         | Pyraclostrobin                                                                                                                                      | EU Reg. 2017/1016: Pyraclostrobin                                                                                                                                                                                                                  | Yes                                                                        |                |
|                         |                                                                                                                                                     |                                                                                                                                                                                                                                                    |                                                                            |                |
|                         | The residue is fat soluble                                                                                                                          | The residue is fat soluble                                                                                                                                                                                                                         |                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                      | Pyraclostrobin                                                                                                                                                                                                                                     | Art.12 (EFSA, [2011e](#efs25797-bib-0019){ref-type="ref"}): Pyraclostrobin | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+
| Animal products         | Pyraclostrobin                                                                                                                                      | Art.12 (EFSA, [2011e](#efs25797-bib-0019){ref-type="ref"}): Sum of pyraclostrobin and its metabolites containing the 1‐(4‐chlorophenyl)‐1*H*‐pyrazole moiety or the 1‐(4‐chloro‐2‐hydroxyphenyl)‐1*H*‐pyrazole moiety, expressed as pyraclostrobin | No                                                                         |                |
|                         |                                                                                                                                                     |                                                                                                                                                                                                                                                    |                                                                            |                |
|                         |                                                                                                                                                     | Conversion factor of 4 for ruminant liver                                                                                                                                                                                                          |                                                                            |                |
|                         |                                                                                                                                                     |                                                                                                                                                                                                                                                    |                                                                            |                |
|                         |                                                                                                                                                     | Conversion factor of 6.8 for milk                                                                                                                                                                                                                  |                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for enforcement are compatible                                                                                              |                                                                                                                                                                                                                                                    |                                                                            |                |
|                         |                                                                                                                                                     |                                                                                                                                                                                                                                                    |                                                                            |                |
|                         | The difference in the residue definition for animal products (risk assessment) can be compensated by using the conversion factors derived in the EU |                                                                                                                                                                                                                                                    |                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment.

John Wiley & Sons, Ltd

### 5.13.4. Codex MRL proposals {#efs25797-sec-0105}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                           | Codex MRL proposal                             | EU MRL                                                                 | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+=====================================================================================+================================================+========================================================================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Apple                                                                               | W 0.5                                          |                                                                        | The existing CXL is proposed to be withdrawn and replaced by the group MRL for pome fruit                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Asparagus                                                                           | 0.01[\*](#efs25797-note-0096){ref-type="fn"}   | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: Germany, 2 foliar applications (BBCH \> 69, after harvest of spears) at 0.1 kg a.i./ha, PHI not specified                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Avocado                                                                             | **0.2**                                        | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: USA, 2 foliar applications of 0.166 kg a.i./ha, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Beans with pods, subgroup of, except common beans (poroto)                          | 0.3                                            | 0.6                                                                    | Critical GAP: USA (for whole subgroup of beans with pods), 3 applications of 0.16 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 7 trials with 2 × 0.23 kg/ha, PHI 7 days; trials were scaled (scaling factor 0.7). Scaling was considered acceptable, considering that decline trials demonstrated that the first application does not significantly contribute to the final residues                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: EFSA proposes to set only one MRL for beans with pods, subgroup (VP2060) at the level of 0.6 mg/kg derived from the EU trials (see below)                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable. However, preferably only one MRL for the whole subgroup should be set. The proposed Codex MRL of 0.6 mg/kg derived for common beans (poroto) would be the appropriate level for the code VP 2060                                                                                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Broad beans without pods (succulent seeds)                                          | 0.01                                           | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: France, 2 applications of 0.1 kg a.i./ha and PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 8 (all at 0.01[\*](#efs25797-note-0096){ref-type="fn"})                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: The proposed Codex MRL refers to the code VP 0523 (*Vicia faba*). A separate MRL proposal of 0.3 mg/kg was derived for *Phaseolus* beans (common beans without pods (succulent seeds, VP 2845)                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable. See comments below on common beans without pods (succulent seeds)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cacao beans                                                                         | 0.01                                           | 0.1[\*](#efs25797-note-0096){ref-type="fn"}                            | Critical GAP: Brazil, 3 foliar applications of 0.2 kg a.i./ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Cocoa beans are a crop of consumption category 2; thus at least 4 trials would be required. At EU level 8 trials would be requested (if residues \< LOQ, 4 trials would be sufficient)                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, considering the level of the MRL proposal. If the proposed Codex MRL is found acceptable, it should be proposed to label it with an asterisk, indicating that the MRL is at the LOQ                                                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrot                                                                              | W 0.5                                          |                                                                        | Existing CXL to be replaced by new MRL for Root and tuber vegetables                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Celery                                                                              | 1.5                                            | 1.5                                                                    | Critical GAP: Poland, 2 foliar applications at 0.1 kg a.i./ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common bean (poroto)                                                                | 0.6                                            | 0.6                                                                    | Critical GAP: France, 2 applications of 0.1 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 17 trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: NEU and SEU residue trials were merged. The proposed Codex MRL refers to code VP2060 (*Vicia faba*)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable. However, it would be preferable to set the MRL for the whole subgroup of beans with pods (VP2060) at this level. (See also comments on Beans with pods, subgroup of, except common beans (poroto)                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common beans (succulent seeds)                                                      | 0.3                                            | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: France, 2 applications of 0.1 kg a.i./ha and PHI = 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: The proposed Codex MRL refers to the code VP 2845 (*Phaseolus vulgaris*). A separate MRL proposal of 0.01 mg/kg was derived for fava beans (Broad beans without pods (succulent seeds, VP 0523)                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: Since in the EU, the two commodities (*Phaseolus* beans and fava beans (codex code VP) are covered by the same code (260020), the MRL proposal of 0.3 mg/kg would be relevant. It is sufficiently supported by data and therefore acceptable. See also comments on broad beans without pods (succulent seeds)                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry peas, Subgroup of (includes all commodities in this subgroup)                   | 0.3                                            | 0.3 dry peas, 0.5 dry lentils                                          | Critical GAP: Canada, 2 foliar applications at 0.15 kg a.i./ha, PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 9 overdose trials, scaled down (scaling factor of 0.67) and 5 trials in lentils                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: The proposed Codex MRL covers peas and lentils                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                            | **0.05**                                       | 0.05[\*](#efs25797-note-0096){ref-type="fn"}                           | See comments on meat (for mammals other than marine mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce, head                                                                       | **40**                                         | 2                                                                      | Critical GAP: in USA of 0.23 kg a.i./ha and PHI = 0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Although at EU level, 8 trials would be required, the number of trials is acceptable at Codex level, since lettuce is not a major crop                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | 2006 JMPR assessed the same trials, but due to an exceedance of the ARfD, the MRL proposal was not advanced. With the higher ARfD value established by 2018 JMPR, the proposed MRL did not exceed the TRV                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | JMPR withdrew previous recommendation of MRL of 2 mg/kg in head lettuce                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is not acceptable because of acute intake concerns identified at EU level (see below)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                       | **0.5 (fat)**                                  | 0.05[\*](#efs25797-note-0096){ref-type="fn"}                           | No feeding study was available. The MRL proposals were derived from metabolism study in lactating goats. At EU level, MRLs are set for muscle. The residue concentration in muscle at the calculated dietary burden of 29 ppm (EU diet) is expected to be between 0.05 and 0.06 mg/kg                                                                                                                                                                                                                                                                                                                               |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is not acceptable; considering the significant dietary burden, a feeding study would be required to derive a reliable MRL for animal products                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                   | **0.5**                                        | 0.05[\*](#efs25797-note-0096){ref-type="fn"}                           | See comments on meat (for mammals other than marine mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                               | **0.6**                                        | 0.05                                                                   | Critical GAP: Brazil, 4 foliar applications at 0.133 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                               | **0.03**                                       | 0.01[\*](#efs25797-note-0096){ref-type="fn"}                           | See comments on meat (for mammals other than marine mammals)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Olives for oil production                                                           | 0.01[\*](#efs25797-note-0096){ref-type="fn"}   | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: See table olives is proposed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Extrapolation from table olives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | In the framework of an Art. 10 application, additional toxicological data were requested for certain degradation products formed under conditions representative for frying and raffination (metabolite 500M04 and 500M49). The application was withdrawn                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | JMPR assessed data on 500M04 and 500M49 (see comments on toxicological reference values)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Olive oil, Virgin                                                                   | **0.07**                                       |                                                                        | Proposed PF for olive oil: 6.24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | It is noted that in the EU MRLs are set only for unprocessed olives, but not for olive oil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peas with pods, Subgroup of                                                         | 0.3                                            | 0.6                                                                    | Critical GAP: Spain, 2 applications of 0.1 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peas (pods and succulent= immature seeds)                                           | 0.02[\*](#efs25797-note-0096){ref-type="fn"} W |                                                                        | The existing CXL is replaced by the new proposal for the subgroup of peas with pods                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Passion fruit                                                                       | **0.2**                                        | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: Brazil, 4 foliar applications of 0.15 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                           | **0.3**                                        | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: Brazil, 4 foliar applications of 0.15 kg a.i./ha, PHI 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: In 4 residue trials, residue concentration was measured in the pulp as well. At EU level, a peeling factor of 0.27 was proposed                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits                                                                         | **0.7**                                        | 0.5 pome fruit,                                                        | Critical GAP: Germany, 4 foliar application of 0.1 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 0.02[\*](#efs25797-note-0096){ref-type="fn"} kaki,                     | Number of trials: 33 (25 in apples + 8 in pears)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 3 azaroles                                                             | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: extrapolation to the entire pome fruits group (apples, pears, quinces, medlar and loquats/Japanese medlars) but also including azarole (0154070) and kaki (Japanese persimmon) (0131060)                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is sufficiently supported by data, but since an acute intake concern was identified for apples, pears and kakis the proposed MRL is not acceptable                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                              | 0.02[\*](#efs25797-note-0096){ref-type="fn"} W |                                                                        | The existing CXL is replaced with the new proposal for tuberous and corm vegetables                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Radish                                                                              | 0.5 W                                          |                                                                        | The existing CXL is replaced with the new proposal for root vegetables                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                                                                | 1.5                                            |                                                                        | Critical GAP: see rice, husked                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, Husked                                                                        | **0.09**                                       | 0.02                                                                   | Critical GAP: Indonesia, 2 foliar applications at 0.1 kg a.i./ha and BBCH 65 (last application at mid‐flowering), PHI not defined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 16 (results for brown rice)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Residue trials conducted in Asian countries, Italy and Spain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, Polished                                                                      | 0.03                                           |                                                                        | PF 0.2 (from brown rice to polished rice); no MRL is set for polished rice in the EU                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw and fodder, dry                                                          | 5(dw)                                          |                                                                        | No MRLs are set for feed items in the EU                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Root vegetables, Subgroup of this subgroup)                                         | 0.5                                            | 0.06 for Jerusalem artichokes,                                         | Critical GAP: in USA for 3 foliar applications at 0.234 kg a.i./ha and PHI 0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 0.09 for swedes and turnips;                                           | Number of trials: 5 trials in radishes (minor crop), 6 in carrots (major crop)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 0.1 beetroots, parsley roots, salsifies;                               | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 0.3 for parsnips and horseradish; 0.5 for radishes, carrots, celeriacs | Specific comments/observations: The number of trials is not sufficient to derive a MRL proposal for the subgroup of root vegetables; furthermore, following the agreed policy on also trials on sugar beet or beetroots would be required                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is not acceptable because the residue trials are not sufficient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Spinach                                                                             | **1.5**                                        | 0.6                                                                    | Critical GAP: Germany and Italy, 2 applications of 0.1 kg a.i./ha, PHI 14 days, RTI 8 days (DE), 7 days (IT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Trials were conducted in Germany, France and Italy. JMPR merged the NEU and SEU trials to derive the MRL proposal. The EU MRL was derived from residue trials reflecting the NEU use. The trial with the highest residue (0.91 mg/kg) that is driving the MRL calculation was not available in the EU data package. Most likely this result is not correctly reflecting the trial results (the total residue (sum of parent plus metabolite is 0.1 mg/kg, while the parent alone was reported as 0.91 mg/kg; the results at a shorter PHI of 7 days were lower than at PHI 14 days) |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: JMPR should be asked to verify the results for the residue trial leading to the highest result. Most likely the value of 0.91 mg/kg is a typo                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Succulent peas without pods Subgroup of (includes all commodities of this subgroup) | 0.08                                           | 0.15 peas                                                              | Critical GAP: Spain, 2 applications of 0.1 kg a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                | 0.02[\*](#efs25797-note-0096){ref-type="fn"} lentils                   | Number of trials: 16 trials in peas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: The proposed Codex MRL covers also fresh lentils. At EU level, the residue trials in peas would not be acceptable to set an MRL for lentils                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sugar cane                                                                          | **0.08**                                       | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: Brazil, single application in‐furrow at 0.133 kg a.i./ha, followed by 5 foliar applications of 0.13 kg a.i./ha with PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 4 + 8 overdosed trails (scaled down to match the GAP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Table olives                                                                        | 0.01[\*](#efs25797-note-0096){ref-type="fn"}   | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: Greece, foliar application, 2 × 0.1 kg a.i./ha, last application no later than BBCH 71; PHI not specified                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tea, Green, Black (black, fermented and dried)                                      | **6**                                          | 0.1[\*](#efs25797-note-0096){ref-type="fn"}                            | Critical GAP: Japan, 2 applications of 0.003 kg a.i./hL, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 6 overdosed trials, scaled down to match the GAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: Tea is a major crop and according to EFSA\'s understanding 8 trials would be required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is not acceptable because the number of trials is insufficient. To discuss with MS if EFSA\'S view is shared                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tuberous and corm vegetables, commodities in this subgroup)                         | 0.02[\*](#efs25797-note-0096){ref-type="fn"}   | 0.02[\*](#efs25797-note-0096){ref-type="fn"}                           | Critical GAP: USA for 6 foliar applications at 0.22 kg a.i./ha and PHI 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 19 trials, probably in potatoes, not specified in which crops the trials were performed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations: The proposed Codex MRL covers arrowroots, cassava, potatoes, sweet potatoes, yams                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Witloof chicory (leaves/sprouts)                                                    | 0.09                                           | 0.09                                                                   | Critical GAP: France, 1 application of 0.42 g a.i./m^2^ tray area, PHI 21 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                     |                                                |                                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                | --                                             |                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------------+------------------------------------------------+------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; LOQ: limit of quantification; NEU: northern European Union; SEU: southern European Union; TRV: toxicological reference values; PF: processing factor; BBCH: growth stages of mono‐ and dicotyledonous plants; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.13.5. Consumer risk assessment {#efs25797-sec-0106}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                     | Chronic exposure assessment                                                                                                                                                                                                                                                                                    | Comments on JMPR exposure assessment                                 |
+===============================================================================================================================================================================================================+================================================================================================================================================================================================================================================================================================================+======================================================================+
| **RA assumptions:**                                                                                                                                                                                           | **RA assumptions:**                                                                                                                                                                                                                                                                                            | **Specific comments:**                                               |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| The short‐term dietary risk assessment was performed for all crops under assessment for which Codex MRL proposals were higher than the existing EU MRLs. The calculations were performed using PRIMo ver. 3.1 | The most recent long‐term risk assessment (EFSA, [2018u](#efs25797-bib-0109){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the crops/commodities, for which the proposed Codex MRLs were higher than the existing EU MRLs | New ARfD derived of 0.7                                              |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| The EU ARfD of 0.03 mg/kg bw was used                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                |                                                                      |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| For animal commodities conversion factors were used for milk and liver to accommodate for the additional metabolites included in the EU residue definition for risk assessment                                |                                                                                                                                                                                                                                                                                                                |                                                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                  | **Results:**                                                                                                                                                                                                                                                                                                   | **Results:**                                                         |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| The risk assessment identified potential consumer risks for:                                                                                                                                                  | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                               | Long‐term exposure:                                                  |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| Lettuce (2,500% of the ARfD)                                                                                                                                                                                  | The overall chronic exposure accounted for 29% of the ADI                                                                                                                                                                                                                                                      | 1--7% of the ADI                                                     |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| pears (319% of the ARfD)                                                                                                                                                                                      | The highest contributor is milk                                                                                                                                                                                                                                                                                | Short‐term exposure:                                                 |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| apples (247.90% of the ARfD)                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                | 0--60% of the ARfD for children to 0--30% for the general population |
|                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                |                                                                      |
| kaki/Japanese (107.07% of the ARfD)                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                |                                                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue; PRIMo: (EFSA) Pesticide Residues Intake Model; ADI: acceptable daily intake.
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5.14. Fludioxonil (211) R {#efs25797-sec-0107}
-------------------------

### 5.14.1. Background information {#efs25797-sec-0108}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                          | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+==========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use                  |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FR                       | Co‐RMS: ES                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approval process ongoing | Commission Directive 2007/76/EC[a](#efs25797-note-0099){ref-type="fn"} amended by Commission Implementing Regulation (EU) 2018/1262[b](#efs25797-note-0100){ref-type="fn"}                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments        | EFSA ([2007](#efs25797-bib-0005){ref-type="ref"})                                                                                                                                                                 |
|                                                                                                                                        |                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                          | Renewal ongoing                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments        | EFSA ([2011d](#efs25797-bib-0018){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments        | EFSA ([2016b](#efs25797-bib-0065){ref-type="ref"}) Art.10 in fennel (ongoing)                                                                                                                                     |
|                                                                                                                                        |                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                          | Assessment of confirmatory data (ongoing, combined with renewal)                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded            | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                                                                 |
|                                                                                                                                        |                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                          | EU Peer Review proposal for CMR: no proposal for CMR properties                                                                                                                                                   |
|                                                                                                                                        |                          |                                                                                                                                                                                                                   |
|                                                                                                                                        |                          | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[c](#efs25797-note-0810){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2007/76/EC of 20 December 2007 amending Council Directive 91/414/EEC to include fludioxonil, clomazone and prosulfocarb as active substances. OJ L 337, 21.12.2007, p. 100--104.

Commission Implementing Regulation (EU) 2018/1262 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1‐methylcyclopropene, beta‐cyfluthrin, chlorothalonil, chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, dimethenamid‐p, diuron, fludioxonil, flufenacet, flurtamone, fosthiazate, indoxacarb, MCPA, MCPB, prosulfocarb, thiophanate‐methyl and tribenuron. OJ L 238, 21.9.2018, p. 62--64.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.14.2. Toxicological reference values {#efs25797-sec-0109}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------+-----+
|                         | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | EU evaluation | TRV comparable        |                                                                                               |     |
+=========================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+===============================================================================================+=====+
| **ADI**                 | 0.4 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | JMPR (2004)   | 0.37 mg/kg bw per day | EFSA ([2007](#efs25797-bib-0005){ref-type="ref"}) (2‐y rat with an uncertainty factor of 100) | Yes |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |               |                       |                                                                                               |     |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |               |                       | confirmed in European Commission ([2007b](#efs25797-bib-0129){ref-type="ref"})                |     |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------+-----+
| **ARfD**                | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR (2004)   | Not applicable        | Not allocated -- not necessary (EFSA, [2007](#efs25797-bib-0005){ref-type="ref"})             | Yes |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------+-----+
| **Conclusion/ comment** | During the previous peer review at EU level (EFSA, [2007](#efs25797-bib-0005){ref-type="ref"}), the ADI was based on the NOAEL of 37 mg/kg bw per day in the 2‐year rat study; the same basis than the JMPR in 2004. The differences are because different policy in rounding. During the EU assessment, no assessment was done on whether metabolites oxidised to metabolite 2,2‐difluoro‐benzo\[1,3\]dioxole‐4 carboxylic acid (CGA 192155) could be covered by the parent compound |               |                       |                                                                                               |     |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |               |                       |                                                                                               |     |
|                         | In the framework of the renewal process in the EU, the RMS proposed 0.1 mg/kg bw per day for both the ADI and ARfD, whereas the proposal of the co‐RMS was 0.37 mg/kg bw per day for both reference values. (Discussion at Expert meeting foreseen in April 2019). The toxicological profile of metabolites including CGA 192155 will be also discussed during Expert meeting foreseen in April, 2019                                                                                 |               |                       |                                                                                               |     |
+-------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; RMS: rapporteur Member State.
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### 5.14.3. Residue definitions {#efs25797-sec-0110}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR evaluation                                                                                                                                         | EU evaluation                                                                                                                                           | RDs comparable |
+=========================+===========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================================================================+=========================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Fludioxonil                                                                                                                                             | EU Reg. 2016/1902: Fludioxonil                                                                                                                          | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         | EFSA ([2007](#efs25797-bib-0005){ref-type="ref"}, [2011d](#efs25797-bib-0018){ref-type="ref"}) (Peer‐review, Art.12 MRL Review): Fludioxonil            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Fludioxonil and its benzopyrrole metabolites, determined as 2,2‐difluoro‐1,3‐benzodioxole‐4‐carboxylic acid and expressed as fludioxonil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | EU Reg. 2016/1902: Sum of fludioxonil and its metabolites oxidised to metabolite 2,2‐difluoro‐benzo\[1,3\]dioxole‐4 carboxylic acid                     | Yes                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | The residue is fat soluble                                                                                                                              |                                                                                                                                                         |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Fludioxonil                                                                                                                                             | EFSA ([2007](#efs25797-bib-0005){ref-type="ref"}, [2011d](#efs25797-bib-0018){ref-type="ref"}):                                                         | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         | Sum of fludioxonil and its metabolites oxidised to metabolite 2,2‐difluoro‐benzo\[1,3\]dioxole‐4 carboxylic acid (CGA 192155), expressed as fludioxonil |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Fludioxonil and its benzopyrrole metabolites, determined as 2,2‐difluoro‐1,3‐benzodioxole‐4‐carboxylic acid and expressed as fludioxonil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | EFSA ([2007](#efs25797-bib-0005){ref-type="ref"}, [2011d](#efs25797-bib-0018){ref-type="ref"}):                                                         | Yes                                                                                                                                                     |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | Sum of fludioxonil and its metabolites oxidised to metabolite 2,2‐difluoro‐benzo\[1,3\]dioxole‐4 carboxylic acid (CGA 192155), expressed as fludioxonil |                                                                                                                                                         |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | For cereals (seed treatment), fruits and leafy vegetables, pulses and oilseeds, the conversion factor (CF) of 1 between residue definitions for enforcement and risk assessment was derived which reflects the fact that no significant concentrations of metabolites containing the 2,2‐difluoro‐benzo\[1,3\]dioxole‐4 carboxylic moiety are expected. For root vegetables after foliar application the conversion factor of 2.8 (derived from the metabolism study on spring onions) from enforcement to risk assessment residue definition is proposed (EFSA, [2007](#efs25797-bib-0005){ref-type="ref"}, [2011d](#efs25797-bib-0018){ref-type="ref"}) |                                                                                                                                                         |                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         | For the commodities for which Codex MRLs were proposed by JMPR, the different residue definition is not expected to have a major impact as for root vegetables a CF derived from metabolism studies can be used in risk assessment to account for the presence metabolites measured as CGA 192155 (CF 2.8); for the other commodities similarly as in the MRL review a CF of 1 can be used, assuming that the metabolites is not present in significant concentrations.                                                                                                                                                                                   |                                                                                                                                                         |                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                         |                                                                                                                                                         |                |
|                         | The dietary risk assessment may need to be reviewed pending the conclusion of the ongoing renewal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                         |                                                                                                                                                         |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues
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### 5.14.4. Codex MRL proposals {#efs25797-sec-0111}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                                               | Codex MRL proposal                           | EU MRL                                                                           | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+=========================================================================================================================+==============================================+==================================================================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Avocado                                                                                                                 | **1.5**                                      | 0.4                                                                              | Critical GAP: Australia post‐harvest dip/drench/flood spray application at a rate of 60 g a.i./hL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 8 (dip treatment) + 2 (flood spray); trials combined                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: JMPR agreed to use the STMR of 0.01 mg/kg derived from the combined residues in the flesh. However, as information is not available on the time of sampling (whether samples analysed after a realistic storage period, allowing for penetration of residues in edible part of the fruit, as fludioxonil is fat soluble) the STMR relevant for the whole fruit was used in the exposure calculation                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Blueberries                                                                                                             | 2                                            | 2                                                                                | Critical GAP: Canada: 3 × 244 g a.i./ha, RTI 7 days, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 8 trials (JMPR, 2004); 2 new trials compliant with the Canadian GAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: JMPR concluded that the existing CXL derived in 2004 for the US GAP (4 × 250 g a.i./ha PHI: 0 day) covers the Canadian GAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: No change to the current Codex MRL is foreseen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Bulb onions, Subgroup of (includes all commodities in this subgroup)                                                    | 0.5                                          | onions: 0.5                                                                      | Critical GAP: US, 4 × 245 g a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | garlic and shallots: 0.02                                                        | Number of trials: 16 (13 assessed by JMPR in 2004)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: JMPR proposed to set a group tolerance which covers also garlic (0220010), and shallots (0220030). It should be verified whether the US GAP applies to the whole group of bulb onions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable, provided US GAP for the subgroup exists                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cabbages, head                                                                                                          | 2                                            | 2                                                                                | Critical GAP: US, 4 × 250 g a.i./ha, PHI 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 6 (JMPR 2004) + 5 new trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: The previous MRL and STMR recommendations were maintained                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: No change necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrot                                                                                                                  | 1                                            | 1                                                                                | Critical GAP: EU (DE), 3 × 250 g a.i./ha, RTI and PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: The RTI in the trials were 14 days, but was considered acceptable based on decline studies showing limited degradation. In the EU, a CF of 2.8 is proposed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Celery                                                                                                                  | **15**                                       | 1.5 (stem vegetable)                                                             | Critical GAP: USA, 4 × 245 g a.i./ha, RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 8 (±25% GAP)Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: Pending on the setting of the ARfD an acute risk may occur (if ARfD is set at 0.1 mg/kg bw per day; no concern if set at 0.37 mg/kg)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Chick‐pea (dry)                                                                                                         | 0.3                                          | 0.4                                                                              | Critical GAP: Canada, 3 × 244 g a.i./ha foliar; PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: In the EU food classification, chick peas are classified under peas (dry): 8 trials would be required for peas. However, considering that the EU MRL is higher than the proposed Codex MRL, the lack of 1 study may not be of relevance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Currants, Black, Red, White                                                                                             | **3**                                        | 2                                                                                | Critical GAP: Ireland 3 × 250 g a.i./ha, 10 days interval between 1st and 2nd applications and 28 days interval between 2nd and 3rd application, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: Same GAP assessed by EFSA([2011d](#efs25797-bib-0018){ref-type="ref"}). In the MRL review, the MRL was based on 9 GAP compliant residue trials on blueberries (0.15; 0.31; 0.31; 0.37) and currants (0.26; 0.6; 0.62; 0.63; 1.44) combined. The trials on currants are the same                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                                                                | **0.1**                                      | Swine liver, kidney, edible offals: 0.05[\*](#efs25797-note-0104){ref-type="fn"} | Critical GAP: Australian animal burden -- dairy cattle (max dietary burden 23 ppm/mean dietary burden 6.4 ppm); since the dietary burden calculation was not presented in Annex 6 of the JMPR report, the calculations cannot be checked                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Liver, kidney of other species: 0.2(ft)                                          | Sufficiently supported by data: Yes, a new feeding study was provided that covered the calculated dietary burden                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: In the EU, a livestock feeding study was requested as confirmatory data (deadline 30 January 2016). Confirmatory data assessment currently ongoing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                                                                    | 0.02                                         | 0.05[\*](#efs25797-note-0104){ref-type="fn"}                                     | Critical GAP: EU, laying hen (maximum dietary burden calculation 1.9 ppm/mean dietary burden 0.86 ppm)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Green onion, Subgroup of (includes all commodities in this subgroup)                                                    | **0.8**                                      | Spring onions: 5                                                                 | Critical GAP: EU (Italy), 3 × 250 g a.i./ha, RTI 10 days and PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| VA 2032                                                                                                                 |                                              | Leek: 0.01[\*](#efs25797-note-0104){ref-type="fn"}                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Chives: 20                                                                       | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | The MRL proposal would also cover leeks and chives which are classified in the subgroup of green onions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Guava                                                                                                                   | **0.5**                                      | 0.01[\*](#efs25797-note-0104){ref-type="fn"}                                     | Critical GAP: USA, 4 × 245 g a.i./ha; RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leaves of Brassicaceae, subgroup of (includes all commodities in this subgroup) Subgroup 013B, Brassica leafy vegetable | **15**                                       | 0.3                                                                              | Critical GAP: US, 4 × 240 g a.i./ha, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Chinese cabbage: 10                                                              | Number of trials: 9 trials in mustard greens and water cress (assessed in 2004 JMPR) + 1 new trial in mustard greens                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | land cress: 20,                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Kale: 0.01[\*](#efs25797-note-0104){ref-type="fn"}                               | Specific comments/observations: JMPR proposed to extrapolate to the whole subgroup of leaves of Brassicaceae. This crop group covers several crops that are classified differently in the EU food classification (e.g. Chinese cabbage, cress, kale, Chinese broccoli and rucola). It is noted that the higher MRL derived compared to the existing MRL is due to change in the method of calculation (OECD calculator, 2015) This approach is acceptable, however it needs to be confirmed that a US GAP refers to the whole group of Brassica. Based on the preliminary acute exposure calculation if the ARfD will be set at 0.1 mg/kg, a concern is foreseen for kales, broccoli and Chinese cabbage. No concern is expected if the ARfD is set at 0.37 mg/kg bw per day. |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Broccoli (covering chinese broccoli): 0.7                                        | Conclusion: The proposed Codex MRL is acceptable, provided the US GAP covers the whole group; an acute intake concern may be expected if the ARfD is lowered as proposed by the RMS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | Rucola: 20                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lentils                                                                                                                 | **0.3**                                      | 0.05                                                                             | Critical GAP: Canada, 3 × 244 g a.i./ha foliar; PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 7 on dry peas                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                                                       | 0.02                                         | swine fat: 0.05[\*](#efs25797-note-0104){ref-type="fn"}                          | See edible offal (Mammalians);                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | other species: 0.2(ft)                                                           | In the EU a metabolism study was requested as confirmatory data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                                                           | 0.02(fat)                                    | swine muscle: 0.01[\*](#efs25797-note-0104){ref-type="fn"}                       | See edible offal (Mammalians)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              | other species: 0.04 (ft)                                                         | In the EU, a metabolism study was requested as confirmatory data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable. The respective MRL for muscle would be 0.01 or 0.02 mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                                                   | **0.04**                                     | 0.01[\*](#efs25797-note-0104){ref-type="fn"}                                     | Critical GAP: Australian animal burden -- dairy cattle (maximum dietary burden 23 ppm/mean dietary burden 6.4 ppm)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mustard greens                                                                                                          | W 10                                         | 10                                                                               | JMPR proposed to withdraw the existing CXL for mustard greens and to replace it with the new MRL for Subgroup of Leaves of Brassicaceae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Onion, bulb                                                                                                             | W 0.5                                        | 0.5                                                                              | Existing CXL is proposed to be withdrawn, and replaced by a CXL applicable to the whole subgroup                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                                                               | 5Po                                          | 7                                                                                | Critical GAP: USA, one drench treatment and one spray treatment at a rate of 60 g a.i./hL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: To be discussed with MS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: According to the JMPR crop classification, at least 5 trials are required for pineapples. However, for the post‐harvest use 4 trials may be considered sufficient. In an US import tolerance application, EFSA derived the MRL proposal currently implemented in the EU legislation. In addition, pending on the ARfD to be set an acute risk may occur                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL may not acceptable if MS agree that the number of trials is insufficient. Nonetheless, in Europe a higher MRL is in place for pineapples                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pomegranate                                                                                                             | 3Po                                          | 3                                                                                | Critical GAP: USA two post‐harvest dip applications at a rate of 36 g a.i./hL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: The current CXL for fludioxonil is 2 mg/kg. This change in CXL has no implications on the current EU MRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                                                                            | 0.01[\*](#efs25797-note-0104){ref-type="fn"} | 0.05[\*](#efs25797-note-0104){ref-type="fn"}                                     | See eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                                                            | 0.01[\*](#efs25797-note-0104){ref-type="fn"} | 0.01[\*](#efs25797-note-0104){ref-type="fn"}                                     | See eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable. For muscle the corresponding MRL would be 0.01[\*](#efs25797-note-0104){ref-type="fn"} mg/kg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                                                                                                | **0.1**                                      | 0.05[\*](#efs25797-note-0104){ref-type="fn"}                                     | See eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                                                                         | **0.2**                                      | 0.01[\*](#efs25797-note-0104){ref-type="fn"}                                     | Critical GAP: Brazil, foliar, 2 × 250 g a.i./ha, RTI 7 days, PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Specific comments/observations: --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                         |                                              |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                                         |                                              |                                                                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrots (canned)                                                                                                        |                                              |                                                                                  | JMPR derived a PF of 0.14, based on 4 processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrots (cooked)                                                                                                        |                                              |                                                                                  | JMPR derived a PF of 0.12, based on 4 processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Carrots (pasteurised)                                                                                                   |                                              |                                                                                  | JMPR derived a PF of 0.18, based on 4 processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                                                    | --                                           |                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+----------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue; PHI: preharvest interval; CXL: Codex Maximum Residue Limit; MRL: maximum residue level; CF: conversion factor; OECD: Organisation for Economic Co‐operation and Development; RMS: rapporteur Member State; PF: processing factor; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.
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### 5.14.5. Consumer risk assessment {#efs25797-sec-0112}

###### 

Summary of the consumer risk assessment

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                             | Comments on JMPR exposure assessment |
+================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                     | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                         |                                      |
| The short‐term dietary risk assessment was not performed as an EU ARfD was not yet established. Within the scope of the renewal an ARfD will be set. An indicative risk assessment was carried out for the commodities where a new CXL was proposed using both reference values proposed by the RMS and co‐RMS (0.1 and 0.37 mg/kg bw per day) | The most recent long‐term risk assessment (ongoing application for fennel) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the RACs having a higher Codex MRL proposed compared to the existing EU MRLs and using a CF of 2.8 for garlic and shallots |                                      |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                         |                                      |
| Since the EU residue definition for risk assessment in plants is wider, a CF of 2.8 was applied for bulb vegetables to account for the additional metabolites (see comments on residue definition)                                                                                                                                             | The risk assessment is indicative                                                                                                                                                                                                                                                                                       |                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                   | **Results:**                                                                                                                                                                                                                                                                                                            | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                         |                                      |
| No short‐term consumer health risk was identified when the ARfD of 0.37 mg/kg bw was used                                                                                                                                                                                                                                                      | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                        | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                         |                                      |
| However, if the ARfD proposed by FR will be accepted (ARfD of 0.1 mg/kg bw), short‐term intake concerns are expected for kales, broccoli, celery, pineapples, Chinese cabbage, spring onions and pomegranate                                                                                                                                   | The overall chronic exposure accounted for 20% of the existing ADI; if the ADI will be lowered as proposed by FR, the exposure accounts for 75%                                                                                                                                                                         | Up to: 6% of the ADI                 |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; ARfD: acute reference dose; CXL: Codex Maximum Residue Limit; RMS: rapporteur Member State; CF: conversion factor; STMR: STMR: supervised trials median residue; RAC: raw agricultural commodity; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; bw: body weight; ADI: acceptable daily intake.
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5.15. Mandipropamid (231) T/R {#efs25797-sec-0113}
-----------------------------

### 5.15.1. Background information {#efs25797-sec-0114}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | AT                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) No 188/2013[a](#efs25797-note-0107){ref-type="fn"}                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2012d](#efs25797-bib-0023){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2018i](#efs25797-bib-0098){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2018t](#efs25797-bib-0108){ref-type="ref"}) (cocoa bean import tolerance)                                                                                                                                  |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2019c](#efs25797-bib-0112){ref-type="ref"}) (beetroot, Brussels sprouts, cauliflower, globe artichoke, peas, radish, witloof, Belgian endive)                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonized classification and labelling for CMR -- Annex VI: no entry for CMR                                                                                                                                     |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU Peer review proposal for CMR: none                                                                                                                                                                             |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0811){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) No 188/2013 of 5 March 2013 approving the active substance mandipropamid, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 62, 6.3.2013, p. 13--16.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.15.2. Toxicological reference values {#efs25797-sec-0115}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable        |                                                                                                                                                                                 |     |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+=================================================================================================================================================================================+=====+
| **ADI**                | 0.2 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                          | JMPR (2008)   | 0.15 mg/kg bw per day | Rat, 2‐year with an uncertainty factor of 100                                                                                                                                   | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                                                                                 |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                               |               |                       | (EFSA, [2012d](#efs25797-bib-0023){ref-type="ref"}, [2018i](#efs25797-bib-0098){ref-type="ref"}) confirmed in European Commission ([2018a](#efs25797-bib-0146){ref-type="ref"}) |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                   | JMPR (2008)   | Not                   | (EFSA, [2012d](#efs25797-bib-0023){ref-type="ref"}, [2018i](#efs25797-bib-0098){ref-type="ref"}) confirmed in European Commission ([2018a](#efs25797-bib-0146){ref-type="ref"}) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                                                                                 |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                               |               | necessary             |                                                                                                                                                                                 |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The different ADI values derived by JMPR and at EU level are the result of different policy on rounding (same study, same NOAEL)                                                                                                                                                                                                                                              |               |                       |                                                                                                                                                                                 |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                                                                                                 |     |
|                        | For the metabolite **SYN500003**, more acutely toxic than mandipropamid, JMPR concluded that it was unlikely to be genotoxic based on genotoxicity studies not available for the EU peer review. Nevertheless, both JMPR and EU review concluded that the ADI for mandipropamid is not applicable to the metabolite SYN500003, and no specific ADI or ARfD can be established |               |                       |                                                                                                                                                                                 |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.15.3. Residue definitions {#efs25797-sec-0116}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                | JMPR evaluation                                                                | EU evaluation                                                                                                                                                                                                                                                  | RDs comparable                                         |
+=========================+================================================================================================================================================================================================================================================================================================================================================================+================================================================================+================================================================================================================================================================================================================================================================+========================================================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                 | Mandipropamid                                                                  | EU Reg. 2015/845: Mandipropamid                                                                                                                                                                                                                                | Yes                                                    |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+
| Animal products         | Mandipropamid                                                                                                                                                                                                                                                                                                                                                  | EU Reg. 2015/845: Mandipropamid                                                | Yes                                                                                                                                                                                                                                                            |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                 | The residue is not fat soluble                                                 |                                                                                                                                                                                                                                                                |                                                        |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                 | Mandipropamid                                                                  | Art.12 (EFSA, [2018i](#efs25797-bib-0098){ref-type="ref"}): Fruits and leafy vegetables: mandipropamid (any ratio of constituent isomers)                                                                                                                      | No for root crops; yes for fruits and leafy vegetables |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                | Root crops: Sum of mandipropamid and SYN 500003 \[tentative, pending on the submission of toxicological information on SYN 500003\]                                                                                                                            |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                | Peer‐review (EFSA, [2012d](#efs25797-bib-0023){ref-type="ref"}): Mandipropamid except for root/tuber crops where the definition is provisionally proposed as 'mandipropamid and SYN 500003', pending the submission of toxicological information on SYN 500003 |                                                        |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+
| Animal products         | Mandipropamid                                                                                                                                                                                                                                                                                                                                                  | Art.12 (EFSA, [2018i](#efs25797-bib-0098){ref-type="ref"}): not required       | Yes                                                                                                                                                                                                                                                            |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                | Peer‐review (EFSA, [2012d](#efs25797-bib-0023){ref-type="ref"}): Mandipropamid |                                                                                                                                                                                                                                                                |                                                        |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+
| **Conclusion/comments** | The JMPR and EU residue definitions for enforcement and risk assessment for plant and animal commodities are comparable except for the risk assessment residue definition for root/tuber crops, where the EU residue definition is provisionally proposed as 'mandipropamid and SYN 500003', pending the submission of toxicological information on SYN 500003 |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         | The JMPR plant risk assessment residue definition, in contrast to the EU definition for root/tuber crops, does not include the plant metabolite SYN 500003                                                                                                                                                                                                     |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         | The residue definition for enforcement proposed in the Peer Review and the MRL Review are equivalent to the residue definition set in Regulation (EC) No 396/2005, although they specifically detail that it covers any ratio of constituent isomers                                                                                                           |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         | The different risk assessment residue definition for root crops (due to the inclusion of SYN 500003), is a relevant issue in the risk assessment only with regard to the Codex MRL proposal for potatoes                                                                                                                                                       |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
|                         | The RMS informed EFSA that for renewal of the active, the notifier plans to fully address the toxicological properties of metabolite SYN500003                                                                                                                                                                                                                 |                                                                                |                                                                                                                                                                                                                                                                |                                                        |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.
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### 5.15.4. Codex MRL proposals {#efs25797-sec-0117}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                | Codex MRL proposal                              | EU MRL                                                                    | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+==========================================================================+=================================================+===========================================================================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Beans with pods, subgroup of (includes all commodities in this subgroup) | **1**                                           | 0.01[\*](#efs25797-note-0111){ref-type="fn"}                              | Critical GAP: Canada, 4 × 150 g/ha, RTI not reported, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Number of trials: 10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Specific comments/observations: Trials on snap beans. The available plant metabolism studies conducted on leafy crops and fruit crops are sufficient to address the metabolic behaviour for the specific use on beans (with pods).                                                                                                                                                                                                                                                                                                                          |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cacao bean                                                               | **0.06**                                        | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | Critical GAP: Cameroon, 6 × 90 g/ha, retreatment interval not reported, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 | (0.06 proposed EU MRL; EFSA, [2018i](#efs25797-bib-0098){ref-type="ref"}) | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Specific comments/observations: Residue trials on cacao beans assessed previously in an EU import tolerance application (EFSA, [2018i](#efs25797-bib-0098){ref-type="ref"}). The available plant metabolism studies conducted on leafy crops and fruit crops are sufficient to address the metabolic behaviour for the specific use on cocoa                                                                                                                                                                                                                |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                 | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | The dietary burden was calculated, including cabbage head, grape pomace, potato by‐products                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Since a feeding study is not available, the Codex MRL proposals were derived from the available lactating goat metabolism study                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                     | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | The dietary burden was calculated, including the cabbage head and potato by‐products. No animal feeding studies on poultry are available and Codex MRL proposals were derived for poultry from the poultry metabolism study. The highest dose level covers the max DB                                                                                                                                                                                                                                                                                       |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                        | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                            | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                    | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                   | **0.1**                                         | 0.01[\*](#efs25797-note-0111){ref-type="fn"}                              | Critical GAP: Canada and USA, seed treatment at 1 × 100 g/t seed potato followed by foliar treatment at 3 × 146 g/ha, retreatment interval not reported, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Number of trials: 18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Specific comments/observations: The metabolite SYN500003 was identified in potato tubers at levels up to 0.013 mg/kg with an estimated median reside of 0.005 mg/kg for SYN500003. No ADI or ARfD established for the metabolite SYN500003. The JMPR applied the threshold of toxicological concern (TTC) approach for the metabolite SYN500003 (the chronic exposure based on the median residue accounted for 0.027 μg/kg bw; an acute exposure was not calculated by JMPR; in the EU, this approach was not accepted to address the EU data requirements |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs. Toxicological reference vales (ADI or ARfD) are not available for the metabolite SYN500003 which was identified in potato tubers at levels above 0.01 mg/kg                                                                                                                                                                                                                                                    |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | The RMS proposed to accept the proposed Codex MRLs, considering that individual residue levels of the metabolite are expected to be low (in all trials provided levels were below 0.01 mg/kg with the exception of 2, for which residues in potatoes were 0.01 mg/kg and 0.013 mg/kg). The use of TTC concept is according to the RMS acceptable. NL supported this view                                                                                                                                                                                    |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal                                                     | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                             | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                             | 0.01[\*](#efs25797-note-0111){ref-type="fn"}    | 0.02[\*](#efs25797-note-0111){ref-type="fn"}                              | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                          |                                                 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                          |                                                 |                                                                           | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cocoa butter                                                             | --                                              | --                                                                        | A reduction of residues in cocoa butter occurs and a PF of 0.53 was derived from two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cocoa powder                                                             | --                                              | --                                                                        | A reduction of residues in cocoa powder occurs and a PF of 0.48 was derived from two processing studies                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                     | EU MRLs established by Regulation (EU) 2015/845 |                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+--------------------------------------------------------------------------+-------------------------------------------------+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake; ARfD: acute reference dose; RMS: rapporteur Member State; DB: Dietary Burden; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.
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### 5.15.5. Consumer risk assessment {#efs25797-sec-0118}

###### 

Summary of the consumer risk assessment

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                    | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Comments on JMPR exposure assessment                                                                                                                                                                                                                                |
+==============================================================================================================================================================================================================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                          | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | **Specific comments:**                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
| A short‐term dietary risk assessment was not required for the parent mandipropamid because an acute reference dose (ARfD) was not applicable for the active substance considering the toxicological profile. | The most recent long‐term risk assessment (EFSA, [2019c](#efs25797-bib-0112){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for beans with pods and cacao beans (mandipropamid only), and potato (sum of mandipropamid and SYN500003). The long‐term risk assessment is indicative because a toxicological reference value (ADI) is not available for the metabolite SYN500003 and was performed based on the assumption that SYN500003 is of similar chronic toxicity as the parent mandipropamid. The indicative calculation did not indicate a risk to consumers although the overall risk might be underestimated if the metabolite SYN500003 possesses a higher chronic toxicity than the parent mandipropamid (relevant for uses on root/tuber crops: potatoes, onions and spring onions) | Toxicological reference values (ADI or ARfD) are not available for the metabolite SYN500003. The JMPR. The JMPR applied the threshold of toxicological concern (TTC) approach for the metabolite SYN500003 based on the estimated the chronic exposure for potatoes |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
| A short‐term dietary risk assessment may be required for the metabolite SYN500003 for the proposed Codex MRL on potatoes, pending on the toxicological profile of this metabolite                            | The EU ADI for mandipropamid was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                              | The risk assessment was performed disregarding the possible impact of enantiomer ratio due to plant or livestock metabolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                 | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | **Results:**                                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
| No short‐term dietary risk assessment was performed                                                                                                                                                          | No long‐term consumer health risk was identified. The overall chronic exposure accounted for 5% of the ADI (NL toddler). From the commodities under consideration, the contribution to the total exposure was the highest for residues in beans with pods (0.12% of the ADI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Long‐term exposure:                                                                                                                                                                                                                                                 |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0--6% of the ADI                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | No short‐term dietary risk assessment was performed                                                                                                                                                                                                                 |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; MRL: maximum residue level; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake.
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5.16. Fluopyram (243) R {#efs25797-sec-0119}
-----------------------

### 5.16.1. Background information {#efs25797-sec-0120}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                      | Comments, references                                                                                                                                                                                                                                          |
+========================================================================================================================================+======================+===============================================================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Follow‐up assessment | In 2017 JMPR MRL proposals were derived only for tomatoes; JMPR did not consider it appropriate to derive a MRL proposal for the whole subgroup. Following comments in the CCPR meeting, JMPR reconsidered its policy for extrapolation to the whole subgroup |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | DE                   |                                                                                                                                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved             | Commission Implementing Regulation (EU) 802/2013[a](#efs25797-note-0114){ref-type="fn"}                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments    | EFSA ([2013b](#efs25797-bib-0026){ref-type="ref"})EFSA ([2018a](#efs25797-bib-0076){ref-type="ref"}) (confirmatory data)                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                   | Ongoing                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments    | EFSA ([2017j](#efs25797-bib-0087){ref-type="ref"}) (purslanes)                                                                                                                                                                                                |
|                                                                                                                                        |                      |                                                                                                                                                                                                                                                               |
|                                                                                                                                        |                      | EFSA ([2019d](#efs25797-bib-0113){ref-type="ref"})                                                                                                                                                                                                            |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met.             | Harmonised classification and labelling for CMR -- Annex VI: none                                                                                                                                                                                             |
|                                                                                                                                        |                      |                                                                                                                                                                                                                                                               |
|                                                                                                                                        | ED: not concluded    | EU Peer Review proposal (2013b):                                                                                                                                                                                                                              |
|                                                                                                                                        |                      |                                                                                                                                                                                                                                                               |
|                                                                                                                                        |                      | R40: Limited evidence of a carcinogenic effect (Carc. Cat. 3)                                                                                                                                                                                                 |
|                                                                                                                                        |                      |                                                                                                                                                                                                                                                               |
|                                                                                                                                        |                      | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0812){ref-type="fn"}): not conducted                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+----------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

802/2013/EU: Commission Implementing Regulation (EU) No 802/2013 of 22 August 2013 approving the active substance fluopyram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 225, 23.8.2013, p. 13--16.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.16.2. Toxicological reference values {#efs25797-sec-0121}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                | EU evaluation | TRV comparable         |                                                                                                                            |     |
+========================+================================================================================================================================================================================================================================+===============+========================+============================================================================================================================+=====+
| **ADI**                | 0.01 mg/kg bw per day                                                                                                                                                                                                          | JMPR (2010)   | 0.012 mg/kg bw per day | EFSA ([2013b](#efs25797-bib-0026){ref-type="ref"}) (2‐yr, rat, uncertainty factor 100)                                     | Yes |
|                        |                                                                                                                                                                                                                                |               |                        |                                                                                                                            |     |
|                        |                                                                                                                                                                                                                                |               |                        | confirmed in European Commission ([2013a](#efs25797-bib-0138){ref-type="ref"})                                             |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.5 mg/kg bw                                                                                                                                                                                                                   | JMPR (2010)   | 0.5 mg/kg bw           | EFSA ([2013b](#efs25797-bib-0026){ref-type="ref"}) (acute                                                                  | Yes |
|                        |                                                                                                                                                                                                                                |               |                        |                                                                                                                            |     |
|                        |                                                                                                                                                                                                                                |               |                        | neurotoxicity, rat, uncertainty factor 100) confirmed in European Commission ([2013a](#efs25797-bib-0138){ref-type="ref"}) |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The agreed EU ADI is 0.012 mg/kg bw per day based on the NOAEL of the 2‐year study applying an uncertainty factor of 100. The EU ARfD is 0.5 mg/kg bw based on the acute neurotoxicity NOAEL with an uncertainty factor of 100 |               |                        |                                                                                                                            |     |
|                        |                                                                                                                                                                                                                                |               |                        |                                                                                                                            |     |
|                        | The slightly different ADI values are probably the result of a different policy on rounding                                                                                                                                    |               |                        |                                                                                                                            |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+----------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.16.3. Residue definitions {#efs25797-sec-0122}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                    | JMPR evaluation                                        | EU evaluation                                                                                     | RDs comparable |
+=========================+====================================================================================================================================================================================================================================================================================================================================================================================================================+========================================================+===================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                     | Fluopyram                                              | Fluopyram                                                                                         | Yes            |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fluopyram and 2‐(trifluoromethyl) benzamide, expressed as fluopyram                                                                                                                                                                                                                                                                                                                                         | Sum fluopyram and fluopyram‐benzamide (M25), expressed | Yes                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                     | as fluopyram                                           |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    | The residue is not fat soluble                         |                                                                                                   |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                     | Fluopyram                                              | Sum fluopyram, fluopyram‐benzamide (M25), fluopyram‐E/Z‐olefine (M02/M03), expressed as fluopyram | No             |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of fluopyram, 2‐(trifluoromethyl)benzamide and the combined residues of *N*‐{(*E*)‐2‐\[3‐chloro‐5‐(trifluoromethyl)pyridin‐2‐yl\]ethenyl}‐2‐trifluoromethyl) benzamide and *N*‐{(*Z*)‐2‐\[3‐chloro‐5‐(trifluoromethyl)pyridin‐2‐yl\]ethenyl}‐2‐trifluoromethyl) benzamide, all expressed as fluopyram                                                                                                          | Sum of fluopyram, fluopyram‐benzamide (M25), expressed | Yes                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    | as fluopyram                                           |                                                                                                   |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The residue definitions for enforcement (plant and animal commodities) derived by JMPR and applicable in the EU are identical. Thus, the Codex MRLs are compatible with the EU legal framework                                                                                                                                                                                                                     |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | As regards the residue definition for risk assessment for plants, the EU residue definition is wider                                                                                                                                                                                                                                                                                                               |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | It is noted that metabolite M25 was observed at important proportions in the metabolism study in beans. At EU level, a conversion factor was derived for fruit crops (1.1), peas without pods (1.5), peas/beans with pods, oilseeds, stem vegetables (1.2)                                                                                                                                                         |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | The lack of conversion factors introduces an uncertainty in the exposure calculations and the consumer risk assessment should be considered as tentative and may underestimate the actual exposure for plant products for which JMPR derived MRL proposals that are higher than the existing EU MRLs                                                                                                               |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | Rotational crop studies in cereals, leafy vegetables and roots were assessed in the peer review (EFSA, [2013b](#efs25797-bib-0026){ref-type="ref"}). Fluopyram and the metabolites resulting from the cleavage of the parent (fluopyram‐benzamide (M25) and fluopyram‐PCA (M43)) major components of the residues in rotational crops. 7‐hydroxy metabolites observed in higher proportions than in primary crops. |                                                        |                                                                                                   |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                        |                                                                                                   |                |
|                         | Residues in rotational crops cannot be excluded. (Default MRL proposals have been made for root/tuber and leafy crops (0.1 mg/kg), cereals, oilseeds and perennial crops (0.01\*))                                                                                                                                                                                                                                 |                                                        |                                                                                                   |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+---------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.16.4. Codex MRL proposals {#efs25797-sec-0123}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                         | Codex MRL proposal                                        | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                         |
+===================================================================+===========================================================+==============================================+=================================================================================================================================================================================================================================================================================================================================================================================================================+
| Cherry Tomato                                                     | W 0.4                                                     | 0.9 (tomato)                                 | JMPR proposed to withdraw the existing CXL for cherry tomato and to replace it with the new MRL for Subgroup of Tomatoes                                                                                                                                                                                                                                                                                        |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | At EU level, the MRL established for tomatoes is also applicable to cherry tomatoes                                                                                                                                                                                                                                                                                                                             |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, husked                                                      | **1.5**                                                   | 0.01[\*](#efs25797-note-0118){ref-type="fn"} | Critical GAP: Thailand 2 × 0.024 kg/hL (up to BBCH 59)                                                                                                                                                                                                                                                                                                                                                          |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Number of trials: 8 trials in rice grain; 1 processing study (JMPR, 2017)                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Sufficiently supported by data: No                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Specific comments/observations: The Codex MRL proposal of 4 mg/kg derived by JMPR in 2017 referred to cereal grain (GC 0649). The MRL proposal for husked rice of 1.5 mg/kg (MRL relevant for rice, according to Annex I of Reg (EU) 2018/62) was derived by applying the processing factor of 0.29 (JMPR, 2017). Since only one processing study is available, the proposed MRL is not sufficiently supported. |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Conclusion: The proposed Codex MRL is not acceptable because the number of processing studies is insufficient                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                                    | **0.5**                                                   | --                                           | Critical GAP: Thailand 2 × 0.024 kg/hL (up to BBCH 59)                                                                                                                                                                                                                                                                                                                                                          |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Number of trials: 8 trials in rice grain; 1 processing study (JMPR, 2017)                                                                                                                                                                                                                                                                                                                                       |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Specific comments/observations: The Codex MRL proposal of 4 mg/kg by JMPR in 2017 referred to cereal grain (GC 0649). The MRL proposal for polished rice of 0.5 mg/kg was derived by applying the processing factor of 0.11 JMPR (2017)                                                                                                                                                                         |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Conclusion: The proposed Codex MRL is acceptable, noting that in the EU the relevant commodity is husked rice                                                                                                                                                                                                                                                                                                   |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                            | W 0.5                                                     | 0.9                                          | JMPR proposed to withdraw the existing CXL for tomato and to replace it with the new MRL for subgroup of Tomatoes                                                                                                                                                                                                                                                                                               |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomatoes, subgroup of (includes all commodities in this subgroup) | 0.5                                                       | 0.9 (tomato)                                 | Critical GAP: USA, 2 × 0.25 kg a.i./ha, PHI 0 days                                                                                                                                                                                                                                                                                                                                                              |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Specific comments/observations: revised from 2017 to accommodate comments by EU and Canada. MRL extrapolated from tomato to the whole group of tomato (no change, in the EU classification tomatoes cover the whole subgroup)                                                                                                                                                                                   |
|                                                                   |                                                           |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                   |                                                           |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                              | The changes are based on studies assessed by JMPR in 2017 |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                 |
+-------------------------------------------------------------------+-----------------------------------------------------------+----------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; CXL: Codex Maximum Residue Limit; MRL: maximum residue level; BBCH: growth stages of mono‐ and dicotyledonous plants; GAP: Good Agricultural Practice; PHI: preharvest interval.

Indicates that the input value is proposed at the limit of quantification.
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### 5.16.5. Consumer risk assessment {#efs25797-sec-0124}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                 | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Comments on JMPR exposure assessment                                            |
+===========================================================================================================================================================================================================================+========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================================+
| **RA assumptions:**                                                                                                                                                                                                       | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | **Specific comments:**                                                          |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
| An indicative short‐term dietary risk assessment was performed for rice for which the Codex MRL proposal is higher than the existing EU MRLs were derived, as outlined in Section [2](#efs25797-sec-0006){ref-type="sec"} | An indicative long‐term dietary risk assessment was performed with PRIMo rev. 3.1. The calculation is based input values derived in the framework of the most recent MRL application (broccoli). Considering that following the completeness check performed for the MRL review under Art. 12, EFSA expects that the livestock dietary burden calculation might result in lower livestock exposure and consequently lower residues in animal products, and considering that milk is a major driver for the long‐term intake calculation and inaccurate input values have a major effect on the outcome of the calculation, EFSA did not include the previously derived STMR value for milk. Thus, risk assessment is therefore considered as indicative; a more accurate risk assessment taking into account the available data submitted in support of the existing MRLs will be presented in the framework of the Art. 12 MRL review | The commodities were assessed in the previous assessment (JMPR, 2017)           |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
| STMR residue value was used for the exposure calculation                                                                                                                                                                  | For rice, the STMR value derived by JMPR for husked rice was included in the calculation. A conversion factor to accommodate for the wider EU residue definition was not available                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                 |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
| The residues conversion from enforcement to risk assessment residue definitions has not been done due to the lack of reliable CF. Therefore, the risk assessment needs to be considered in indicative                     | The EU ADI was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                 |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
| The EU ARfD was used                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                              | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | **Results:**                                                                    |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
| No short‐term exposure concern was identified (4% of the ARfD for rice)                                                                                                                                                   | The indicative long‐term exposure assessment (without milk) accounted for 99% of the ADI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | No consumer risk identified in previous assessment related to rice (JMPR, 2017) |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
|                                                                                                                                                                                                                           | The contribution of rice was max. 2% of the ADI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
|                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
|                                                                                                                                                                                                                           | Risk managers to discuss whether the existing MRL for rice should be amended before the MRL review is completed, considering that currently a comprehensive risk assessment cannot be performed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                 |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------+

RA: risk assessment; MRL: maximum residue level; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; ADI: acceptable daily intake.
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5.17. Sulfoxaflor (252) R {#efs25797-sec-0125}
-------------------------

### 5.17.1. Background information {#efs25797-sec-0126}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | IE                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) 2015/1295[a](#efs25797-note-0121){ref-type="fn"}                                                                                                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes               | EFSA ([2014e](#efs25797-bib-0039){ref-type="ref"}) EFSA ([2019f](#efs25797-bib-0115){ref-type="ref"})                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2017d](#efs25797-bib-0075){ref-type="ref"}) (statement; no MRL review required since MRLs were set in the framework of the first approval of the a.s.)                                                     |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes               | EFSA ([2017n](#efs25797-bib-0091){ref-type="ref"}) (grape leaves, artichoke)                                                                                                                                      |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2019b](#efs25797-bib-0111){ref-type="ref"}) (various crop)                                                                                                                                                 |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | Harmonized classification and labelling‐entry into Annex VI: no entry in Annex VI for CMR properties                                                                                                              |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU Peer Review proposal for CMR: no proposal for CMR properties                                                                                                                                                   |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0813){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level; a.s.: active substance.

Commission Implementing Regulation (EU) 2015/1295 of 27 July 2015 approving the active substance sulfoxaflor, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 199, 29.7.2015, p. 8--11.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.17.2. Toxicological reference values {#efs25797-sec-0127}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                  | EU evaluation | TRV comparable        |                                                                   |    |
+========================+==================================================================================================================================================================================================================================================================================================+===============+=======================+===================================================================+====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                                            | JMPR (2011)   | 0.04 mg/kg bw per day | EFSA ([2014e](#efs25797-bib-0039){ref-type="ref"});               | No |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       | European Commission ([2015b](#efs25797-bib-0142){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       | (Rat, 2‐year study, UF 100)                                       |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------+----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                     | JMPR (2011)   | 0.25 mg/kg bw         | EFSA ([2014e](#efs25797-bib-0039){ref-type="ref"});               | No |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       | European Commission ([2015b](#efs25797-bib-0142){ref-type="ref"}) |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       | (Rat, acute                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       |                                                                   |    |
|                        |                                                                                                                                                                                                                                                                                                  |               |                       | Neurotoxicity, UF 100)                                            |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------+----+
| **Conclusion/comment** | The slight difference in the toxicological reference values are probably resulting from a different policy on rounding (ARfD) or conversion from ppm to mg/kg bw per day (ADI). During the EU peer review, it was agreed that references values of sulfoxaflor can apply to metabolite X11719474 |               |                       |                                                                   |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose.

John Wiley & Sons, Ltd

### 5.17.3. Residue definitions {#efs25797-sec-0128}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR evaluation                                                              | EU evaluation                                                                | RDs comparable |
+=========================+=============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==============================================================================+==============================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Sulfoxaflor                                                                  | EU Reg. 2018/832: Sulfoxaflor (sum of isomers)                               | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| Animal products         | Sulfoxaflor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | EU Reg. 2018/832: Sulfoxaflor (sum of isomers)                               | Yes                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                              |                                                                              |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | The residue is not fat soluble                                               |                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Sulfoxaflor                                                                  | Sum of parent sulfoxaflor and metabolite X11719474, expressed as sulfoxaflor | No             |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| Animal products         | Sulfoxaflor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Sum of parent sulfoxaflor and metabolite X11719474, expressed as sulfoxaflor | No                                                                           |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant and animal commodities**: The residue definitions for enforcement set by JMPR and at EU level are substantially identical. Since the routine analytical method could not separate the two diastereomeric pairs of enantiomers in sulfoxaflor, the residue definitions apply to the sum of all isomers                                                                                                                                                                                                                                                                                                                                                                                               |                                                                              |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                              |                                                                              |                |
|                         | At EU level, the residue definition for risk assessment in plant and animal commodities is more comprehensive and includes the metabolite X11719474. X11719474 is a plant and soil metabolite, which has shown to be preferentially taken up by the roots of the plants and to be present (\> LOQ) in the leafy parts of the crops in rotation crops, particularly in feed items. However, its inclusion in the residue definition for risk assessment of plant and animal products is provisional. It was agreed that if the metabolite X11719474 is shown to be significantly less toxic than sulfoxaflor, then the residue definitions for risk assessment will be restricted to parent sulfoxaflor only |                                                                              |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                              |                                                                              |                |
|                         | For several crops, including crops previously assessed by JMPR (JMPR evaluation 2011) and recently assessed by EFSA ([2019f](#efs25797-bib-0115){ref-type="ref"}), results for X11719474 were reported separately. At the uses and PHIs assessed, concentrations of this metabolite were at or close to the LOQ of 0.01 mg/kg, except in cereal straw (up to 0.034 mg/kg). Considering the low concentrations and its toxicological profile, the differences between the two risk assessment residue definitions is of low practical implication                                                                                                                                                            |                                                                              |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                              |                                                                              |                |
|                         | Both assessments concluded residues in products of animal origin are not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                              |                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------+------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; LOQ: limit of quantification; PHI: preharvest interval.

John Wiley & Sons, Ltd

### 5.17.4. Codex MRL proposals {#efs25797-sec-0129}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                          | Codex MRL proposal                                                                                                                                                                                                                                                                                                            | EU MRL                                                                        | Comment                                                                                                                                                                                                                                                                                             |
+====================================================================+===============================================================================================================================================================================================================================================================================================================================+===============================================================================+=====================================================================================================================================================================================================================================================================================================+
| Edible offal (Mammalian)                                           | **1**                                                                                                                                                                                                                                                                                                                         | 0.6                                                                           | New maximum dietary burden of sulfoxaflor was calculated from the Australian diet for beef cattle. The Codex MRL proposal is based on estimates from previously assessed feeding studies                                                                                                            |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               | (edible offal, liver, kidney from farmed terrestrial animals, except poultry) | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                              | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                                                                                                                                                                                                                                                                  | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                  | Critical GAP: Canada, 2 × 36 g/ha, interval 7 days PHI 14 days (restriction max 72 g/ha per season)                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 14                                                                                                                                                                                                                                                                                |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: All trials overdosed (50 g/ha) with residues \< LOQ (12) and at LOQ (2) proportionally scaled to derive STMR of 0.007 mg/kg, scaling factor 0.7. However, it is not a good practice to scale down overdosed trials with residues below the LOQ                      |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder (dry)                                                 | 0.6                                                                                                                                                                                                                                                                                                                           | --                                                                            | Critical GAP: Canada, 2 × 36 g/ha, interval 7 days, PHI 14 days (restriction max 72 g/ha per season)                                                                                                                                                                                                |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 15                                                                                                                                                                                                                                                                                |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | No MRLs are set for feed items at EU level                                                                                                                                                                                                                                                          |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats                                                     | **0.2**                                                                                                                                                                                                                                                                                                                       | 0.1                                                                           | See comments on mammalian edible offal                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               | (farmed terrestrial animals, except poultry)                                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (mammalian except marine mammals)                             | **0.4**                                                                                                                                                                                                                                                                                                                       | 0.3                                                                           | See comments on mammalian edible offal                                                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               | (farmed terrestrial animals, except poultry)                                  | The Codex MRL proposal refers to meat; for muscle the same MRL proposal would be derived                                                                                                                                                                                                            |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                              | **0.3**                                                                                                                                                                                                                                                                                                                       | 0.2                                                                           | New maximum dietary burden of sulfoxaflor was calculated from the Australian diet for dairy cattle. The Codex MRL proposal is based on estimates from previously assessed feeding studies. It was derived according to the residue definition set by JMPR, which includes parent compound only      |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                       | **0.7**                                                                                                                                                                                                                                                                                                                       | 0.1                                                                           | New maximum dietary burden of sulfoxaflor was calculated from the Australian diet for broilers. The Codex MRL proposal was derived from a previously assessed feeding studies (JMPR 2011). The Codex MRL proposal refers to meat; for muscle the same MRL proposal would be derived                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal                                               | No modification proposed (existing CXL 0.3)                                                                                                                                                                                                                                                                                   | 0.3                                                                           | See comments on poultry meat                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               | (edible offal, liver, kidney)                                                 | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                       | No modification proposed (existing CXL 0.03)                                                                                                                                                                                                                                                                                  | 0.03                                                                          | See comments on poultry meat                                                                                                                                                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                               | No modification proposed (existing CXL 0.1)                                                                                                                                                                                                                                                                                   | 0.1                                                                           | New maximum dietary burden of sulfoxaflor was calculated from the Australian diet for laying hens. The revised dietary burden calculation required a modification of the STMR and HR values for eggs, but did not lead to a modification of the existing CXL which is set at the level of 0.1 mg/kg |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                                               | 7                                                                                                                                                                                                                                                                                                                             | --                                                                            | Critical GAP: Indonesia, 4 × 100 g/ha, interval 7 days, PHI 10 days (restriction 400 g/ha season)                                                                                                                                                                                                   |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: Trials conducted in Philippines and Australia. The Codex MRL proposal was derived from residues of sulfoxaflor in paddy rice                                                                                                                                        |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is not acceptable because it refers to paddy rice, which is not the commodity to which the EU MRL applies                                                                                                                                                        |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                                     | 1                                                                                                                                                                                                                                                                                                                             | --                                                                            | Critical GAP: not reported in the Summary report                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 3                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: median PF of 0.14                                                                                                                                                                                                                                                   |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, husked                                                       | **1.5**                                                                                                                                                                                                                                                                                                                       | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                  | Critical GAP: not reported in the Summary report                                                                                                                                                                                                                                                    |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 8 residue trials in paddy rice, 3 processing studies                                                                                                                                                                                                                              |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: The MRL proposal was derived by applying the median PF of 0.2 on the MRL proposal derived for rice                                                                                                                                                                  |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable; it refers to the commodity which is included in the EU MRL legislation                                                                                                                                                                            |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw and fodder (dry)                                        | 20                                                                                                                                                                                                                                                                                                                            |                                                                               | Critical GAP: Indonesia, 4 × 100 g/ha, interval 7 days, PHI 10 days (restriction 400 g/ha season)                                                                                                                                                                                                   |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | No MRLs are set in the EU for feed items                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sorghum                                                            | **0.2**                                                                                                                                                                                                                                                                                                                       | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                  | Critical GAP: Canada, 2 × 36 g/ha, interval 7 days, PHI 14 days (restriction max 72 g/ha per season)                                                                                                                                                                                                |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: All trials overdosed (50 g/ha) proportionally scaled, scaling factor 0.7                                                                                                                                                                                            |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sorghum straw and fodder (dry)                                     | 0.7                                                                                                                                                                                                                                                                                                                           | --                                                                            | Critical GAP: Critical GAP: Canada, 2 × 36 g/ha, interval 7 days, PHI 14 days                                                                                                                                                                                                                       |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: All trials overdosed (50 g/ha) proportionally scaled, scaling factor 0.7                                                                                                                                                                                            |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | No MRLs are set in the EU for feed items                                                                                                                                                                                                                                                            |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet corn (corn‐on‐the‐cob) kernels plus cobs with husks removed) | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                                                                                                                                                                                                                                                                  | 0.01[\*](#efs25797-note-0125){ref-type="fn"}                                  | Critical GAP: Canadian, 2 × 36 g/ha, interval 7 days, PHI 7 days (restriction max 72 g/ha per season)                                                                                                                                                                                               |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 9                                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: All trials overdosed (50 g/ha) with residues \< LOQ (9)                                                                                                                                                                                                             |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tree nuts                                                          | **0.03**                                                                                                                                                                                                                                                                                                                      | 0.02[\*](#efs25797-note-0125){ref-type="fn"}                                  | Critical GAP: USA, 4 × 101 g/ha, interval 7 days, PHI 7 days (restriction max 298 g/ha per season)                                                                                                                                                                                                  |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Number of trials: 10 trials conducted on almonds (5) and pecans (5) with 3 × 100 g/ha                                                                                                                                                                                                               |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                 |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Specific comments/observations: Residues \< LOQ except in one trial (0.02 mg/kg). The previously derived MRL proposal of 0.015 mg/kg (step 4) should be withdrawn                                                                                                                                   |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                    |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                               | Information on the concentrations of the metabolite X11719474, currently included in the EU residue definitions for risk assessment, in the products of plant and animal origin under assessment are not available. It is expected that this deviation does not have a practical implication for the consumer risk assessment |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    |                                                                                                                                                                                                                                                                                                                               |                                                                               |                                                                                                                                                                                                                                                                                                     |
|                                                                    | **Typos** (summary report) STMR for maize fodder (dry) 0.16 mg/kg instead of 0.6 mg/kg                                                                                                                                                                                                                                        |                                                                               |                                                                                                                                                                                                                                                                                                     |
+--------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue level; GAP: Good Agricultural Practice; PHI: preharvest interval; LOQ: limit of quantification; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; CXL: Codex Maximum Residue Limit: HR: highest residue; PF: processing factor.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.17.5. Consumer risk assessment {#efs25797-sec-0130}

###### 

Summary of the consumer risk assessment

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Comments on JMPR exposure assessment |
+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
| The short‐term dietary risk assessment was performed for the products of plant and animal origin for which higher Codex MRLs were proposed, compared to the existing EU MRLs                                                                                                                                                                                                                                                                                                                                   | The most recent long‐term risk assessment (EFSA, [2019f](#efs25797-bib-0115){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the products of plant and animal origin which higher Codex MRLs were proposed, compared with the existing EU MRLs                                                                                                                                                                              | --                                   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
| The EU ARfD was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | STMR related to the Codex MRLs refer to parent compound only, except citrus different than limes, where a conversion factor for risk assessment of 1.16 was used                                                                                                                                                                                                                                                                                                                                               |                                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
| No short‐term exposure concern was identified (maximum 7% of the ARfD for milk)                                                                                                                                                                                                                                                                                                                                                                                                                                | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
| In the framework of the EFSA conclusion, a theoretical factor of 2 was applied to the risk assessment in order to accommodate for the lack of information on the ratio of the enantiomers present in the individual diastereomers of sulfoxaflor and X11719474 (EFSA, [2014e](#efs25797-bib-0039){ref-type="ref"}). Following this approach, the margin of safety of the exposure calculation is still sufficiently large to conclude that the assessed uses are unlikely to present a consumer health concern | The overall chronic exposure accounted for 34% of the ADI                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 2--9% of the JMPR ADI                |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | In the framework of the EFSA conclusion, a theoretical factor of 2 was applied to the risk assessment in order to accommodate for the lack of information on the ratio of the enantiomers present in the individual diastereomers of sulfoxaflor and X11719474 (EFSA, [2014e](#efs25797-bib-0039){ref-type="ref"}). Following this approach, the margin of safety of the exposure calculation is still sufficiently large to conclude that the assessed uses are unlikely to present a consumer health concern | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Max. 20% of the ARfD                 |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

MRL: maximum residue level; ARfD: acute reference dose; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake.
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5.18. Chlorfenapyr (254) T/R {#efs25797-sec-0131}
----------------------------

### 5.18.1. Background information {#efs25797-sec-0132}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |               | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===============+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use       | In 2012 and 2013, JMPR assessed the active substance, however could not conclude on residue definitions and therefore did not propose Codex MRLs                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | ES            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved  | Commission Decision No 2001/697/EC[a](#efs25797-note-0128){ref-type="fn"}                                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | No            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded | **Chlorfenapyr** is approved for use as a biocide in the EEA and/or Switzerland for wood preservation                                                                                                             |
|                                                                                                                                        |               |                                                                                                                                                                                                                   |
|                                                                                                                                        |               | Harmonized classification and labelling for CMR -- Annex VI: No classification                                                                                                                                    |
|                                                                                                                                        |               |                                                                                                                                                                                                                   |
|                                                                                                                                        |               | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0814){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+---------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Decision of 5 September 2001 concerning the non‐inclusion of chlorfenapyr in Annex I to Council Directive 91/414/EEC (2001/697/EC). OJ L 249, 19.9.2001. pp. 19‐20.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33‐36.
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### 5.18.2. Toxicological reference values {#efs25797-sec-0133}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-----------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | EU evaluation | TRV comparable         |           |    |
+========================+==============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+========================+===========+====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR (2012)   | 0.015 mg/kg bw per day | ECCO (99) | No |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-----------+----+
| **ARfD**               | 0.03 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR (2012)   | 0.015 mg/kg bw         | ECCO (99) | No |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-----------+----+
| **Conclusion/comment** | Parent compound: No recent toxicological assessment available for the a.s. used as a pesticide                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | The **ADI** established by the JMPR is based on a NOAEL of 2.8 mg/kg bw per day for decreases in body weight gain and vacuolation of the white matter of the brain in an 18‐month mouse study and a NOAEL of 2.9 mg/kg bw per day for reduced body weight and body weight gain and increased liver weight associated with hepatocellular enlargement in a 2‐year rat study. This was supported by a NOAEL of 2.6 mg/kg bw per day for reversible vacuolar myelopathy, vacuolation and/or myelin sheath swelling of the brain and spinal cord in males in a 1‐year neurotoxicity study in rats. An uncertainty factor (UF) of 100 was applied |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | The **ARfD** is based on the NOAEL of 3 mg/kg bw for depression of grooming and reactivity and decreased spontaneous motor activity observed in a pharmacological study in mice and applying an UF of 100                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | In the framework of the EU biocides assessment, an ADI of 0.028 mg/kg bw per day was derived, based on the same NOAELs from the same studies as the ones used by the JMPR; no ARfD was allocated under Reg. 98/8/EC, however it seems that the biocide assessment may not have had access to the study that was used by the JMPR to establish the ARfD                                                                                                                                                                                                                                                                                       |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | According to JMPR, the metabolite 4‐bromo‐2‐(*p*‐chlorophenyl)‐5‐(trifluoromethyl)‐pyrrole‐3‐carbonitrile (tralopyril) which was observed in plant metabolism studies, is more toxic than parent chlorfenapyr and an additional uncertainty factor of 10 was applied with regards to chlorfenapyr toxicological reference values (JMPR*,* 2013)                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | Details on the studies on genotoxicity are not reported in the JMPR report (it states only that *in vitro* and *in vivo* studies were provided); EFSA could not find evidence on these genotoxicity studies in JMPR Evaluations and therefore a conclusion cannot be derived whether all genotoxicity endpoint have been covered                                                                                                                                                                                                                                                                                                             |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | .....                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |               |                        |           |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |               |                        |           |    |
|                        | Six metabolites identified in residue studies were considered toxicologically not relevant at currently estimated dietary exposures using TTC approach (exposure was estimated individually for the 6 metabolites and compared to the TTC threshold of 1.5 μg/kg bw for Cramer Class 3). Toxicological data on these substances are not available to justify the use of the TTC threshold for Cramer Class 3. The calculated exposure for these metabolites ranged from \< 0.001 μg/kg bw (CL 152832), to 0.003 μg/kg bw (CL322250, CL151835 and CL325157, respectively), 0.015 μg/kg bw (CL152837) and 0.018 μg/kg bw (CL 325195)           |               |                        |           |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------+-----------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; TTC: threshold of toxicological concern.
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### 5.18.3. Residue definitions {#efs25797-sec-0134}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                           | JMPR evaluation                                                                                                    | EU evaluation                            | RDs comparable         |
+=========================+===========================================================================================================================================================================================================================================================================================================================================================================================+====================================================================================================================+==========================================+========================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                            | Chlorfenapyr                                                                                                       | Reg. 396/2005: Chlorfenapyr              | Yes                    |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+
| Animal products         | Chlorfenapyr                                                                                                                                                                                                                                                                                                                                                                              | Reg. 396/2005: Chlorfenapyr                                                                                        | Yes                                      |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                    |                                          |                        |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                | The residue is not labelled as fat soluble                                                                         |                                          |                        |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                            | Sum of chlorfenapyr plus 10 × 4‐bromo‐2‐(*p*‐chlorophenyl)‐5‐(trifluoromethyl)‐pyrrole‐3‐carbonitrile (tralopyril) | No formally approved RD for RA available | No comparison possible |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+
| Animal products         | Sum of chlorfenapyr plus 10 × 4‐bromo‐2‐(*p*‐chlorophenyl)‐5‐(trifluoromethyl)‐pyrrole‐3‐carbonitrile (tralopyril)                                                                                                                                                                                                                                                                        | No comparison possible                                                                                             |                                          |                        |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+
| **Conclusion/comments** | Plant metabolism studies were assessed by the 2012 JMPR. Metabolism studies in oranges, tomatoes, head lettuce, potatoes and cotton are available                                                                                                                                                                                                                                         |                                                                                                                    |                                          |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                    |                                          |                        |
|                         | JMPR recommended that if in future further uses of chlorfenapyr result in an increase in exposure to the metabolites for which no toxicological studies (except genotoxicity data) are available, the residue definition should be reconsidered                                                                                                                                           |                                                                                                                    |                                          |                        |
|                         |                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                    |                                          |                        |
|                         | EU assessment: RMS informed EFSA that in the peer review a residue definition for plants was agreed (residue definition was finally proposed as chlorfenapyr + AC 303268 (= tralopyril) expressed as AC 303268); for animal products the proposed residue definition was finally proposed as chlorfenapyr + CL 303268 (= tralopyril), expressed as CL 303268 (Evaluation table; ECCO, 99) |                                                                                                                    |                                          |                        |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------+------------------------------------------+------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State.
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### 5.18.4. Codex MRL proposals {#efs25797-sec-0135}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                 | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                            | EU MRL           | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+===========================================================================+===============================================================================================================================================================================================================================================================================================================================================================================================================+==================+================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Chili pepper, dry                                                         | **3**                                                                                                                                                                                                                                                                                                                                                                                                         | --               | The proposed Codex MRL is based on the MRL proposal for peppers, applying the default dehydration factor of 10                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | No MRLs are set in the EU for processed products                                                                                                                                                                                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                  | **0.05**                                                                                                                                                                                                                                                                                                                                                                                                      | --               | The MRL proposal was derived from a feeding study assessed previously by JMPR (2012), taking into account the updated dietary burden calculation. Since the samples taken in the feeding study were not analysed for tralopyril, JMPR derived conversion factors on the basis of metabolism studies                                                                                                                                                                            |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable with the EU policy on setting MRLs, considering the approach to derive input values for risk assessment using conversion factors derived from metabolism studies                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                      | **0.01**                                                                                                                                                                                                                                                                                                                                                                                                      | --               | The MRL proposal was derived from a metabolism study assessed previously by JMPR (2012), taking into account the updated dietary burden calculation. JMPR should be asked to verify the correctness of the dietary burden calculation: according to Annex 6, p 602 of JMPR report, the maximum dietary burden for EU poultry broiler and layer is 0.008 ppm and 0.007 ppm, while the calculation of the MRL was based on an assumption of a maximum dietary burden of 0.47 ppm |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Garlic                                                                    | 0.01\*                                                                                                                                                                                                                                                                                                                                                                                                        | 0.02\*           | Critical GAP: BR, 24 g a.i./hL, 1,000 L/ha, PHI 14 days, number of application was not specified (GAP originally reported in 2012 JMPR)                                                                                                                                                                                                                                                                                                                                        |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 5 trials with 3 × 240 g a.i./ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: If it is confirmed by JMPR/BR that the residue trials reflect an approved GAP, the supporting residue trials are sufficient. See also general comments below                                                                                                                                                                                                                                                                                   |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lemons and Limes, subgroup pf (includes all commodities in this subgroup) | **0.8**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: BR, 3 × 15 g a.i./hL, PHI 14 days. Water amount per ha are not specified                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               | Kumquats: 0.01\* | Number of trials: 8 trials with 3 × 15 g/hL, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Specific comments/observations: See general comments below                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats                                                            | **0.6**                                                                                                                                                                                                                                                                                                                                                                                                       | --               | See edible offal mammalians                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                             | **0.6(fat)**                                                                                                                                                                                                                                                                                                                                                                                                  | --               | See edible offal mammalians                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Melons, except Watermelon                                                 | **0.4**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: BR, 12--24 g/ha, PHI 14 days, number of applications and water amount per ha not specified                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 9 trials, with 3 × 24 g/hL, PHI 14 days; in 5 trials residues in edible part of the crop were measured                                                                                                                                                                                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Before a conclusion on the appropriateness of the MRL proposal and the validity of trials can be taken, further details on the Brazilian GAP need to be reported (i.e. number of applications, water amount/ha). See also general comment                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                     | **0.03**                                                                                                                                                                                                                                                                                                                                                                                                      | --               | See edible offal mammalians                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Onion, bulb                                                               | 0.01\*                                                                                                                                                                                                                                                                                                                                                                                                        | 0.02\*           | Critical GAP: BR, 120--180 g/ha, 800--1000 l/ha, PHI 14 days, number of applications not specified                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 9 trials with 3 × 180 g/ha, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Before a conclusion on the appropriateness of the MRL proposal and the validity of trials can be taken, further details on the Brazilian GAP need to be reported (i.e. number of applications). See also general comment                                                                                                                                                                                                                                                       |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, Sweet, Sour, subgroup                                            | **1.5**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: BR, 3 × 15 g a.i./hL, PHI 14 days. Water amount per ha not specified                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| of (includes all commodities in this subgroup)                            |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 7 trials with 3 × 15 g/hL, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: No; one additional trial would be required                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Specific comments/observations: See general comments below                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Papaya                                                                    | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: 7.2--12 g/hL, PHI 14 days, number of applications and water amount per application not specified                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 5 trials with 3 × 12 g/hL, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Before a conclusion on the appropriateness of the MRL proposal and the validity of trials can be taken, further details on the Brazilian GAP need to be reported (i.e. number of applications). See also general comment                                                                                                                                                                                                                                                       |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers                                                                   | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: BR, 7.2 g/ha, 7‐day PHI, number of applications not specified                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 7 trial with 3 × 7.2 g/ha, 1,000 L/ha, 7‐day PHI                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: Not fully supported (1 additional trial would be required)                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Specific comments/observations: From metabolism studies, a conversion factor of 1 was derived. Since in the metabolism study the sampling was 1 day after the last application, the residues are shifted to the unmetabolised parent compound. Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable/compatible with the EU policy on setting MRLs                                                                                     |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                                                  | **0.01**                                                                                                                                                                                                                                                                                                                                                                                                      | --               | See eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, fats                                                             | **0.02**                                                                                                                                                                                                                                                                                                                                                                                                      | --               | See edible offal mammalians                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, meat                                                             | **0.02(fat)**                                                                                                                                                                                                                                                                                                                                                                                                 | --               | See edible offal mammalians                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                    | 0.01\*                                                                                                                                                                                                                                                                                                                                                                                                        | 0.01\*           | Critical GAP: BR; 180 g a.i./ha, 7‐day PHI, number of applications not reported.                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 9 trial (4 × 180 g a.i./ha, 7‐day PHI                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: Unclear                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Before a conclusion on the appropriateness of the MRL proposal, further details on the Brazilian GAP need to be reported (i.e. number of applications, water amount/ha). See also general comment                                                                                                                                                                                                                                                                              |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                           | **0.08**                                                                                                                                                                                                                                                                                                                                                                                                      | 0.02\*           | Critical GAP: BR, 3 × 0.29 kg a.i./ha, PHI 30 days                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 14 trials representative for the BR GAP                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Specific comments/observations: see general comment                                                                                                                                                                                                                                                                                                                                                                                                                            |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean fodder                                                          | 7(DM)                                                                                                                                                                                                                                                                                                                                                                                                         | --               | No MRLs are set in the EU for feed                                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean, crude oil                                                      | 0.4                                                                                                                                                                                                                                                                                                                                                                                                           | --               | The proposed Codex MRL is based on the MRL proposal for soya beans, applying the processing factor of 4.5 derived from 3 processing studies                                                                                                                                                                                                                                                                                                                                    |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | No MRLs are set in the EU for processed products                                                                                                                                                                                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomatoes                                                                  | **0.4**                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01\*           | Critical GAP: BR, 12 g a.i./hL, 7 d PHI, number of applications and water amount/ha not specified (JMPR 2012)                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 8 trials with 5 × 24 g/hL, 1,000 L/ha. The results were adjusted to the GAP using scaling.                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: Unclear                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Before a conclusion on the appropriateness of the MRL proposal and the validity of scaling can be taken, further details on the Brazilian GAP need to be reported (i.e. number of applications, water amount/ha). See also general comment                                                                                                                                                                                                                                     |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tea, Green, Black (black, fermented and dried)                            | **60**                                                                                                                                                                                                                                                                                                                                                                                                        | 50               | Critical GAP: Japan, 2 × 100 g/ha (5 g/hL), 7‐day PHI.                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Number of trials: 4 trials with 2 × 200 g/ha (5 g/hL), 7‐day PHI                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Sufficiently supported by data: To be discussed with MS. At EU level 8 trials would be required. Number of trials required by JMPR is not clearly specified. Scaling might be appropriate for the residue trials, leading to a lower MRL proposal                                                                                                                                                                                                                              |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | Conclusion: The proposed Codex MRL is not acceptable because the number of residue trials is probably insufficient, the residue trials are not reflecting the GAP in terms of application rate per hectare and because of the intake concern identified (short‐term exposure \> EU ARfD)                                                                                                                                                                                       |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  | See also general comment                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                      | In none of the residue trials, tralopyril was analysed. To derive the risk assessment values, JMPR derived conversion factors on the basis of the ratio of parent compound and tralopyril measured in plant metabolism studies representative for the GAP. In the conversion factors the higher toxicity of the metabolite was also taken into account                                                        |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           | In general, this approach leads to additional uncertainties for the risk assessment, in particular where samples were taken shortly after the last application (i.e. peppers, eggplants, tomatoes), because this is likely to shift the ratio of parent and metabolite in direction of the less toxic parent compound, leading to an underestimation of the risk for consumers. See risk assessment see below |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                               |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                           | The RMS provided detailed information on the GAPs (EU uses) and the residue trials assessed in the DAR; however, since the active substance has not been approved in the EU, the data provided in the EU peer review do not affect the proposed Codex MRL proposals                                                                                                                                           |                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+---------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

MRL: maximum residue level; ARfD: acute reference dose; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake; DM: dry matter; DAR: draft assessment factor.

John Wiley & Sons, Ltd

### 5.18.5. Consumer risk assessment {#efs25797-sec-0136}

###### 

Summary of the consumer risk assessment

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                            | Chronic exposure assessment                                                                                                                                                                                                                                                               | Comments on JMPR exposure assessment |
+======================================================================================================================================================================================================================================================================================================================================================================================================================================+===========================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                  | **RA assumptions:**                                                                                                                                                                                                                                                                       | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
| An indicative short‐term dietary risk assessment was performed with PRIMo rev. 3.1 using the HR/STMR values derived by JMPR for the crops for which Codex MRL proposals were higher than the corresponding EU MRL. For the remaining crops, the current EU MRL was used as input value                                                                                                                                               | An indicative long‐term dietary risk assessment was performed using the STMR values derived by JMPR for crops for which Codex MRL proposals were higher than the corresponding EU MRL. For the remaining crops, the current EU MRL was used in input value                                |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
| The EU ARfD was used.                                                                                                                                                                                                                                                                                                                                                                                                                | The EU ADI was used                                                                                                                                                                                                                                                                       |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
| The risk assessment is indicative, because of additional, non‐standard uncertainties, related to the lack of data on the occurrence of the more toxic metabolite tralopyril, which was overcome by JMPR using conversion factors derived from metabolism studies and the relative toxicity. In addition, an indicative peeling factor (0.017) for citrus was derived based on the ration of TRR found in metabolism study in oranges | The risk assessment is indicative because of additional, non‐standard uncertainties, related to the lack of data on the occurrence of the more toxic metabolite tralopyril, which was overcome by JMPR using conversion factors derived from metabolism studies and the relative toxicity |                                      |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                         | **Results:**                                                                                                                                                                                                                                                                              | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
| The indicative short‐term exposure exceeded the ARfD for tea (122% of the ARfD). Further refinements might be possible, considering the transfer to the tea infusion. However, no appropriate processing factors are available at the moment. For other crops, no short‐term intake concerns were identified                                                                                                                         | No long‐term consumer health risk was identified                                                                                                                                                                                                                                          | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
| For the other commodities no exceedance of the ARfD was identified                                                                                                                                                                                                                                                                                                                                                                   | The overall chronic exposure accounted for 28% of the ADI                                                                                                                                                                                                                                 | 1‐6% of the ADI                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                           | 0‐60% of the ARfD                    |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; HR: highest residue; STMR: supervised trials median residue; PRIMo: (EFSA) Pesticide Residues Intake Model; MRL: maximum residue level; ARfD: acute reference dose; ADI: acceptable daily intake; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRR: total radioactive residues.
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5.19. Fluxapyroxad (256) T/R {#efs25797-sec-0137}
----------------------------

### 5.19.1. Background information {#efs25797-sec-0138}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments**, references**                                                                                                                                                                                          |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FR                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) No 589/2012[a](#efs25797-note-0134){ref-type="fn"}                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2012a](#efs25797-bib-0020){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                | Ongoing                                                                                                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2017i](#efs25797-bib-0086){ref-type="ref"}) (various crops);                                                                                                                                               |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2016a](#efs25797-bib-0064){ref-type="ref"}) (various crops);                                                                                                                                               |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2015o](#efs25797-bib-0058){ref-type="ref"}) (grapes and potatoes);                                                                                                                                         |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2011c](#efs25797-bib-0017){ref-type="ref"}) (various crops)                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded     | EU Peer Review proposal for CMR: Carc 2                                                                                                                                                                           |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0815){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) No 589/2012 of 4 July 2012 approving the active substance fluxapyroxad, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 175, 5.7.2012, p. 7--10.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.19.2. Toxicological reference values {#efs25797-sec-0139}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | EU evaluation | TRV comparable        |                                                                                                                                                        |     |
+========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+========================================================================================================================================================+=====+
| **ADI**                | 0.02 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | JMPR (2012)   | 0.02 mg/kg bw per day | EFSA ([2012a](#efs25797-bib-0020){ref-type="ref"}) (Rat, 2‐year study, UF 100)                                                                         | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | Same in European Commission ([2012](#efs25797-bib-0137){ref-type="ref"})                                                                               |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | JMPR (2012)   | 0.25 mg/kg bw         | EFSA ([2012a](#efs25797-bib-0020){ref-type="ref"}) (Rabbit (developmental effects), and rat (maternal effects) developmental toxicity studies; UF 100) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | Same in European Commission ([2012](#efs25797-bib-0137){ref-type="ref"})                                                                               |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The 2018 JMPR assessed additional *in vitro* studies, which supported the conclusions of 2012 JMPR that high doses of fluxapyroxad cause hepatocellular adenomas and carcinomas in rats. The Meeting concluded that new studies support the existing ADI and have not impact on the ARfD established.                                                                                                                                                                                                                                                                                                                                                              |               |                       |                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                                                        |     |
|                        | The ADI and ARfD established by the JMPR and the EU assessments are based on the same NOAELs from the same studies; the final ARfD value established by the JMPR resulted from rounding. It is noted that such rounding would not be applied at EU level since it represents more than 10% variation between the two values                                                                                                                                                                                                                                                                                                                                        |               |                       |                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                                                        |     |
|                        | According to the EU assessment, the toxicological reference values of fluxapyroxad are applicable to metabolites **M700F048** and **M700F008**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |               |                       |                                                                                                                                                        |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                                                                        |     |
|                        | The EU assessment established an ADI of 0.25 mg/kg bw per day for the metabolite **M700F001** based on a developmental toxicity study in rabbits and applying an uncertainty factor (UF) of 1000; no ARfD was allocated to this metabolite as considered unnecessary. The metabolite would not share the carcinogenic potential of the parent. The metabolite **M700F002** would not share the carcinogenic properties of the parent either; the EU peer review established an ADI of 0.3 mg/kg bw per day for this metabolite based on a developmental toxicity study in rabbits and applying an UF of 1,000. No ARfD needs to be established for this metabolite |               |                       |                                                                                                                                                        |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 5.19.3. Residue definitions {#efs25797-sec-0140}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | JMPR evaluation                                                                                                                                                                                                                     | EU evaluation                  | RDs comparable |
+=========================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================+================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Fluxapyroxad                                                                                                                                                                                                                        | EC Reg. 2018/685: Fluxapyroxad | Yes            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+
| Animal products         | Fluxapyroxad                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | EC Reg. 2018/685: Fluxapyroxad                                                                                                                                                                                                      | Yes                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | The residue is fat soluble                                                                                                                                                                                                          |                                |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+
| **RD‐RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | [Plants]{.ul}:                                                                                                                                                                                                                      | [Plants:]{.ul} Fluxapyroxad    | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Sum of fluxapyroxad and 3‐difluoromethyl)‐ *N*‐(3',4',5'‐trifluoro\[1,1'‐biphenyl\]‐2‐yl)‐1*H*‐pyrazole‐4‐carboxamide (M700F008) and 3‐(difluoromethyl)‐1‐(ß‐D‐glucopyranosyl)‐*N*‐(3',4',5'‐triflurobipheny‐2‐yl)‐1*H*‐pyrzaole‐4‐ |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | carboxamide (M700F048) and expressed as parent equivalents                                                                                                                                                                          |                                |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+
| Animal products         | [Animals:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | [Animals:]{.ul} Fluxapyroxad (BAS 700F) and metabolite M700F008 expressed as parent equivalent                                                                                                                                      | Yes                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | Sum of fluxapyroxad and 3‐(difluoromethyl)‐ *N*‐(3',4',5'‐trifluoro\[1,1'‐                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | biphenyl\]‐2‐yl)‐1*H*‐pyrazole‐4‐carboxamide (M700F008) expressed as parent equivalents                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                     |                                |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+
| **Conclusion/comments** | The plant and animal residue definitions for enforcement are comparable, as both refer to the parent fluxapyroxad only. The risk assessment residue definitions in animal commodities are also comparable                                                                                                                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | For the plant risk assessment residue definition, the JMPR, in contrast to EU, has included two plant metabolites (M700F008 and M700F048). Although the fluxapyroxad metabolites were observed in the primary and rotational crop metabolism studies, they were not included in the EU risk assessment residue definition for plant commodities, since they were never observed at levels above the LOQ in residue trials or rotational crop studies (Comment of RMS: the EU risk assessment residue definition for plants should be reconsidered.) |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | The reside trials submitted for the JMPR assessment indicate that the overall contribution of metabolites is low                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                     |                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                     |                                |                |
|                         | Using the risk assessment values derived by JMPR will lead to a slightly more conservative result                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                     |                                |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; LOQ: limit of quantification.
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### 5.19.4. Codex MRL proposals {#efs25797-sec-0141}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                            | Codex MRL proposal | EU MRL                                                                              | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                        |
+======================================================================================================+====================+=====================================================================================+================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Alfalfa hay                                                                                          | 20 (DM)            | --                                                                                  | Critical GAP: USA, 2 × 100 g/ha, 14‐day interval, PHI 14 days (max 3 annual applications)                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 10 (CAN/USA)                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: The Meeting derived risk assessment values for alfalfa forage and alfalfa hay for the DB calculation. Since the dietary burden did not change significantly compared to the previous JMPR assessment, no modification of MRLs for animal products were derived                                                                                                                                                 |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | No MRLs are set in the EU for this crop which is used exclusively as feed items                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus fruit, Group of (includes all commodities in this group)                                      | **1**              | 0.01[\*](#efs25797-note-0138){ref-type="fn"} except grapefruit and oranges with 0.3 | Critical GAP: USA, 4 × 138 g/ha, 10‐day interval, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 23 (7 lemons, 5 grapefruit, 1 mandarin, 10 oranges)                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: to be discussed with MS                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | According to agreed extrapolation at Codex levels, to derive MRL proposals for citrus fruit the following information is required: lemon or lime; mandarin; orange or pummelo or grapefruit. The minimum number of trials per commodity and the requirement to demonstrate that trials on different commodities belong to the same population are not defined in detail in the agreed extrapolation document (Appendix XI of 2012 CCPR Report) |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | The JMPR combined residue trials for lemons, grapefruit, mandarins and oranges, since the number of trials was considered sufficient to derive a group MRL                                                                                                                                                                                                                                                                                     |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | The CXL would be applicable also to kumquats (classified as miscellaneous fruit, edible peel). The appropriateness of the MRL proposal for kumquat should be addressed by JMPR. No information on the residue distribution between peel and pulp was provided                                                                                                                                                                                  |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, considering that the number of mandarin trials is very limited (mandarins are a major crop at Codex level) and that the data sets for oranges, lemons and grapefruit are significantly different (Kruskal--Wallis H‐test)                                                                                                                       |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Instead of deriving a group MRL for citrus, the data would allow to set a MRL for oranges (1.5 mg/kg), lemon/lime/kumquat (1 mg/kg) and grapefruit (0.6 mg/kg)                                                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus oil, edible                                                                                   | **60**             | --                                                                                  | The PF of 59 derived from two processing studies                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Coffee beans                                                                                         | **0.15**           | 0.01[\*](#efs25797-note-0138){ref-type="fn"}                                        | Critical GAP: Brazil, 3 × 100 g/ha, 45‐day interval, PHI 45 days                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: None                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed                                                                                          | **0.5**            | 0.3                                                                                 | Critical GAP: Brazil, 4 × 58.5 g/ha, 12‐day interval, PHI 14 days                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: Cotton seed according to EU classification is considered a major crop in the SEU/World. According to the JMPR criteria 4 trials are sufficient                                                                                                                                                                                                                                                                 |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL was derived in accordance with the JMPR policy                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                                                | **0.6**            | 0.5                                                                                 | Critical GAP: Brazil, 4 × 66.8 g/ha, 7‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: None                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, Sweet, Sour (including Orange‐like hybrids)                                                 | W 0.3              |                                                                                     | The existing CXL will be withdrawn; instead the new Codex MRL proposed for citrus fruit (group) will be applicable                                                                                                                                                                                                                                                                                                                             |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Papaya                                                                                               | **1**              | 0.01[\*](#efs25797-note-0138){ref-type="fn"}                                        | Critical GAP: Brazil, 4 × 66.8 g/ha, 7‐days interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: None                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                                               | 0.07               | 0.1                                                                                 | Critical GAP: Italy, 1 × 240 g/ha (in‐furrow), no PHI                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 16                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: The same GAP and trials were already assessed by EFSA in 2015 with an MRL proposal of 0.07 mg/kg. On the basis of residues in rotational crops an MRL of 0.1 mg/kg was enforced                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tuberous and corm vegetables, except potato, Subgroup of (includes all commodities in this subgroup) | 0.03               | 0.1 tropical root and tuber vegetables; 0.3 Jerusalem artichokes                    | Critical GAP: USA, 3 × 99 g/ha, 7‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Number of trials: 19                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Specific comments/observations: According to the EU classification, the CXL is applicable to a) tropical root and tuber vegetables group; Jerusalem artichoke                                                                                                                                                                                                                                                                                  |
|                                                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                      |                    |                                                                                     | Conclusion: The proposed Codex MRL is acceptable.                                                                                                                                                                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus juice                                                                                         |                    | --                                                                                  | PF 0.12; the reduction of residues in citrus juice occurs; the PF derived from two processing studies                                                                                                                                                                                                                                                                                                                                          |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus peel                                                                                          |                    | --                                                                                  | PF 1.9; residues concentrate in the peel; the concentration factor derived from two data points                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus marmalade                                                                                     |                    | --                                                                                  | PF 0.042; the reduction of residues in citrus marmalade occurs; the PF derived from two processing studies                                                                                                                                                                                                                                                                                                                                     |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cotton seed refined oil                                                                              |                    | --                                                                                  | PF 0.045; the processing factors for cotton were derived by 2015 JMPR. Now with new MRL proposal for raw cotton seed, the input values for processed commodities for the risk assessment are updated                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato baked tuber (with peel)                                                                       |                    | --                                                                                  | PF 0.5; the processing factors for potato were derived by 2012 JMPR. Now with new MRL proposal for raw potato, the input values for processed commodities for the risk assessment are updated                                                                                                                                                                                                                                                  |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato boiled tuber (with peel)                                                                      |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato chips                                                                                         |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato fried tuber (with peel)                                                                       |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato granules/flakes                                                                               |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato peeled tuber                                                                                  |                    |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                                 | --                 |                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------+--------------------+-------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MS: Member State; CXL: Codex Maximum Residue Limit; PF: processing factor; DM: dry matter; DB: Dietary Burden.

Indicates that the input value is proposed at the limit of quantification.
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### 5.19.5. Consumer risk assessment {#efs25797-sec-0142}

###### 

Summary of the consumer risk assessment

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                            | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                             | Comments on JMPR exposure assessment                                                   |
+======================================================================================================================================================================================+=========================================================================================================================================================================================================================================================================================================================================================================================================+========================================================================================+
| **RA assumptions:**                                                                                                                                                                  | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                     | **Specific comments:**                                                                 |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
| The acute exposure assessment was performed using EFSA PRIMo rev. 3, considering the existing EU MRLs (Reg. 2018/685)                                                                | The chronic exposure assessment was performed using EFSA PRIMo rev. 3, considering the existing EU MRLs (Reg. 2018/685)                                                                                                                                                                                                                                                                                 | The risk assessment considers also metabolites of fluxapyroxad (M700F008 and M700F048) |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
| For citrus fruits, kumquats, mango, papaya, coffee beans and cotton seed the HR values derived for parent fluxapyroxad were used as input values                                     | For citrus fruits, kumquats, mango, papaya, coffee beans and cotton seed the STMR values derived for parent fluxapyroxad were used as input values. For several commodities, which contributed most to the chronic exposure, the STMR values related to previously assessed EU uses were included to refine the exposure calculation. Further refinements of the exposure calculation would be possible |                                                                                        |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
| The EU ARfD was used                                                                                                                                                                 |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                         | **Results:**                                                                                                                                                                                                                                                                                                                                                                                            | **Results:**                                                                           |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
| No short‐term exposure concern was identified (citrus fruits (5--31% of the ARfD), kumquats (1% of the ARfD), mango (12%), papaya (9%), coffee beans (0%) and cotton seed (no data)) | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                                                                                        | Long‐term exposure:                                                                    |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
|                                                                                                                                                                                      | The overall chronic exposure accounted for a maximum of 89% of the ADI (further refinements would be possible).                                                                                                                                                                                                                                                                                         | 6--20% of the ADI                                                                      |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
|                                                                                                                                                                                      | From the crops under consideration, the contribution to the total exposure was the highest for residues in oranges (6.6% of the ADI)                                                                                                                                                                                                                                                                    | Short‐term exposure:                                                                   |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                        |
|                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                         | 0--10% of the ARfD                                                                     |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+

RA: risk assessment; PRIMo: (EFSA) Pesticide Residues Intake Model; MRL: maximum residue level; HR: highest residue; STMR: supervised trials median residue; ARfD: acute reference dose; ADI: acceptable daily intake.
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5.20. Benzovindiflupyr (261) R {#efs25797-sec-0143}
------------------------------

### 5.20.1. Background information {#efs25797-sec-0144}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                               | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===============================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | Other evaluation, see comment | Request of manufacturer to set a group MRL for the subgroup of dry peas and the subgroup of dry beans (instead of individual MRLs for dry peas and dry beans)                                                     |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | NL                            |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                      | Commission Implementing Regulation (EU) 2016/177[a](#efs25797-note-0141){ref-type="fn"}                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments             | EFSA ([2015f](#efs25797-bib-0049){ref-type="ref"}) EFSA ([2017b](#efs25797-bib-0073){ref-type="ref"}) (E‐fate, phys/chem,ecotox)                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                            | Not required                                                                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                            | EFSA ([2016h](#efs25797-bib-0071){ref-type="ref"}) Import tolerance                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded                 | Harmonized classification and labelling for CMR -- Annex VI: No classification                                                                                                                                    |
|                                                                                                                                        |                               |                                                                                                                                                                                                                   |
|                                                                                                                                        |                               | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0817){ref-type="fn"}): not finalised |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

(EU) 2016/177: Commission Implementing Regulation (EU) 2016/177 of 10 February 2016 approving the active substance benzovindiflupyr, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No 540/2011. OJ L 35, 11.2.2016, p. 1--5.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.20.2. Toxicological reference values {#efs25797-sec-0145}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                 | EU evaluation | TRV comparable        |                                                                                                                       |     |
+========================+=================================================================================================================================================================================================================================================================+===============+=======================+=======================================================================================================================+=====+
| **ADI**                | 0.05 mg/kg                                                                                                                                                                                                                                                      | JMPR (2013)   | 0.05 mg/kg bw per day | EFSA ([2015f](#efs25797-bib-0049){ref-type="ref"}); European Commission ([2015a](#efs25797-bib-0141){ref-type="ref"}) | Yes |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        | bw per day                                                                                                                                                                                                                                                      |               |                       | (Rat, 2‐year study, UF 100)                                                                                           |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.1 mg/kg bw                                                                                                                                                                                                                                                    | JMPR (2013)   | 0.1 mg/kg bw          | EFSA ([2015f](#efs25797-bib-0049){ref-type="ref"}); European Commission ([2015a](#efs25797-bib-0141){ref-type="ref"}) | Yes |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       | (Rat, acute neurotoxicity                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       | Study, UF 100)                                                                                                        |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The toxicological reference values derived at EU level and by JMPR are identical and are based on the same NOAELs from the same studies                                                                                                                         |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        | The JMPR concluded that **SYN546039** and **SYN545720** are less toxic than the parent based on acute oral toxicity studies                                                                                                                                     |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        | The EU assessment established an **ADI of 0.3 mg/kg bw per day** for the metabolite **SYN545720** (CSCD465008), based on a developmental toxicity study in rabbits and applying an uncertainty factor (UF) of 1000, **no ARfD** being needed for the metabolite |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        | An **ADI of 0.25 mg/kg bw per day** was established for the metabolite **NOA449410** (CSAA798670) based on a developmental toxicity study in rabbits and applying an UF of 1000; **no ARfD** was set, as considered not necessary                               |               |                       |                                                                                                                       |     |
|                        |                                                                                                                                                                                                                                                                 |               |                       |                                                                                                                       |     |
|                        | **Insufficient information** was provided on metabolite **SYN546039** (CSCD695908) to conclude on its toxicological profile, including its genotoxicity potential                                                                                               |               |                       |                                                                                                                       |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-----------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.20.3. Residue definitions {#efs25797-sec-0146}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | JMPR evaluation                                                                                                         | EU evaluation                      | RDs comparable |
+=========================+==============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================================+====================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Benzovindiflupyr                                                                                                        | EC Reg. 2018/687: Benzovindiflupyr | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| Animal products         | Benzovindiflupyr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | EC Reg. 2018/687: Benzovindiflupyr                                                                                      | Yes                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                         |                                    |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | The residue is not fat soluble                                                                                          |                                    |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Benzovindiflupyr                                                                                                        | Benzovindiflupyr                   | Yes            |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| Animal products         | Benzovindiflupyr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Benzovindiflupyr and mono hydroxylated benzovindiflupyr, free and conjugated (SYN546039), expressed as benzovindiflupyr | No                                 |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| **Conclusion/comments** | **Plant commodities:** The residue definitions for enforcement and risk assessment set by JMPR and at EU level are identical                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                         |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                         |                                    |                |
|                         | **Animal commodities:** The residue definition for enforcement set by JMPR and at EU level are identical. For risk assessment, the residue definition at EU level is more comprehensive and includes the mono‐hydroxylated metabolite SYN546039 (free and conjugated). In the metabolism study in goats, the metabolite represented 22% to 50% TRR in tissues and milk. A conversion factor of 2 was proposed to account for the residue definition for consumer risk assessment for animal commodities. Furthermore, the residues were not considered fat soluble in the EU |                                                                                                                         |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                         |                                    |                |
|                         | For the current request, the difference in the residue definitions is not relevant                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                         |                                    |                |
+-------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRR: total radioactive residues.
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### 5.20.4. Codex MRL proposals {#efs25797-sec-0147}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                                                                                                                                                     | EU MRL                 | Comment                                                                                                                                                                                                                                                                                                                                                                                            |
+===============================================+========================================================================================================================================================================================================================================================+========================+====================================================================================================================================================================================================================================================================================================================================================================================================+
| Beans (dry)                                   | W 0.15                                                                                                                                                                                                                                                 |                        | The previous CXL will be replaced by the proposed CXL for the Subgroup of dry beans                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry beans, subgroup of, except soya bean, dry | 0.15                                                                                                                                                                                                                                                   | 0.2 (beans and lupins) | Critical GAP: Canada, 2 × 0.075 kg/ha, interval 7 days, PHI 15 days                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Number of trials: 13                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Specific comments/observations: Residue trials already assessed by JMPR in 2016. Extrapolation of the individual CXL to the subgroup of dry beans possible. The MRL proposal for dry beans covers also lupins                                                                                                                                                                                      |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | At EU level, the same MRL would have been derived for the whole group of dry pulses from the combined data set of residues in beans and peas                                                                                                                                                                                                                                                       |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry peas, subgroup of (includes               | 0.2                                                                                                                                                                                                                                                    | 0.2 (peas and lentils) | Critical GAP: 2 × 0.075 kg/ha, interval 7 days, PHI 15 days                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
| all commodities in this subgroup)             |                                                                                                                                                                                                                                                        |                        | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                               |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Specific comments/observations: Residue trials already assessed by JMPR in 2016. Extrapolation of the individual CXL to the subgroup of dry peas possible. At EU level, a slightly lower MRL of 0.15 mg/kg (OECD calculator) would have been derived for the whole group of dry pulses from the combined data set of residues in beans and peas. The MRL proposal for dry peas covers also lentils |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peas (dry)                                    | W 0.2                                                                                                                                                                                                                                                  |                        | The previous CXL will be covered by the proposed CXL for the Subgroup of dry peas                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                          | Upon request from the manufacturer, JMPR decided to expand the CXL in beans (dry) and peas (dry) derived based on the GAP for Canada for pulses (not including soybeans) to the respective subgroups                                                   |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               |                                                                                                                                                                                                                                                        |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                               | A **typo** was noted in the 2018 publications (both Summary report & Report): the STMR for peas (dry) has been reported as '0.014 mg/kg' instead of '0.011 mg/kg' (please refer to 2016 Summary report & Report, where the residue data were assessed) |                        |                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

CXL: Codex Maximum Residue Limit; GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; OECD: Organisation for Economic Co‐operation and Development; STMR: supervised trials median residue.
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### 5.20.5. Consumer risk assessment {#efs25797-sec-0148}

###### 

Summary of the consumer risk assessment

+--------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                              | Chronic exposure assessment                                                                                                                                                                                                                                                                | Comments on JMPR exposure assessment                                                                                    |
+========================================================================================================================================================+============================================================================================================================================================================================================================================================================================+=========================================================================================================================+
| **RA assumptions:**                                                                                                                                    | **RA assumptions:**                                                                                                                                                                                                                                                                        | **Specific comments:**                                                                                                  |
|                                                                                                                                                        |                                                                                                                                                                                                                                                                                            |                                                                                                                         |
| The short‐term dietary risk assessment was conducted using for pulses the STMR value of 0.011 mg/kg derived by JMPR from studies on dry beans and peas | The long‐term risk assessment was conducted using the approach as outlined in Section 'Assessment' and the STMR value of 0.011 mg/kg derived by JMPR from studies on dry beans and peas. MRLs of products of animal origin were multiplied by a conversion factor for risk assessment of 2 | JMPR did not provide an update of the consumer exposure performed in EFSA ([2016h](#efs25797-bib-0071){ref-type="ref"}) |
+--------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                           | **Results:**                                                                                                                                                                                                                                                                               | **Results:**                                                                                                            |
|                                                                                                                                                        |                                                                                                                                                                                                                                                                                            |                                                                                                                         |
| No short‐term exposure concern was identified for dry beans (0.2% of the ARfD), peas and lentils (0.07% of the ARfD)                                   | No long‐term consumer health risk was identified                                                                                                                                                                                                                                           | --                                                                                                                      |
|                                                                                                                                                        |                                                                                                                                                                                                                                                                                            |                                                                                                                         |
|                                                                                                                                                        | The overall chronic exposure accounted for 16% of the ADI                                                                                                                                                                                                                                  |                                                                                                                         |
|                                                                                                                                                        |                                                                                                                                                                                                                                                                                            |                                                                                                                         |
|                                                                                                                                                        | The maximum contribution of pulses to the exposure was 0.02% of the ADI (dry beans)                                                                                                                                                                                                        |                                                                                                                         |
+--------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; STMR: supervised trials median residue; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; ADI: acceptable daily intake.
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5.21. Cyantraniliprole (263) R {#efs25797-sec-0149}
------------------------------

### 5.21.1. Background information {#efs25797-sec-0150}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | UK                | Co‐RMS: FR                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) 2016/1414[a](#efs25797-note-0148){ref-type="fn"}                                                                                                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2014g](#efs25797-bib-0041){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | Statement EFSA ([2017d](#efs25797-bib-0075){ref-type="ref"})                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2017m](#efs25797-bib-0090){ref-type="ref"}) (Raspberries and blackberries)                                                                                                                                 |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EFSA ([2018c](#efs25797-bib-0092){ref-type="ref"}) (leeks)                                                                                                                                                        |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | 3 MRL applications on various crops: ongoing                                                                                                                                                                      |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | Table olives and olives for oil production: ongoing                                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met.          | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                                                                 |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        | ED: not concluded | EU Peer Review proposal (2014g): none                                                                                                                                                                             |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0818){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) 2016/1414 of 24 August 2016 approving the active substance cyantraniliprole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 230, 25.8.2016, p. 16--19.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.21.2. Toxicological reference values {#efs25797-sec-0151}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-----------------------+-------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                           | EU evaluation         | TRV comparable        |                                                                               |     |
+========================+===========================================================================================================================================================================================================================================================================+=======================+=======================+===============================================================================+=====+
| **ADI**                | 0.03 mg/kg bw per day                                                                                                                                                                                                                                                     | JMPR (2013)           | 0.01 mg/kg bw per day | EFSA ([2014g](#efs25797-bib-0041){ref-type="ref"}) (1‐year dog study, UF 100) | No  |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           | (dog studies, SF 100) |                       | European Commission ([2016a](#efs25797-bib-0144){ref-type="ref"})             |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-----------------------+-------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                               | JMPR (2013)           | Not necessary         | EFSA ([2014g](#efs25797-bib-0041){ref-type="ref"})                            | Yes |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       | European Commission ([2016a](#efs25797-bib-0144){ref-type="ref"})             |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-----------------------+-------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The ADI values set by JMPR and EU are not comparable                                                                                                                                                                                                                      |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        | The EU ADI is 0.01 mg/kg bw per day, based on the 1‐year dog study and applying an uncertainty factor (UF) of 100. In the 90‐day and 1‐year dog studies, the agreed NOAEL was 1 mg/kg bw per day based on increased relative liver weights and altered clinical chemistry |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        | On the contrary, in the JMPR report of 2013, the NOAEL from the 90‐day oral toxicity study was 3.08 mg/kg bw per day (based on increased total protein, albumin and AP levels in males) which is the basis for the ADI                                                    |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        | **Metabolites considered during the EU peer review:**                                                                                                                                                                                                                     |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        | The plant metabolite IN‐J9Z38, it is covered by the reference values derived for cyantraniliprole.                                                                                                                                                                        |                       |                       |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                           |                       |                       |                                                                               |     |
|                        | For the metabolites IN‐F6L99 and IN‐N5M09 (found in processed commodities), an assessment of their toxicological properties is still missing (data gap)                                                                                                                   |                       |                       |                                                                               |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------+-----------------------+-------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.21.3. Residue definitions {#efs25797-sec-0152}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR evaluation                                                                        | EU evaluation                                                                                                                                                               | RDs comparable |
+=========================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+========================================================================================+=============================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Cyantraniliprole                                                                       | EU Reg. 2016/486:                                                                                                                                                           | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        | Cyantraniliprole                                                                                                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Cyantraniliprole                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | EU Reg. 2016/486:                                                                      | Yes                                                                                                                                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Cyantraniliprole                                                                       |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | The residue is not fat soluble                                                         |                                                                                                                                                                             |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Cyantraniliprole                                                                       | Peer review (EFSA, [2014g](#efs25797-bib-0041){ref-type="ref"}, [2017j](#efs25797-bib-0087){ref-type="ref"}, [2018c](#efs25797-bib-0092){ref-type="ref"}): Cyantraniliprole | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | For processed plant commodities:                                                       | For processed commodities:                                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Sum of cyantraniliprole and IN‐J9Z38, expressed as cyantraniliprole                    | Sum cyantraniliprole and 2‐\[3‐bromo‐1‐(3‐chloropyridin‐2‐yl)‐1*H*‐pyrazol‐5‐yl\]‐3,8‐                                                                                      |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        | dimethyl‐4‐oxo‐3,4‐dihydroquinazoline‐6‐carbonitrile (IN‐J9Z38), expressed as                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        | cyantraniliprole                                                                                                                                                            |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of:‐cyantraniliprole, 2‐\[3‐Bromo‐1‐(3‐chloro‐2‐pyridinyl)‐1*H*‐pyrazol‐5‐yl\]‐3,4‐dihydro‐3,8‐dimethyl‐4‐oxo‐6‐quinazoline‐carbonitrile (IN‐J9Z38), 2‐\[3‐Bromo‐1‐(3‐chloro‐2‐pyridinyl)‐1*H*‐pyrazol‐5‐yl\]‐1,4‐dihydro‐8‐methyl‐4‐oxo‐6‐quinazoline carbonitrile (IN‐MLA84), 3‐Bromo‐1‐(3‐chloro‐2‐pyridinyl)‐*N*‐\[4‐cyano‐2‐(hydroxymethyl)‐6‐\[(methylamino)carbonyl\]phenyl\]‐1*H*‐pyrazole‐5‐carboxamide (IN‐N7B69) and 3‐Bromo‐1‐(3‐chloro‐2‐pyridinyl)‐*N*‐\[4‐cyano‐2\[\[(hydroxymethyl) amino\]carbonyl\]‐6‐methylphenyl\]‐1*H*‐pyrazole‐5‐carboxamide expressed as cyantraniliprole (IN‐MYX98) | [Peer review (EFSA,]{.ul} [[2014g]{.ul}](#efs25797-bib-0041){ref-type="ref"} [):]{.ul} | No                                                                                                                                                                          |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Sum cyantraniliprole, IN‐                                                              |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | J9Z38, IN‐MLA84 and IN‐                                                                |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                        |                                                                                                                                                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | N7B69, expressed as cyantraniliprole                                                   |                                                                                                                                                                             |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The RA RDs for animals are not compatible. The metabolite IN‐MYX98 is included (highlighted in green) in the RA RD derived by JMPR, but not in the one derived by EFSA. Since no Codex MRLs are proposed for animal commodities this year, it is not expected that this has an impact on the assessment                                                                                                                                                                                                                                                                                                         |                                                                                        |                                                                                                                                                                             |                |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue levels.
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### 5.21.4. Codex MRL proposals {#efs25797-sec-0153}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                         | Codex MRL proposal                                                                                                                                                                                                                    | EU MRL                                                             | Comment                                                                                                                                                                                                                                                                                                                                              |
+===================================================================================+=======================================================================================================================================================================================================================================+====================================================================+======================================================================================================================================================================================================================================================================================================================================================+
| Cranberries                                                                       | **0.08**                                                                                                                                                                                                                              | 0.01[\*](#efs25797-note-0152){ref-type="fn"}                       | Critical GAP: Canada (3 × 150 g a.i./ha, PHI 14 days)                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 5                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Specific comments/observations: trials compliant with the GAP                                                                                                                                                                                                                                                                                        |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, Cucurbits                                                    | W 0.3                                                                                                                                                                                                                                 |                                                                    | CXL withdrawn, see below the new proposal                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, Cucurbits, Group of (includes all commodities in this group) | 0.3                                                                                                                                                                                                                                   | cucurbits with edible peel: 0.4; cucurbits with inedible peel: 0.3 | Critical GAP: JMPR 2018: USA (3 × 150 g a.i./ha, PHI 0 days, indoor use)                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | 2013: Canada (4 × 0.025--0.15 kg/ha, max. 0.45 kg/ha per season, PHI 1 day, outdoor use)                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 5 trials for indoor use assessed by 2015 JMPR were found to match the US GAP                                                                                                                                                                                                                                                       |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | 10 trials on cucumbers and 9 trials in summer squash for outdoor use (JMPR 2013)                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: No for indoor use, Yes for outdoor use                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | In 2013, a MRL proposal of 0.3 mg/kg was derived for fruiting vegetables (cucurbits) based on a sufficient data package. The new data submitted for the indoor use (see GAP mentioned above); since the data were insufficient, the previously derived MRL was maintained                                                                            |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials considered insufficient to derive MRL for major crops. 4 additional trials compliant to Canadian GAP (4 × 100 g a.i./ha, PHI 0 days), also deemed insufficient. Both data set could not be matched using the 'GAP versus trial model'                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL reflecting the Canadian GAP assessed in 2013 is acceptable                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mango                                                                             | **0.7**                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0152){ref-type="fn"}                       | Critical GAP: Cambodia (2 × 180 g a.i./ha, PHI 7 days)                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 8                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Specific comments/observations: residue results available for RAC and pulp                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, Husked                                                                      | 0.01[\*](#efs25797-note-0152){ref-type="fn"}                                                                                                                                                                                          | 0.01[\*](#efs25797-note-0152){ref-type="fn"}                       | Critical GAP: China (2 × 60 g a.i./ha, PHI 21 days)                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 33                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Specific comments/observations: Residues in overdosed trials performed to: 2 or 3 × 100 g a.i./ha, PHI 21 days, were all \< 0.01 mg/kg (n = 12). Residues in overdosed trials performed to: 2 or 3 × 150 g a.i./ha, PHI 21 days, ranged from \< 0.01 (n = 9) to 0.019 mg/kg (n = 12). No residue situation anticipated when applied according to GAP |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                                                    | 0.01[\*](#efs25797-note-0152){ref-type="fn"}                                                                                                                                                                                          |                                                                    | Estimations from husked rice apply to polish rice                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | At EU level no MRL is set for processed products                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice straw & fodder (dry)                                                         | 1.7 (dw)                                                                                                                                                                                                                              |                                                                    | Critical GAP: China (2 × 60 g a.i./ha, PHI 21 days)                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 6                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | No EU MRLs are set for feed items like straw and fodder                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberry                                                                        | **1.5**                                                                                                                                                                                                                               | 0.05[\*](#efs25797-note-0152){ref-type="fn"}                       | Critical GAP: Canada (3 × 150 g a.i./ha, PHI 1 day)                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 8                                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Specific comments/observations:                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Winegrapes                                                                        | 1                                                                                                                                                                                                                                     | 1.5                                                                | Critical GAP: Italy (2 × 112.5 g a.i./ha, PHI 10 days)                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Number of trials: 27                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                  |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Specific comments/observations: combined data set of trials compliant with the GAP (n = 4) and overdosed (n = 23). Results from overdosed residue trials were scaled down according to the proportionality principle                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape, juice                                                                      | --                                                                                                                                                                                                                                    |                                                                    | Median PF: 0.52                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Robust (n = 3)                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grapes (= currants, raisins and sultanas)                                   | --                                                                                                                                                                                                                                    |                                                                    | Median PF: 0.52                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Robust (n = 3)                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape, wine                                                                       | --                                                                                                                                                                                                                                    |                                                                    | Median PF: 1.0                                                                                                                                                                                                                                                                                                                                       |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Robust (n = 3)                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape, must                                                                       | --                                                                                                                                                                                                                                    |                                                                    | Median PF: 1.5                                                                                                                                                                                                                                                                                                                                       |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                   |                                                                                                                                                                                                                                       |                                                                    | Robust (n = 3)                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                              | General discussion with risk managers how to deal with data gaps identified in the EU peer review for metabolites (metabolites IN‐F6L99 and IN‐N5M09 (found in processed commodities), see comments on toxicological reference values |                                                                    |                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; CXL: Codex Maximum Residue Limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RAC: raw agricultural commodity; PF: processing factor.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.21.5. Consumer risk assessment {#efs25797-sec-0154}

###### 

Summary of the consumer risk assessment

+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                     | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                       | Comments on JMPR exposure assessment |
+===============================================+===================================================================================================================================================================================================================================================================================================================================================================================================================+======================================+
| Not relevant for the EU (no ARfD was derived) | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                               | **Specific comments:**               |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | The most recent long‐term risk assessment (EFSA, [2018c](#efs25797-bib-0092){ref-type="ref"}) was updated including the STMR values derived by JMPR for cranberries, mangoes and strawberries. The calculations is based on the STMR values; where the MRL was set above the LOQ and no STMR value was available, the MRL was used as input value. Crops with MRLs at the LOQ are not included in the calculation | --                                   |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | The risk assessment was performed with the EU ADI                                                                                                                                                                                                                                                                                                                                                                 |                                      |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| ** **                                         | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                      | **Results:**                         |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | A long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                                                                                                   | Long‐term exposure:                  |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | The overall chronic exposure accounted for 152% of the ADI                                                                                                                                                                                                                                                                                                                                                        | 4‐40% of the ADI                     |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | The contribution of cranberries, mangoes and strawberries to the exposure was \< 0.01, 0.03 and 2.3% of the ADI, respectively                                                                                                                                                                                                                                                                                     |                                      |
|                                               |                                                                                                                                                                                                                                                                                                                                                                                                                   |                                      |
|                                               | The main contributor were the STMR for cattle milk (96% of the ADI, Dutch toddler), apples (20% for German child), and olives for oil production (12%, calculation with MRL, further refinement would be possible)                                                                                                                                                                                                |                                      |
+-----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; LOQ: limit of quantification; ARfD: acute reference dose; ADI: acceptable daily intake.

John Wiley & Sons, Ltd

5.22. Cyazofamid (281) R {#efs25797-sec-0155}
------------------------

### 5.22.1. Background information {#efs25797-sec-0156}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                                           |
+========================================================================================================================================+=========================+================================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use                 |                                                                                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FR                      |                                                                                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Renewal of the approval | Commission Directive 2003/23/EC[a](#efs25797-note-0155){ref-type="fn"} as amended by Commission Implementing Regulation (EU) 2018/917[b](#efs25797-note-0156){ref-type="fn"}, A decision on the renewal has not yet been taken |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2016e](#efs25797-bib-0068){ref-type="ref"})                                                                                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments       | EFSA ([2012e](#efs25797-bib-0024){ref-type="ref"})                                                                                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | EFSA ([2013g](#efs25797-bib-0031){ref-type="ref"}) (grapes)                                                                                                                                                                    |
|                                                                                                                                        |                         |                                                                                                                                                                                                                                |
|                                                                                                                                        |                         | EFSA ([2015d](#efs25797-bib-0047){ref-type="ref"}) (aubergines)                                                                                                                                                                |
|                                                                                                                                        |                         |                                                                                                                                                                                                                                |
|                                                                                                                                        |                         | EFSA ([2015n](#efs25797-bib-0057){ref-type="ref"}) (spring/welsh onions, globe artichoke, leek and hops)                                                                                                                       |
|                                                                                                                                        |                         |                                                                                                                                                                                                                                |
|                                                                                                                                        |                         | Confirmatory data following Art. 12 review ongoing                                                                                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | No                      | Harmonised classification: none for tox.                                                                                                                                                                                       |
|                                                                                                                                        |                         |                                                                                                                                                                                                                                |
|                                                                                                                                        |                         | Peer review proposal: none                                                                                                                                                                                                     |
|                                                                                                                                        |                         |                                                                                                                                                                                                                                |
|                                                                                                                                        |                         | ED: assessed before EU criteria were defined and implemented (2018)                                                                                                                                                            |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2003/23/EC of 25 March 2003 amending Council Directive 91/414/EEC to include imazamox, oxasulfuron, ethoxysulfuron, foramsulfuron, oxadiargyl and cyazofamid as active substances OJ L 81, 28.3.2003, p. 39--42.

Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha‐cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl‐m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos‐methyl, propamocarb, prothioconazole, pymetrozine and s‐metolachlor. OJ L 163, 28.6.2018, p. 13--16.

John Wiley & Sons, Ltd

### 5.22.2. Toxicological reference values {#efs25797-sec-0157}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------------+--------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                    | EU evaluation | TRV comparable               |                                                                          |     |
+========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+==============================+==========================================================================+=====+
| **ADI**                | 0.2 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR (2015)   | 0.17 mg/kg bw per day        | EFSA ([2016e](#efs25797-bib-0068){ref-type="ref"}) (rat, 2‐year, UF 100) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              | Same in European Commission ([2002](#efs25797-bib-0126){ref-type="ref"}) |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------------+--------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR (2015)   | Not allocated, not necessary | EFSA ([2016e](#efs25797-bib-0068){ref-type="ref"})                       | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              | Same in European Commission ([2002](#efs25797-bib-0126){ref-type="ref"}) |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------------+--------------------------------------------------------------------------+-----+
| **Conclusion/comment** | Parent compound:                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | The ADI established by JMPR is based on the NOAEL of 17.1 mg/kg bw per day for increase in kidney weight and changes in blood urea nitrogen and urine volume in the 2‐year carcinogenicity study in rat and applying an uncertainty factor (UF) of 100                                                                                                                                                                             |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | The EU evaluation derived a comparable ADI based on the NOAEL of 17.1 mg/kg bw per day from the same study (2‐year carcinogenicity study in the rat) considered by JMPR and applying an UF of 100. The small difference between JMPR and EU assessment is due to different rounding of the values obtained                                                                                                                         |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | As regards the ARfD, JMPR and EU came to the same conclusion that no ARfD was necessary                                                                                                                                                                                                                                                                                                                                            |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | Metabolite CCIM:                                                                                                                                                                                                                                                                                                                                                                                                                   |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | JMPR concluded that the ADI derived for parent compound is also applicable for CCIM.                                                                                                                                                                                                                                                                                                                                               |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | For this metabolite, an ARfD of 0.2 mg/kg bw was agreed by JMPR                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                              |                                                                          |     |
|                        | In the EU Experts' meeting 141, the same ADI was proposed for CCIM. However, as reported in the EFSA Conclusion, considering that a data gap was identified for CCIM with regard to genotoxicity testing (mammalian cell mutation assay, *in vitro* mutation test using mouse lymphoma L518Y cells) EFSA, after the experts' meeting, considered preferable not to set an ARfD for CCIM until its genotoxic potential is clarified |               |                              |                                                                          |     |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+------------------------------+--------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 5.22.3. Residue definitions {#efs25797-sec-0158}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
|                 | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR evaluation                                                                                                           | EU evaluation                                                                                                                    | RDs comparable |
+=================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===========================================================================================================================+==================================================================================================================================+================+
| **RD enf**      | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Cyazofamid                                                                                                                | Reg. 396/2005: Cyazofamid                                                                                                        | Yes            |
+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products | Not defined                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Reg. 396/2005: Cyazofamid                                                                                                 | Yes                                                                                                                              |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 | Fat solubility not specified                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | The residue is fat soluble                                                                                                |                                                                                                                                  |                |
+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**       | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | [Long‐term dietary intake]{.ul}: Cyazofamid plus CCIM, expressed as cyazofamid                                            | Peer review and Art. 12 review (EFSA, [2012e](#efs25797-bib-0024){ref-type="ref"}, [2016e](#efs25797-bib-0068){ref-type="ref"}): | No             |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | [short‐term dietary intake]{.ul}:                                                                                         | Cyazofamid                                                                                                                       |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | CCIM                                                                                                                      |                                                                                                                                  |                |
+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products | Not defined                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Peer review (EFSA, [2016e](#efs25797-bib-0068){ref-type="ref"}):                                                          | Yes                                                                                                                              |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Cyazofamid                                                                                                                |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Art. 12 MRL review (EFSA, [2012e](#efs25797-bib-0024){ref-type="ref"}): no RD proposed due to expected low dietary burden |                                                                                                                                  |                |
+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/** | [Primary crops:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
| **comments**    | The JMPR and EU evaluations resulted in the same residue definitions for enforcement (cyazofamid) but different residue definitions for risk assessment were proposed                                                                                                                                                                                                                                                                                                                                                                                           |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 | [Processed commodities:]{.ul}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 | Peer review proposal: Cyazofamid and CCIM. Due to data gaps regarding the genotoxic potential and a repeated dose toxicity study to conclude on the toxicological relevance of CCIM, a final decision whether the residue definition should cover the sum or the two compounds separately has not been taken yet                                                                                                                                                                                                                                                |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 | [Animal matrices]{.ul}:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                           |                                                                                                                                  |                |
|                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                           |                                                                                                                                  |                |
|                 | As the metabolism studies in poultry and ruminants clearly showed that residues are not expected in animal matrices considering the dietary burden calculation based on the representative uses, EFSA proposes for monitoring and risk assessment to set the residue definition by default as cyazofamid only and no MRLs are required. Also, in the framework of Art.12 MRL review, the livestock exposure assessment was not triggered based on the EU authorised uses and no RD for monitoring and risk assessment was derived for products of animal origin |                                                                                                                           |                                                                                                                                  |                |
+-----------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.22.4. Codex MRL proposals {#efs25797-sec-0159}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                             | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
+=======================================================================+====================+==============================================+===========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Bulb onions, Subgroup of (includes all commodities in this subgroup)  | **1.5**            | 0.01[\*](#efs25797-note-0160){ref-type="fn"} | Critical GAP: USA GAP (bulb vegetables, including dry bulb onions): 6 × 0.087 kg a.s./ha (minimum interval of 7 days between application) and a PHI: 0 d (max. seasonal rate: 0.47 kg a.s./ha)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Number of trials: 10 US residue trials on onion bulbs with a possible extrapolation to garlic and shallots                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Specific comments/observations: The proposed Codex MRL covers garlic, onions, shallots. It is noted the MRL proposal was reported for the wrong code (VA0035) which refers to the group of bulb vegetables. The correct code for the subgroup of bulb onions is VA2031                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable, considering the data gap related to the metabolite CCIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Green onions, Subgroup of (includes all commodities in this subgroup) | **6**              | 0.01[\*](#efs25797-note-0160){ref-type="fn"} | Critical GAP: US GAP (bulb vegetables, including spring onions and chive leaves): 6 × 0.087 kg a.s./ha (minimum interval of 7 days between application) and a PHI: 0 days (max. seasonal rate: 0.47 kg a.s./ha)                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Number of trials: 5 trials on spring onions matching the GAP and 5 trials on chives but conducted with 9 instead of 6 applications                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Specific comments/observations: The proposed Codex MRL covers spring onions, chives and leek. The MRL proposal for the green onions, subgroup was derived from the residue data set on chives only and extrapolated to the whole subgroup. According to the JMPR extrapolation rules, residue trials on spring onion or leek can be used to derive a group MRL; data on chives are not appropriate. In the given case, it would be more appropriate to derive a MRL proposal of 6 mg/kg for chives and a MRL of 2 mg/kg for green onions, subgroup of, except chives (this MRL would be applicable also to leek). This proposal is in line with the JMPR methodology (FAO manual p 91 ff) |
|                                                                       |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                       |                    |                                              | Conclusion: The proposed Codex MRL is not acceptable because this MRL is derived from the residue trials on chives extrapolated to the whole subgroup. Furthermore, it should be discussed whether the proposed Codex MRL is acceptable, considering the data gap related to the metabolite CCIM                                                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                  | --                 |                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; a.s.: active substance; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

Indicates that the input value is proposed at the limit of quantification.
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### 5.22.5. Consumer risk assessment {#efs25797-sec-0160}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                 | Chronic exposure assessment                                                                                                                                                                                                                                 | Comments on JMPR exposure assessment |
+===========================================================================+=============================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                       | **RA assumptions:**                                                                                                                                                                                                                                         | **Specific comments:**               |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
| Not relevant. An ARfD was not allocated to cyazofamid                     | The most recent long‐term risk assessment (EFSA, [2015n](#efs25797-bib-0057){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the crops for which Codex MRLs were derived | None                                 |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
|                                                                           | For the remaining commodities, the existing EU MRL was used as an input value                                                                                                                                                                               |                                      |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
|                                                                           | The calculations are indicative, since the residue definitions of JMPR and EU level are not fully compatible. Furthermore, data to exclude genotoxicity of CCIM were considered as not sufficient in the recent EU peer review                              |                                      |
+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                              | **Results:**                                                                                                                                                                                                                                                | **Results:**                         |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
| Not relevant. An ARfD was not allocated to cyazofamid and is not required | No long‐term consumer health risk was identified                                                                                                                                                                                                            | Long‐term exposure:                  |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
|                                                                           | The overall chronic exposure accounted for 1% of the ADI (DE child)                                                                                                                                                                                         | 0.3% of the ADI                      |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
|                                                                           | The contribution of the crops under consideration to the exposure was low (max. for leek, 0.24%)                                                                                                                                                            | Short‐term exposure:                 |
|                                                                           |                                                                                                                                                                                                                                                             |                                      |
|                                                                           |                                                                                                                                                                                                                                                             | Not relevant                         |
+---------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

ARfD: acute reference dose; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; ADI: acceptable daily intake.
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5.23. Lufenuron (286) R {#efs25797-sec-0161}
-----------------------

### 5.23.1. Background information {#efs25797-sec-0162}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New uses          |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | PT                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Directive 2009/77/EU[a](#efs25797-note-0163){ref-type="fn"}                                                                                                                                            |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2009a](#efs25797-bib-0009){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments | EFSA ([2017l](#efs25797-bib-0089){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met           | Harmonised classification and labelling for CMR -- Annex VI: none                                                                                                                                                 |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        | ED: not concluded | EU Peer Review proposal for CMR (EFSA, [2009a](#efs25797-bib-0009){ref-type="ref"}): none                                                                                                                         |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0819){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2009/77/EC of 1 July 2009 amending Council Directive 91/414/EEC to include chlorsulfuron, cyromazine, dimethachlor, etofenprox, lufenuron, penconazole, tri‐allate and triflusulfuron as active substances OJ L 172, 2.7.2009, p. 23--33.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.23.2. Toxicological reference values {#efs25797-sec-0163}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+------------------------+-------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                           | EU evaluation                                      | TRV comparable         |                                                                               |     |
+========================+===========================================================================================================================================================================================================================================================================================================================================+====================================================+========================+===============================================================================+=====+
| **ADI**                | 0.02 mg/kg bw per day                                                                                                                                                                                                                                                                                                                     | JMPR (2015) (2‐year dietary study in rats, SF 100) | 0.015 mg/kg bw per day | EFSA ([2009a](#efs25797-bib-0009){ref-type="ref"}) (1‐year dog study, UF 100) | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                           |                                                    |                        |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                           |                                                    |                        | European Commission ([2011d](#efs25797-bib-0136){ref-type="ref"})             |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+------------------------+-------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                               | JMPR (2015)                                        | Not needed             | EFSA ([2009a](#efs25797-bib-0009){ref-type="ref"})                            | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                           |                                                    |                        |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                           |                                                    |                        | European Commission ([2011d](#efs25797-bib-0136){ref-type="ref"})             |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+------------------------+-------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | An ADI of 0.02 mg/kg bw was established on the basis of the NOAEL of 1.93 mg/kg bw per day for tonic‐clonic seizures and findings in lungs, gastrointestinal tract, liver and urinary tract in the 2‐year dietary study in rats, using a safety factor of 100. The same NOAEL from the 2‐year rat study was derived by the EU peer review |                                                    |                        |                                                                               |     |
|                        |                                                                                                                                                                                                                                                                                                                                           |                                                    |                        |                                                                               |     |
|                        | However, the EU peer review set the ADI on the NOAEL of 1.5 mg/kg bw per day based on liver changes (increased weight and incidence of cell hypertrophy) from a 1‐year study, while in the JMPR report of 2015 a NOAEL of 7.02 mg/kg bw per day was proposed for this study                                                               |                                                    |                        |                                                                               |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------+------------------------+-------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.23.3. Residue definitions {#efs25797-sec-0164}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                          | JMPR evaluation                                                  | EU evaluation                                                    | RDs comparable |
+=========================+==========================================================================================================+==================================================================+==================================================================+================+
| **RD enf**              | Plant products                                                                                           | Lufenuron                                                        | EU Reg. 2018/78: Lufenuron                                       | Yes            |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Art 12 MRL review:                                               |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Lufenuron (any ratio of constituent isomers)                     |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Peer review (EFSA, [2009a](#efs25797-bib-0009){ref-type="ref"}): |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Constituent isomers of lufenuron                                 |                |
+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| Animal products         | Lufenuron                                                                                                | EU Reg. 2018/78: Lufenuron                                       | Yes                                                              |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         | The residue is fat soluble                                                                               | Art 12 MRL review:                                               |                                                                  |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          | Lufenuron (any ratio of constituent isomers)                     |                                                                  |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          | Peer review (EFSA, [2009a](#efs25797-bib-0009){ref-type="ref"}): |                                                                  |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          | Constituent isomers of lufenuron                                 |                                                                  |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          | The residue is fat soluble                                       |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                           | Lufenuron                                                        | Peer review (EFSA, [2009a](#efs25797-bib-0009){ref-type="ref"}): | Yes            |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | constituent isomers of lufenuron                                 |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Art 12 MRL review:                                               |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  | Lufenuron (any ratio of constituent isomers)                     |                |
+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| Animal products         | Yes                                                                                                      |                                                                  |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| **Conclusion/comments** | **Plant:** Residue definitions for enforcement and risk assessment in plant commodities are comparable   |                                                                  |                                                                  |                |
|                         |                                                                                                          |                                                                  |                                                                  |                |
|                         | **Animal:** Residue definitions for enforcement and risk assessment in animal commodities are comparable |                                                                  |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.
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### 5.23.4. Codex MRL proposals {#efs25797-sec-0165}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                    | Codex MRL proposal | EU MRL                                       | Comment                                                                                                                                                                                                                                                                                                                                                                    |
+==============================================================================+====================+==============================================+============================================================================================================================================================================================================================================================================================================================================================================+
| Coffee beans                                                                 | **0.07**           | 0.05[\*](#efs25797-note-0167){ref-type="fn"} | Critical GAP: BR, 2 × 40 g a.i./ha, interval of 30 days; PHI = 7 days                                                                                                                                                                                                                                                                                                      |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: Trials from Brazil matching the critical GAP                                                                                                                                                                                                                                                                                               |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                     | **0.15**           | 0.04 kidney, liver, 0.7 other edible offals  | See meat (mammalian)                                                                                                                                                                                                                                                                                                                                                       |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lime                                                                         | **0.4**            | 0.01[\*](#efs25797-note-0167){ref-type="fn"} | Critical GAP: BR, 1 × 3.75 g a.i./ha, PHI = 28 days                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: Trials from Brazil on limes matching the critical GAP                                                                                                                                                                                                                                                                                      |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats                                                               | **2**              | 0.7                                          | See meat (mammalian except marine mammals)                                                                                                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (mammalian except marine mammals)                                       | **2(fat)**         | 0.03 (muscle)                                | Two feeding studies on lactating cows and steer are available                                                                                                                                                                                                                                                                                                              |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes; according to the RMS the feeding studies evaluated in the JMPR are the same as the evaluated in the EU. Three dose levels were used in the feeding study. According to the RMS the quality of the study is acceptable                                                                                                                 |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: The Meeting based its recommendations for mammalian products on the lactating cow feeding study, generally showing higher residues than the study with steer                                                                                                                                                                               |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable. However, at EU level, MRLs are established only for muscle. The expected residue in muscle is 0.06 mg/kg, thus, the MRL for muscle should be set between 0.06 mg/kg and 0.08 mg/kg                                                                                                                                       |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                                        | **0.01**           | 0.01[\*](#efs25797-note-0167){ref-type="fn"} | Critical GAP: BR, 1 × 15 g a.i./ha; PHI = 35 days                                                                                                                                                                                                                                                                                                                          |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: Trials from Brazil matching the critical GAP (4). In addition, the no‐residue situation is supported by four trials where two foliar applications were made with harvest at 35 days (immature corn=sweet corn) and at approximately 50 days after last application (maize), residues were \< 0.01 mg/kg for both immature and mature maize |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable. However, it is recommended to label the Codex MRL with an asterisk, indicating that the MRL is equal to the LOQ, considering the no‐residue situation                                                                                                                                                                    |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                        | **0.15**           | 0.1                                          | One feeding study on lactating cows is available. See comments on meat (mammalian except marine mammals)                                                                                                                                                                                                                                                                   |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                                                    | **5**              | --                                           | Not relevant                                                                                                                                                                                                                                                                                                                                                               |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges sweet, sour, Subgroup of (includes all commodities in this subgroup) | **0.3**            | 0.01[\*](#efs25797-note-0167){ref-type="fn"} | Critical GAP: BR, 1 × 3.75 g a.i./ha, PHI = 28 days                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: Residue trials from Brazil on oranges according to the critical GAP                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil, edible                                                           | **8**              | --                                           | The MRL proposal was derived taking into account the PF of 24                                                                                                                                                                                                                                                                                                              |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | At EU level, MRLs are set only for the unprocessed products, but not for processed products like orange oil                                                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits, Group of (includes all commodities in this group)               | **1**              | 0.15                                         | Critical GAP: Chile, 3 × 5 g a.i./hL; PHI = 18 days                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                        |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Specific comments/observations: Residues in 8 trials approximating critical GAP in Chile (deviations were noted for the PHI with sampling between 14 and 21 days)                                                                                                                                                                                                          |
|                                                                              |                    |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                              |                    |                                              | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                           |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange juice                                                                 |                    |                                              | PF \< 0.02                                                                                                                                                                                                                                                                                                                                                                 |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple juice                                                                  |                    |                                              | PF \< 0.2, based on 1 processing study; at EU level one processing study would not e sufficient to derive a processing factor                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple pure                                                                   |                    |                                              | PF \< 0.2, based on 1 processing study; at EU level one processing study would not e sufficient to derive a processing factor                                                                                                                                                                                                                                              |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                         | --                 |                                              |                                                                                                                                                                                                                                                                                                                                                                            |
+------------------------------------------------------------------------------+--------------------+----------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; RMS: rapporteur Member State; PF: processing factor; MRL: maximum residue level; LOQ: limit of quantification.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.23.5. Consumer risk assessment {#efs25797-sec-0166}

###### 

Summary of the consumer risk assessment

+---------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment | Chronic exposure assessment                                                                                                                                                                                                                                         | Comments on JMPR exposure assessment |
+===========================+=====================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**       | **RA assumptions:**                                                                                                                                                                                                                                                 | **Specific comments**                |
|                           |                                                                                                                                                                                                                                                                     |                                      |
| Not relevant              | The most recent long‐term risk assessment EFSA ([2017l](#efs25797-bib-0089){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for the commodities for which MRL proposals were derived | --                                   |
|                           |                                                                                                                                                                                                                                                                     |                                      |
|                           | The EU ADI was used                                                                                                                                                                                                                                                 |                                      |
+---------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**              | **Results:**                                                                                                                                                                                                                                                        | **Results:**                         |
|                           |                                                                                                                                                                                                                                                                     |                                      |
| --                        | No long‐term consumer health risk was identified                                                                                                                                                                                                                    | Long‐term exposure:                  |
|                           |                                                                                                                                                                                                                                                                     |                                      |
|                           | The overall chronic exposure accounted for 83% of the ADI                                                                                                                                                                                                           | 2--10% of the ADI                    |
+---------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; STMR: supervised trials median residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ADI: acceptable daily intake.

John Wiley & Sons, Ltd

5.24. Isofetamid (290) R {#efs25797-sec-0167}
------------------------

### 5.24.1. Background information {#efs25797-sec-0168}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                    |
+========================================================================================================================================+===================+=========================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | BE                |                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) 2016/1425[a](#efs25797-note-0170){ref-type="fn"}                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion (including MRL application)                                                                                            | Yes, see comments | EFSA ([2015q](#efs25797-bib-0060){ref-type="ref"}); in the conclusion, MRL proposals were derived for a number of crops |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                | Not foreseen, since MRLs were set in the framework of the first approval                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments | EFSA ([2018h](#efs25797-bib-0097){ref-type="ref"}) (tomatoes, peppers, aubergines, okra and cucurbits with edible peel) |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met           | Harmonised classification: none for tox                                                                                 |
|                                                                                                                                        |                   |                                                                                                                         |
|                                                                                                                                        | Not met           | EU Peer Review proposal for CMR: none                                                                                   |
|                                                                                                                                        |                   |                                                                                                                         |
|                                                                                                                                        | Not met           | ED assessment: not conducted because the peer review was finalised before the implementation of the current ED criteria |
|                                                                                                                                        |                   |                                                                                                                         |
|                                                                                                                                        | Not met           |                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

2016/1425: Commission Implementing Regulation (EU) 2016/1425 of 25 August 2016 approving the active substance isofetamid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 231, 26.8.2016, p. 30--33.

John Wiley & Sons, Ltd

### 5.24.2. Toxicological reference values {#efs25797-sec-0169}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                  | EU evaluation | TRV comparable        |                                                                                                       |    |
+========================+==================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+=======================================================================================================+====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                            | JMPR (2016)   | 0.02 mg/kg bw per day | EFSA ([2015g](#efs25797-bib-0050){ref-type="ref"}) (1‐year dog study, UF 100)                         | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       | European Commission ([2016b](#efs25797-bib-0145){ref-type="ref"})                                     |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **ARfD**               | 3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                       | JMPR (2016)   | 1 mg/kg bw            | EFSA ([2015g](#efs25797-bib-0050){ref-type="ref"}) (developmental toxicity study with rabbit, UF 100) | No |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       | European Commission ([2016b](#efs25797-bib-0145){ref-type="ref"})                                     |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+
| **Conclusion/comment** | The ADI established by JMPR is 0.05 mg/kg bw per day, based on the NOAEL of 5.34 mg/kg bw per day for liver toxicity in the 90‐day and 1‐year toxicity studies in dog and applying an uncertainty factor (UF) of 100                                                                                                                                                                             |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        | The EU evaluation derived a different ADI (0.02 mg/kg bw per day) based on the NOAEL of 1.57 mg/kg bw per day for effects on body weight and body weight gain in the 1‐year toxicity study in dog and applying an UF of 100                                                                                                                                                                      |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        | The ARfD established by JMPR is based on the NOAEL of 300 mg/kg bw per day for skeletal anomalies in the developmental toxicity study in rabbit and applying an UF of 100                                                                                                                                                                                                                        |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        | The EU evaluation derived a different ARfD (1 mg/kg bw) based on the NOAEL of 100 mg/kg bw per day based on skeletal variations observed in the developmental study in rabbit and applying an UF of 100                                                                                                                                                                                          |               |                       |                                                                                                       |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                  |               |                       |                                                                                                       |    |
|                        | According to EFSA, [2015g](#efs25797-bib-0050){ref-type="ref"}, the reference values of parent compound (isofetamid) are applicable to metabolites and therefore also for metabolite GPTC (*N*‐{1‐\[4‐(b‐[d]{.smallcaps}‐glucopyranosyloxy)‐2‐methylphenyl\]‐2‐methyl‐1‐oxopropan‐2‐yl}‐3‐methylthiophene‐2‐carboxamide) which was included in the risk assessment residue definition for plants |               |                       |                                                                                                       |    |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+-------------------------------------------------------------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.

John Wiley & Sons, Ltd

### 5.24.3. Residue definitions {#efs25797-sec-0170}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | JMPR evaluation                                                                                         | EU evaluation                                                                                                                    | RDs comparable |
+=========================+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=========================================================================================================+==================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Isofetamid                                                                                              | EU Reg. 2018/1514: Isofetamid                                                                                                    | Yes            |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of isofetamid and 2‐\[3‐methyl‐4‐\[2‐methyl‐2‐(3‐methylthiophene‐2‐carboxamido) propanoyl\]phenoxy\] propanoic acid (PPA), expressed as isofetamid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | EU Reg. 2018/1514: Isofetamid                                                                           | No                                                                                                                               |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Peer review (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}): Isofetamid (provisional, not required) |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Fat solubility open (pending confirmation by livestock feeding                                          |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | study, not required at this stage)                                                                      |                                                                                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Isofetamid                                                                                              | Peer review (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}); Art 10 MRL (EFSA, [2018h](#efs25797-bib-0097){ref-type="ref"}): | No             |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         | Sum isofetamid and GPTC, expressed as isofetamid                                                                                 |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of isofetamid and 2‐\[3‐methyl‐4‐\[2‐methyl‐2‐(3‐methylthiophene‐2‐carboxamido) propanoyl\]phenoxy\]propanoic acid (PPA), expressed as isofetamid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | Peer review (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}):                                        | Yes                                                                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Sum isofetamid and PPA expressed as isofetamid                                                          |                                                                                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | [Plant commodities]{.ul}: The plant residue definitions for enforcement are identical, as both refer to the parent isofetamid only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         | For the plant risk assessment residue definition, the JMPR, in contrast to the EU, does not include the plant metabolite GPTC EFSA previously derived conversion factors (CF) for risk assessment for peaches, plums, grapes (CF 1.1) and lettuce (CF 1.3) (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}). A conversion for risk assessment was not deemed necessary for strawberries, tomatoes, aubergines, peppers, okra and cucurbits with edible peel (CF 1.0 and/or GPTC \< LOQ) (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}, [2018h](#efs25797-bib-0097){ref-type="ref"}). For apricots, cherries and rapeseed, CFs could not be derived in the framework of the EU peer review, because residue levels of parent and GPTC were \< LOQ (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"})                                                                                                                                                                                                                                                               |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         | [Animal commodities]{.ul}: For the animal residue definitions for enforcement, the JMPR, in contrast to provisional EU definition, has included the metabolite PPA. EFSA set the residue definition provisionally as isofetamid (only) considering that significant intake of isofetamid residues by livestock was not expected by livestock. This residue definition would have to be reconsidered when additional uses will lead to significant residue intakes by animals and considering the results of animal feeding studies. It is noted that in 2017 CCPR, the EU made a reservation for MRL proposals for animal commodities due to the different residue definition for enforcement. According to the EU assessment, isofetamid was extensively metabolised in poultry and goat, and almost only present in significant proportions in milk fat (76% TRR) and goat fat (62% TRR), and other identified metabolites were all below 5% TRR except metabolite PPA present at ca 20% in kidney and liver of goat (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}) |                                                                                                         |                                                                                                                                  |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                         |                                                                                                                                  |                |
|                         | The risk assessment residue definitions in animal commodities are identical, as both refer to the parent isofetamid and PPA expressed as isofetamid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                         |                                                                                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; LOQ: limit of quantification.

John Wiley & Sons, Ltd

### 5.24.4. Codex MRL proposals {#efs25797-sec-0171}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                                           | Codex MRL proposal | EU MRL                                              | Comment                                                                                                                                                                                                                                                                                                                                                                                                                               |
+=====================================================================================================+====================+=====================================================+=======================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Beans with pods, subgroup of (includes all commodities in this subgroup)                            | **0.6**            | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 2 × 500 g/ha, 7‐ to 14‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 7                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: trials on snap beans. Beans (with pods) are classified as a major crop in the EU, requiring 8 trials, but according to Codex criteria, a minimum of 5 trials are required                                                                                                                                                                                                                             |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Bush berries, subgroup of (includes all commodities in this subgroup)                               | **5**              | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada, 3 × 496 g/ha, 7‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    | (blueberries, currants, gooseberries and rose hips) | Number of trials: 10 trials on blueberry conducted at higher application rates of 650 g/ha (1.31N) and scaled using the proportionality approach                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: According to the EU classification, the number of trials is not sufficient to support extrapolation to the group of small fruit and berries but compliant with the Codex criteria. One residue trial outlier value of 3 mg/kg (scaled value) affects the MRL calculation (without the outlier, the calculated MRL would be 1.5 mg/kg); details on this trial should be checked in the JMPR evaluation |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Using the OECD MRL calculator, the residue trials would suggest a MRL of 4 mg/kg                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | The bush berries MRL would be applicable also to currants (154030), gooseberries (154040) and rose hips (154050)                                                                                                                                                                                                                                                                                                                      |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: A lower MRL should be sufficient (4 mg/kg), if the highest value is a valid result                                                                                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cane berries, subgroup of (includes all commodities in this subgroup)                               | **3**              | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada, 3 × 496 g/ha, 7‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 5 trials on raspberries conducted at higher application rates of 650 g/ha (1.31N) and scaled using the proportionality approach                                                                                                                                                                                                                                                                                     |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: According to the EU classification, extrapolation to whole subgroup cane fruit (153000) is possible                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherries, subgroup of (includes all commodities in this subgroup)                                   | **4**              | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 3 × 365 g/ha, 7‐day interval, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 13                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: None                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry beans, subgroup of (except soya bean (dry))                                                     | **0.05**           | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 2 × 500 g/ha, 7‐day interval, PHI 30 days                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 8 trials on beans and 11 trials on peas                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: Residues from dry beans and dry peas were similar (Mann--Whitney test) and data sets could be combined. The MRL of 0.05 mg/kg proposed by JMPR is questionable, as it is lower than the HR (0.08 mg/kg); The MRL proposal derived using the OECD calculator is 0.09 mg/kg. The Codex MRL would be applicable also to dry lupin (300040)                                                               |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The available residue trials would suggest a higher MRL of 0.09 mg/kg                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dry peas, subgroup of (includes all commodities in this subgroup)                                   | **0.05**           | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 2 × 500 g/ha, 7‐day interval, PHI 30 days                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 11 trials on peas and 8 trials on beans                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: The MRL of 0.05 mg/kg proposed by JMPR is questionable, as it is lower than the HR (0.08 mg/kg); The MRL proposal derived using the OECD calculator is 0.09 mg/kg                                                                                                                                                                                                                                     |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | The MRL proposal for dry peas would be also applicable to dry lentils (300020)                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The available residue trials would suggest a higher MRL of 0.09 mg/kg                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peaches, subgroup of (including Nectarine and Apricots) (includes all commodities in this subgroup) | **3**              | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 3 × 365 g/ha, 7‐day interval, PHI 1 days                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 11                                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: The Codex MRL would be applicable also to apricots. At EU level, the trials on peaches would not be used for extrapolation to apricots                                                                                                                                                                                                                                                                |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peas with pods, subgroup of (includes all commodities in this subgroup)                             | **0.6**            | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 2 × 500 g/ha, 7‐ to 14‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 7 trials are available on snap beans (beans with pods)                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: According to the JMPR, beans with pods (*Phaseolus vulgaris* varieties) are a representative crop for peas with pods and therefore the trials can be used to support the use in peas with pods. The extrapolation from beans with pods to peas with pods is also allowed according to the EU guidance document on extrapolation                                                                       |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Plums, subgroup of (including fresh Prunes) (includes all commodities in this subgroup)             | **0.8**            | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: Canada and USA, 3 × 365 g/ha, 7‐day interval, PHI 1 day                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: None                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits, group of (includes all commodities in this group)                                      | **0.6**            | 0.01[\*](#efs25797-note-0174){ref-type="fn"}        | Critical GAP: USA, 6 × 365 g/ha, 7‐day interval, PHI 20 days                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Number of trials: 16 apples, 9 pears                                                                                                                                                                                                                                                                                                                                                                                                  |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Specific comments/observations: The JMPR combined residue trials as of the same residue populations (Mann‐Whitney test). The CXL would be applicable to the whole group of pome fruits and to azaroles (154070) and kaki (161060). At EU level the extrapolation from apples and pears to azaroles would not be accepted                                                                                                              |
|                                                                                                     |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                     |                    |                                                     | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                                                      |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Prunes, dried                                                                                       | 3                  | --                                                  | A concentration of residues in dried prunes occurs and a PF of 4.0 was derived from two processing studies. No EU MRLs are set for processed prunes                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Apple juice                                                                                         | --                 | --                                                  | A reduction of residues in juice occurs and a PF of 0.31 was derived from one processing study. 1 study is not sufficient to derive a robust processing factor                                                                                                                                                                                                                                                                        |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                                |                    |                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------------------------------------------------------------+--------------------+-----------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; OECD: Organisation for Economic Co‐operation and Development; HR: highest residue; CXL: Codex Maximum Residue Limit; PF: processing factor.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.24.5. Consumer risk assessment {#efs25797-sec-0172}

###### 

Summary of the consumer risk assessment

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Comments on JMPR exposure assessment                                                                                                                                                                          |
+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | **Specific comments:**                                                                                                                                                                                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
| The short‐term dietary risk assessment was performed using PRIMo rev.3, for commodities assessed by JMPR as outlined in Section [2](#efs25797-sec-0006){ref-type="sec"} Assessment'. In order to estimate the contribution of the plant metabolite GPTC, according to the EU risk assessment residue definition, EFSA applied the previously derived conversion factor (CF) for risk assessment for peaches (also used for apricots) and plums (CF 1.1) (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}). The risk assessment is indicative for the other commodities under consideration (pome fruit, cherries, blackberries, dewberries, raspberries, other cane fruit, blueberries, currants, gooseberries, rose hips, azarole, kaki, beans (with pods), peas (with pods), beans, lentils, peas, lupins and other pulses) because a conversion factor to accommodate the possible occurrence of residues of metabolite GPTC was not available which may lead to an underestimation of residue levels | The most recent long‐term risk assessment (EFSA, [2018h](#efs25797-bib-0097){ref-type="ref"}) was updated using PRIMo rev.3 as outlined in the Section 'Assessment'. An indicative risk assessment was performed using the STMR values derived by the JMPR for pome fruit, apricots, cherries, peaches, plums, blackberries, dewberries, raspberries, other cane fruit, blueberries, currants, gooseberries, rose hips, azarole, kaki, beans (with pods), peas (with pods), beans, lentils, peas, lupins and other pulses. In order to estimate the contribution of the plant metabolite GPTC, according to the EU risk assessment residue definition, EFSA applied the previously derived conversion factor (CF) for risk assessment for peaches (also used for apricots) and plums (CF 1.1) (EFSA, [2015q](#efs25797-bib-0060){ref-type="ref"}). For other commodities under consideration, a conversion factor was not available which may lead to an underestimation of residue levels. For all other commodities EFSA applied the MRLs established in Commission Regulation (EU) 2018/1514 | The JMPR exposure assessment according to the residue definition for risk assessment for plant commodities covers isofetamid (only) whereas the EU residue definition includes also the plant metabolite GPTC |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
| The EU ARfD was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | The EU ADI was used                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                               |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | **Results:**                                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
| No short‐term exposure concern was identified. The commodities under consideration leading to highest exposure are (in rank order): peaches (18% of the ARfD), apricots (7% of the ARfD), pears (6% of the ARfD), apples (5% of the ARfD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | No long‐term consumer health risk was identified. The overall chronic exposure accounted for 29% of the ADI (NL toddler). From the commodities under consideration, the contribution to the total exposure was the highest for residues in apples (7% of the ADI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Long‐term exposure:                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0--6% of the ADI                                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | Short‐term exposure:                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 3% of the ARfD                                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PRIMo: (EFSA) Pesticide Residues Intake Model; STMR: supervised trials median residue; MRL: maximum residue level; ARfD: acute reference dose; ADI: acceptable daily intake.
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5.25. Oxathiapiproline (291) R {#efs25797-sec-0173}
------------------------------

### 5.25.1. Background information {#efs25797-sec-0174}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                   | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+===================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New use           |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | IE                |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved          | Commission Implementing Regulation (EU) 2017/239[a](#efs25797-note-0177){ref-type="fn"}                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments | EFSA ([2016f](#efs25797-bib-0069){ref-type="ref"})                                                                                                                                                                |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU MRLs were derived in the EFSA conclusion (cucumber, gherkins, courgette, melons, as well as for the representative uses (table and wine grapes, tomatoes, aubergines, lettuces, grape leaves)                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                | Not foreseen, since EU MRLs were assessed in the framework of the first approval                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | ongoing           | MRLs and IT applications in various crops (under clock stop)                                                                                                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disruptive (ED) potential | Not concluded     | Harmonized classification and labelling for CMR -- Annex VI: no entry                                                                                                                                             |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | EU Peer Review proposal for CMR: none                                                                                                                                                                             |
|                                                                                                                                        |                   |                                                                                                                                                                                                                   |
|                                                                                                                                        |                   | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0977){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

2017/239: Commission Implementing Regulation (EU) 2017/239 of 10 February 2017 approving the active substance oxathiapiprolin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 36, 11.2.2017, p. 39--42.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.25.2. Toxicological reference values {#efs25797-sec-0175}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+-----------------------+----------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                    | EU evaluation              | TRV comparable        |                                                    |     |
+========================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================+============================+=======================+====================================================+=====+
| **ADI**                | 4 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                 | JMPR (2016)                | 0.14 mg/kg bw per day | EFSA ([2016f](#efs25797-bib-0069){ref-type="ref"}) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | (2‐generation rat, SF 100) |                       | (1‐year dog, UF 100)                               |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+-----------------------+----------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR (2016)                | Not necessary         | EFSA ([2016f](#efs25797-bib-0069){ref-type="ref"}) | Yes |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+-----------------------+----------------------------------------------------+-----+
| **Conclusion/comment** | For the 1‐year dog study, JMPR has concluded that no adverse findings were observed up to the top dose level in the dog studies (i.e. at least 1,242 mg/kg bw per day), whereas the EU peer review concluded that the increase in relative liver weight (more than 20% compared to the control group) at the two high‐dose levels was triggering a NOAEL of 13.6 mg/kg bw per day                                                                                  |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        | For the rat multigeneration study, JMPR established an ADI of 4 mg/kg bw per day on the basis of the NOAEL of 430 mg/kg bw per day for delayed balanopreputial separation in offspring at the top dose, whereas the EU peer review concluded that the NOAEL for the offspring was 86.37 mg/kg bw per day based on delayed preputial separation at the two high doses                                                                                               |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        | EU peer review (EFSA, [2016f](#efs25797-bib-0069){ref-type="ref"}):                                                                                                                                                                                                                                                                                                                                                                                                |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        | --the metabolite **IN‐E8S72**, with no genotoxic potential, was granted an ADI of 1.157 mg/kg bw per day, on the basis of a 28‐day rat study and applying an uncertainty factor of 1,000 to cover the extrapolation of subacute to long‐term toxicity and for the lack of a complete toxicity data package--the metabolite **IN‐SXS67**, with no genotoxic potential, was considered as covered by the toxicological profile of IN‐E8S72, being its glucoside form |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        | It is noted that JMPR (in 2016f) concluded that these metabolites are all covered by studies in the rat                                                                                                                                                                                                                                                                                                                                                            |                            |                       |                                                    |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                            |                       |                                                    |     |
|                        | For the metabolite **IN‐WR791**, additional data (*in vitro* micronucleus test) have been submitted in the context of the MRL evaluation (February 2019). Based on the overall weight of evidence, EFSA considers that this metabolite is unlikely to be genotoxic. No further assessment of the toxicological profile of the metabolite in comparison with oxathiapiprolin has been provided                                                                      |                            |                       |                                                    |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------+-----------------------+----------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; MRL: maximum residue level.
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### 5.25.3. Residue definitions {#efs25797-sec-0176}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR evaluation                                                                                                                                                                                                     | EU evaluation                      | RDs comparable |
+=========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================+====================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Oxathiapiprolin                                                                                                                                                                                                     | EU Reg. 2017/1016: Oxathiapiprolin | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| Animal products         | Oxathiapiprolin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU Reg. 2017/1016: Oxathiapiprolin                                                                                                                                                                                  | Yes                                |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | The residue is not fat soluble                                                                                                                                                                                      |                                    |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Sum of oxathiapiprolin, 5‐(Trifluoromethyl)‐1*H*‐pyrazole‐3‐carboxylic acid (IN‐E8S72) and 1‐β‐[d]{.smallcaps}‐Glucopyranosyl‐3‐(‐(trifluoromethyl)‐1*H*‐pyrazole‐5‐carboxylic acid (IN‐SXS67), expressed as parent | Oxathiapiprolin                    | No             |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| Animal products         | No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                     |                                    |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+
| **Conclusion/comments** | The enforcement residue definitions for plant and animal commodities are comparable                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | The risk assessment residue definition derived by the JMPR includes two major soil/rotational crop metabolites IN‐E8S72 and IN‐SXS67                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | The EFSA peer review concluded that both metabolites are of lower toxicity than oxathiapiprolin and therefore did not include them in the risk assessment residue definition                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | In the framework of Article 10 (Regulation (EC) No 396/2005), an MRL application was submitted to EFSA on the setting of import tolerances and modification of existing EU MRLs of oxathiapiprolin in a wide range of crops. An assessment was temporarily suspended, awaiting the applicant to address data requirements related to toxicity of metabolite IN‐WR791, which is one of the major metabolites in crops following soil treatment (see also comments on IN‐WR791 in section toxicological reverence values) |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | The 2016 JMPR decided not to include this metabolite in the residue definitions as                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | 1\) its toxicity is no greater than parent,                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | 2\) low residues are expected and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                     |                                    |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                     |                                    |                |
|                         | 3\) low contribution to max long‐term burden                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                     |                                    |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.
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### 5.25.4. Codex MRL proposals {#efs25797-sec-0177}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                             | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU MRL                                                                                                                                        | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
+=======================================================================================+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Basil (fresh)                                                                         | **10**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 0.02[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: USA, foliar, indoor/outdoor, 4 × 35 g/ha, interval 5 days, PHI 0 day                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 6 (outdoor) + 2 (indoor)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: The indoor and outdoor residue data sets were merged. According to EU and JMPR rules, for indoor use, additional 2 trials would be necessary. Outdoor use is sufficiently supported, but from the merged data it is not possible to identify which values refer to outdoor use. For risk assessment, mean residues in rotational leafy vegetables added to the STMR value (see comments below)                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the limited information on indoor uses and the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Basil, dry                                                                            | **80**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | --                                                                                                                                            | Critical GAP: USA (indoor/outdoor) 4 × 35 g/ha, interval 5 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Choose an item.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Samples from 4 residue trials with fresh basil (see above) were dehydrated                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | No EU MRLs are set for dry basil                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cane berries, Subgroup of (includes all commodities in this subgroup)                 | **0.5**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: USA, soil 2 × 281 g/ha, 7‐day interval, PHI 7 days                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 5 (4 raspberry, 1 blackberry)                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: On the basis of 5 trials, an extrapolation to cane berry subgroup is proposed (raspberries, blackberries, dewberries). According to EU rules, another trial on blackberry would be required, but according the Codex criteria, 5 trials are sufficient. The highest value 0.22 mg/kg seems to be an outlier (remaining values: 3 × \< 0.01, 0.022)                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus fruit, Group of (includes all commodities in this group)                       | **0.05**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: USA, foliar 1 × 35 g/ha, PHI 0 d                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 23 (5 lemon, 6 grapefruit, 12 orange)                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: The trials were performed with soil + foliar treatment and considered acceptable on the basis that side‐by‐side trials performed with only soil application indicated no‐residue situation from soil treatments. CXL applies also to kumquat (miscellaneous fruit). The MRL proposal may not be sufficient for kumquat                                                                                                                                                                        |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus oil, edible                                                                    | **3**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                               | The PF of 47 derived from 2 processing studies with parent compound. No EU MRLs are set for citrus oil                                                                                                                                                                                                                                                                                                                                                                                                                        |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus pulp, dry                                                                      | 0.15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                               | The PF of 2.7 derived from 2 processing studies with parent compound. No EU MRLs are set for citrus pulp                                                                                                                                                                                                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                              | W0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | JMPR estimated the mean and maximum dietary burden for parent compound and for the sum of the two metabolites included in the residue definition for risk assessment (IN.E8S72 + IN‐SXS67). However, from the presentation of the calculation in Annex 6 of the JMPR report, it is not possible to verify the correctness of the calculation for parent oxathiapiprolin (the tables presenting the dietary burden calculation cover only soybean meal and soybean seed; all other feed items are not considered/not reported) |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Feeding studies are not available. In 2016, MRL proposals were derived from the goat metabolism study with oxathiapiprolin (1.2 N the max Australian DB for dairy cattle). 2018 JMPR decided to withdraw the previously recommended MRLs for meat, edible offal, fat and milk. The rationale is not further explained in the JMPR report                                                                                                                                                                                      |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | To discuss with risk managers whether it is acceptable to establish MRLs for commodities that are used as feed items (e.g. kale), if the expected residues in animal commodities cannot be estimated reliably                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                                  | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The calculated critical dietary burden (EU) for poultry has increased but does not affect the conclusions of 2016 JMPR that residues of oxathiapiprolin, IN‐E8S72 and IN‐SXS67 are not expected in poultry commodities. However, from the presentation of the calculation in Annex 6 of the JMPR report, it is not possible to verify the correctness of the calculation for parent oxathiapiprolin (the tables only present soybean meal and soybean seed residues; all other feed items are not considered/not reported)    |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | The Meeting confirmed the existing CXL which is set at the same level as the EU MRL                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leaves of Brassicaceae, Subgroup of (includes all commodities in this subgroup)       | **10**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 0.01[\*](#efs25797-note-0181){ref-type="fn"}(leafy brassica; land cress, rucola, red mustards, baby leaf crops)                               | Critical GAP: USA, 4 × 35 g/ha, foliar, interval 5 days, PHI 0 day                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 10 (mustard greens)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: According to EU rules, such extrapolation would not be acceptable (only kale to leafy brassica and no extrapolation from leafy brassica to crops in lettuce group). According to CCPR, the extrapolation is acceptable. For risk assessment mean residues in rotational leafy vegetables added to the STMR value (see comments below)                                                                                                                                                         |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                                                                 | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: Indonesia, 1 × 0.882 g/kg seed (220 μ/seed)                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Residue trials on maize from India and Thailand. For risk assessment mean residues in rotational cereals (grain) added to the STMR value (see comments below)                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: The proposed Codex MRL is acceptable, considering that the MRL is proposed at the LOQ                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder                                                                          | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The fodder and forage samples from maize (treated according to the GAP on maize, as mentioned above) were analysed for residues, which were \< LOQ. For dietary burden calculation for metabolites IN‐E8S72 and IN‐SXS67, residues in rotational crops (cereal forage and straw) were added to the risk assessment values                                                                                                                                                                                                     |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | No EU MRLs are set for maize fodder                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                     | W 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                         | W 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                 | W 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poppy seed                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: Australia, foliar 1 × 35 g/ha, PHI 42 days                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Trials from 5 locations (5 independent), consisting of 4 trials GAP compliant, 4 trials 2 × cGAP and 1 trial 4 × cGAP. Since residues in all trials \< LOQ, overdosed trials acceptable. For risk assessment, mean residues in rape seed rotational crop added to the STMR value (see comment below)                                                                                                                                                                                          |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: The proposed Codex MRL is acceptable, considering that the MRL is proposed at the LOQ                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Potato                                                                                | W 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Existing CXL is proposed to be replaced by group MRL for tuberous and corm vegetables                                                                                                                                                                                                                                                                                                                                                                                                                                         |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal                                                                  | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                                                          | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meats                                                                         | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The calculated critical dietary burden (EU) for poultry has increased but does not affect the conclusions of 2016 JMPR that residues of oxathiapiprolin, IN‐E8S72 and IN‐SXS67 are not expected in poultry commodities. The Meeting confirmed the existing MRLs                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                                                                       | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: USA, 12--24 μg/seed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 6 overdosed trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: No quantifiable residues were found in the overdosed residue trails; thus, the reduced number of trials is acceptable. For risk assessment, the mean residues measured in rotational crops (pulses) were to the STMR value derived in primary crops (see comments below)                                                                                                                                                                                                                      |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: The proposed Codex MRL is acceptable, considering that the MRL is proposed at the LOQ                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean hay                                                                         | 0.02                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The hay and forage samples from soya (treated according to the GAP on soya bean, as mentioned above) were analysed for residues, which were \<LOQ. For dietary burden calculation, for metabolites IN‐E8S72 and IN‐SXS67, residues in rotational crops (legume forage and hay) were added to the risk assessment values                                                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | No EU MRLs are set for soya bean hay                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sunflower seed                                                                        | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | Critical GAP: USA 1 × 9.4--18.8 μg/seed                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 8 (CAN/USA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Identical NEU/SEU uses reported under Art. 10 MRL assessment (clock stop). For risk assessment mean residues in rape seed rotational crop added to the STMR value                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: The proposed Codex MRL is acceptable, considering that the MRL is proposed at the LOQ                                                                                                                                                                                                                                                                                                                                                                                                                             |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sweet potato                                                                          | W0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | See comments on tuberous and corm vegetables                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tuberous and corm vegetables, Subgroup of (includes all commodities in this subgroup) | **0.04**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 0.01[\*](#efs25797-note-0181){ref-type="fn"} (potatoes, arrowroot, cassava, sweet potato, yams, yacons (listed in part B under chicory roots) | Critical GAP: USA, 2 × 140 g/ha (in‐furrow+ soil)                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 16 trial on potatoes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Extrapolation from potatoes to whole group is in line with Codex rules. However, at EU level, extrapolation would not be acceptable to Jerusalem/Chinese artichoke and chicory roots (yacons). For risk assessment mean residues in rotational root vegetables added to the STMR value (see comments below)                                                                                                                                                                                   |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Young shoots, Subgroup of(includes all commodities in this subgroup)                  | **2**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0181){ref-type="fn"} (asparagus, bamboo shoots)                                                                       | Critical GAP: USA, 2 × 281 g/ha, soil, interval 14 days, PHI 0 days                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Number of trials: 8 trials in asparagus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Specific comments/observations: Extrapolation from asparagus to whole group is in line with Codex rules, but is not allowed in the EU. For risk assessment mean residues in rotational stem vegetables added to the STMR value (see comments below).                                                                                                                                                                                                                                                                          |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRL is acceptable considering the ongoing discussion on the toxicological properties for IN‐WR791                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Broccoli                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (broccoli) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + In‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                          |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cabbages, Head                                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (head cabbage) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + In‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cauliflower                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (cauliflower) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + In‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                       |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Citrus juice                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                               | The processing factor of \< 0.2 derived from 2 processing studies. Residues of parent and metabolites were below the LOQ. No EU MRLs are set for citrus juice                                                                                                                                                                                                                                                                                                                                                                 |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Garlic                                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (bulb onion) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + In‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                        |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Kumquats (whole fruit)                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leek                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (leek) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + In‐SXS67                                                                                                                                                                                                                                                                            |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Onion, bulb                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (bulb onion) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + IN‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                        |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Spring onion                                                                          | ** **                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 0.01[\*](#efs25797-note-0181){ref-type="fn"}                                                                                                  | The STMR value derived by 2016 JMPR in primary crop (spring onion) was updated, adding the residues observed in rotational crops, i.e. stem vegetables (0.056 mg/kg). The STMR value refers to the total residues of oxathiapiprolin + IN‐E8S72 + IN‐SXS67. It is unclear why in this case residues in rotational [stem]{.ul} vegetables group were considered, instead of leafy vegetables (0.33 mg/kg)                                                                                                                      |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                                  | JMPR accounted for the presence of metabolites IN‐E8S72 and IN‐SXS67 which are metabolites expected in rotational crops by adding a constant residue concentration of these two metabolites (expressed as parent) to the residue concentration measured in primary crops. These constant values ranged from 0.33 mg/kg for leafy vegetables to 0.056 for stem vegetables and cereal grains. Using the risk assessment values derived by JMPR is therefore leading to higher exposure compared to the EU residue definition |                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
+---------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue; MRL: maximum residue level; CXL: Codex Maximum Residue Limit; MS: Member State; PF: processing factor; LOQ: limit of quantification; NEU: northern European Union; SEU: southern European Union; DB: Dietary Burden.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.25.5. Consumer risk assessment {#efs25797-sec-0178}

###### 

Summary of the consumer risk assessment

+-------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                               | Chronic exposure assessment                                                                                                                                                                                                                            | Comments on JMPR exposure assessment                                                                                                                                                                                                                  |
+=========================================================================+========================================================================================================================================================================================================================================================+=======================================================================================================================================================================================================================================================+
| **RA assumptions:**                                                     | **RA assumptions:**                                                                                                                                                                                                                                    | **Specific comments:**                                                                                                                                                                                                                                |
|                                                                         |                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                       |
| Short‐term risk assessment was not undertaken as no ARfD is established | An indicative long‐term risk assessment was performed using PRIMo rev.3.                                                                                                                                                                               | The JMPR exposure assessment is more conservative, as it also considers the contribution of oxathiapiprolin metabolites E8S72 and IN‐SXS67. In addition, the residue accumulation in primary commodities from the crop rotation is taken into account |
|                                                                         |                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                       |
|                                                                         | The EU MRLs as established for oxathiapiprolin in Regulation (EC) No 2017/1016 were used as input values. For those commodities for which the CXL proposal is higher than the existing EU MRL, the STMR value proposed by JMPR was used as input value |                                                                                                                                                                                                                                                       |
|                                                                         |                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                       |
|                                                                         | Further refinements of the calculation would be possible. The calculation is indicative, awaiting the assessment of the toxicological data for metabolite IN‐WR791. The EU ADI was used                                                                |                                                                                                                                                                                                                                                       |
+-------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| ** **                                                                   | **Results:**                                                                                                                                                                                                                                           | **Results:**                                                                                                                                                                                                                                          |
|                                                                         |                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                       |
|                                                                         | No long‐term consumer health risk was identified                                                                                                                                                                                                       | Long‐term exposure:                                                                                                                                                                                                                                   |
|                                                                         |                                                                                                                                                                                                                                                        |                                                                                                                                                                                                                                                       |
|                                                                         | The overall chronic exposure accounted for 3% of the ADI                                                                                                                                                                                               | 0% of the ADI                                                                                                                                                                                                                                         |
+-------------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; MRL: maximum residue level; CXL: Codex Maximum Residue Limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PRIMo: (EFSA) Pesticide Residues Intake Model; ADI: acceptable daily intake.

John Wiley & Sons, Ltd

5.26. Ethiprole (304) R,T {#efs25797-sec-0179}
-------------------------

### 5.26.1. Background information {#efs25797-sec-0180}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | UK                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved            | Never notified and authorised in the EU                                                                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | ongoing                 | Application for setting of an import tolerance in rice (EMS: UK)                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded.          | Harmonised classification for CMR -- Annex VI: no entry in Annex VI                                                                                                                                               |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EU Peer Review proposal for CMR: not conducted                                                                                                                                                                    |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[a](#efs25797-note-0850){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.26.2. Toxicological reference values {#efs25797-sec-0181}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-------------------+------------------------+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable |                   |                        |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+================+===================+========================+
| **ADI**                | 0.005 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                        | JMPR (2018)   | --             | No agreed EU ADI  | No comparison possible |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-------------------+------------------------+
| **ARfD**               | 0.005 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                | JMPR (2018)   | --             | No agreed EU ARfD | No comparison possible |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-------------------+------------------------+
| **Conclusion/comment** | JMPR proposes to apply the ADI and the ARfD to ethiprole, ethiprole‐amide and ethiprole‐sulfone, expressed as ethiprole. The substance has not been assessed in Europe                                                                                                                                                                                                                                                                                        |               |                |                   |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                |                   |                        |
|                        | The assessment of an import tolerance application under Article 10 is ongoing. The main data gaps identified were the hazard assessment of the ED potential of ethiprole, the assessment of classification and labelling of ethiprole regarding carcinogenicity and reproductive toxicity and the assessment of the developmental neurotoxicity potential of ethiprole (including assessment of published one generation developmental neurotoxicity in mice) |               |                |                   |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                |                   |                        |
|                        | Data gaps were identified regarding the assessment of the clastogenic and aneugenic potential of RPA 112916 and clarifications on whether RPA097973 is covered by parent                                                                                                                                                                                                                                                                                      |               |                |                   |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                |                   |                        |
|                        | In the framework of the import tolerance application, the EMS proposed an ADI of 0.005 mg/kg bw per day and an ARfD of 0.03 mg/kg bw. As long as the data gaps are not sufficiently addressed, a conclusion on EU TRV is pending. EFSA noted that the published one generation developmental neurotoxicity in mice might trigger lower reference values as the one proposed by JMPR (this study seems not to be available to JMPR)                            |               |                |                   |                        |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------+-------------------+------------------------+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose.
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### 5.26.3. Residue definitions {#efs25797-sec-0182}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                   | JMPR evaluation                                                                                                                                                                                                                                                                         | EU evaluation                                                                                                                                                         | RDs comparable |
+=========================+===================================================================================================================================================================+=========================================================================================================================================================================================================================================================================================+=======================================================================================================================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                    | Ethiprole                                                                                                                                                                                                                                                                               | Ethiprole (no specific residue definition reported in Regulation (EC) No 396/2005; thus, the default residue definition containing parent compound only is applicable | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of ethiprole and 5‐amino‐1‐(2,6‐dichloro‐4‐trifluoromethylphenyl)‐4‐ethylsulfonylpyrazole‐3‐carbonitrile (ethiprole‐sulfone), expressed as parent equivalents | Ethiprole (no specific residue definition reported in Regulation (EC) No 396/2005; thus, the default residue definition containing parent compound only is applicable                                                                                                                   | No                                                                                                                                                                    |                |
|                         |                                                                                                                                                                   |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                       |                |
|                         | The residue is fat soluble                                                                                                                                        | Fat solubility currently not specified in the EU legislation. However, considering the findings of animal metabolism studies, it is recommended to classify the residues as fat soluble                                                                                                 |                                                                                                                                                                       |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                    | Sum of ethiprole, 5‐amino‐1‐\[2,6‐dichloro‐4‐(trifluoromethyl)phenyl\]‐4‐(ethylsulfinyl)‐1*H*‐pyrazole‐3‐carboxamide (ethiprole‐amide) and 5‐amino‐1‐(2,6‐dichloro‐4‐trifluoromethylphenyl)‐4‐ethylsulfonylpyrazole‐3‐carbonitrile (ethiprole‐sulfone), expressed as parent equivalents | RD proposed in MRL application for rice (assessment ongoing): Sum of ethiprole and RPA097973 (ethiprole sulfone), expressed as ethiprole                              | No             |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| Animal products         | Sum of ethiprole and 5‐amino‐1‐(2,6‐dichloro‐4‐trifluoromethylphenyl)‐4‐ethylsulfonylpyrazole‐3‐carbonitrile (ethiprole‐sulfone), expressed as parent equivalents | No residue definition set at EU level                                                                                                                                                                                                                                                   | No comparison possible                                                                                                                                                |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | Metabolism in plants was investigated in rice, sweet pepper and cotton as well as in rotational crops. Metabolism studies in goats and poultry available          |                                                                                                                                                                                                                                                                                         |                                                                                                                                                                       |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.
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### 5.26.4. Codex MRL proposals {#efs25797-sec-0183}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                                                                                                   | EU MRL                                               | Comment                                                                                                                                                                                                                                                                                                                                                                                           |
+===============================================+======================================================================================================================+======================================================+===================================================================================================================================================================================================================================================================================================================================================================================================+
| Coffee beans                                  | **0.07**                                                                                                             | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | Critical GAP: BR, 2 × 500 g/ha, 60‐day PHI                                                                                                                                                                                                                                                                                                                                                        |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Number of trials: 10 GAP‐compliant trials                                                                                                                                                                                                                                                                                                                                                         |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Sufficiently supported by data: if it is confirmed that the trials are valid, yes                                                                                                                                                                                                                                                                                                                 |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Specific comments/observations:                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Coffee beans, roasted                         | 0.2                                                                                                                  |                                                      | The MRL proposal was derived from the trials in coffee beans (green) using PF derived from one processing study (1.95) and rounding to the next MRL class                                                                                                                                                                                                                                         |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | No MRLs are set in the EU for roasted coffee beans                                                                                                                                                                                                                                                                                                                                                |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | **0.1**                                                                                                              | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | JMPR calculated the dietary burden and estimated the expected residues in animal commodities using a feeding study (lactating cows). The dietary burden calculation was not reported in Annex 6 of the JMPR report to verify the calculations                                                                                                                                                     |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | According to the information provided in the JMPR report, the MRL proposal is plausible                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | **0.05**                                                                                                             | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | JMPR calculated the dietary burden and estimated the expected residues in animal commodities using a feeding study (laying hens). The dietary burden calculation was not reported in Annex 6 of the JMPR report to verify the calculations                                                                                                                                                        |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | According to the information provided in the JMPR report, the MRL proposal is plausible                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | **0.15**                                                                                                             | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | **0.15(fat)**                                                                                                        | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                          |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | For muscle, no MRL proposal was derived by JMPR. From the feeding study, EFSA assumes that a value of 0.03 mg/kg would be appropriate for muscle                                                                                                                                                                                                                                                  |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                     | 0.5                                                                                                                  | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | Usually, the MRL for milk fat would be expected to be 25 times higher than the MRL in milk. Thus, for milk fat, a value of 0.375 mg/kg would be derived using the default approach. In the current case, JMPR derived the MRL for milk fat from one samples of the feeding study where milk cream was analysed. The milk fat value was derived by using an assumption on the fat content of cream |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | EFSA is of the opinion that the approach used by JMPR is not appropriate. A slightly lower MRL of 0.4 mg/kg would be sufficient for milk cream                                                                                                                                                                                                                                                    |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | **0.015**                                                                                                            | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | **0.05 (fat)**                                                                                                       | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                              |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | For muscle, no MRL proposal was derived by JMPR. From the feeding study, EFSA assumes that a value of \< 0.02 mg/kg would be appropriate for poultry muscle                                                                                                                                                                                                                                       |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal of                       | **0.05**                                                                                                             | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fats                                  | **0.05**                                                                                                             | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice                                          | 3                                                                                                                    | --                                                   | In the EU, MRLs are set for husked rice, but not for paddy rice                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Critical GAP: TH, 94 g/ha (foliar application), 14‐day PHI; number of applications not specified                                                                                                                                                                                                                                                                                                  |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Number of trials: 12 trials with 3 or 4 × 91 to 110 g/ha (foliar applications), PHI 14--16 days                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, husked                                  | **1.5**                                                                                                              | Default 0.01[\*](#efs25797-note-0187){ref-type="fn"} | MRL for husked rice was derived from residue trials in rice, using a PF derived from one processing study (0.36) and rounding the result up                                                                                                                                                                                                                                                       |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | If the validity of the residue trials is confirmed, the MRL proposal would not be acceptable, because the number of processing studies is insufficient. In the EU at least 2 processing studies are required to derive a robust processing factor                                                                                                                                                 |
|                                               |                                                                                                                      |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                               |                                                                                                                      |                                                      | Furthermore, the proposed MRL is too high: the results of the residue trials should be recalculated to husked rice individually; these residue concentrations should be used in the MRL calculator to derive the MRL proposal. Following this approach, the derived MRL would be 0.8 mg/kg                                                                                                        |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice, polished                                | 0.4                                                                                                                  |                                                      | One processing study was provided (PF 0.11)                                                                                                                                                                                                                                                                                                                                                       |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                          | If risk managers decide to accept the Codex MRLs for animal products, the EU residue definition needs to be modified |                                                      |                                                                                                                                                                                                                                                                                                                                                                                                   |
+-----------------------------------------------+----------------------------------------------------------------------------------------------------------------------+------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; MRL: maximum residue level; PF: processing factor; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

Indicates that the input value is proposed at the limit of quantification.
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### 5.26.5. Consumer risk assessment {#efs25797-sec-0184}

###### 

Summary of the consumer risk assessment

+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                               | Chronic exposure assessment                                                                                                                                                                              | Comments on JMPR exposure assessment |
+=========================================================================================================================================================================================================+==========================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                     | **RA assumptions:**                                                                                                                                                                                      | **Specific comments**                |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
| An indicative short‐term dietary risk assessment was performed for coffee beans, rice husked and the animal products for which MRL proposals were derived by JMPR                                       | EFSA calculated an indicative long‐term exposure, using the existing (default) EU MRLs and the STMR derived for the commodities under assessment                                                         | --                                   |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
| The JMPR ARfD was used.                                                                                                                                                                                 | The JMPR ADI was used                                                                                                                                                                                    |                                      |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
| The risk assessment is indicative, pending a detailed evaluation of the toxicological properties of the active substance and a final conclusion on the residue definitions(Art. 10 application on rice) | The risk assessment is indicative, pending a detailed evaluation of the toxicological properties of the active substance and a final conclusion on the residue definitions (Art. 10 application on rice) |                                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                            | **Results:**                                                                                                                                                                                             | **Results:**                         |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
| No short‐term exposure concern was identified (35% of the ARfD for rice)                                                                                                                                | No long‐term consumer health risk was identified                                                                                                                                                         | Long‐term exposure:                  |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                         | The overall chronic exposure accounted for 29% of the ADI                                                                                                                                                | 1--6% of the ADI                     |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                         | The highest contributor was milk (13% of the ADI)                                                                                                                                                        | Short‐term exposure:                 |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          |                                      |
|                                                                                                                                                                                                         |                                                                                                                                                                                                          | 80% of the ARfD                      |
+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; MRL: maximum residue level; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; STMR: supervised trials median residue; ADI: acceptable daily intake.
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5.27. Fenpicoxamid (XDE‐777) (305) R,T {#efs25797-sec-0185}
--------------------------------------

### 5.27.1. Background information {#efs25797-sec-0186}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | UK                      | Co‐RMS: FR                                                                                                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                | Commission Implementing Regulation (EU) 2018/1265[a](#efs25797-note-0190){ref-type="fn"}                                                                                                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"}) (including MRL application)                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | Bananas, rye, wheat, assessed together with the application for approval, see EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"})                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not met.                | Harmonised classification and labelling for CMR -- Annex VI: none                                                                                                                                                 |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        | ED: not concluded       | EU Peer Review proposal for CMR: none                                                                                                                                                                             |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0990){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) 2018/1265 of 20 September 2018 approving the active substance fenpicoxamid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011. OJ L 238, 21.9.2018, p. 77--80.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.27.2. Toxicological reference values {#efs25797-sec-0187}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------+-----------------------+---------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | EU evaluation                              | TRV comparable        |                                                                                             |     |
+========================+=========================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+============================================+=======================+=============================================================================================+=====+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | JMPR (2018) (18‐month mouse study, SF 100) | 0.05 mg/kg bw per day | EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"}) (18‐month mouse study, UF 100)           | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       | (European Commission, [2018b](#efs25797-bib-0147){ref-type="ref"})                          |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------+-----------------------+---------------------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | JMPR (2018)                                | 1.8 mg/kg bw          | EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"}) (Developmental study in rabbits, UF 100) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       | (European Commission, [2018b](#efs25797-bib-0147){ref-type="ref"})                          |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------+-----------------------+---------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | Same ADI based on a NOAEL of 5.3 mg/kg bw per day from the 18‐months mouse carcinogenicity study based on liver changes observed at 32 mg/kg bw per day. However, JMPR takes also into consideration an 'equivocal increase in the incidence of adenomas at 32 mg/kg bw per day', while the EU peer review concluded that the incidence of adenomas was not clearly dose‐related and within historical control data. Therefore, this finding was not considered for the NOAEL setting                                   |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | Regarding the ARfD derivation, the EU peer review considered the maternal toxicity observed in the rabbit developmental study (i.e. a body weight loss occurring during the first days of the study (with subsequent recovery)) relevant for the derivation of the ARfD. Therefore, the agreed ARfD was 1.8 mg/kg bw based on the maternal NOAEL of 177 mg/kg bw per day from the rabbit developmental toxicity study                                                                                                   |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | It is also noted that for the same rabbit developmental toxicity study, JMPR proposes a NOAEL for maternal toxicity at 52.8 mg/kg bw per day based on decreased body weight gain, feed consumption and faecal output at 177 mg/kg bw per day, while the EU peer review did not consider the effects observed at this dose as adverse                                                                                                                                                                                    |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | Concerning the metabolites considered during the **EU peer review**:                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | --for X642188, same assessment for acute toxicity and Ames test as in JMPR report--for X12326349, the reference values of the parent are applicable, since it is considered a major rat metabolite, while in the **JMPR report** it is mentioned that **insufficient information** was available--for X12019520, X12335723 and X12264475, further data are needed to exclude a genotoxic potential--for X12314005, X12019520, X12264475, and X12335723 further data may be needed to perform a consumer risk assessment |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | On the contrary, JMPR uses the TTC approach for X12314005, X12264475, X12335723 for the assessment of chronic toxicity                                                                                                                                                                                                                                                                                                                                                                                                  |                                            |                       |                                                                                             |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                            |                       |                                                                                             |     |
|                        | The metabolite X696872 is mentioned in the JMPR report but not in the EU peer review                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                            |                       |                                                                                             |     |
+------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------+-----------------------+---------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; UF: uncertainty factor; NOAEL: no observed adverse effect level; TTC: threshold of toxicological concern.
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### 5.27.3. Residue definitions {#efs25797-sec-0188}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                 | JMPR evaluation                                                 | EU evaluation                                                                | RDs comparable |
+=========================+=================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================+==============================================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                  | Fenpicoxamid                                                    | [Regulation 396/2005:]{.ul}                                                  | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 | Fenpicoxamid                                                                 |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| Animal products         | No residue definition was derived by JMPR                                                                                                                                                                                                                                                                                                                                                       | Regulation 396/2005:                                            | Comparison not relevant                                                      |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | Ruminants: X12326349 expressed as fenpicoxamid                  |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | The residue is not fat soluble                                  |                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                  | Fenpicoxamid                                                    | Peer review EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"}): Fenpicoxamid | Yes            |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| Animal products         | No residue definition was derived by JMPR                                                                                                                                                                                                                                                                                                                                                       | Peer review EFSA ([2018d](#efs25797-bib-0093){ref-type="ref"}): | Comparison not relevant                                                      |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | Ruminants:                                                      |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | X12326349 expressed as fenpicoxamid                             |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | Poultry: Not necessary (in the                                  |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 | view of the representative use)                                 |                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+
| **Conclusion/comments** | The same metabolism studies in plant were submitted and assessed under EU peer review process. The residue definition for enforcement and risk assessment in plant proposed by the JMPR are comparable with the EU proposals                                                                                                                                                                    |                                                                 |                                                                              |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                 |                                                                 |                                                                              |                |
|                         | Under processing condition simulating (pasteurisation, sterilisation, boiling), fenpicoxamid degraded completely into **X12314005, X12016520, X12335723, and X12264475**. Therefore, for processed commodities, the risk assessment residue definition was provisional proposed as fenpicoxamid, X12019520, X12314005, X12335723, X12264475 (EFSA, [2018d](#efs25797-bib-0093){ref-type="ref"}) |                                                                 |                                                                              |                |
+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------+------------------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 5.27.4. Codex MRL proposals {#efs25797-sec-0189}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------+--------------------------------------------------+
| Commodity        | Codex MRL proposal                                                                                                                                                                                                                                                                                              | EU MRL                       | Comment                                          |
+==================+=================================================================================================================================================================================================================================================================================================================+==============================+==================================================+
| Banana           | 0.15                                                                                                                                                                                                                                                                                                            | 0.15 proposed in peer review | Critical GAP: 3 × 0.05 kg/ha, PHI 8 days         |
|                  |                                                                                                                                                                                                                                                                                                                 |                              |                                                  |
|                  |                                                                                                                                                                                                                                                                                                                 |                              | Number of trials: 11                             |
|                  |                                                                                                                                                                                                                                                                                                                 |                              |                                                  |
|                  |                                                                                                                                                                                                                                                                                                                 |                              | Sufficiently supported by data: Yes              |
|                  |                                                                                                                                                                                                                                                                                                                 |                              |                                                  |
|                  |                                                                                                                                                                                                                                                                                                                 |                              | Specific comments/observations:                  |
|                  |                                                                                                                                                                                                                                                                                                                 |                              |                                                  |
|                  |                                                                                                                                                                                                                                                                                                                 |                              | Conclusion: The proposed Codex MRL is acceptable |
+------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------+--------------------------------------------------+
| General comments | The same residue data set was submitted and evaluated under peer review process. Although, no data on processed bananas were available, since the residue levels in peeled bananas were all below 0.01 mg/kg, currently, not further investigation is necessary. The proposed MRL is based on un‐bagged bananas |                              |                                                  |
+------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------+--------------------------------------------------+

PHI: preharvest interval; MRL: maximum residue limit; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GAP: Good Agricultural Practice.

John Wiley & Sons, Ltd

### 5.27.5. Consumer risk assessment {#efs25797-sec-0190}

###### 

Summary of the consumer risk assessment

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+
| Acute exposure assessment                                                                                                              | Chronic exposure assessment                                                                                                                                                                                             | Comments on JMPR exposure assessment         |
+========================================================================================================================================+=========================================================================================================================================================================================================================+==============================================+
| **RA assumptions:**                                                                                                                    | **RA assumptions:**                                                                                                                                                                                                     |                                              |
|                                                                                                                                        |                                                                                                                                                                                                                         |                                              |
| The short‐term dietary risk assessment was performed for bananas peeled as outlined in Section [2](#efs25797-sec-0006){ref-type="sec"} | The most recent long‐term risk assessment (EFSA, [2018d](#efs25797-bib-0093){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for bananas |                                              |
|                                                                                                                                        |                                                                                                                                                                                                                         |                                              |
| The EU ARfD was used                                                                                                                   |                                                                                                                                                                                                                         |                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+
| **Results:**                                                                                                                           | **Results:**                                                                                                                                                                                                            | **Results:**                                 |
|                                                                                                                                        |                                                                                                                                                                                                                         |                                              |
| No short‐term exposure concern was identified for bananas (0.05% of the ARfD)                                                          | No long‐term consumer health risk was identified                                                                                                                                                                        | Long‐term exposure: 0--0.2% of the ADI       |
|                                                                                                                                        |                                                                                                                                                                                                                         |                                              |
|                                                                                                                                        | The overall chronic exposure accounted for 1% of the ADI                                                                                                                                                                | Short‐term exposure: not applicable since no |
|                                                                                                                                        |                                                                                                                                                                                                                         |                                              |
|                                                                                                                                        | The contribution of bananas peeled to the exposure was 0.11% of the ADI (NL toddler)                                                                                                                                    | ARfD was considered necessary by JMPR        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; ADI: acceptable daily intake; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

5.28. Fluazinam (306) R,T {#efs25797-sec-0191}
-------------------------

### 5.28.1. Background information {#efs25797-sec-0192}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                                  |
+========================================================================================================================================+=========================+=======================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | AT                      |                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                | Commission Directive 2008/108/EC[a](#efs25797-note-0197){ref-type="fn"}                                                                                                                                               |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2008a](#efs25797-bib-0006){ref-type="ref"})                                                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Yes, see comments       | EFSA ([2015p](#efs25797-bib-0059){ref-type="ref"})                                                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | Blueberries: EFSA ([2016c](#efs25797-bib-0066){ref-type="ref"})                                                                                                                                                       |
|                                                                                                                                        |                         |                                                                                                                                                                                                                       |
|                                                                                                                                        |                         | Onions, shallots and garlic: EFSA ([2017f](#efs25797-bib-0083){ref-type="ref"})                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonized classification and labelling for CMR -- Annex VI: Toxic for reproduction cat. 2                                                                                                                            |
|                                                                                                                                        |                         |                                                                                                                                                                                                                       |
|                                                                                                                                        |                         | Peer review proposal for CMR: Toxic for reproduction cat. 2.                                                                                                                                                          |
|                                                                                                                                        |                         |                                                                                                                                                                                                                       |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0851){ref-type="fn"}): not yet available |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Directive 2008/108/EC of 26 November 2008 amending Council Directive 91/414/EEC to include flutolanil, benfluralin, fluazinam, fuberidazole and mepiquat as active substances. OJ L 317, 27.11.2008, p. 6--13.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.28.2. Toxicological reference values {#efs25797-sec-0193}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------+------------------------+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                    | EU evaluation | TRV comparable        |                                                                           |                        |
+========================+====================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+===========================================================================+========================+
| **ADI**                | Not established                                                                                                                                                                                                                                                                                                                                                                    | JMPR (2018)   | 0.01 mg/kg bw per day | EFSA ([2008a](#efs25797-bib-0006){ref-type="ref"})                        | No comparison possible |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | (2‐yr mouse,                                                              |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | supported by 1‐yr                                                         |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | dog, UF 100)                                                              |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | Same in European Commission ([2011c](#efs25797-bib-0135){ref-type="ref"}) |                        |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------+------------------------+
| **ARfD**               | Not established                                                                                                                                                                                                                                                                                                                                                                    | JMPR (2018)   | 0.07 mg/kg bw         | EFSA ([2008a](#efs25797-bib-0006){ref-type="ref"}) (rabbit,               | No comparison possible |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | developmental, UF 100)                                                    |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       | Same in European Commission ([2011c](#efs25797-bib-0135){ref-type="ref"}) |                        |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------+------------------------+
| **Conclusion/comment** | JMPR did not derive toxicological reference values because information on the level of impurity B‐1457 (5‐chloro‐*N*‐(3‐chloro‐5‐trifluoromethyl‐2‐pyridyl)‐α,α,α‐trifluoro‐4,6‐dinitro‐o‐toluidine) in batches used for toxicity studies was not reported                                                                                                                         |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        | The FAO specification for fluazinam limits the level of this impurity to 0.3%                                                                                                                                                                                                                                                                                                      |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        | In the EU, the maximum concentration of this impurity is specified in Directive 2008/108/EC as not more than 2 g/kg (0.2%), based on the maximum amount present in the batches used for key toxicological studies                                                                                                                                                                  |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        | The RMS informed EFSA that in the framework of the renewal of the approval, the RMS will propose the same ADI/ARfD as currently in place                                                                                                                                                                                                                                           |               |                       |                                                                           |                        |
|                        |                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                           |                        |
|                        | The metabolite TFAA has been discussed during the first EU peer review (EFSA, [2008a](#efs25797-bib-0006){ref-type="ref"}), and its toxicological profile could not be concluded on the basis of the available data. It was also noted that a new assessment including a developmental toxicity study were provided after the peer review (and will be considered for the renewal) |               |                       |                                                                           |                        |
+------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+---------------------------------------------------------------------------+------------------------+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose.

John Wiley & Sons, Ltd

### 5.28.3. Residue definitions {#efs25797-sec-0194}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                 | JMPR evaluation                                                                                     | EU evaluation                                                          | RDs comparable         |
+=========================+=================================================================================================================================================================================================================================================================+=====================================================================================================+========================================================================+========================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                  | Fluazinam                                                                                           | EU Reg. 2018/70: fluazinam                                             | Yes                    |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+
| Animal products         | No proposal; due to lack of information on storage stability, the validity of the livestock metabolism studies cannot be concluded                                                                                                                              | EU Reg. 2018/70: fluazinam                                                                          | No comparison possible                                                 |                        |
|                         |                                                                                                                                                                                                                                                                 |                                                                                                     |                                                                        |                        |
|                         |                                                                                                                                                                                                                                                                 | Art 12 MRL review (EFSA, [2015p](#efs25797-bib-0059){ref-type="ref"}): No proposal, MRLs not needed |                                                                        |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                  | No proposal                                                                                         | Art 12 MRL review (EFSA, [2015p](#efs25797-bib-0059){ref-type="ref"}): | No comparison possible |
|                         |                                                                                                                                                                                                                                                                 |                                                                                                     |                                                                        |                        |
|                         |                                                                                                                                                                                                                                                                 |                                                                                                     | Sum of fluazinam, AMPA‐fluazinam and AMGT, expressed as fluazinam      |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+
| Animal products         | No proposal                                                                                                                                                                                                                                                     | Art 12 MRL review (EFSA, [2015p](#efs25797-bib-0059){ref-type="ref"}): No proposal--MRLs not needed | Not relevant                                                           |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+
| **Conclusion/comments** | Proposed EU enforcement RD for processed commodities: sum of fluazinam, AMPA‐fluazinam and AMGT, expressed as fluazinam (tentative) (processed commodities subject to hydrolysis conditions such as boiling, baking, cooking, pasteurisation and sterilisation) |                                                                                                     |                                                                        |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+------------------------------------------------------------------------+------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.28.4. Codex MRL proposals {#efs25797-sec-0195}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity            | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                       |
+======================+==========================================================================================================================================================================================================================================================================================================================================================================================================================+
| **General comments** | JMPR did not derive MRL proposals, due to serious deficiencies of the dossier. The sponsor did not submit critical information on the levels of a toxicologically relevant impurity in batches used in the toxicity studies. The Meeting was aware that this information had been made available to a number of regulatory authorities. **The Meeting was therefore unable to proceed with the evaluation of fluazinam** |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                      | No Maximum residue levels are recommended, nor are levels estimated for use in long‐term and acute dietary exposure assessments as the Meeting could not reach a conclusion on the residue definition for dietary risk assessment for plant commodities                                                                                                                                                                  |
|                      |                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                      | In addition, the Meeting could not reach a conclusion on the residue levels of TFAA in the crops considered in this Meeting                                                                                                                                                                                                                                                                                              |
+----------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.28.5. Consumer risk assessment {#efs25797-sec-0196}

###### 

Summary of the consumer risk assessment

+---------------------------+-----------------------------+--------------------------------------+
| Acute exposure assessment | Chronic exposure assessment | Comments on JMPR exposure assessment |
+===========================+=============================+======================================+
| **RA assumptions:**       | **RA assumptions:**         | **Specific comments:**               |
|                           |                             |                                      |
| Not relevant              | Not relevant                | Not relevant                         |
+---------------------------+-----------------------------+--------------------------------------+
| **Results:**              | **Results:**                | **Results:**                         |
|                           |                             |                                      |
| Not relevant              | Not relevant                | Not relevant                         |
+---------------------------+-----------------------------+--------------------------------------+

RD: residue definition; RA: risk assessment.

John Wiley & Sons, Ltd

5.29. Norflurazon (308) R,T {#efs25797-sec-0197}
---------------------------

### 5.29.1. Background information {#efs25797-sec-0198}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | --                      | None                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Not approved            | Commission Regulation (EC) No 2076/2002[a](#efs25797-note-0896){ref-type="fn"}                                                                                                                                    |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | No                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                                                                 |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EU Peer Review proposal for CMR: no assessment at EU level is available                                                                                                                                           |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0897){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Regulation (EC) No 2076/2002 of 20 November 2002 extending the time period referred to in Article 8(2) of Council Directive 91/414/EEC and concerning the non‐inclusion of certain active substances in Annex I to that Directive and the withdrawal of authorisations for plant protection products containing these substances. OJ L 319, 23.11.2002, p. 3--11.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.29.2. Toxicological reference values {#efs25797-sec-0199}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------------------------------------------+----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | EU evaluation | TRV comparable                                     |    |
+========================+==================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+====================================================+====+
| **ADI**                | 0.005 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | JMPR (2018)   | No toxicological information available at EU level | No |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------------------------------------------+----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | JMPR (2018)   | No                                                 |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------------------------------------------+----+
| **Conclusion/comment** | Norflurazon is not approved in the EU and TRV at EU level are not available. It is noted by the JMPR that the database was of poor quality. An additional uncertainty factor of 3 was applied to setting of the ADI because of poor quality. It is noted that all relevant endpoints appear to be covered. At EU level, the setting of a reference value using an additional factor to compensate for the poor quality of the data package might not be acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |               |                                                    |    |
|                        | According to 2018 JMPR, the toxicity of desmethyl norflurazon and its conjugates and 6‐methyl sulfoxide norflurazon are covered by the parent compound, as these metabolites were identified in significant amounts in animal studies. Desmethyl norflurazon was found in rat urine (max. 7%); 6‐methyl sulfoxide norflurazon appeared in rat urine at greater than 10%. During the peer review, a trigger of 10% is used to consider a metabolite covered by the parent compound. The JMPR monograph does not provide additional explanations. In this case, desmethyl norflurazon was present at 7% in urine                                                                                                                                                                                                                                                                                                                                                                   |               |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |               |                                                    |    |
|                        | For the metabolite NOA‐452075 (ethanolamine conjugate) (major metabolite in milk accounting 17% TRR), no specific data were available on the toxicity. The JMPR estimated exposure to this metabolite would be well below the toxicological threshold of concern (TTC) (1.5 μg/kg bw) and therefore, based on the TTC approach, the JMPR concluded that NOA‐452075 need not be included in the residue definition for dietary risk assessment for animal commodities. According to EFSA, the genotoxicity of this metabolite should be addressed first (it is note reported in the monograph if QSARs for genotoxicity were used). If the genotoxic potential of this metabolite can be excluded, the sum of the exposure for all non‐toxicological characterised metabolites should be compared to the TTC. It is noted that currently the TTC is not used at European Level for assessing residues metabolites since there is no agreement yet on how this tool should be used |               |                                                    |    |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |               |                                                    |    |
|                        | The metabolite 5,6‐dihydrodiol desmethyl norflurazon (major metabolite in milk accounting 22% TRR, 0.26 mg eq/kg) was identified in rat and goat matrices; however, an explicit conclusion on whether this metabolite is covered by the parent compound is not provided                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |               |                                                    |    |
+------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+----------------------------------------------------+----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; TRR: total radioactive residues; QSAR: quantitative structure--activity relationship; eq: residue expressed as a.s. equivalent.

John Wiley & Sons, Ltd

### 5.29.3. Residue definitions {#efs25797-sec-0200}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR evaluation                                                                              | EU evaluation                                                          | RDs comparable             |
+=========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+==============================================================================================+========================================================================+============================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Sum of norflurazon and desmethyl norflurazon, expressed as norflurazon                       | No specific residue definition.                                        | No                         |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              | Default residue definition covering parent compound only is applicable |                            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+
| Animal products         | Sum of norflurazon and desmethyl norflurazon (free and conjugated), expressed as norflurazon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | No                                                                                           |                                                                        |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         | The residue is not fat soluble                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                              |                                                                        |                            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Sum of norflurazon and desmethyl norflurazon (free and conjugated), expressed as norflurazon | --                                                                     | Comparison not appropriate |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+
| Animal products         | Sum of desmethyl norflurazon (free and conjugated)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | --                                                                                           | Comparison not appropriate                                             |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         | and 6‐methyl sulfoxide norflurazon, expressed as norflurazon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                              |                                                                        |                            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+
| **Conclusion/comments** | Plant metabolism was investigated following either soil treatment or root treatment in crops belonging to the group of fruit crops (orange), cereals/grass (maize), pulses/oilseeds (alfalfa, cotton and soya bean). Similar metabolic pathways were observed in the three crop groups where the major residues identified were norflurazon (free and conjugated) and the metabolite desmethyl norflurazon (free and conjugated). The nature of residues was investigated in crops grown as confined rotational crops representative of the groups of leafy crops (spinach), cereals/grass (maize), pulses/oilseeds (soya bean) and root crops (beet and radish), where the nature of residues was found to be similar to that observed in the primary crops following soil or root treatment                                                                                                                                                                                                                                                 |                                                                                              |                                                                        |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         | Metabolism in animals has been assessed in rats, lactating goats and laying hens where animals were dosed with phenyl ring‐ or pyridazinyl ring‐labelled norflurazon. The parent norflurazon was present in tissues at up to 9% TRR (goat fat) but was found only at low levels in other tissues and eggs (up to 2% TRR). The predominant residue in most tissue was desmethyl norflurazon (free and conjugated) which was found at around 10--25% TRR in liver, kidney and poultry muscle. Other major residues present at above 10% TRR and 0.01 mg eq/kg include 6‐methyl sulfoxide norflurazon in milk (22% TRR), deschloro desmethyl norflurazon (free and conjugated) in eggs (10% TRR) and 6‐methylsulfone desmethyl norflurazon (free and conjugated) in poultry muscle (45% TRR), poultry liver (20% TRR) and poultry fat (38% TRR). In a second high‐dose study in lactating goats, major metabolites in milk were 5,6‐dihydrodiol desmethyl norflurazon (22% TRR, 0.26 mg eq/kg) and NOA‐452075 (ethanolamine conjugate) (17% TRR) |                                                                                              |                                                                        |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         | The metabolites desmethyl norflurazon (free and conjugated) and 6‐methyl sulfoxide norflurazon were identified in the rat metabolism study and the JMPR considered these metabolites were no more toxic than norflurazon. However, in rat urine desmethyl norflurazon was not found to be a major metabolite (7%). No specific toxicity data were available for the metabolite NOA‐452075 (ethanolamine conjugate) and the JMPR applied a TTC approach. The metabolite 5,6‐dihydrodiol desmethyl norflurazon (major metabolite in milk accounting 22% TRR, 0.26 mg eq/kg) in indicated to be identified in rat and goat matrices; however, a conclusion on whether this metabolite is covered by the parent compound is not provided                                                                                                                                                                                                                                                                                                          |                                                                                              |                                                                        |                            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                              |                                                                        |                            |
|                         | Taking into account the results of the metabolism studies assessed by JMPR, EFSA recommends to set a specific residue definition for enforcement in the EU legislation, similar to the ones proposed by JMPR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                              |                                                                        |                            |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------+------------------------------------------------------------------------+----------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; TRR: total radioactive residues; eq: residue expressed as a.s. equivalent.
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### 5.29.4. Codex MRL proposals {#efs25797-sec-0201}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                         | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | EU MRL                                                 | Comment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
+===================================================================================+===================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+========================================================+====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Alfalfa fodder                                                                    | 7(DW)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | --                                                     | Critical GAP: Canada and USA, 2,200 g/ha during dormancy or after cutting, PHI 28 days, maximum application 2,200 g/ha per annum                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Number of trials: 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Specific comments/observations: The JMPR considered desmethyl norflurazon (free and conjugated) should be included in the livestock dietary burden calculation. In four trials, only free norflurazon and desmethyl norflurazon residues were measured and the JMPR applied a conversion factor of 2.2 derived from the alfalfa metabolism study to estimate the residues of total norflurazon and desmethyl norflurazon (free and conjugated). The HR/STMR derived for alfalfa forage/hay were taken into account for the dietary burden calculation of livestock |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | No MRLs are set in the EU for feed items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                          | **0.3**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | The dietary burden was calculated, including alfalfa forage and hay, rape forage, wheat forage, corn field forage/silage, corn sweet forage, rye straw, rice straw, rice grain, sorghum grain and corn field grain                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Apart from alfalfa forage and hay, the estimated residues in animal feed commodities were derived from the field rotational crop studies                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | The highest maximum dietary burden was calculated for the EU. EFSA is of the opinion that the calculations are not realistic, since wheat straw containing norflurazon is not expected to be fed to European ruminants                                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | A dairy cow feeding study was available; the calculated maximum and mean dietary burden was below the lowest feeding level                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | To estimate total residues in the dietary risk assessment residue definition, the JMPR applied a conversion factor based on the relative proportions of metabolites in the goat metabolism studies                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRLs for animal products (mammalian) are acceptable, considering the deficiencies of the dossier (see below general comments)                                                                                                                                                                                                                                                                                                                                                          |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                              | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | The dietary burden was calculated, including wheat straw, rice grain, sorghum grain and corn field grain. The estimated residues in animal feed commodities were derived from the field rotational crop studies                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | The highest dietary burden was calculated for the EU diet, with wheat straw being the main contributor. EFSA is of the opinion that the calculations are not realistic, since wheat straw containing norflurazon is not expected to be fed to European poultry                                                                                                                                                                                                                                                                                                     |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | A feeding study in laying hens was assessed by JMPR; the calculated maximum and mean dietary burden was below the lowest feeding level                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Since the poultry feeding study did not measure conjugates, the JMPR used the poultry metabolism study to estimate                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | STMRs, HRs and MRLs for poultry commodities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Residues of 6‐methylsulfoxide norflurazon and NOA‐452075 (ethanolamine conjugate) were not detected in the poultry feeding study, and for desmethyl norflurazon (free and conjugated) the highest average concentration of was 0.085 mg/kg in liver. Since the highest dietary burden was approximately 50‐fold lower than the metabolism study does, the JMPR concluded that residues of these metabolites are not expected in poultry commodities                                                                                                                |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        | Conclusion: It is recommended to discuss with MS whether the proposed Codex MRLs for poultry products are acceptable, considering the deficiencies of the dossier (see below general comments)                                                                                                                                                                                                                                                                                                                                                                     |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)                                                 | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                     | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                             | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on edible offal (mammalian)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fat                                                                       | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                      | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, Edible offal of                                                          | **0.02** [\*](#efs25797-note-0206){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | See comments on eggs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Wheat, Subgroup of (includes all commodities in this subgroup)                    | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize cereals, Subgroup of (includes all commodities in this subgroup)            | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sorghum grain and Millet, Subgroup of (includes all commodities in this subgroup) | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Rice cereals, Subgroup of (includes all commodities in this subgroup)             | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leafy greens, Subgroup of (includes all commodities in this subgroup)             | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leaves of Brassicaceae, Subgroup of (includes all commodities in this subgroup)   | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Root vegetables, Subgroup of (includes all commodities in this subgroup)          | --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 0.01[\*](#efs25797-note-0206){ref-type="fn"}           | Specific comments/observations: The JMPR concluded the data were not sufficient to estimate MRLs for rotational crops. The field rotational crop studies were used to estimate consumer dietary exposure and livestock dietary burdens                                                                                                                                                                                                                                                                                                                             |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Conclusion: Since no Codex MRL proposal was made by JMPR, there is no need to take an EU position                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                              | Overall, the following deficiencies of the dossier were noted which should be taken into account by risk managers to decide whether the proposed Codex MRLs are acceptable: the toxicological studies used to derive the ADI were of low quality; to compensate for outdated (non‐GLP) studies an additional factor of 3 was used;the applicability of the TRV to the metabolite desmethyl norflurazon is not sufficiently demonstrated (the metabolite was not a major metabolite in urine);data to exclude genotoxicity for a major milk metabolite (NOA‐452075) was not reported;the rotational crop studies are not sufficient to predict in a reliable manner the residues in feed (used for dietary burden calculation) and food;the calculation of the dietary burden for livestock is not reliable (see previous bullet point) and not realistic (EU livestock is not expected to be exposed to norflurazon via crops such as alfalfa forage, cereal straw, rape forage etc. containing residues mostly via uptake from soil (rotational crops), because these commodities are not traded |                                                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
+-----------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; PHI: preharvest interval; STMR: supervised trials median residue; HR: highest residue; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; GLP: Good Laboratory Practice; TRV: toxicological reference values.

Indicates that the input value is proposed at the limit of quantification.
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### 5.29.5. Consumer risk assessment {#efs25797-sec-0202}

###### 

Summary of the consumer risk assessment

+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                 | Chronic exposure assessment                                                                                                                                                                                                                                                                                                                    | Comments on JMPR exposure assessment                                                                                                                                                          |
+===========================================================================================================================================================================================================================================+================================================================================================================================================================================================================================================================================================================================================+===============================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                       | **RA assumptions:**                                                                                                                                                                                                                                                                                                                            | **Specific comments:**                                                                                                                                                                        |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
| An indicative short‐term dietary risk assessment was performed for mammalian fats, meat and edible offal, poultry fat, meat and edible offal, eggs and milks as outlined in Section [2](#efs25797-sec-0006){ref-type="sec"}               | An indicative long‐term risk assessment was performed using the approach as outlined in Section 'Assessment', using the STMR values derived by JMPR for mammalian fats, meat and edible offal, poultry fat, meat and edible offal, eggs and milks. For other commodities EFSA applied the default MRL according to Art 18(1)(b) Reg. 396/ 2005 | For rotational crops, data were not sufficient to estimate MRLs however the JMPR used STMR and HR values derived from the field rotational crop studies to estimate consumer dietary exposure |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
| The JMPR ARfD was used                                                                                                                                                                                                                    | The JMPR ADI was used                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                               |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
| The calculation is indicative, because no decision has been taken yet at EU level on the residue definition and the ARfD                                                                                                                  | The calculation is indicative, because no decision has been taken yet at EU level on the residue definition and the ADI.                                                                                                                                                                                                                       |                                                                                                                                                                                               |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
| In contrast to the JMPR risk assessment, EFSA did not include the residue levels expected in rotational crops in the dietary intake calculation, since these residues (HR between 0.21 and 0.56 mg/kg) would violate the existing EU MRLs | In contrast to the JMPR risk assessment, EFSA did not include the residue levels expected in rotational crops in the dietary intake calculation, since these residues (STMR values between 0.04 and 0.096 mg/kg) would violate the existing EU MRLs                                                                                            |                                                                                                                                                                                               |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                              | **Results:**                                                                                                                                                                                                                                                                                                                                   | **Results:**                                                                                                                                                                                  |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
| No short‐term exposure concern was identified. The commodities under consideration leading to highest exposure are (in rank order): bovine liver (0.6% of the ARfD) and bovine edible offal (0.5% of the ARfD)                            | No long‐term consumer health risk was identified                                                                                                                                                                                                                                                                                               | Long‐term exposure:                                                                                                                                                                           |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
|                                                                                                                                                                                                                                           | The overall chronic exposure accounted for 14% of the ADI (NL toddler). From the commodities under consideration, the contribution to the total exposure was the highest for residues in bovine milk (2% of the ADI)                                                                                                                           | 0--20% of the ADI                                                                                                                                                                             |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                | Short‐term exposure:                                                                                                                                                                          |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                               |
|                                                                                                                                                                                                                                           |                                                                                                                                                                                                                                                                                                                                                | 10% of the ARfD                                                                                                                                                                               |
+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; HR: highest residue; ADI: acceptable daily intake.
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5.30. Mandestrobin (307) T {#efs25797-sec-0203}
--------------------------

### 5.30.1. Background information {#efs25797-sec-0204}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | AT                      |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                | Commission Implementing Regulation (EU) 2015/2085[a](#efs25797-note-0209){ref-type="fn"}                                                                                                                          |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2015k](#efs25797-bib-0054){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | Not required            | MRLs have been established in the framework of the peer review.                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | Apricot, cherry, peach and plum: EFSA (2018f)                                                                                                                                                                     |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | Strawberry and grapes: EFSA ([2018l](#efs25797-bib-0101){ref-type="ref"})                                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCaringogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                                                                 |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EU Peer Review proposal for CMR: none                                                                                                                                                                             |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0825){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) 2015/2085 of 18 November 2015 approving the active substance mandestrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011. OJ L 302, 19.11.2015, p. 93--96.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.
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### 5.30.2. Toxicological reference values {#efs25797-sec-0205}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                | EU evaluation                                              | TRV comparable        |                                                                                                                                     |     |
+========================+================================================================================================================================================================================================================================================================================================================================================================================+============================================================+=======================+=====================================================================================================================================+=====+
| **ADI**                | 0.2 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                           | JMPR (2018) (1‐year toxicity study in dogs, SF 100)        | 0.19 mg/kg bw per day | EFSA ([2015k](#efs25797-bib-0054){ref-type="ref"}) (52‐week dog (UF 100), supported by multigeneration rat (parental LOAEL, UF 300) | Yes |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                     | JMPR (2018) (developmental toxicity study in rats, SF 100) | Not required          | EFSA ([2015k](#efs25797-bib-0054){ref-type="ref"})                                                                                  | No  |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The EU ADI is 0.19 mg/kg bw per day based on the 1‐year dog study (applying an uncertainty factor of 100), and supported by the parental LOAEL from the multigeneration rat study (applying an UF of 300). The JMPR proposes the same ADI also based on the 1‐year dog study. The different ADI values are a result of different policies on rounding                          |                                                            |                       |                                                                                                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                |                                                            |                       |                                                                                                                                     |     |
|                        | In the EU, the derivation of an ARfD was not considered needed on the basis of the low acute toxicity profile of mandestrobin by the peer review experts                                                                                                                                                                                                                       |                                                            |                       |                                                                                                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                |                                                            |                       |                                                                                                                                     |     |
|                        | The ARfD of 3 mg/kg bw derived by JMPR applies only to women of childbearing age and is based on a NOAEL of 300 mg/kg bw per day for malformations observed in a developmental toxicity study in rats and using a safety factor of 100. The same NOAEL from this study was set by the EU peer review (based on foetal findings) but was not considered for the ARfD derivation |                                                            |                       |                                                                                                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                |                                                            |                       |                                                                                                                                     |     |
|                        | Metabolites considered during the EU peer review:                                                                                                                                                                                                                                                                                                                              |                                                            |                       |                                                                                                                                     |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                |                                                            |                       |                                                                                                                                     |     |
|                        | 4‐OH‐S‐2200 and De‐Xy‐S‐2200 were considered to be covered by the toxicological profile of mandestrobin, whereas the plant metabolite 2‐CH~2~OH‐S‐2200 was not covered by the studies performed with mandestrobin                                                                                                                                                              |                                                            |                       |                                                                                                                                     |     |
+------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+-----------------------+-------------------------------------------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; LOAEL: lowest observed adverse effect level.
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5.31. Pydiflumetofen (309)R,T {#efs25797-sec-0206}
-----------------------------

### 5.31.1. Background information {#efs25797-sec-0207}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                          | Comments, references                                                                                                                                                                                                                                                                                                                                                                                                                            |
+========================================================================================================================================+==========================+=================================================================================================================================================================================================================================================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation  |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | FR                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approval process ongoing | NAS application under Regulation (EC) No 1107/2009                                                                                                                                                                                                                                                                                                                                                                                              |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | ongoing                  | EFSA Conclusion not yet finalised, pending endocrine assessment to be conducted by EFSA                                                                                                                                                                                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | No                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments        | MRL application ongoing as part of the approval process for pome fruit, grapes, potatoes, tropical root and tuber vegetables, solanacea, cucurbits, brassica and soybeans                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded            | Harmonised classification and labelling -- Annex VI:                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                        |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                                        |                          | Under discussion at the ECHA RAC (March 2019)                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                                                        |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                                        |                          | RMS informed EFSA that a classification as Carc. 2 H351 and Repr. 2 H361f (fertility) has been proposed for during the meeting of the Committee for the risk assessment of ECHA (RAC‐47; November 2018; minutes not available yet). This classification proposal will be re‐discussed in RAC‐48 (March 2019) in order to clarify the arguments justifying a double classification carcinogen and reprotoxic and to make the opinion more robust |
|                                                                                                                                        |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                                                                                        |                          | ED assessment ongoing                                                                                                                                                                                                                                                                                                                                                                                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+--------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.
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### 5.31.2. Toxicological reference values {#efs25797-sec-0208}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | EU evaluation | TRV comparable        |                                                                                                |     |
+========================+===============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+===============+=======================+================================================================================================+=====+
| **ADI**                | 0.1 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | JMPR (2018)   | 0.09 mg/kg bw per day | 18‐month mouse study with an UF of 100                                                         | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       | Proposal derived in peer review expert meeting (September 2018)                                |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------+-----+
| **ARfD**               | 0.3 mg/kg bw                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | JMPR (2018)   | 0.3 mg/kg bw          | Developmental toxicity study in the rat and based on effects on body weight, with an UF of 100 | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       | Proposal derived in peer review expert meeting (September 2018)                                |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | The EFSA conclusion is not finalised, thus, EU TRV are not yet formally approved.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | The **ADI** established by the JMPR is based on the NOAEL of 9.9 mg/kg bw per day for reduced body weight in males from the two‐year study in rats and applying an uncertainty factor (UF) of 100. The ADI discussed during the EU peer review and proposed in the RAR is based on the NOAEL of 9.2 mg/kg bw per day for reduced body weight from the 18‐month carcinogenicity study in mice and applying an UF of 100. The **ARfD** set by the JMPR at 0.3 mg/kg bw is based on the NOAEL of 30 mg/kg bw per day for reduced maternal body weight gain and feed consumption early during treatment from the developmental toxicity study in rabbits and applying an UF of 100. This value is in agreement with the EU peer review discussion |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | According to 2018 JMPR, the toxicity of **2,4,6‐TCP and its conjugates** would be covered by the parent compound, as this metabolite was identified as a major metabolite in rats. The ADI/ARfD derived by JMPR applies to pydiflumetofen and the metabolites 2,4,6‐TCP and SYN547897                                                                                                                                                                                                                                                                                                                                                                                                                                                         |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | In the ongoing EU peer review, additional toxicological data on 2,4,6‐TCP were taken into consideration from the published literature[a](#efs25797-note-0213){ref-type="fn"} indicating that the metabolite present carcinogenic potential, the genotoxicity database was considered inconclusive and no toxicological reference values could be concluded                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | An ADI of 0.25 mg/kg bw per day was discussed for **NOA449410**, based on NOAEL of 250 mg/kg bw per day from the developmental toxicity study in rabbits and applying an UF of 1,000. No ARfD being necessary for this metabolite                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | An ADI and ARfD of 0.04 mg/kg bw (per day) were discussed for **SYN508272**, based on the 28‐day study in rats, applying an UF of 1,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |               |                       |                                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |               |                       |                                                                                                |     |
|                        | The metabolites **SYN545547**,**SYN548263** and **SYN547897** were considered non‐genotoxic; however insufficient data was available to conclude on their general toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |               |                       |                                                                                                |     |
+------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------+-----------------------+------------------------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.

The RMS informed EFSA that a literature review on the 2,4,6‐TCP metabolite performed according to the EFSA Guidance document (EFSA Journal 2011; 9(2):2092) was submitted by the applicant and assessed by the RMS. On this basis, the toxicological profile of 2,4,6‐TCP (and conjugates) and appropriate reference values have been discussed in expert meeting PPR 182 (September 2018). It was concluded that although 2,4,6‐TCP is the major metabolite in rat, its toxicity could not be covered by the parent. Indeed, 2,4,6‐TCP is classified carcinogen category 2 (Reg 1272/2008, ATP0) based on lymphoma/leukaemias observed in male rats and liver tumours in mice. In addition, a genotoxic mode of action could not be ruled out since the genotoxicity database  was considered inconclusive based on quality and limitations of the available studies performed on the metabolite; particularly for the in vivo studies. This was considered by the majority of experts as data gap and a complete data package, including in vivo Comet assay exploring the site of contact and the target organs identified in the carcinogenesis studies, was recommended. If a genotoxic potential can be ruled out for 2,4,6‐TCP, the repeated‐dose toxicity profile of the metabolite in comparison with the toxicity profile of the parent pydiflumetofen will need to be addressed to perform the consumer risk assessment.
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### 5.31.3. Residue definitions {#efs25797-sec-0209}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                                                                                                                                                                                                                                                                        | JMPR evaluation                                                                                                                                             | EU evaluation                                              | RDs comparable |
+=========================+========================================================================================================================================================================================================================================================================================================================================================================================================+=============================================================================================================================================================+============================================================+================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                                                                                                                                                                         | Pydiflumetofen                                                                                                                                              | Peer Review proposal (September 2018):                     | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             | Pydiflumetofen                                             |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+
| Animal products         | Pydiflumetofen                                                                                                                                                                                                                                                                                                                                                                                         | Peer Review proposal (September 2018):                                                                                                                      | Yes                                                        |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | The residue is fat soluble                                                                                                                                                                                                                                                                                                                                                                             | Pydiflumetofen                                                                                                                                              |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        | The residue is fat soluble                                                                                                                                  |                                                            |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                                                                                                                                                                         | Pydiflumetofen                                                                                                                                              | Peer Review proposal (September 2018):                     | Yes            |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             | Pydiflumetofen                                             |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             | (for all categories of crops following foliar application) |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+
| Animal products         | Animal products other than mammalian liver and kidney: Sum of pydiflumetofen and 2,4,6‐trichlorophenol (2,4,6‐TCP) and its conjugates, expressed as pydiflumetofen                                                                                                                                                                                                                                     | Peer Review proposal (September 2018):                                                                                                                      | No                                                         |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | For mammalian liver and kidney: Sum of pydiflumetofen, 2,4,6‐trichlorophenol (2,4,6‐TCP) and its conjugates, and 3‐(difluoromethyl)‐*N*‐methoxy‐1‐methyl‐*N*‐\[1‐methyl‐2‐(2,4,6‐trichloro‐3‐hydroxy‐ phenyl) ethyl\]pyrazole‐4‐carboxamide (SYN547897) and its conjugates, expressed as pydiflumetofen                                                                                                | Parent and 2,4,6‐TCP for all animal matrices (provisional, pending on toxicological data on 2,4,6‐TCP, including genotoxicity potential) (majority opinion) |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        | See also comments below                                                                                                                                     |                                                            |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+
| **Conclusion/comments** | The EFSA conclusion is not finalised; thus, EU residue definitions are not yet formally approved.                                                                                                                                                                                                                                                                                                      |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | The EU pesticides peer review meeting of experts proposed a residue definition for enforcement for plant and animal products and for risk assessment for plant products which is identical to the JMPR residue definition, as both refer to the parent pydiflumetofen only                                                                                                                             |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | As regards the residue definition for risk assessment (animal products), the peer review meeting of experts proposed a provisional residue definition as parent and 2,4,6‐TCP for all animal matrices (provisional)(majority opinion). A minority of experts proposed residue definition for ruminant liver to also include SYN547897; and for ruminant kidney to also include SYN547897 and SYN548263 |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | In contrast, the JMPR residue definition for animal products other than mammalian liver and kidney includes also conjugates of 2,4,6‐TCP; and for mammalian liver and kidney it includes also conjugates of 2,4,6‐TCP, and SYN547897 and its conjugates. Thus, the JMPR residue definitions would be wider than the provisional EU RD                                                                  |                                                                                                                                                             |                                                            |                |
|                         |                                                                                                                                                                                                                                                                                                                                                                                                        |                                                                                                                                                             |                                                            |                |
|                         | Considering that JMPR derived MRL proposals only for plant commodities, the open issue regarding the residue definition for animal commodities is not of immediate relevance                                                                                                                                                                                                                           |                                                                                                                                                             |                                                            |                |
+-------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level.
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### 5.31.4. Codex MRL proposals {#efs25797-sec-0210}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                                          | Codex MRL proposal                                                                                                                                                                                                                                                                                                                                                                                                          | EU MRL                                                 | Comment                                                                                                                                                                                                                                                                                 |
+====================================================================================+=============================================================================================================================================================================================================================================================================================================================================================================================================================+========================================================+=========================================================================================================================================================================================================================================================================================+
| Dried grapes (= Currants, Raisins and Sultanas)                                    | 4                                                                                                                                                                                                                                                                                                                                                                                                                           | --                                                     | A concentration of residues in dried grapes (currants, raisins, sultanas) occurs and a PF of 2.45 was derived from 6 processing studies                                                                                                                                                 |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | No EU MRLs are set for processed grapes, such as raisins                                                                                                                                                                                                                                |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Small fruit vine climbing, Subgroup of (includes all commodities in this subgroup) | **1.5**                                                                                                                                                                                                                                                                                                                                                                                                                     | 0.01[\*](#efs25797-note-0216){ref-type="fn"}           | Critical GAP: USA, grape and small fruit vine climbing, except fuzzy kiwifruit, up to 200 g/ha at a maximum annual rate of 400 g/ha, RTI not reported, PHI 7 days                                                                                                                       |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             | (Default MRL according to Art 18(1)(b) Reg. 396/ 2005) | Number of trials: 11 trials on grapes                                                                                                                                                                                                                                                   |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                     |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | Specific comments/observations: The Codex MRL for the subgroup 'Small fruit vine climbing' would be applicable to table grapes (0151010) and wine grapes (0151020)                                                                                                                      |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | The NAS application under Regulation (EC) No 1107/2009 includes an application to set EU MRLs for table and wine grapes (proposed MRL 2 mg/kg on the basis of combined NEU and SEU residue trials; critical GAP (NEU and SEU: 2 × 200 g/ha at BBCH 67‐89, 14‐day interval, PHI 21 days) |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                        |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape juice                                                                        | --                                                                                                                                                                                                                                                                                                                                                                                                                          | --                                                     | A reduction of residues in grape juice occurs and a PF of 0.06 was derived from 6 processing studies                                                                                                                                                                                    |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        |                                                                                                                                                                                                                                                                                         |
|                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                        | No EU MRLs are set for processed grape products                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape must                                                                         | --                                                                                                                                                                                                                                                                                                                                                                                                                          | --                                                     | A concentration of residues in grape must occurs and a PF of 1.06 was derived from 8 processing studies. No EU MRLs are set for processed grape products                                                                                                                                |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape seed oil, refined                                                            | --                                                                                                                                                                                                                                                                                                                                                                                                                          | --                                                     | A concentration of residues in grape seed oil (refined) occurs and a PF of 1.05 was derived from 4 processing studies. No EU MRLs are set for processed grape products                                                                                                                  |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Red wine                                                                           | --                                                                                                                                                                                                                                                                                                                                                                                                                          | --                                                     | A reduction of residues in red wine occurs and a PF of 0.135 was derived from 4 processing studies. No EU MRLs are set for processed grape products                                                                                                                                     |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| White wine                                                                         | --                                                                                                                                                                                                                                                                                                                                                                                                                          | --                                                     | A reduction of residues in white wine occurs and a PF of 0.315 was derived from 4 processing studies. No EU MRLs are set for processed grape products                                                                                                                                   |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                               | For several annual crops for which residue trials were received, the JMPR concluded that accumulation in soil and uptake of residues into rotational crops may significantly contribute to the terminal residue in food and feed commodities and no recommendations could be made. The NAS application under Regulation (EC) No 1107/2009 includes applications to set MRLs for various commodities and an import tolerance |                                                        |                                                                                                                                                                                                                                                                                         |
+------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

PF: processing factor; MRL: maximum residue limit; GAP: Good Agricultural Practice; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; PHI: preharvest interval; NEU: northern European Union; SEU: southern European Union; BBCH: growth stages of mono‐ and dicotyledonous plants; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.
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### 5.31.5. Consumer risk assessment {#efs25797-sec-0211}

###### 

Summary of the consumer risk assessment

+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Chronic exposure assessment                                                                                                                                                                                                                                                                                     | Comments on JMPR exposure assessment |
+============================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=================================================================================================================================================================================================================================================================================================================+======================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                        | **RA assumptions:**                                                                                                                                                                                                                                                                                             | **Specific comments:**               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
| An indicative short‐term dietary risk assessment was performed for table grapes and wine grapes as outlined in Section [2](#efs25797-sec-0006){ref-type="sec"}                                                                                                                                                                                                                                                                                                             | An indicative long‐term risk assessment was performed using the approach as outlined in Section 'Assessment', including the STMR values derived by JMPR for grapes (table grapes and wine grapes). EFSA applied the processing factors (PF) derived by JMPR for dried grapes, grape juice and wine (white wine) | None                                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
| The proposed EU ARfD (equal to the JMPR ARfD) was used                                                                                                                                                                                                                                                                                                                                                                                                                     | For other crop commodities, EFSA assumed no uses are authorised.                                                                                                                                                                                                                                                |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
| The calculation is indicative, because no decision has been taken yet on the residue definition and the ARfD                                                                                                                                                                                                                                                                                                                                                               | The calculation is indicative, because no decision has been taken yet on the residue definition and the ADI                                                                                                                                                                                                     |                                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                               | **Results:**                                                                                                                                                                                                                                                                                                    | **Results:**                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
| No short‐term exposure concern was identified. The estimated short‐term exposure was 21% of the ARfD (table grapes) and 3% of the ARfD (wine grapes)                                                                                                                                                                                                                                                                                                                       | No long‐term consumer health risk was identified. The overall chronic exposure accounted for 0.9% of the ADI (PT general). The contributions of the grape commodities under consideration were 0.8% of the ADI (wine grapes) and 0.1% of the ADI (table grapes)                                                 | Long‐term exposure:                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
| Pydiflumetofen is applied as a racemic mixture and the risk assessment was performed disregarding the possible impact of enantiomer ratio due to plant or livestock metabolism. Considering a worst‐case theoretical factor of 2 for the toxicological burden, the potential change of isomer ratios is of low concern since the exposure represent less than 50% of the ADI. Further consideration may be required in case future uses lead to a higher consumer exposure | Pydiflumetofen is applied as a racemic mixture and the risk assessment was performed disregarding the possible impact of enantiomer ratio due to plant or livestock metabolism                                                                                                                                  | 0% of the ADI                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | Considering a worst‐case theoretical factor of 2 for the toxicological burden, the potential change of isomer ratios is of low concern since the exposure represent less than 50% of the ADI. Further consideration may be required in case future uses lead to a higher consumer exposure                      | Short‐term exposure:                 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 |                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |                                                                                                                                                                                                                                                                                                                 | 20% of the ARfD                      |
+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; ARfD: acute reference dose; ADI: acceptable daily intake; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; STMR: supervised trials median residue.
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5.32. Pyriofenone (310) R,T {#efs25797-sec-0212}
---------------------------

### 5.32.1. Background information {#efs25797-sec-0213}

###### 

Background information

+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
|                                                                                                                                        |                         | Comments, references                                                                                                                                                                                              |
+========================================================================================================================================+=========================+===================================================================================================================================================================================================================+
| Type of JMPR evaluation                                                                                                                | New compound evaluation |                                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| RMS                                                                                                                                    | LV                      | Previous RMS UK                                                                                                                                                                                                   |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Approval status                                                                                                                        | Approved                | Commission Implementing Regulation (EU) No 833/2013[a](#efs25797-note-0219){ref-type="fn"}                                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| EFSA conclusion                                                                                                                        | Yes, see comments       | EFSA ([2013c](#efs25797-bib-0027){ref-type="ref"})                                                                                                                                                                |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL review                                                                                                                             | ongoing                 | Publication planned by June 2019                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| MRL applications                                                                                                                       | Yes, see comments       | Wheat, barley and grapes, animal products: EFSA ([2013f](#efs25797-bib-0030){ref-type="ref"})Grapes: EFSA ([2015h](#efs25797-bib-0051){ref-type="ref"})                                                           |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential | Not concluded           | Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI                                                                                                                                 |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | EU Peer Review proposal for CMR (2013): Carc. 2                                                                                                                                                                   |
|                                                                                                                                        |                         |                                                                                                                                                                                                                   |
|                                                                                                                                        |                         | ED assessment according to ECHA/EFSA guidance ([2018](#efs25797-bib-0002){ref-type="ref"}) and scientific criteria (Commission Regulation (EC) No 2018/605[b](#efs25797-note-0826){ref-type="fn"}): not conducted |
+----------------------------------------------------------------------------------------------------------------------------------------+-------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

Commission Implementing Regulation (EU) No 833/2013 of 30 August 2013 approving the active substance pyriofenone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No 540/2011. OJ L 233, 31.8.2013, p. 7--10.

Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties. OJ L 101, 20.4.2018, p. 33--36.

John Wiley & Sons, Ltd

### 5.32.2. Toxicological reference values {#efs25797-sec-0214}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+-----------------------+--------------------------------------------------------------------------------+-----+
|                        | JMPR evaluation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | EU evaluation                          | TRV comparable        |                                                                                |     |
+========================+=====================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+========================================+=======================+================================================================================+=====+
| **ADI**                | 0.09 mg/kg bw per day                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | JMPR (2018) (2‐year rat study, SF 100) | 0.07 mg/kg bw per day | EFSA ([2013c](#efs25797-bib-0027){ref-type="ref"}) (rat, 2‐year study, UF 100) | No  |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       |                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       | European Commission ([2013b](#efs25797-bib-0139){ref-type="ref"})              |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+-----------------------+--------------------------------------------------------------------------------+-----+
| **ARfD**               | Unnecessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | JMPR (2018)                            | Not required          | EFSA ([2013c](#efs25797-bib-0027){ref-type="ref"})                             | Yes |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       |                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       | European Commission ([2013b](#efs25797-bib-0139){ref-type="ref"})              |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+-----------------------+--------------------------------------------------------------------------------+-----+
| **Conclusion/comment** | Although ADI derived by EFSA is slightly lower than JMPR, the values are in the same order of magnitude                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                        |                       |                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       |                                                                                |     |
|                        | The EU ADI of pyriofenone is 0.07 mg/kg bw per day, based on the NOAEL of 7.25 mg/kg bw per day from the rat, 2‐year study based on liver effects, applying the standard uncertainty factor (UF) of 100. The same 2‐year rat study was considered by JMPR for the ADI derivation and the NOAEL is set at 9.13 mg/kg bw per day for chronic nephropathy in females. Actually, the NOAEL retained is the same (200 ppm) but JMPR considers the corresponding concentration expressed in mg/kg bw per day in females while the EU peer review considered that of males |                                        |                       |                                                                                |     |
|                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                        |                       |                                                                                |     |
|                        | In the EU peer review, 4HDPM did not present mutagenic potential and it was concluded that the reference values of the parent are applicable to the metabolite. No other information on other metabolites available                                                                                                                                                                                                                                                                                                                                                 |                                        |                       |                                                                                |     |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----------------------------------------+-----------------------+--------------------------------------------------------------------------------+-----+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level.
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### 5.32.3. Residue definitions {#efs25797-sec-0215}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+
|                         | Commodity group                                                                                                                                          | JMPR evaluation                                                                                                                                      | EU evaluation                                                    | RDs comparable |
+=========================+==========================================================================================================================================================+======================================================================================================================================================+==================================================================+================+
| **RD enf**              | Plant products                                                                                                                                           | Pyriofenone                                                                                                                                          | EU Reg. 2016/1: Pyriofenone                                      | Yes            |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| Animal products         | Pyriofenone                                                                                                                                              | EU Reg. 2016/1: Pyriofenone                                                                                                                          | Yes                                                              |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         | No conclusion on fat solubility, due to the low residues in muscle and fat found in the metabolism study                                                 | The residue is not fat soluble:                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          | Peer review (EFSA, [2013c](#efs25797-bib-0027){ref-type="ref"}):                                                                                     |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          | Not required, considering the representative uses;                                                                                                   |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          | Provisional RD proposed for ruminant products: pyriofenone                                                                                           |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| **RD RA**               | Plant products                                                                                                                                           | Pyriofenone                                                                                                                                          | Peer review (EFSA, [2013c](#efs25797-bib-0027){ref-type="ref"}): | Yes            |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      | Pyriofenone                                                      |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| Animal products         | Pyriofenone                                                                                                                                              | Peer review (EFSA, [2013c](#efs25797-bib-0027){ref-type="ref"}):                                                                                     | No comparison appropriate                                        |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          | Not required, considering the representative uses; Provisional RD proposed for ruminant products: Sum of pyriofenone and 2MDPM (free and conjugated) |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+
| **Conclusion/comments** | For plant commodities, the EU and JMPR residue definitions are the same                                                                                  |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         | For animal products, so far no definitive residue definitions have been derived in the EU, since no significant dietary intake is expected for livestock |                                                                                                                                                      |                                                                  |                |
|                         |                                                                                                                                                          |                                                                                                                                                      |                                                                  |                |
|                         | 2018 JMPR proposed the parent compound as the residue definition for animal products                                                                     |                                                                                                                                                      |                                                                  |                |
+-------------------------+----------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------+----------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues.

John Wiley & Sons, Ltd

### 5.32.4. Codex MRL proposals {#efs25797-sec-0216}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                                             | Codex MRL proposal | EU MRL                                                   | Comment                                                                                                                                                                                                                                                                                                                                                                      |
+=======================================================================+====================+==========================================================+==============================================================================================================================================================================================================================================================================================================================================================================+
| Cane berries, (includes all commodities in this subgroup)             | 0.9                | Default MRL 0.01[\*](#efs25797-note-0223){ref-type="fn"} | Critical GAP: max 110 g a.s./ha per application, up to a seasonal maximum rate of 350 g a.s./ha, RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                      |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Number of trials: 6 trials in blackberries                                                                                                                                                                                                                                                                                                                                   |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Specific comments/observations: Trials conducted with 4 × 85--93 g a.s./ha, max seasonal rate of 350--370 g a.s/ha. The proposed Codex MRL would cover blackberries and raspberries                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Bush berries, (includes all commodities in this subgroup)             | 1.5                | Default MRL 0.01[\*](#efs25797-note-0223){ref-type="fn"} | Critical GAP: USA, max 110 g a.s/ha per application, up to a seasonal maximum rate of 350 g a.s./ha, RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                  |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Number of trials: 10 trials on blueberries                                                                                                                                                                                                                                                                                                                                   |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Specific comments/observations: Trials conducted with 4 × 82--100 g a.s./ha, max seasonal rate of 350--380 g a.s/ha. The proposed Codex MRL would cover blueberries, currants, gooseberries, rose hips. At EU level, the extrapolation from blueberries to currants, gooseberries, and rose hops would not be acceptable                                                     |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Dried grapes (=Currants, Raisins and Sultanas)                        | 2.5                | --                                                       | Median value of PF (2.8) and the STMR of 0.23 mg/kg for grapes was used to derive a STMR‐p of 0.64 mg/kg. Since residues concentrate in dried grapes, a MRL of 2.5 mg/kg is proposed                                                                                                                                                                                         |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | At EU level, no MRLs are set for processed grapes                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, Cucurbits                                        | 0.2                | Default MRL 0.01[\*](#efs25797-note-0223){ref-type="fn"} | Critical GAP: USA, max 110 g a.s/ha per application, up to a seasonal maximum rate of 350 g a.s./ha, RTI 7 days, PHI 0 days                                                                                                                                                                                                                                                  |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Number of trials: 26 trials (8 trials in cucumbers, 9 trials in summer squash, 9 trials in cantaloupe)                                                                                                                                                                                                                                                                       |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Specific comments/observations: MRL proposal was derived from the combined data set of trials on cucumbers, summer squash and cantaloupe/melon; trials were approximating the GAP (4 applications of 88--100 g a.s./ha at 7 days interval). At EU level the setting of a group MRL for cucurbits (edible and inedible peel) based on a merged data set would not be accepted |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Low growing berries, (includes all commodities in this subgroup)      | 0.5                | Default MRL 0.01[\*](#efs25797-note-0223){ref-type="fn"} | Critical GAP: max 110 g a.s/ha per application, up to a seasonal maximum rate of 350 g a.s./ha, with an interval of 7 days, PHI 0 days                                                                                                                                                                                                                                       |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Number of trials: 9 trials in strawberries                                                                                                                                                                                                                                                                                                                                   |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Specific comments/observations: The proposed Codex MRL would cover cranberries and strawberries.                                                                                                                                                                                                                                                                             |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Small fruit vine climbing (includes all commodities in this subgroup) | 0.8                | Table grapes: 0.9                                        | Critical GAP: USA, max 110 g a.s/ha per application, up to a seasonal maximum rate of 350 g a.s./ha, RTI 14 days, PHI 0 days                                                                                                                                                                                                                                                 |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    | Wine grapes: 0.2                                         | Number of trials: 12                                                                                                                                                                                                                                                                                                                                                         |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Sufficiently supported by data: Yes                                                                                                                                                                                                                                                                                                                                          |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Specific comments/observations: The EU GAP on table grapes (3 × 90 g a.s./ha; PHI 14 days), for which a MRL of 0.9 mg/kg is set, is fully supported by data                                                                                                                                                                                                                  |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                                                                                                                                                                                                             |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape juice                                                           | --                 | --                                                       | 8 processing studies available, PF 0.06                                                                                                                                                                                                                                                                                                                                      |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | At EU level, no MRLs are set for processed grapes                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape must                                                            | --                 | --                                                       | 2 processing studies available, PF 0.46                                                                                                                                                                                                                                                                                                                                      |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | At EU level, no MRLs are set for processed grapes                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grape wine                                                            | --                 | --                                                       | 16 processing studies available (8 for white wine and 8 for red wine); PF for red wine: 0.06, PF for white wine 0.04.                                                                                                                                                                                                                                                        |
|                                                                       |                    |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                       |                    |                                                          | At EU level, no MRLs are set for processed grapes                                                                                                                                                                                                                                                                                                                            |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                                                  | --                 |                                                          |                                                                                                                                                                                                                                                                                                                                                                              |
+-----------------------------------------------------------------------+--------------------+----------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; a.s.: active substance; PHI: preharvest interval; MRL: maximum residue level; PF: processing factor; STMR: supervised trials median residue; RTI: re‐treatment interval.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.32.5. Consumer risk assessment {#efs25797-sec-0217}

###### 

Summary of the consumer risk assessment

+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Acute exposure assessment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Chronic exposure assessment                                                                                                                                                                                                                                                         | Comments on JMPR exposure assessment                                                                                                                                                                 |
+==============================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================================+=====================================================================================================================================================================================================================================================================================+======================================================================================================================================================================================================+
| **RA assumptions:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | **RA assumptions:**                                                                                                                                                                                                                                                                 | **Specific comments:**                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
| The short‐term dietary risk assessment was not performed as no ARfD is deemed necessary (EFSA, [2013a](#efs25797-bib-0025){ref-type="ref"}, [2013b](#efs25797-bib-0026){ref-type="ref"}, [2013c](#efs25797-bib-0027){ref-type="ref"}, [2013d](#efs25797-bib-0028){ref-type="ref"}, [2013e](#efs25797-bib-0029){ref-type="ref"}, [2013f](#efs25797-bib-0030){ref-type="ref"}, [2013g](#efs25797-bib-0031){ref-type="ref"}, [2013h](#efs25797-bib-0032){ref-type="ref"}, [2013i](#efs25797-bib-0033){ref-type="ref"}--[j](#efs25797-bib-0034){ref-type="ref"}) | The most recent long‐term risk assessment (EFSA, [2018h](#efs25797-bib-0097){ref-type="ref"}) was updated using the approach as outlined in Section 'Assessment', including the STMR values for the commodities for which the proposed Codex MRL is higher than the existing EU MRL | The chronic exposure made by JMPR was performed with the ADI of 0.09 mg/kg bw per day. The IEDI was 0% of the maximum ADI                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | The EU ADI was used                                                                                                                                                                                                                                                                 | JMPR also considered that an ARfD is unnecessary. Therefore, the acute dietary exposure to residues of pyriofenone from the uses assessed was considered unlikely to present a public health concern |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Results:**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | **Results:**                                                                                                                                                                                                                                                                        | **Results:**                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
| No short‐term exposure assessment is necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | No long‐term consumer health risk was identified. The overall chronic exposure accounted for 2% of the ADI                                                                                                                                                                          | Long‐term exposure:                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                     | 0% of the ADI                                                                                                                                                                                        |
+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

RA: risk assessment; ARfD: acute reference dose; ADI: acceptable daily intake; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; MRL: maximum residue level; IEDI: international estimated daily intake.

John Wiley & Sons, Ltd

5.33. Tioxazafen (311) R,T {#efs25797-sec-0218}
--------------------------

### 5.33.1. Background information {#efs25797-sec-0219}

###### 

Background information

                                                                                                                                                                       Comments, references
  ---------------------------------------------------------------------------------------------------------------------------------------- --------------------------- -----------------------------------------------------------------------------------
  Type of JMPR evaluation                                                                                                                  New compound evaluation     
  RMS                                                                                                                                      --                          N/A
  Approval status                                                                                                                          Not approved                Never notified and authorised in the EU
  EFSA conclusion                                                                                                                          No                          
  MRL review                                                                                                                               No                          
  MRL applications                                                                                                                         No                          Import tolerance application under preparation in NL (cotton, maize and soybeans)
  Cut‐off criteria: Mutagen cat. 1A or 1BCarcinogen cat. 1A or 1BToxic for reproduction cat. 1A or 1BEndocrine disrupting (ED) potential   No assessment at EU level   Harmonised classification and labelling for CMR -- Annex VI: no entry in Annex VI

JMPR: Joint FAO/WHO Meeting on Pesticide Residues; RMS: rapporteur Member State; MRL: maximum residue level.

John Wiley & Sons, Ltd

### 5.33.2. Toxicological reference values {#efs25797-sec-0220}

###### 

Comparison of toxicological reference values (TRV) derived by JMPR and at EU level

+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------+----------------------------+----------------------------+
|                        | JMPR evaluation                                                                                                                                                                 | EU evaluation                                           | TRV comparable             |                            |
+========================+=================================================================================================================================================================================+=========================================================+============================+============================+
| **ADI**                | 0.05 mg/kg bw per day                                                                                                                                                           | JMPR (2018) (2‐year toxicity study in rats, SF 100)     | No information available   | Comparison not appropriate |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------+----------------------------+----------------------------+
| **ARfD**               | 0.5 mg/kg bw                                                                                                                                                                    | JMPR (2018) (acute neurotoxicity study in rats, SF 500) | Comparison not appropriate |                            |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------+----------------------------+----------------------------+
| **Conclusion/comment** | So far no assessment of the active substance was performed in the EU                                                                                                            |                                                         |                            |                            |
|                        |                                                                                                                                                                                 |                                                         |                            |                            |
|                        | JMPR assessment: The ADI is based on a 2‐year toxicity study in rats, applying a safety factor of 100                                                                           |                                                         |                            |                            |
|                        |                                                                                                                                                                                 |                                                         |                            |                            |
|                        | The ARfD was derived from the acute neurotoxicity study in rats, using a safety factor of 500; the additional factor of 5 was applied for the use of a LOAEL instead of a NOAEL |                                                         |                            |                            |
|                        |                                                                                                                                                                                 |                                                         |                            |                            |
|                        | Both the ADI and the ARfD can be applied to benzamidine                                                                                                                         |                                                         |                            |                            |
|                        |                                                                                                                                                                                 |                                                         |                            |                            |
|                        | Since the detailed study reports are not available, no comment on the acceptability of the toxicological reference values derived by JMPR can be provided                       |                                                         |                            |                            |
+------------------------+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+---------------------------------------------------------+----------------------------+----------------------------+

ADI: acceptable daily intake; bw: body weight; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; NOAEL: no observed adverse effect level; LOAEL: lowest observed adverse effect level.

John Wiley & Sons, Ltd

### 5.33.3. Residue definitions {#efs25797-sec-0221}

###### 

Comparison of the residue definitions derived by JMPR and at EU level

+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+
|                         | Commodity group                                                                                                                                                                                                                               | JMPR evaluation                                                                     | EU evaluation                                                                                                                   | RDs comparable         |
+=========================+===============================================================================================================================================================================================================================================+=====================================================================================+=================================================================================================================================+========================+
| **RD enf**              | Plant products                                                                                                                                                                                                                                | Sum of tioxazafen and benzamidine (benzenecarboximidamide), expressed as tioxazafen | No specific residue definition is set in the EU; the default residue definition covering the parent compound only is applicable | No comparison possible |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+
| Animal products         | Sum of tioxazafen and benzamidine (benzenecarboximidamide), expressed as tioxazafen                                                                                                                                                           | No comparison possible                                                              |                                                                                                                                 |                        |
|                         |                                                                                                                                                                                                                                               |                                                                                     |                                                                                                                                 |                        |
|                         | The residue is not fat soluble                                                                                                                                                                                                                |                                                                                     |                                                                                                                                 |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+
| **RD RA**               | Plant products                                                                                                                                                                                                                                | Sum of tioxazafen and benzamidine (benzenecarboximidamide), expressed as tioxazafen | No comparison possible                                                                                                          |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+
| Animal products         | No comparison possible                                                                                                                                                                                                                        |                                                                                     |                                                                                                                                 |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+
| **Conclusion/comments** | The plant residue definitions derived by JMPR are based on metabolism studies in GM soya bean, GM maize and cotton, reflecting seed treatments (the GM varieties used in the metabolism studies are not reported) and rotational crop studies |                                                                                     |                                                                                                                                 |                        |
|                         |                                                                                                                                                                                                                                               |                                                                                     |                                                                                                                                 |                        |
|                         | For animal commodities, JMPR assessed metabolism study in rats, lactating goats and laying hens                                                                                                                                               |                                                                                     |                                                                                                                                 |                        |
|                         |                                                                                                                                                                                                                                               |                                                                                     |                                                                                                                                 |                        |
|                         | Considering that tioxazafen was found to be extensively metabolised, parent compound is not a good marker substance. Thus, at EU level the setting of specific residue definitions as proposed by JMPR is recommended                         |                                                                                     |                                                                                                                                 |                        |
+-------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------+---------------------------------------------------------------------------------------------------------------------------------+------------------------+

RD: residue definition; RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; GM: genetically modified.

John Wiley & Sons, Ltd

### 5.33.4. Codex MRL proposals {#efs25797-sec-0222}

###### 

Comparison of Codex MRL proposals derived by JMPR and EU MRLs

+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Commodity                                     | Codex MRL proposal                           | EU MRL                                               | Comment                                                                                                                                                                              |
+===============================================+==============================================+======================================================+======================================================================================================================================================================================+
| Cotton gin trash                              | 0.02                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Critical GAP: USA, see GAP for cotton seed                                                                                                                                           |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 4                                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: In the EU, MRLs are not set for feed items                                                                                                           |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cottonseed                                    | 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Critical GAP: USA, 1 mg/seed, 210 g a.i./ha                                                                                                                                          |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 12                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: In all trials residues were \< 0.005 mg/kg                                                                                                           |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                      | 0.03                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Feeding study in lactating cows was available. The lowest feeding level tested was 6 times higher than the calculated maximum dietary burden                                         |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable However, a lower level would be sufficient (0.02 or 0.015 mg/kg)                                                                    |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                          | 0.02[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | The MRL proposal was derived from metabolism studies in poultry performed with a feeding level approximately 30 times the calculated maximum dietary burden                          |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize                                         | 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Critical GAP: USA, seed treatment 1 mg/seed; 99 g a.i./ha                                                                                                                            |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 22                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: In all trials residues were \< 0.005 mg/kg                                                                                                           |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Maize fodder                                  | 0.03(DM)                                     |                                                      | Critical GAP: USA, see GAP for maize                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 22                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: In the EU, MRLs are not set for feed items                                                                                                           |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats)             | 0.03                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                             |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable. However, a lower level would be sufficient (0.02 or 0.015 mg/kg)                                                                   |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals) | 0.02                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                             |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is not compatible with the EU legislation, because MRLs are not set for meat but for muscle. The corresponding MRL for muscle would be 0.01 mg/kg |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                         | 0.02                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on edible offal (mammalian)                                                                                                                                             |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry edible offal                          | 0.02[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on eggs                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry fat                                   | 0.02[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on eggs                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                  | 0.02[\*](#efs25797-note-0229){ref-type="fn"} | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | See comments on eggs                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean (dry)                               | 0.04                                         | Default 0.01[\*](#efs25797-note-0229){ref-type="fn"} | Critical GAP: USA, 0.5 mg/seed (309 g a.i./ha)                                                                                                                                       |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 22                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: --                                                                                                                                                   |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Conclusion: The proposed Codex MRL is acceptable                                                                                                                                     |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean fodder                              | 0.4(DM)                                      |                                                      | Critical GAP: USA, see GAP for soya beans dry                                                                                                                                        |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Number of trials: 22                                                                                                                                                                 |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Sufficiently supported by data: Yes                                                                                                                                                  |
|                                               |                                              |                                                      |                                                                                                                                                                                      |
|                                               |                                              |                                                      | Specific comments/observations: In the EU, MRLs are not set for feed items                                                                                                           |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean meal                                | 0.06                                         |                                                      | MRL proposal was derived by applying a PF of 1.41 to soybeans. One processing study would not be sufficient in the EU                                                                |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Soya bean oil, Refined                        |                                              |                                                      | PF \< 0.06. One processing study would not be sufficient in the EU                                                                                                                   |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **General comments**                          | --                                           |                                                      |                                                                                                                                                                                      |
+-----------------------------------------------+----------------------------------------------+------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

GAP: Good Agricultural Practice; MRL: maximum residue level; PF: processing factor.

Indicates that the input value is proposed at the limit of quantification.

John Wiley & Sons, Ltd

### 5.33.5. Consumer risk assessment {#efs25797-sec-0223}

###### 

Summary of the consumer risk assessment

+------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| Acute exposure assessment                                                                            | Chronic exposure assessment                                                                                          | Comments on JMPR exposure assessment |
+======================================================================================================+======================================================================================================================+======================================+
| **RA assumptions:**                                                                                  | **RA assumptions:**                                                                                                  | **Specific comments:**               |
|                                                                                                      |                                                                                                                      |                                      |
| The short‐term dietary risk assessment was performed for the commodities under consideration.        | The long‐term exposure was calculated using the STMR values derived by JMPR for the commodities under consideration. | --                                   |
|                                                                                                      |                                                                                                                      |                                      |
| The JMPR ARfD was used                                                                               | For the remaining commodities, the default MRL of 0.01 mg/kg was used in the exposure calculation                    |                                      |
|                                                                                                      |                                                                                                                      |                                      |
|                                                                                                      | The JMPR ADI was used                                                                                                |                                      |
+------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------+--------------------------------------+
| **Results:**                                                                                         | **Results:**                                                                                                         | **Results:**                         |
|                                                                                                      |                                                                                                                      |                                      |
| No short‐term exposure concern was identified (maximum exposure via poultry meat, 0.07% of the ARfD) | No long‐term consumer health risk was identified                                                                     | Long‐term exposure:                  |
|                                                                                                      |                                                                                                                      |                                      |
|                                                                                                      | The overall chronic exposure accounted for 4% of the ADI                                                             | 0% of the ADI                        |
|                                                                                                      |                                                                                                                      |                                      |
|                                                                                                      | The contribution of milk to the exposure was 2% of the ADI                                                           | Short‐term exposure:                 |
|                                                                                                      |                                                                                                                      |                                      |
|                                                                                                      |                                                                                                                      | 0% of the ARfD                       |
+------------------------------------------------------------------------------------------------------+----------------------------------------------------------------------------------------------------------------------+--------------------------------------+

RA: risk assessment; JMPR: Joint FAO/WHO Meeting on Pesticide Residues; ARfD: acute reference dose; STMR: supervised trials median residue; ADI: acceptable daily intake.

John Wiley & Sons, Ltd

 {#efs25797-sec-0224}

AbbreviationsADIacceptable daily intakea.i.active ingredientARfDacute reference doseAOELacceptable operator exposure levela.s.active substanceBMDbenchmark doseBBCHgrowth stages of mono‐ and dicotyledonous plantsbwbody weightCCPRCodex Committee on Pesticide ResiduesCFconversion factor for enforcement residue definition to risk assessment residue definitionCMRCarcinogenic, Mutagenic or Toxic for ReproductionCXLCodex Maximum Residue Limit (Codex MRL)DARdraft assessment report (prepared under Council Directive 91/414/EEC)DARTdevelopmental and reproductive toxicityDBdietary burdenDMdry matterDMSdocument management systemdwdry weightEMSevaluating Member Stateeqresidue expressed as a.s. equivalentFAOFood and Agriculture Organization of the United NationsGAPGood Agricultural PracticeGLPGood Laboratory PracticeGMgenetically modifiedHRhighest residueIEDIinternational estimated daily intakeIESTIinternational estimated of short‐term intakeILVindependent laboratory validationJECFAJoint FAO/WHO Expert Committee on Food AdditivesJMPRJoint FAO/WHO Meeting on Pesticide ResiduesLD~50~lethal dose, medianLOAELlowest observed adverse effect levelLOQlimit of quantification (determination)LPlarge portionMORmagnitude of residueMRLmaximum residue limitMSMember StatesMWmolecular weightNEUnorthern European UnionNOAELno observed adverse effect levelOECDOrganisation for Economic Co‐operation and DevelopmentPFprocessing factorPHIpreharvest intervalPRIMo(EFSA) Pesticide Residues Intake ModelQSARquantitative structure--activity relationshipRArisk assessmentRACraw agricultural commodityRARrenewal assessment reportRD‐RAresidue definition for risk assessmentRD‐ENFresidue definition for enforcement practiceRMSrapporteur Member StateRTIre‐treatment intervalRVIMNational Institute for Public Health and the EnvironmentSEUsouthern European UnionSTMRsupervised trials median residueTDMStriazole‐derivative metabolitesTTCthreshold of toxicological concernTRRtotal radioactive residuesTRVtoxicological reference valuesVFvariation factorWHOWorld Health OrganizationUFuncertainty factor

Appendix A -- Calculations of Consumer exposure with Pesticide Residue Intake Model (Primo) {#efs25797-sec-1001}
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Appendix B -- Comments on draft Codex MRL proposals maintained at step 4 or 7 {#efs25797-sec-1002}
=============================================================================
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In the following table, EFSA provides some background information on MRL proposals presented in previous CCPR meetings that were not advanced due to concerns raised by the governmental delegations or other procedural reasons.

###### 

Detailed information on the MRL proposals maintained at step 4 or 7

+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Active substance                                                                                                                 | Commodity                                                          | Step            | CXL proposal/existing CXL | Discussions in previous CCPR meetings                                                                                                                                                                                                                                                                                                                                  | EU MRL | Recent EU assessments                                                                                                                                                                                                                                                 |
+==================================================================================================================================+====================================================================+=================+===========================+========================================================================================================================================================================================================================================================================================================================================================================+========+=======================================================================================================================================================================================================================================================================+
| **Diquat (31)**                                                                                                                  | Beans (dry)                                                        | 4               | 0.05/0.2                  | In 2014, Canada asked to maintain the existing CXLs for bean (dry) (0.2 mg/kg); and lentil (dry) (0.2 mg/kg) under the 4 year rule awaiting data from Canada.                                                                                                                                                                                                          | 0.2    | See EFSA report. Section [5.1](#efs25797-sec-0029){ref-type="sec"}                                                                                                                                                                                                    |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2014, the CCPR also decided to maintain the proposed draft MRLs for edible offal (mammalian), eggs, meat (from mammals other than marine mammals), poultry (edible offal), poultry meat (all 0.01\*) and milks (0.001\*) at step 4 (CCPR 46, [ftp.fao.org/codex/reports/REPORTS_2014/REP14_PRe.pdf](ftp.fao.org/codex/reports/REPORTS_2014/REP14_PRe.pdf),‐para 40) |        | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2015: The proposed draft MRL for beans dry and livestock commodities were retained at step 4 waiting data from Canada and Australia                                                                                                                                                                                                                               |        | In the light of the new residue definitions derived in the EU, the proposed MRLs would not be compatible with the EU residue definitions derived in the peer review                                                                                                   |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2016: No discussion                                                                                                                                                                                                                                                                                                                                               |        | Following the 4‐year rule, a decision should be taken in 2019 CCPR meeting to withdraw the CXLs and the Codex MRL proposals at step 4                                                                                                                                 |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2017: No discussion                                                                                                                                                                                                                                                                                                                                               |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2018: No discussion                                                                                                                                                                                                                                                                                                                                               |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2019: New MRL proposals have been derived by JMPR for the commodities under discussion, except edible offal mammalian, eggs, milk and poultry edible offal. In the 2018, JMPR report the withdrawal of the existing CXLs was recommended                                                                                                                          |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (Mammalian)                                                                                                         | 4                                                                  | 0.01\*/0.05\*   | 0.05\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggs                                                                                                                             | 4                                                                  | 0.01\*/0.05\*   | 0.05                      |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                                                                    | 4                                                                  | 0.01\*/0.05\*   | 0.05\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                                                            | 4                                                                  | 0.001\*/0.01\*  | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry meat                                                                                                                     | 4                                                                  | 0.01\*0.05\*    | 0.05\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Poultry, edible offal of                                                                                                         | 4                                                                  | 0.01\*/0.05\*   | 0.05\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Oxamyl (126)**                                                                                                                 | Peppers chili, dried                                               | 4               | 0.01\*                    | The Codex MRL proposals were kept at step 4 awaiting a re‐evaluation of the issue related to the setting of MRLs for the subgroup of peppers (in 2017 JMPR proposed to exclude martynia, okra and roselle)                                                                                                                                                             | 0.01\* | The EU position of 2018 is still valid where the EU supported the advancement of the proposed MRLs for the two commodities                                                                                                                                            |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2018, JMPR confirmed the previous MRL proposals since the GAPs under consideration do not cover the minor crops listed in the subgroup of peppers                                                                                                                                                                                                                   |        | It is noted that for dried chili peppers, usually the EU would not express its support, since it is a processed commodity for which no EU MRLs are established                                                                                                        |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers subgroup of (includes all commodities in this subgroup, except martynia, okra and roselle)                               | 4                                                                  | 0.01\*          | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Propamocarb**                                                                                                                  | Cabbages, Head                                                     | 4               | 1                         | In 2015, CCPR agreed to hold the proposed draft MRLs for cabbages and kale at step 4, awaiting new data (livestock feeding study) from the manufacturer and re‐evaluation by JMPR in 2018                                                                                                                                                                              | 0.7    | In 2015 CCPR, EU made a reservation regarding the advancement of the proposed MRLs for the two crops because a different policy on establishing MRLs for animal feed commodities when livestock dietary burdens exceed the dose levels used in animal feeding studies |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
| **148**                                                                                                                          |                                                                    |                 |                           | No new information was provided for the 2018 JMPR meeting                                                                                                                                                                                                                                                                                                              |        | The renewal process of the approval of propamocarb is currently ongoing; EFSA expert meeting is planned for April 2019                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        | In 2019, no discussion is expected for this substance                                                                                                                                                                                                                 |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        | Overall, the advancement of the proposed MRLs is not supported as long as the expected residues in food of animal origin were not assessed, taking into account the residues in cabbage and kale                                                                      |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Kale                                                                                                                             | 4                                                                  | 20              | 20                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Propiconazole**                                                                                                                | Cherries, subgroup of (including all commodities in this subgroup) | 4               | 3Po                       | In 2018, the EU proposed that the MRLs should be derived using a different calculation method (using the mean residue + 4SD). CCPR agreed to keep all the proposed draft MRLs at step 4 awaiting JMPR re‐evaluation in 2018                                                                                                                                            | 0.01\* | [**Conclusions:**]{.ul}                                                                                                                                                                                                                                               |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
| **160**                                                                                                                          |                                                                    |                 |                           | In 2018 JMPR, revised MRL proposals were derived by JMPR                                                                                                                                                                                                                                                                                                               |        | See comments in EFSA report Section [5.5](#efs25797-sec-0053){ref-type="sec"}                                                                                                                                                                                         |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lemons and Limes (including citron) Subgroup of (including all commodities in this subgroup)                                     | 4                                                                  | 10Po            | 5                         |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mandarins (including mandarin‐like hybrids) Subgroup of (including all commodities in this subgroup)                             | 4                                                                  | 10Po            | 5                         |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Orange oil                                                                                                                       | 4                                                                  | 2800            | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Oranges, sweet, sour (including orange‐like hybrids) subgroup of (including all commodities in this subgroup)                    | 4                                                                  | 15Po            | 9                         |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                                                                            | 4                                                                  | 0.7Po           | 5                         |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pineapple                                                                                                                        | 4                                                                  | 4Po             | 0.02\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Plums, subgroup of (includes all commodities in this subgroup)                                                                   | 4                                                                  | 0.5Po           | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pumelo and grapefruit (including Shaddock‐like hybrids) subgroup of (including all commodities in this subgroup)                 | 4                                                                  | 6Po             | 5                         |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Bifenthrin (178)**                                                                                                             | Okra                                                               | 7               | 0.2                       | For the proposed Codex MRLs for strawberries, celery and lettuce JMPR identified acute intake concerns; the proposals was retained at step 4 awaiting data from the manufacturer for an alternative GAP to be assessed by 2017 JMPR                                                                                                                                    | 0.2    | In 2012 the EU proposed to withdraw the MRL for strawberries, due to acute intake concerns identified by JMPR. For the remaining MRL proposals no EU reservation was made                                                                                             |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2017, CCPR decided to retain the draft MRL proposals for okra at step 7, awaiting information on authorised GAP to be submitted by India before 2019                                                                                                                                                                                                                |        | In the MRL review under Article 12 (Reg. (EU) 2017/170, the MRL derived for okra was identical with the proposed CXLs. For celery and lettuce the MRL is set at the LOQ in the EU                                                                                     |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | Bifenthrin is now scheduled for 2019 JMPR (BARLEY, BARLEY (STRAW FODDER) -- 4‐year rule granted in 2014/STRAWBERRY, LETTUCE HEAD, CELERY                                                                                                                                                                                                                               |        | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | (alternative GAP)/okra -- India)                                                                                                                                                                                                                                                                                                                                       |        | No discussion is expected in 2019, since the data are expected to be assessed by 2019 JMPR                                                                                                                                                                            |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | If data will not be submitted by 2019, a decision on withdrawal of the MRL proposal will be taken                                                                                                                                                                                                                                                                      |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Strawberry                                                                                                                       | 4                                                                  | 3/1             | 0.1                       |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Celery                                                                                                                           | 4                                                                  | 3               | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Lettuce head                                                                                                                     | 4                                                                  | 4               | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Fenpyroximate (193)**                                                                                                          | Apricot                                                            | 4               | 0.4                       | In 2018, the EU opposed the advancement of the proposed MRLs for cherries, peaches, plums subgroup, watermelons and tomatoes because of acute intake concerns identified by JMPR                                                                                                                                                                                       |        | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2018, CCPR agreed to keep the proposed draft MRLs for apricot; cherries (subgroup); cherry tomato; peach; plums (subgroup); watermelon; and tomato at step 4, awaiting evaluation of the additional toxicological data by the 2020 JMPR                                                                                                                             |        | No discussion expected for 2019 CCPR                                                                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherries, subgroup of (includes all commodities in this subgroup)                                                                | 4                                                                  | 2               |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                                                                                    | 4                                                                  | 0.3             |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peach                                                                                                                            | 4                                                                  | 0.8             |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Plums, subgroup of (including fresh prunes) (includes all commodities in this subgroup)                                          | 4                                                                  | 0.8             |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                                                                           | 4                                                                  | 0.8             |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Watermelon                                                                                                                       | 4                                                                  | 0.05            |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Cyprodinil**                                                                                                                   | Pomegranate                                                        | 4               | 10                        | In 2018, the EU proposed that the MRL should be derived using a different calculation method (using the mean residue + 4SD). CCPR agreed to keep the proposed draft MRL at step 4 awaiting JMPR re‐evaluation in 2018                                                                                                                                                  | 0.02\* | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
| **207**                                                                                                                          |                                                                    |                 |                           | In 2018, JMPR revised MRL proposals were derived by JMPR                                                                                                                                                                                                                                                                                                               |        | See comments in EFSA report 2019, Section [5.12](#efs25797-sec-0095){ref-type="sec"}                                                                                                                                                                                  |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Sulfoxaflor (252)**                                                                                                            | Tree nuts                                                          | 4               | 0.015                     | In 2015, CCPR decided to retain the MRL proposal at step 4 awaiting JMPR evaluation in 2016. (the proposed MRL at step 4 was not advanced since the GAP authorised in US differed from the GAP that was reported to JMPR)                                                                                                                                              | 0.02\* | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2016, JMPR reported that data on tree nuts have been provided, but since the label was submitted too late, no assessment was performed                                                                                                                                                                                                                              |        | See comments in EFSA report 2019, Section [5.17](#efs25797-sec-0125){ref-type="sec"}                                                                                                                                                                                  |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2016: no discussion                                                                                                                                                                                                                                                                                                                                               |        | If the new MRL proposal for tree nuts is advanced in 2019 CCPR, the previous proposal should be withdrawn                                                                                                                                                             |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2016, JMPR assessed sulfoxaflor for new uses. However, since no information on the authorised GAPs was provided, no new MRL proposal was derived                                                                                                                                                                                                                    |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | CCPR 2017: It was decided to assess tree nuts together with the new uses on other crops that were scheduled for the 2018 JMPR                                                                                                                                                                                                                                          |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2018, JMPR derived a MRL proposal of 0.03 mg/kg for tree nuts                                                                                                                                                                                                                                                                                                       |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Cyclaniliprole (296)**                                                                                                         | Cherries, subgroup of (includes all commodities in this subgroup)  | 4               | 0.9                       | In 2017, JMPR used a model to estimate MRLs for the crops listed since the submitted residue trials did not match with the GAP. The EU and other Codex Members noted that the model needed validation to ensure that the derived MRL proposals were appropriate.                                                                                                       | 0.01\* | [**Conclusion:**]{.ul}                                                                                                                                                                                                                                                |
|                                                                                                                                  |                                                                    |                 |                           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
|                                                                                                                                  |                                                                    |                 |                           | In 2018, CCPR agreed to keep all the proposed draft MRLs at step 4 pending the evaluation of new data and revised GAP information by the 2019 JMPR. CCPR also invited JMPR to engage with national regulators to continue validation of the model                                                                                                                      |        | No discussions are expected for 2019 CCPR                                                                                                                                                                                                                             |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cherry tomato                                                                                                                    | 4                                                                  | 0.1             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Edible offal (mammalian)                                                                                                         | 4                                                                  | 0.01 (\*)       | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Eggplants, subgroup of (includes all commodities in this subgroup)                                                               | 4                                                                  | 0.1             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Flowerhead brassicas, subgroup of (includes all commodities in this subgroup)                                                    | 4                                                                  | 1               | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, cucurbits‐ cucumbers and summer squashes, subgroup of (includes all commodities in this subgroup)           | 4                                                                  | 0.06            | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Fruiting vegetables, cucurbits -- melons, pumpkins and winter squashes (subgroup of) (includes all commodities in this subgroup) | 4                                                                  | 0.15            | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Grapes                                                                                                                           | 4                                                                  | 0.8             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Head brassicas, subgroup of (includes all commodities in this subgroup)                                                          | 4                                                                  | 0.7             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Leaves of Brassicaceae, subgroup of, (includes all commodities in this subgroup)                                                 | 4                                                                  | 15              | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Mammalian fats (except milk fats                                                                                                 | 4                                                                  | 0.01 (\*)       | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Meat (from mammals other than marine mammals)                                                                                    | 4                                                                  | 0.01 (\*) (fat) | 0.01\* (muscle)           |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milk fats                                                                                                                        | 4                                                                  | 0.01 (\*)       | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Milks                                                                                                                            | 4                                                                  | 0.01 (\*)       | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peaches, subgroup of (including apricots and nectarine) (includes all commodities in this subgroup)                              | 4                                                                  | 0.3             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers chili, dried                                                                                                             | 4                                                                  | 2               | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Peppers, subgroup of (includes all (except martynia, okra and roselle) commodities in this subgroup)                             | 4                                                                  | 0.2             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Plums, subgroup of (including fresh Prunes) (includes all commodities in this subgroup)                                          | 4                                                                  | 0.2             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Pome fruits, group of (includes all commodities in this group)                                                                   | 4                                                                  | 0.3             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Prunes, dried                                                                                                                    | 4                                                                  | 0.8             | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Straw and fodder (dry) of cereal grains                                                                                          | 4                                                                  | 0.45 (dw)       | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato                                                                                                                           | 4                                                                  | 0.1             | 0.01\*                    |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Tomato, dried                                                                                                                    | 4                                                                  | 0.4             | --                        |                                                                                                                                                                                                                                                                                                                                                                        |        |                                                                                                                                                                                                                                                                       |
+----------------------------------------------------------------------------------------------------------------------------------+--------------------------------------------------------------------+-----------------+---------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
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